
<html lang="en"     class="pb-page"  data-request-id="f8852d55-9c5a-43eb-834d-3cf39af4acb4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm801354e;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2009.52.issue-7"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Selective 5-Hydroxytryptamine 2C Receptor Agonists Derived from the Lead Compound Tranylcypromine: Identification of Drugs with Antidepressant-Like Action" /></meta><meta name="dc.Creator" content="Sung Jin  Cho" /></meta><meta name="dc.Creator" content="Niels H.  Jensen" /></meta><meta name="dc.Creator" content="Toru  Kurome" /></meta><meta name="dc.Creator" content="Sudhakar  Kadari" /></meta><meta name="dc.Creator" content="Michael L.  Manzano" /></meta><meta name="dc.Creator" content="Jessica E.  Malberg" /></meta><meta name="dc.Creator" content="Barbara  Caldarone" /></meta><meta name="dc.Creator" content="Bryan L.  Roth" /></meta><meta name="dc.Creator" content="Alan P.  Kozikowski" /></meta><meta name="dc.Description" content="We report here the design, synthesis, and pharmacological properties of a series of compounds related to tranylcypromine (9), which itself was discovered as a lead compound in a high-throughput scr..." /></meta><meta name="Description" content="We report here the design, synthesis, and pharmacological properties of a series of compounds related to tranylcypromine (9), which itself was discovered as a lead compound in a high-throughput scr..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 13, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm801354e" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm801354e" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm801354e" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm801354e" /></link>
        
    
    

<title>Selective 5-Hydroxytryptamine 2C Receptor Agonists Derived from the Lead Compound Tranylcypromine: Identification of Drugs with Antidepressant-Like Action | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm801354e" /></meta><meta property="og:title" content="Selective 5-Hydroxytryptamine 2C Receptor Agonists Derived from the Lead Compound Tranylcypromine: Identification of Drugs with Antidepressant-Like Action" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0001.jpeg" /></meta><meta property="og:description" content=" We report here the design, synthesis, and pharmacological properties of a series of compounds related to tranylcypromine (9), which itself was discovered as a lead compound in a high-throughput screening campaign. Starting from 9, which shows modest activity as a 5-HT2C agonist, a series of 1-aminomethyl-2-phenylcyclopropanes was investigated as 5-HT2C agonists through iterative structural modifications. Key pharmacophore feature of this new class of ligands is a 2-aminomethyl-trans-cyclopropyl side chain attached to a substituted benzene ring. Among the tested compounds, several were potent and efficacious 5-HT2C receptor agonists with selectivity over both 5-HT2A and 5-HT2B receptors in functional assays. The most promising compound is 37, with 120- and 14-fold selectivity over 5-HT2A and 5-HT2B, respectively (EC50 = 585, 65, and 4.8 nM at the 2A, 2B, and 2C subtypes, respectively). In animal studies, compound 37 (10−60 mg/kg) decreased immobility time in the mouse forced swim test." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm801354e"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm801354e">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm801354e&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm801354e&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm801354e&amp;href=/doi/10.1021/jm801354e" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 1885-1902</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm801335z" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm801344j" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Selective 5-Hydroxytryptamine 2C Receptor Agonists Derived from the Lead Compound Tranylcypromine: Identification of Drugs with Antidepressant-Like Action</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sung+Jin++Cho">Sung Jin Cho</a></span><span class="author-xref-symbol "><sup>†</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Niels+H.++Jensen">Niels H. Jensen</a></span><span class="author-xref-symbol "><sup>‡</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Toru++Kurome">Toru Kurome</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sudhakar++Kadari">Sudhakar Kadari</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+L.++Manzano">Michael L. Manzano</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jessica+E.++Malberg">Jessica E. Malberg</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Caldarone">Barbara Caldarone</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryan+L.++Roth">Bryan L. Roth</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+P.++Kozikowski">Alan P. Kozikowski</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy (M/C781), University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612-7230, Department of Pharmacology, Psychiatry, Comprehensive Cancer Center, Center for Neurobiology Division of Medicinal Chemistry and Natural Products, and NIMH Psychoactive Drug Screening Program, University of North Carolina Medical School, Chapel Hill, CB 7365, North Carolina 27599, Psychogenics, Inc., Tarrytown, New York 10591</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. For B.L.R.: phone, 919-966-7535; fax, 919-843-5788; E-mail: <a href="/cdn-cgi/l/email-protection#fc9e8e859d92a38e938894bc919998d289929fd2999889"><span class="__cf_email__" data-cfemail="791b0b001817260b160d1139141c1d570c171a571c1d0c">[email protected]</span></a>. For A.P.K.: phone, 312-996-7577; fax, 312-996-7107; E-mail, <a href="/cdn-cgi/l/email-protection#9af1f5e0f3f1f5edfbdaeff3f9b4fffeef"><span class="__cf_email__" data-cfemail="046f6b7e6d6f6b736544716d672a616071">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†University of Illinois at Chicago.</div><div class="corresp-fn" id="afn2">‡University of North Carolina at Chapel Hill.</div><div class="corresp-fn" id="afn3">§These authors contributed equally to this work.</div><div class="corresp-fn" id="afn4">∥Psychogenics, Inc.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm801354e&amp;href=/doi/10.1021%2Fjm801354e" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 1885–1902</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 13, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 October 2008</li><li><span class="item_label"><b>Published</b> online</span>13 March 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 April 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm801354e" title="DOI URL">https://doi.org/10.1021/jm801354e</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1885%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSung%2BJin%2BCho%252C%2BNiels%2BH.%2BJensen%252C%2BToru%2BKurome%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D7%26contentID%3Djm801354e%26title%3DSelective%2B5-Hydroxytryptamine%2B2C%2BReceptor%2BAgonists%2BDerived%2Bfrom%2Bthe%2BLead%2BCompound%2BTranylcypromine%253A%2BIdentification%2Bof%2BDrugs%2Bwith%2BAntidepressant-Like%2BAction%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1902%26publicationDate%3DApril%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm801354e"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">6380</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">43</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm801354e" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Selective 5-Hydroxytryptamine 2C Receptor Agonists Derived from the Lead Compound Tranylcypromine: Identification of Drugs with Antidepressant-Like Action&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Sung&quot;,&quot;last_name&quot;:&quot;Jin Cho&quot;},{&quot;first_name&quot;:&quot;Niels&quot;,&quot;last_name&quot;:&quot;H. Jensen&quot;},{&quot;first_name&quot;:&quot;Toru&quot;,&quot;last_name&quot;:&quot;Kurome&quot;},{&quot;first_name&quot;:&quot;Sudhakar&quot;,&quot;last_name&quot;:&quot;Kadari&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;L. Manzano&quot;},{&quot;first_name&quot;:&quot;Jessica&quot;,&quot;last_name&quot;:&quot;E. Malberg&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Caldarone&quot;},{&quot;first_name&quot;:&quot;Bryan&quot;,&quot;last_name&quot;:&quot;L. Roth&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;P. Kozikowski&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;1885-1902&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm801354e&quot;},&quot;abstract&quot;:&quot;We report here the design, synthesis, and pharmacological properties of a series of compounds related to tranylcypromine (9), which itself was discovered as a lead compound in a high-throughput screening campaign. Starting from 9, which shows modest activity as a 5-HT2C agonist, a series of 1-aminomethyl-2-phenylcyclopropanes was investigated as 5-HT2C agonists through iterative structural modifications. Key pharmacophore feature of this new class of ligands is a 2-aminomethyl-trans-cyclopropyl side chain attached to a substituted benzene ring. Among the tested compounds, several were potent and efficacious 5-HT2C receptor agonists with selectivity over both 5-HT2A and 5-HT2B receptors in functional assays. The most promising compound is 37, with 120- and 14-fold selectivity over 5-HT2A and 5-HT2B, respectively (EC50 = 585, 65, and 4.8 nM at the 2A, 2B, and 2C subtypes, respectively). In animal studies, compound 37 (10−60 mg/kg) decreased immobility time in the mouse forced swim test.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm801354e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801354e" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm801354e&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801354e" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm801354e&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801354e" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm801354e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801354e&amp;href=/doi/10.1021/jm801354e" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm801354e" /></input><a href="/doi/pdf/10.1021/jm801354e" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (540 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm801354e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm801354e%26sid%3Dliteratum%253Aachs%26pmid%3D19284718%26genre%3Darticle%26aulast%3DCho%26date%3D2009%26atitle%3DSelective%2B5-Hydroxytryptamine%2B2C%2BReceptor%2BAgonists%2BDerived%2Bfrom%2Bthe%2BLead%2BCompound%2BTranylcypromine%253A%2BIdentification%2Bof%2BDrugs%2Bwith%2BAntidepressant-Like%2BAction%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D7%26spage%3D1885%26epage%3D1902%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We report here the design, synthesis, and pharmacological properties of a series of compounds related to tranylcypromine (<b>9</b>), which itself was discovered as a lead compound in a high-throughput screening campaign. Starting from <b>9</b>, which shows modest activity as a 5-HT<sub>2C</sub> agonist, a series of 1-aminomethyl-2-phenylcyclopropanes was investigated as 5-HT<sub>2C</sub> agonists through iterative structural modifications. Key pharmacophore feature of this new class of ligands is a 2-aminomethyl-<i>trans</i>-cyclopropyl side chain attached to a substituted benzene ring. Among the tested compounds, several were potent and efficacious 5-HT<sub>2C</sub> receptor agonists with selectivity over both 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub> receptors in functional assays. The most promising compound is <b>37</b>, with 120- and 14-fold selectivity over 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub>, respectively (EC<sub>50</sub> = 585, 65, and 4.8 nM at the 2A, 2B, and 2C subtypes, respectively). In animal studies, compound <b>37</b> (10−60 mg/kg) decreased immobility time in the mouse forced swim test.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31554" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31554" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Serotonin (5-HT<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: 5-HT, 5-hydroxytryptamine (serotonin); LSD, lysergic acid diethylamide; CNS, central nervous system; MAO, monoamine oxidase; SAR, structure−activity relationship; SERT, 5-HT transporter; NET, norepinephrine transporter; DAT, dopamine transporter.</p></div> ) (<b>1</b>) mediates or regulates a wide variety of behaviors including cognition, emotion, attention, and appetite among others.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> The diverse effects of this neurotransmitter are related to the extensive projections of serotonergic neurons throughout the brain and to the presence of at least 14 different receptor subtypes in humans.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a> The 5-HT<sub>2</sub> subtype family includes the 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, and 5-HT<sub>2C</sub> receptors. The 5-HT<sub>2A</sub> receptor mediates the hallucinogenic activity of drugs such as lysergic acid diethylamide (LSD) and is a major target for treating schizophrenia as well as insomnia.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The 5-HT<sub>2B</sub> receptor mediates the potentially lethal valvulopathic side effects of several compounds that were used as prescription drugs.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> Two decades after its initial identification, the 5-HT<sub>2C</sub> receptor has only recently emerged as a promising target in the treatment of depression, anxiety, eating disorders, obsessive−compulsive disorder, chronic pain conditions, obesity, epilepsy, and erectile dysfunction.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19">(10-19)</a> The 5-HT<sub>2C</sub> receptor is abundantly expressed throughout the central nervous system (CNS) and displays high-affinity interactions with a wide variety of psychiatric medications.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23">(20-23)</a> Due to the serious side effects caused by the activation of the pharmacologically and structurally closely related subtypes,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> it is essential that 5-HT<sub>2C</sub> agonists developed for clinical use have a high specificity and subtype selectivity. To date, a number of designed synthetic compounds have been identified that show 5-HT<sub>2C</sub> receptor agonistic activity (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref18 ref25 ref26 ref27 ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref18 ref25 ref26 ref27 ref28 ref29 ref30 ref31">(18, 25-31)</a> Several compounds have shown efficacy in preclinical animal models and are currently being tested in clinical trials.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. The classical 5-HT<sub>2C</sub> receptor agonist <i>m</i>-CPP and several more recently developed 5-HT<sub>2C</sub> ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite recent progress in obtaining crystal structures of G protein-coupled receptors,<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33-35)</a> information about the structure and function of 5-HT receptors is still restricted to homology modeling using rhodopsin or β-adrenergic receptors as a starting template. However, it is well-known that there are inherent limitations in the use of such homology models for drug design purposes<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and they still lack sufficient predictive power for drug discovery.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Therefore, we based our search for selective 5-HT<sub>2C</sub> receptor agonists on high-throughput chemical library screening to identify a suitable lead structure followed by stepwise activity-guided chemical modification. Using this approach, we have identified the reversible monoamine oxidase (MAO) inhibitor tranylcypromine <b>9</b><a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> as a lead compound from screening the Prestwick Drug Library of 800 compounds (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of <b>9</b> and its analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In initial experiments, we then examined the effects of side chain homologation, stereochemistry, and amine substitution in 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, and 5-HT<sub>2C</sub> functional calcium flux assays (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The <i>trans</i>-2-phenylcyclopropylmethylamine hydrochloride <b>14a</b> turned out to be a potent (EC<sub>50</sub> = 13 nM), moderately selective, and fully efficacious (<i>E</i><sub>max</sub> = 96%) agonist at the 5-HT<sub>2C</sub> receptor. Thus, this core structure was selected for substitution screening in all of the subsequent SAR studies. Several ring-unsubstituted <i>N</i>-alkyl derivatives of <i>trans</i>-aminomethyl-2-phenylcyclopropane (<b>14a</b>) have previously been found to have sympathomimetic activity in animal tests, but these effects were probably mediated by a 5-HT<sub>2C</sub> independent mechanism.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a></div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2"> Chemistry</h3><div class="NLM_p">Both the <i>trans</i>- and <i>cis</i>-(2-phenylcyclopropyl)methylamine hydrochlorides were prepared as structurally more flexible analogues of the lead compound <b>9</b> starting from styrene <b>10</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Cyclopropanation was carried out using ethyl diazoacetate in the presence of Cu(acac)<sub>2</sub> as a catalyst.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The ester product was obtained as a 2:1 racemic mixture of the <i>trans</i> and <i>cis</i> isomers. After separation of the configurational isomers on silica gel, the resulting ester isomers <i>trans</i>-<b>11a</b> and <i>cis</i>-<b>11b</b> were converted to the corresponding amine hydrochlorides <b>14a</b> and <b>14b</b>, respectively, employing a standard sequence of reactions involving amide formation, followed by borane reduction.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0004.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) N<sub>2</sub>CHCO<sub>2</sub>Et, Cu(acac)<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, reflux, 5 h. (b) 2 N KOH, MeOH. (c) (i) SOCl<sub>2</sub>, toluene, 80 °C, 3 h; (ii) NH<sub>3</sub> (liquid), toluene/CH<sub>2</sub>Cl<sub>2</sub>. (d) (i) BH<sub>3</sub>/THF, reflux, 20 h; (ii) 1 M HCl, 0 °C.</p></p></figure><div class="NLM_p"><i>N</i>-Monomethylation of the amino group in compound <b>9</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, <i>n</i> = 0) and of the elongated cyclopropylmethylamine derivative (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, <i>n</i> = 1) was carried out by reduction of the corresponding <i>N</i>-formyl derivatives. Formylation of the amine with acetic formic anhydride followed by in situ borane−dimethyl sulfide reduction afforded the corresponding <i>N</i>-methylamines.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The products <b>15</b> and <b>16</b> obtained in this way were free of any contamination by the dialkylation product. The <i>N,N</i>-dimethylamine derivative <b>17</b> of compound <b>9</b> was prepared by reductive <i>N</i>-alkylation using an excess of 37% aqueous formaldehyde and NaBH<sub>3</sub>CN according to a literature procedure.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> The monoisopropyl and monobenzylamine analogues <b>18</b>−<b>20</b> were prepared by similar reductive <i>N</i>-alkylation protocols<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0005.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) acetic formic anhydride, BH<sub>3</sub>·SMe<sub>2</sub>/THF. (b) HCHO (excess), NaBH<sub>3</sub>CN, acetonitrile/H<sub>2</sub>O. (c) acetone or benzaldehyde, NaBH<sub>3</sub>CN, MeOH.</p></p></figure><div class="NLM_p">Next, we explored the activity of derivatives bearing various substituents on the aromatic ring or having the aromatic ring replaced by the larger naphthyl ring or by a biphenyl structure (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The substituted phenyl and naphthyl derivatives <b>26</b>−<b>61</b> were synthesized from the corresponding styrenes <b>22</b>, followed by application of the same chemistry used in the preparation of <b>14a</b> and <b>14b</b>. Some of styrenes were prepared from the corresponding aldehydes <b>21</b> by Wittig chemistry (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Aromatic substitution screening of <i>trans</i>-(2-phenylcyclopropyl)methylamine hydrochloride analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0007.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyltriphenylphosphonium bromide, NaH, THF, 20 h. (b) N<sub>2</sub>CHCO<sub>2</sub>Et, Cu(acac)<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, reflux, 5 h. (c) 2 N KOH, MeOH. (d) (i) SOCl<sub>2</sub>, toluene, 80 °C, 3 h; (ii) NH<sub>3</sub> (liquid), toluene/CH<sub>2</sub>Cl<sub>2</sub>. (e) (i) BH<sub>3</sub>/THF, reflux, 20 h; (ii) 1 M HCl, 0 °C; (f) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C.</p></p></figure><div class="NLM_p">The <i>N</i>-Boc protected aminomethylcyclopropane derivatives <b>62</b>−<b>64</b> were very useful intermediates for the preparation of other analogues. The bromophenyl derivatives <b>29</b>, <b>36</b>, or <b>43</b> were thus used as convenient starting materials to generate a limited number of biphenyl and heteroarylphenyl derivatives <b>66</b>−<b>74</b> by means of the Suzuki coupling reaction.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Some of amide and amine substituted phenyl derivatives <b>78</b> and <b>80</b>−<b>84</b> were prepared through Pd catalyzed conversion of the bromo group to an amine. These amines were reacted in turn with acid chlorides or aryl- and alkylisocyanates to afford the corresponding amides and urethanes. An alkynyl group was also successfully introduced as a side chain appendage into the arylcyclopropane by the Sonogashira coupling reaction (<b>86</b>−<b>90</b>)<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0008.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Boc<sub>2</sub>O, triethylamine, CH<sub>2</sub>Cl<sub>2</sub>. (b) Ar−B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, 80 °C, 20 h. (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt. (d) (i) benzophenone imine, Pd(OAc)<sub>2</sub>, BINAP, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 80 °C; (ii) NaOAc, NH<sub>2</sub>OH·HCl, MeOH, rt, 2 h. (e) RCHO, NaBH<sub>3</sub>CN, MeOH. (f) various anhydrides, DMAP, CH<sub>2</sub>Cl<sub>2</sub>. (g) R′C≡CH, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, PPh<sub>3</sub>, CuI, triethylamine, reflux. (h) 2 M HCl, rt.</p></p></figure><div class="NLM_p">To prepare the pure enantiomers of <b>14a</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>), we first converted the intermediate carboxylic acid formed in the cyclopropanation step into its diastereomeric amides. This was brought about by coupling the racemic carboxylic acid <b>12a</b> with (<i>R</i>)-phenylglycinol.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The resulting diastereomeric pair was then separated by silica gel column chromatography. The choice of (<i>R</i>)-phenylglycinol as the alcohol component was based on its successful use in the resolution of other racemic carboxylic acids and the ease of cleavage of the resulting diastereomers under acidic conditions that involves an <i>N</i>,<i>O</i>-acyl transfer. The carboxylic acids (+)-<b>12a</b> and (−)-<b>12a</b>, whose optical rotations were compared with the known compounds in the literature,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> were then converted individually to (+)- and (−)-<i>trans</i>-(2-phenylcyclopropyl)methylamine hydrochloride ((+)-<b>14a</b> and (−)-<b>14a</b>) using the same method as described above.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0009.jpeg" id="gs5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (<i>R</i>)-phenylglycinol, EDCI, HOBT, CH<sub>2</sub>Cl<sub>2</sub>. (b) H<sub>2</sub>SO<sub>4</sub>, 100 °C.</p></p></figure></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Biological Results and Discussion</h3><div id="sec1_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i4" class="anchor-spacer"></div><h4 class="article-section__title" id="_i4"> In Vitro SAR Studies</h4><div class="NLM_p">The functional activity of the compounds was determined by measuring G<sub>q</sub> mediated transient intracellular calcium mobilization in HEK-293 cells stably expressing the human 5-HT<sub>2A</sub>, human 5-HT<sub>2B</sub>, and human 5-HT<sub>2C (INI)</sub> receptors.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The results are summarized in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Throughout the course of the project, different batches of cell lines or passages were used. In contrast to binding affinities, the potencies in functional assays can vary strongly depending on cell type, receptor expression level, and passage number. Direct comparisons of the potencies and efficacies are only valid within the bounds of each particular table section. In overexpressing cell lines such as those utilized in the current screening, it is common to observe EC<sub>50</sub> potency concentrations much lower than the <i>K</i><sub>i</sub> binding constant, particularly when antagonist radioligands are used for competition binding studies.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Functional Activity and Selectivity of the Lead Compound <b>9</b> and its Initial Analogues <b>14</b>−<b>20</b> and <b>26</b> at Human 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, and 5-HT<sub>2C</sub> Receptors in Calcium Flux Assays Using Stably Transfected HEK-293 Cells</div></div></div><div class="scrollable-table-wrap"><table class="table single-image frame_top"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0010.gif" alt="" id="gr10" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Tested in independent screening campaigns using different cell lines/passages.</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">Percent of maximal activation by 5-HT; activation at 10 μM for compounds without EC<sub>50</sub> value.</p></div><div class="footnote" id="tbl1-fn3"><sup>c</sup><p class="last"><i>n</i>: Number of concentration curves from ≥2 (typically ≥3) independent experiments. NA: <i>E</i><sub>max</sub> ≤ 12%.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Functional Activity of Compounds <b>27</b>−<b>61</b> in Calcium Flux Assays Using HEK-293 Cells Stably Expressing the Human 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, or 5-HT<sub>2C</sub> Receptor</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0011.gif" alt="" id="gr11" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="5" align="center" valign="middle">5-HT<sub><b>2A</b></sub></th><th colspan="5" align="center" valign="middle">5-HT<sub>2B</sub></th><th colspan="5" align="center" valign="middle">5-HT<sub>2C</sub></th><th colspan="2" align="center" valign="middle">selectivity</th></tr><tr valign="top"><th align="center" valign="middle">compd<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></th><th align="center" valign="middle">R<sup>2</sup></th><th align="center" valign="middle">R<sup>3</sup></th><th align="center" valign="middle">R<sup>4</sup></th><th align="center" valign="middle">R<sup>6</sup></th><th colspan="2" align="center" valign="middle">EC<sub>50</sub> ± SEM (nM)</th><th colspan="2" align="center" valign="middle" char="."><i>E</i><sub>max</sub> ± SEM<a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a></th><th align="center" valign="middle" char="."><i>n</i><a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></th><th colspan="2" align="center" valign="middle">EC<sub>50</sub> ± SEM (nM)</th><th colspan="2" align="center" valign="middle" char="."><i>E</i><sub>max</sub> ± SEM<a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a></th><th align="center" valign="middle" char="."><i>n</i><a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></th><th colspan="2" align="center" valign="middle">EC<sub>50</sub> ± SEM (nM)</th><th colspan="2" align="center" valign="middle" char="."><i>E</i><sub>max</sub> ± SEM<a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a></th><th align="center" valign="middle" char="."><i>n</i><a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></th><th align="center" valign="middle">2A/2C</th><th align="center" valign="middle" char=".">2B/2C</th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b></td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">17</td><td align="left">±7.1</td><td align="char" char=".">100%</td><td align="left"> </td><td align="char" char=".">14</td><td align="left">3.0</td><td align="left">±1.5</td><td align="char" char=".">100%</td><td align="left"> </td><td align="char" char=".">12</td><td align="left">0.12</td><td align="left">±0.08</td><td align="char" char=".">100%</td><td align="left"> </td><td align="char" char=".">17</td><td align="left">134</td><td align="char" char=".">24</td></tr><tr valign="top"><td align="left"><b>27</b></td><td align="left">F</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">>1000</td><td align="left"> </td><td align="char" char=".">52%</td><td align="left">±10%</td><td align="char" char=".">3</td><td align="left">1549</td><td align="left">±821</td><td align="char" char=".">65%</td><td align="left">±16%</td><td align="char" char=".">4</td><td align="left">37</td><td align="left">±19</td><td align="char" char=".">94%</td><td align="left">±5%</td><td align="char" char=".">4</td><td align="left">>27</td><td align="char" char=".">42</td></tr><tr valign="top"><td align="left"><b>28</b></td><td align="left">Cl</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">403</td><td align="left">±53</td><td align="char" char=".">54%</td><td align="left">±33%</td><td align="char" char=".">3</td><td align="left">84</td><td align="left">±13</td><td align="char" char=".">82%</td><td align="left">±4%</td><td align="char" char=".">3</td><td align="left">5.1</td><td align="left">±4.2</td><td align="char" char=".">98%</td><td align="left">±14%</td><td align="char" char=".">3</td><td align="left">79</td><td align="char" char=".">16</td></tr><tr valign="top"><td align="left"><b>29</b></td><td align="left">Br</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">585</td><td align="left">±178</td><td align="char" char=".">73%</td><td align="left">±13%</td><td align="char" char=".">3</td><td align="left">154</td><td align="left">±131</td><td align="char" char=".">86%</td><td align="left">±19%</td><td align="char" char=".">4</td><td align="left">2.8</td><td align="left">±2.2</td><td align="char" char=".">93%</td><td align="left">±8%</td><td align="char" char=".">3</td><td align="left">206</td><td align="char" char=".">54</td></tr><tr valign="top"><td align="left"><b>31</b></td><td align="left">CF<sub>3</sub></td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">NA</td><td align="left"> </td><td align="char" char="."> </td><td align="left"> </td><td align="char" char=".">2</td><td align="left">350</td><td align="left">±7.1</td><td align="char" char=".">102%</td><td align="left">±27%</td><td align="char" char=".">2</td><td align="left">49</td><td align="left">±11</td><td align="char" char=".">101%</td><td align="left">±8%</td><td align="char" char=".">2</td><td align="left"> </td><td align="char" char=".">7.2</td></tr><tr valign="top"><td align="left"><b>34</b></td><td align="left"> </td><td align="left">F</td><td align="left"> </td><td align="left"> </td><td align="left">1769</td><td align="left">±2110</td><td align="char" char=".">71%</td><td align="left">±7%</td><td align="char" char=".">2</td><td align="left">51</td><td align="left">±16</td><td align="char" char=".">106%</td><td align="left">±9%</td><td align="char" char=".">3</td><td align="left">3.9</td><td align="left">±3.9</td><td align="char" char=".">92%</td><td align="left">±6%</td><td align="char" char=".">3</td><td align="left">450</td><td align="char" char=".">13</td></tr><tr valign="top"><td align="left"><b>35</b></td><td align="left"> </td><td align="left">Cl</td><td align="left"> </td><td align="left"> </td><td align="left">1886</td><td align="left">±540</td><td align="char" char=".">42%</td><td align="left">±9%</td><td align="char" char=".">2</td><td align="left">59</td><td align="left">±3.8</td><td align="char" char=".">78%</td><td align="left">±7%</td><td align="char" char=".">2</td><td align="left">10.0</td><td align="left">±0.20</td><td align="char" char=".">98%</td><td align="left">±4%</td><td align="char" char=".">2</td><td align="left">189</td><td align="char" char=".">5.9</td></tr><tr valign="top"><td align="left"><b>36</b></td><td align="left"> </td><td align="left">Br</td><td align="left"> </td><td align="left"> </td><td align="left">1680</td><td align="left">±1368</td><td align="char" char=".">55%</td><td align="left">±13%</td><td align="char" char=".">4</td><td align="left">141</td><td align="left">±143</td><td align="char" char=".">74%</td><td align="left">±14%</td><td align="char" char=".">5</td><td align="left">14</td><td align="left">±11</td><td align="char" char=".">90%</td><td align="left">±10%</td><td align="char" char=".">5</td><td align="left">123</td><td align="char" char=".">10</td></tr><tr valign="top"><td align="left"><b>38</b></td><td align="left"> </td><td align="left">CF<sub>3</sub></td><td align="left"> </td><td align="left"> </td><td align="left">1485</td><td align="left">±195</td><td align="char" char=".">35%</td><td align="left">±1%</td><td align="char" char=".">2</td><td align="left">77</td><td align="left">±16</td><td align="char" char=".">78%</td><td align="left">±16%</td><td align="char" char=".">2</td><td align="left">30</td><td align="left">±8.8</td><td align="char" char=".">94%</td><td align="left">±4%</td><td align="char" char=".">2</td><td align="left">50</td><td align="char" char=".">2.6</td></tr><tr valign="top"><td align="left"><b>41</b></td><td align="left"> </td><td align="left"> </td><td align="left">F</td><td align="left"> </td><td align="left">1098</td><td align="left">±971</td><td align="char" char=".">67%</td><td align="left">±5%</td><td align="char" char=".">4</td><td align="left">312</td><td align="left">±150</td><td align="char" char=".">95%</td><td align="left">±6%</td><td align="char" char=".">3</td><td align="left">5.4</td><td align="left">±2.1</td><td align="char" char=".">93%</td><td align="left">±4%</td><td align="char" char=".">2</td><td align="left">202</td><td align="char" char=".">57</td></tr><tr valign="top"><td align="left"><b>42</b></td><td align="left"> </td><td align="left"> </td><td align="left">Cl</td><td align="left"> </td><td align="left">4482</td><td align="left">±2026</td><td align="char" char=".">64%</td><td align="left">±15%</td><td align="char" char=".">2</td><td align="left">404</td><td align="left">±28</td><td align="char" char=".">80%</td><td align="left">±11%</td><td align="char" char=".">2</td><td align="left">76</td><td align="left">±22</td><td align="char" char=".">106%</td><td align="left">±21%</td><td align="char" char=".">2</td><td align="left">59</td><td align="char" char=".">5.3</td></tr><tr valign="top"><td align="left"><b>43</b></td><td align="left"> </td><td align="left"> </td><td align="left">Br</td><td align="left"> </td><td align="left">>1000</td><td align="left"> </td><td align="char" char=".">26%</td><td align="left">±5%</td><td align="char" char=".">2</td><td align="left">2737</td><td align="left">±1540</td><td align="char" char=".">51%</td><td align="left">±16%</td><td align="char" char=".">3</td><td align="left">138</td><td align="left">±82</td><td align="char" char=".">87%</td><td align="left">±4%</td><td align="char" char=".">5</td><td align="left">>7</td><td align="char" char=".">20</td></tr><tr valign="top"><td align="left"><b>45</b></td><td align="left"> </td><td align="left"> </td><td align="left">CF<sub>3</sub></td><td align="left"> </td><td align="left">NA</td><td align="left"> </td><td align="char" char="."> </td><td align="left"> </td><td align="char" char=".">3</td><td align="left">>1000</td><td align="left"> </td><td align="char" char=".">56%</td><td align="left">±10%</td><td align="char" char=".">3</td><td align="left">779</td><td align="left">±286</td><td align="char" char=".">91%</td><td align="left">±4%</td><td align="char" char=".">3</td><td align="left"> </td><td align="char" char=".">>1</td></tr><tr valign="top"><td align="left"><b>46</b></td><td align="left"> </td><td align="left"> </td><td align="left">OMe</td><td align="left"> </td><td align="left">NA</td><td align="left"> </td><td align="char" char="."> </td><td align="left"> </td><td align="char" char=".">2</td><td align="left">NA</td><td align="left"> </td><td align="char" char="."> </td><td align="left"> </td><td align="char" char=".">2</td><td align="left">902</td><td align="left">±442</td><td align="char" char=".">86%</td><td align="left">±6%</td><td align="char" char=".">2</td><td align="left"> </td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>47</b></td><td align="left"> </td><td align="left"> </td><td align="left">OH</td><td align="left"> </td><td align="left">NA</td><td align="left"> </td><td align="char" char="."> </td><td align="left"> </td><td align="char" char=".">2</td><td align="left">NA</td><td align="left"> </td><td align="char" char="."> </td><td align="left"> </td><td align="char" char=".">2</td><td align="left">NA</td><td align="left"> </td><td align="char" char="."> </td><td align="left"> </td><td align="char" char=".">2</td><td align="left"> </td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>50</b></td><td align="left">F</td><td align="left"> </td><td align="left"> </td><td align="left">F</td><td align="left">>1000</td><td align="left"> </td><td align="char" char=".">38%</td><td align="left">±22%</td><td align="char" char=".">4</td><td align="left">3342</td><td align="left">±2622</td><td align="char" char=".">58%</td><td align="left">±9%</td><td align="char" char=".">5</td><td align="left">87</td><td align="left">±76</td><td align="char" char=".">85%</td><td align="left">±14%</td><td align="char" char=".">5</td><td align="left">>11</td><td align="char" char=".">39</td></tr><tr valign="top"><td align="left"><b>1</b></td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">10</td><td align="left">±1.7</td><td align="char" char=".">100%</td><td align="left"> </td><td align="char" char=".">15</td><td align="left">1.0</td><td align="left">±0.10</td><td align="char" char=".">100%</td><td align="left"> </td><td align="char" char=".">15</td><td align="left">0.09</td><td align="left">±0.01</td><td align="char" char=".">100%</td><td align="left"> </td><td align="char" char=".">11</td><td align="left">111</td><td align="char" char=".">11</td></tr><tr valign="top"><td align="left"><b>14a</b></td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">1399</td><td align="left">±169</td><td align="char" char=".">74%</td><td align="left">±8%</td><td align="char" char=".">2</td><td align="left">85</td><td align="left">±10</td><td align="char" char=".">93%</td><td align="left">±0.7%</td><td align="char" char=".">3</td><td align="left">13</td><td align="left">±4.6</td><td align="char" char=".">96%</td><td align="left">±3%</td><td align="char" char=".">3</td><td align="left">106</td><td align="char" char=".">6</td></tr><tr valign="top"><td align="left"><b>27</b></td><td align="left">F</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">942</td><td align="left">±30</td><td align="char" char=".">79%</td><td align="left">±8%</td><td align="char" char=".">2</td><td align="left">199</td><td align="left">±34</td><td align="char" char=".">89%</td><td align="left">±3%</td><td align="char" char=".">3</td><td align="left">29</td><td align="left">±6.4</td><td align="char" char=".">91%</td><td align="left">±0.6%</td><td align="char" char=".">3</td><td align="left">32</td><td align="char" char=".">6.8</td></tr><tr valign="top"><td align="left"><b>28</b></td><td align="left">Cl</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">168</td><td align="left">±21</td><td align="char" char=".">87%</td><td align="left">±8%</td><td align="char" char=".">2</td><td align="left">32</td><td align="left">±3.8</td><td align="char" char=".">95%</td><td align="left">±3%</td><td align="char" char=".">3</td><td align="left">5.5</td><td align="left">±2.0</td><td align="char" char=".">94%</td><td align="left">±4%</td><td align="char" char=".">3</td><td align="left">31</td><td align="char" char=".">5.8</td></tr><tr valign="top"><td align="left"><b>30</b></td><td align="left">Me</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">1606</td><td align="left">±940</td><td align="char" char=".">69%</td><td align="left">±4%</td><td align="char" char=".">2</td><td align="left">53</td><td align="left">±19</td><td align="char" char=".">86%</td><td align="left">±2%</td><td align="char" char=".">2</td><td align="left">23</td><td align="left">±8.3</td><td align="char" char=".">99%</td><td align="left">±6%</td><td align="char" char=".">2</td><td align="left">71</td><td align="char" char=".">2.3</td></tr><tr valign="top"><td align="left"><b>32</b></td><td align="left">OMe</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">2166</td><td align="left">±773</td><td align="char" char=".">61%</td><td align="left">±7%</td><td align="char" char=".">4</td><td align="left">199</td><td align="left">±26</td><td align="char" char=".">83%</td><td align="left">±6%</td><td align="char" char=".">4</td><td align="left">26</td><td align="left">±7.0</td><td align="char" char=".">93%</td><td align="left">±2%</td><td align="char" char=".">4</td><td align="left">84</td><td align="char" char=".">7.7</td></tr><tr valign="top"><td align="left"><b>33</b></td><td align="left">OH</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">513</td><td align="left">±177</td><td align="char" char=".">81%</td><td align="left">±8%</td><td align="char" char=".">3</td><td align="left">492</td><td align="left">±28</td><td align="char" char=".">74%</td><td align="left">±8%</td><td align="char" char=".">3</td><td align="left">161</td><td align="left">±62</td><td align="char" char=".">94%</td><td align="left">±5%</td><td align="char" char=".">3</td><td align="left">3.2</td><td align="char" char=".">3.1</td></tr><tr valign="top"><td align="left"><b>34</b></td><td align="left"> </td><td align="left">F</td><td align="left"> </td><td align="left"> </td><td align="left">733</td><td align="left">±59</td><td align="char" char=".">86%</td><td align="left">±3%</td><td align="char" char=".">2</td><td align="left">13</td><td align="left">±2.5</td><td align="char" char=".">96%</td><td align="left">±3%</td><td align="char" char=".">3</td><td align="left">3.3</td><td align="left">±1.0</td><td align="char" char=".">97%</td><td align="left">±3%</td><td align="char" char=".">3</td><td align="left">225</td><td align="char" char=".">4.0</td></tr><tr valign="top"><td align="left"><b>37</b></td><td align="left"> </td><td align="left">Me</td><td align="left"> </td><td align="left"> </td><td align="left">585</td><td align="left">±148</td><td align="char" char=".">86%</td><td align="left">±4%</td><td align="char" char=".">4</td><td align="left">65</td><td align="left">±15</td><td align="char" char=".">93%</td><td align="left">±2%</td><td align="char" char=".">5</td><td align="left">4.8</td><td align="left">±1.3</td><td align="char" char=".">95%</td><td align="left">±2%</td><td align="char" char=".">4</td><td align="left">123</td><td align="char" char=".">14</td></tr><tr valign="top"><td align="left"><b>39</b></td><td align="left"> </td><td align="left">OMe</td><td align="left"> </td><td align="left"> </td><td align="left">613</td><td align="left">±157</td><td align="char" char=".">90%</td><td align="left">±3%</td><td align="char" char=".">4</td><td align="left">75</td><td align="left">±13</td><td align="char" char=".">96%</td><td align="left">±4%</td><td align="char" char=".">4</td><td align="left">16</td><td align="left">±5.9</td><td align="char" char=".">97%</td><td align="left">±2%</td><td align="char" char=".">4</td><td align="left">39</td><td align="char" char=".">4.8</td></tr><tr valign="top"><td align="left"><b>40</b></td><td align="left"> </td><td align="left">OH</td><td align="left"> </td><td align="left"> </td><td align="left">247</td><td align="left">±138</td><td align="char" char=".">92%</td><td align="left">±3%</td><td align="char" char=".">3</td><td align="left">5.5</td><td align="left">±1.3</td><td align="char" char=".">98%</td><td align="left">±1%</td><td align="char" char=".">3</td><td align="left">3.3</td><td align="left">±1.6</td><td align="char" char=".">94%</td><td align="left">±0.7%</td><td align="char" char=".">3</td><td align="left">75</td><td align="char" char=".">1.7</td></tr><tr valign="top"><td align="left"><b>41</b></td><td align="left"> </td><td align="left"> </td><td align="left">F</td><td align="left"> </td><td align="left">646</td><td align="left">±34</td><td align="char" char=".">80%</td><td align="left">±2%</td><td align="char" char=".">2</td><td align="left">57</td><td align="left">±4.8</td><td align="char" char=".">94%</td><td align="left">±2%</td><td align="char" char=".">3</td><td align="left">8.4</td><td align="left">±2.5</td><td align="char" char=".">94%</td><td align="left">±1%</td><td align="char" char=".">3</td><td align="left">77</td><td align="char" char=".">6.8</td></tr><tr valign="top"><td align="left"><b>48</b></td><td align="left">F</td><td align="left">F</td><td align="left"> </td><td align="left"> </td><td align="left">>5 μM</td><td align="left"> </td><td align="char" char=".">45%</td><td align="left">±9%</td><td align="char" char=".">2</td><td align="left">366</td><td align="left">±88</td><td align="char" char=".">93%</td><td align="left">±2%</td><td align="char" char=".">2</td><td align="left">99</td><td align="left">±37</td><td align="char" char=".">101%</td><td align="left">±6%</td><td align="char" char=".">2</td><td align="left">>50</td><td align="char" char=".">3.7</td></tr><tr valign="top"><td align="left"><b>49</b></td><td align="left">F</td><td align="left"> </td><td align="left">F</td><td align="left"> </td><td align="left">547</td><td align="left">±296</td><td align="char" char=".">85%</td><td align="left">±2%</td><td align="char" char=".">2</td><td align="left">415</td><td align="left">±151</td><td align="char" char=".">88%</td><td align="left">±1%</td><td align="char" char=".">2</td><td align="left">42</td><td align="left">±18</td><td align="char" char=".">98%</td><td align="left">±0.5%</td><td align="char" char=".">2</td><td align="left">13</td><td align="char" char=".">9.9</td></tr><tr valign="top"><td align="left"><b>51</b></td><td align="left"> </td><td align="left">F</td><td align="left">F</td><td align="left"> </td><td align="left">578</td><td align="left">±219</td><td align="char" char=".">96%</td><td align="left">±4%</td><td align="char" char=".">2</td><td align="left">28</td><td align="left">±7.2</td><td align="char" char=".">96%</td><td align="left">±0.1%</td><td align="char" char=".">2</td><td align="left">9.0</td><td align="left">±3.3</td><td align="char" char=".">103%</td><td align="left">±6%</td><td align="char" char=".">2</td><td align="left">64</td><td align="char" char=".">3.2</td></tr><tr valign="top"><td align="left"><b>52</b></td><td align="left">F</td><td align="left"> </td><td align="left">Cl</td><td align="left"> </td><td align="left">774</td><td align="left">±229</td><td align="char" char=".">83%</td><td align="left">±6%</td><td align="char" char=".">3</td><td align="left">459</td><td align="left">±154</td><td align="char" char=".">86%</td><td align="left">±2%</td><td align="char" char=".">3</td><td align="left">128</td><td align="left">±66</td><td align="char" char=".">94%</td><td align="left">±4%</td><td align="char" char=".">3</td><td align="left">6.1</td><td align="char" char=".">3.6</td></tr><tr valign="top"><td align="left"><b>53</b></td><td align="left">Cl</td><td align="left"> </td><td align="left">F</td><td align="left"> </td><td align="left">91</td><td align="left">±33</td><td align="char" char=".">91%</td><td align="left">±6%</td><td align="char" char=".">4</td><td align="left">22</td><td align="left">±8.6</td><td align="char" char=".">97%</td><td align="left">±4%</td><td align="char" char=".">4</td><td align="left">3.0</td><td align="left">±1.2</td><td align="char" char=".">100%</td><td align="left">±2%</td><td align="char" char=".">4</td><td align="left">30</td><td align="char" char=".">7.3</td></tr><tr valign="top"><td align="left"><b>54</b></td><td align="left">Cl</td><td align="left">Cl</td><td align="left"> </td><td align="left"> </td><td align="left">349</td><td align="left">±54</td><td align="char" char=".">77%</td><td align="left">±2%</td><td align="char" char=".">4</td><td align="left">14</td><td align="left">±1.9</td><td align="char" char=".">89%</td><td align="left">±2%</td><td align="char" char=".">5</td><td align="left">11</td><td align="left">±4.1</td><td align="char" char=".">96%</td><td align="left">±3%</td><td align="char" char=".">4</td><td align="left">33</td><td align="char" char=".">1.4</td></tr><tr valign="top"><td align="left"><b>55</b></td><td align="left">Cl</td><td align="left"> </td><td align="left">Cl</td><td align="left"> </td><td align="left">51</td><td align="left">±18</td><td align="char" char=".">88%</td><td align="left">±3%</td><td align="char" char=".">4</td><td align="left">83</td><td align="left">±21</td><td align="char" char=".">89%</td><td align="left">±6%</td><td align="char" char=".">4</td><td align="left">18</td><td align="left">±10</td><td align="char" char=".">98%</td><td align="left">±1%</td><td align="char" char=".">4</td><td align="left">2.9</td><td align="char" char=".">4.7</td></tr><tr valign="top"><td align="left"><b>1</b></td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">27</td><td align="left">±7.2</td><td align="char" char=".">100%</td><td align="left"> </td><td align="char" char=".">11</td><td align="left">1.4</td><td align="left">±0.30</td><td align="char" char=".">99%</td><td align="left"> </td><td align="char" char=".">9</td><td align="left">0.25</td><td align="left">±0.05</td><td align="char" char=".">100%</td><td align="left"> </td><td align="char" char=".">7</td><td align="left">108</td><td align="char" char=".">5.8</td></tr><tr valign="top"><td align="left"><b>59</b></td><td align="left">Me</td><td align="left">Me</td><td align="left"> </td><td align="left"> </td><td align="left">360</td><td align="left">±65</td><td align="char" char=".">59%</td><td align="left">±7%</td><td align="char" char=".">4</td><td align="left">8.4</td><td align="left">±0.81</td><td align="char" char=".">90%</td><td align="left">±4%</td><td align="char" char=".">3</td><td align="left">7.0</td><td align="left">±1.2</td><td align="char" char=".">107%</td><td align="left">±8%</td><td align="char" char=".">5</td><td align="left">52</td><td align="char" char=".">1.2</td></tr><tr valign="top"><td align="left"><b>60</b></td><td align="left"> </td><td align="left">Me</td><td align="left">Me</td><td align="left"> </td><td align="left">2392</td><td align="left">±692</td><td align="char" char=".">40%</td><td align="left">±6%</td><td align="char" char=".">4</td><td align="left">12</td><td align="left">±2.4</td><td align="char" char=".">78%</td><td align="left">±5%</td><td align="char" char=".">3</td><td align="left">35</td><td align="left">±8.4</td><td align="char" char=".">97%</td><td align="left">±7%</td><td align="char" char=".">4</td><td align="left">68</td><td align="char" char=".">0.33</td></tr><tr valign="top"><td align="left"><b>61</b></td><td align="left">F</td><td align="left">Me</td><td align="left"> </td><td align="left">Cl</td><td align="left">330</td><td align="left">±116</td><td align="char" char=".">65%</td><td align="left">±9%</td><td align="char" char=".">3</td><td align="left">116</td><td align="left">±51</td><td align="char" char=".">74%</td><td align="left">±11%</td><td align="char" char=".">3</td><td align="left">13</td><td align="left">±2.7</td><td align="char" char=".">117%</td><td align="left">±11%</td><td align="char" char=".">4</td><td align="left">26</td><td align="char" char=".">9.2</td></tr><tr valign="top"><td align="left">(+)-<b>29</b></td><td align="left">Br</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">67</td><td align="left">±12</td><td align="char" char=".">76%</td><td align="left">±17%</td><td align="char" char=".">4</td><td align="left">13</td><td align="left">±4.8</td><td align="char" char=".">102%</td><td align="left">±4%</td><td align="char" char=".">3</td><td align="left">0.78</td><td align="left">±0.18</td><td align="char" char=".">116%</td><td align="left">±5%</td><td align="char" char=".">4</td><td align="left">86</td><td align="char" char=".">17</td></tr><tr valign="top"><td align="left">(−)-<b>29</b></td><td align="left">Br</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">NA</td><td align="left"> </td><td align="char" char="."> </td><td align="left"> </td><td align="char" char=".">4</td><td align="left">224</td><td align="left">±103</td><td align="char" char=".">96%</td><td align="left">±4%</td><td align="char" char=".">3</td><td align="left">78</td><td align="left">±11</td><td align="char" char=".">113%</td><td align="left">±4%</td><td align="char" char=".">4</td><td align="left">>128</td><td align="char" char=".">2.9</td></tr><tr valign="top"><td align="left"><b>7</b></td><td colspan="4" align="left">5-HT<sub>2C</sub> agonist</td><td align="left">616</td><td align="left">±270</td><td align="char" char=".">26%</td><td align="left">±8%</td><td align="char" char=".">3</td><td align="left">219</td><td align="left">±107</td><td align="char" char=".">92%</td><td align="left">±0.7%</td><td align="char" char=".">3</td><td align="left">2.7</td><td align="left">±0.90</td><td align="char" char=".">124%</td><td align="left">±13%</td><td align="char" char=".">4</td><td align="left">232</td><td align="char" char=".">82</td></tr><tr valign="top"><td align="left"><b>1</b></td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">5.8</td><td align="left">±0.63</td><td align="char" char=".">100%</td><td align="left"> </td><td align="char" char=".">11</td><td align="left">0.50</td><td align="left">±0.04</td><td align="char" char=".">100%</td><td align="left"> </td><td align="char" char=".">8</td><td align="left">0.16</td><td align="left">±0.02</td><td align="char" char=".">100%</td><td align="left"> </td><td align="char" char=".">9</td><td align="left">37</td><td align="char" char=".">3.2</td></tr><tr valign="top"><td align="left"><b>27</b></td><td align="left">F</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">681</td><td align="left">±116</td><td align="char" char=".">62%</td><td align="left">±3%</td><td align="char" char=".">5</td><td align="left">69</td><td align="left">±7.8</td><td align="char" char=".">84%</td><td align="left">±4%</td><td align="char" char=".">4</td><td align="left">33</td><td align="left">±2.3</td><td align="char" char=".">91%</td><td align="left">±2%</td><td align="char" char=".">5</td><td align="left">20</td><td align="char" char=".">2.1</td></tr><tr valign="top"><td align="left"><b>29</b></td><td align="left">Br</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">94</td><td align="left">±9.5</td><td align="char" char=".">71%</td><td align="left">±2%</td><td align="char" char=".">5</td><td align="left">4.8</td><td align="left">±1.7</td><td align="char" char=".">87%</td><td align="left">±6%</td><td align="char" char=".">4</td><td align="left">1.3</td><td align="left">±0.54</td><td align="char" char=".">76%</td><td align="left">±19%</td><td align="char" char=".">5</td><td align="left">73</td><td align="char" char=".">3.7</td></tr><tr valign="top"><td align="left"><b>34</b></td><td align="left"> </td><td align="left">F</td><td align="left"> </td><td align="left"> </td><td align="left">437</td><td align="left">±28</td><td align="char" char=".">73%</td><td align="left">±4%</td><td align="char" char=".">5</td><td align="left">3.6</td><td align="left">±0.41</td><td align="char" char=".">87%</td><td align="left">±5%</td><td align="char" char=".">4</td><td align="left">3.3</td><td align="left">±0.49</td><td align="char" char=".">96%</td><td align="left">±2%</td><td align="char" char=".">5</td><td align="left">131</td><td align="char" char=".">1.1</td></tr><tr valign="top"><td align="left"><b>41</b></td><td align="left"> </td><td align="left"> </td><td align="left">F</td><td align="left"> </td><td align="left">508</td><td align="left">±35</td><td align="char" char=".">68%</td><td align="left">±3%</td><td align="char" char=".">5</td><td align="left">21</td><td align="left">±0.90</td><td align="char" char=".">89%</td><td align="left">±4%</td><td align="char" char=".">4</td><td align="left">11</td><td align="left">±1.2</td><td align="char" char=".">96%</td><td align="left">±2%</td><td align="char" char=".">5</td><td align="left">47</td><td align="char" char=".">1.9</td></tr><tr valign="top"><td align="left"><b>44</b></td><td align="left"> </td><td align="left"> </td><td align="left">Me</td><td align="left"> </td><td align="left">1929</td><td align="left">±300</td><td align="char" char=".">18%</td><td align="left">±3%</td><td align="char" char=".">4</td><td align="left">37</td><td align="left">±3.2</td><td align="char" char=".">79%</td><td align="left">±4%</td><td align="char" char=".">4</td><td align="left">135</td><td align="left">±51</td><td align="char" char=".">69%</td><td align="left">±17%</td><td align="char" char=".">5</td><td align="left">14</td><td align="char" char=".">0.28</td></tr><tr valign="top"><td align="left"><b>56</b></td><td align="left"> </td><td align="left">Me</td><td align="left">F</td><td align="left"> </td><td align="left">235</td><td align="left">±47</td><td align="char" char=".">73%</td><td align="left">±5%</td><td align="char" char=".">4</td><td align="left">4.9</td><td align="left">±0.35</td><td align="char" char=".">83%</td><td align="left">±5%</td><td align="char" char=".">4</td><td align="left">6.0</td><td align="left">±1.4</td><td align="char" char=".">91%</td><td align="left">±4%</td><td align="char" char=".">4</td><td align="left">39</td><td align="char" char=".">0.83</td></tr><tr valign="top"><td align="left"><b>57</b></td><td align="left">Cl</td><td align="left"> </td><td align="left"> </td><td align="left">Me</td><td align="left">726</td><td align="left">±62</td><td align="char" char=".">56%</td><td align="left">±6%</td><td align="char" char=".">5</td><td align="left">7.0</td><td align="left">±0.49</td><td align="char" char=".">90%</td><td align="left">±4%</td><td align="char" char=".">4</td><td align="left">3.5</td><td align="left">±1.0</td><td align="char" char=".">97%</td><td align="left">±3%</td><td align="char" char=".">4</td><td align="left">207</td><td align="char" char=".">2.0</td></tr><tr valign="top"><td align="left"><b>58</b></td><td align="left">Br</td><td align="left"> </td><td align="left">Me</td><td align="left"> </td><td align="left">465</td><td align="left">±95</td><td align="char" char=".">62%</td><td align="left">±6%</td><td align="char" char=".">5</td><td align="left">116</td><td align="left">±10</td><td align="char" char=".">68%</td><td align="left">±4%</td><td align="char" char=".">4</td><td align="left">97</td><td align="left">±20</td><td align="char" char=".">84%</td><td align="left">±5%</td><td align="char" char=".">4</td><td align="left">4.8</td><td align="char" char=".">1.2</td></tr><tr valign="top"><td align="left"><b>6</b></td><td colspan="4" align="left">5-HT<sub>2C</sub> agonist</td><td align="left">NA</td><td align="left"> </td><td align="char" char="."> </td><td align="left"> </td><td align="char" char=".">6</td><td align="left">NA</td><td align="left"> </td><td align="char" char="."> </td><td align="left"> </td><td align="char" char=".">4</td><td align="left">261</td><td align="left">±41</td><td align="char" char=".">69%</td><td align="left">±3%</td><td align="char" char=".">5</td><td align="left"> </td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>7</b></td><td colspan="4" align="left">5-HT<sub>2C</sub> agonist</td><td align="left">151</td><td align="left">±16</td><td align="char" char=".">33%</td><td align="left">±3%</td><td align="char" char=".">11</td><td align="left">39</td><td align="left">±3</td><td align="char" char=".">92%</td><td align="left">±1.7%</td><td align="char" char=".">8</td><td align="left">3.0</td><td align="left">±0.54</td><td align="char" char=".">96%</td><td align="left">±2%</td><td align="char" char=".">9</td><td align="left">51</td><td align="char" char=".">13</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Tested in four independent screening campaigns using different cell lines/passages.</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">Percent of maximal activation by 5-HT; activation at 10 μM for compounds without EC<sub>50</sub> value.</p></div><div class="footnote" id="tbl2-fn3"><sup>c</sup><p class="last"><i>n</i>: Number of concentration curves from ≥2 (typically ≥3) independent experiments. NA: <i>E</i><sub>max</sub> ≤ 12%.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Radioligand Binding Data of Selected Compounds at the Human 5-HT<sub>2A</sub>, Human 5-HT<sub>2B</sub>, and 5-HT<sub>2C</sub> Receptors as Well as the Neurotransmitter Reuptake Transporters for 5-HT (SERT), Norepinephrine (NET), and Dopamine (DAT)<a class="ref internalNav" href="#tbl3-fn3" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="right" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle" char=".">5-HT<sub>2A</sub>[<sup>3</sup>H]-ketanserin</th><th colspan="3" align="center" valign="middle" char=".">5-HT<sub>2B</sub>[<sup>3</sup>H]-LSD<a class="ref internalNav" href="#tbl3-fn1" aria-label="b">b</a></th><th colspan="3" align="center" valign="middle" char=".">5-HT<sub>2C</sub>[<sup>3</sup>H]-mesulergine</th><th colspan="3" align="center" valign="middle" char=".">SERT [<sup>3</sup>H]-citalopram</th><th colspan="3" align="center" valign="middle">NET [<sup>3</sup>H]-nisoxetine</th><th colspan="3" align="center" valign="middle">DAT [<sup>3</sup>H]-WIN35428<a class="ref internalNav" href="#tbl3-fn2" aria-label="c">c</a></th><th colspan="2" align="center" valign="middle" char=".">selectivity</th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle" char="."><i>K</i><sub>i</sub>(nM)</th><th align="center" valign="middle">SEM (nM)</th><th align="center" valign="middle" char="."><i>n</i></th><th align="center" valign="middle" char="."><i>K</i><sub>i</sub>(nM)</th><th align="center" valign="middle">SEM (nM)</th><th align="center" valign="middle" char="."><i>n</i></th><th align="center" valign="middle" char="."><i>K</i><sub>i</sub>(nM)</th><th align="center" valign="middle">SEM (nM)</th><th align="center" valign="middle" char="."><i>n</i></th><th align="center" valign="middle" char="."><i>K</i><sub>i</sub>(nM)</th><th align="center" valign="middle">SEM (nM)</th><th align="center" valign="middle" char="."><i>n</i></th><th align="center" valign="middle"><i>K</i><sub>i</sub>(nM)</th><th align="center" valign="middle">SEM (nM)</th><th align="center" valign="middle" char="."><i>n</i></th><th align="center" valign="middle"><i>K</i><sub>i</sub>(nM)</th><th align="center" valign="middle">SEM (nM)</th><th align="center" valign="middle" char="."><i>n</i></th><th align="center" valign="middle" char=".">2A/2C</th><th align="center" valign="middle" char=".">2B/2C</th></tr></thead><tbody><tr valign="top"><td align="left"><b>7</b></td><td align="char" char=".">2782</td><td align="left">±35.5</td><td align="char" char=".">2</td><td align="char" char=".">189</td><td align="left">±37.2</td><td align="char" char=".">3</td><td align="char" char=".">257</td><td align="left">±63.8</td><td align="char" char=".">3</td><td align="char" char=".">2606</td><td align="left">±494</td><td align="char" char=".">3</td><td align="right">>10 μM</td><td align="left"> </td><td align="char" char=".">1</td><td align="left">>10 μM</td><td align="left"> </td><td align="char" char=".">3</td><td align="char" char=".">10.8</td><td align="char" char=".">0.73</td></tr><tr valign="top"><td align="left"><b>29</b></td><td align="char" char=".">655</td><td align="left">±154</td><td align="char" char=".">2</td><td align="char" char=".">22</td><td align="left">±1.16</td><td align="char" char=".">3</td><td align="char" char=".">124</td><td align="left">±22.0</td><td align="char" char=".">3</td><td align="char" char=".">2716</td><td align="left">±876</td><td align="char" char=".">3</td><td align="right">2733</td><td align="left"> </td><td align="char" char=".">1</td><td align="left">>10 μM</td><td align="left"> </td><td align="char" char=".">3</td><td align="char" char=".">5.3</td><td align="char" char=".">0.18</td></tr><tr valign="top"><td align="left"><b>37</b></td><td align="char" char=".">1846</td><td align="left">±221</td><td align="char" char=".">2</td><td align="char" char=".">85</td><td align="left">±13.8</td><td align="char" char=".">3</td><td align="char" char=".">268</td><td align="left">±32.4</td><td align="char" char=".">3</td><td align="char" char=".">5441</td><td align="left">±1352</td><td align="char" char=".">3</td><td align="right">>10 μM</td><td align="left"> </td><td align="char" char=".">1</td><td align="left">5400</td><td align="left">±2366</td><td align="char" char=".">3</td><td align="char" char=".">6.9</td><td align="char" char=".">0.32</td></tr><tr valign="top"><td align="left"><b>41</b></td><td align="char" char=".">2778</td><td align="left">±1292</td><td align="char" char=".">2</td><td align="char" char=".">89</td><td align="left">±26.1</td><td align="char" char=".">3</td><td align="char" char=".">242</td><td align="left">±54.7</td><td align="char" char=".">3</td><td align="char" char=".">2710</td><td align="left">±979</td><td align="char" char=".">3</td><td align="right">6780</td><td align="left"> </td><td align="char" char=".">1</td><td align="left">3261</td><td align="left">±1251</td><td align="char" char=".">3</td><td align="char" char=".">11.5</td><td align="char" char=".">0.37</td></tr><tr valign="top"><td align="left"><b>53</b></td><td align="char" char=".">254</td><td align="left">±36.7</td><td align="char" char=".">2</td><td align="char" char=".">16</td><td align="left">±5.39</td><td align="char" char=".">3</td><td align="char" char=".">203</td><td align="left">±50.4</td><td align="char" char=".">3</td><td align="char" char=".">1042</td><td align="left">±332</td><td align="char" char=".">3</td><td align="right">>10 μM</td><td align="left"> </td><td align="char" char=".">1</td><td align="left">>10 μM</td><td align="left"> </td><td align="char" char=".">3</td><td align="char" char=".">1.2</td><td align="char" char=".">0.08</td></tr><tr valign="top"><td align="left">(+)-<b>29</b></td><td align="char" char=".">246</td><td align="left">±72.1</td><td align="char" char=".">2</td><td align="char" char=".">16</td><td align="left">±3.73</td><td align="char" char=".">3</td><td align="char" char=".">66</td><td align="left">±11.2</td><td align="char" char=".">3</td><td align="char" char=".">3834</td><td align="left">±559</td><td align="char" char=".">3</td><td align="right">3404</td><td align="left"> </td><td align="char" char=".">1</td><td align="left">2115</td><td align="left">±862</td><td align="char" char=".">3</td><td align="char" char=".">3.7</td><td align="char" char=".">0.24</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn3"><div class="footnote" id="tbl3-fn3"><sup>a</sup><p class="last">For 5-HT<sub>2B</sub>, the agonist radioligand [<sup>3</sup>H]-LSD was used, possibly resulting in higher binding affinities for agonist compounds.</p></div><div class="footnote" id="tbl3-fn1"><sup>b</sup><p class="last">Agonist radioligand, <i>K</i><sub>i</sub> values are ∼30-fold lower than for antagonist radioligands.</p></div><div class="footnote" id="tbl3-fn2"><sup>c</sup><p class="last">(−)-2β-Carbomethoxy-3β-(4-fluorophenyl)tropane (WIN35428).</p></div></div></div><div class="NLM_p">The <i>trans</i> isomer <b>14a</b> with its side chain elongated by one methylene group was much more potent (EC<sub>50</sub> = 13 nM) at the 5-HT<sub>2C</sub> receptor as compared to its parent compound <b>9</b> and the <i>cis</i> isomer <b>14b</b> was much less active than the <i>trans</i> isomer <b>14a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The <i>trans</i>-aminomethyl-2-phenylcyclopropane <b>14a</b> and several of its <i>N</i>-mono- and <i>N</i>-dialkyl analogues have previously been described as centrally active sympathomimetic compounds that cause hyperlocomotion, reverse reserpine-induced depressant effects in a model of antidepressant activity, and cause anorexia similar to compound <b>9</b>,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> while the fully unsubstituted compound <b>14a</b> was devoid of MAO inhibitory activity in a tryptamine potentiation model.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> This behavioral and biochemical profile and the different structure−activity relationships suggest a non-5-HT<sub>2C</sub>-mediated mechanism for these early ring-unsubstituted compounds, perhaps through inhibition of monoamine reuptake.</div><div class="NLM_p">Assay of the two enantiomers revealed that the (<i>S</i>,<i>S</i>)-stereoisomer (+)-<b>14a</b> was significantly more potent than its (<i>R</i>,<i>R</i>)-isomer (−)-<b>14a</b>. We have observed the same stereochemical preference for the corresponding 2-bromo-substituted enantiomeric pair (+)-<b>29</b> and (−)-<b>29</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_p">Alkylation of the amine nitrogen in analogues <b>15</b>−<b>20</b> led to sharply decreased 5-HT<sub>2C</sub> receptor potency in comparison to the parent compounds <b>9</b> or <b>14a</b>. Compound <b>9</b> and its potent analogues <b>14a</b> (racemic) and (+)-<b>14a</b> were full agonists at the 5-HT<sub>2C</sub> receptor and displayed a high selectivity over the 5-HT<sub>2A</sub> receptor and a 3- to 7-fold selectivity over the 5-HT<sub>2B</sub> receptor.</div><div class="NLM_p">As a preliminary summary, the initial SAR studies established the following essential features responsible for high 5-HT<sub>2C</sub> receptor potency: a cyclopropyl ring attached to a phenyl group carrying a primary aminomethyl group in <i>trans</i> orientation. On the basis of these preliminary observations, our further work focused on variations in the phenyl ring of this core structure.</div><div class="NLM_p">In the following four rounds of structural exploration and functional screening, we systematically tested the effects of mono- and disubstitutions at the phenyl ring (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Selected compounds from previous optimization rounds, the known 5-HT<sub>2C</sub> agonist WAY 629 (1,2,3,4,8,9,10,11-octahydro-[1,4]diazepino[6,7,1-<i>jk</i>]carbazole) (<b>6</b>)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and lorcaserin ((1<i>R</i>)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1<i>H</i>-3-benzazepine) (<b>7</b>)<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> as well as <b>1</b> were included as reference compounds for comparison purposes.</div><div class="NLM_p">All tested compounds were highly efficacious 5-HT<sub>2C</sub> agonists. Mono- and disubstituted analogues carrying chloro and bromo substitutions in the 2-position were consistently more potent than their respective fluoro, trifluoromethyl, methyl, methoxy, or hydroxy analogues.</div><div class="NLM_p">In the 3-position, potency was less strongly influenced by the tested substituents and tended to decrease with molecular size from fluoro, methyl, and hydroxy over chloro to bromo and trifluoromethyl.</div><div class="NLM_p">In the 4-position, the optimal substitution was a fluoro group. Any replacement by other halogens, methyl, trifluoromethyl, methoxy, or hydroxy groups resulted in a sharp decrease in 5-HT<sub>2C</sub> potency and selectivity over 5-HT<sub>2B</sub> activity.</div><div class="NLM_p">Qualitatively similar trends of these substituent effects on potency and selectivity were observed between mono- and disubstituted compounds. However, the tested disubstitutions did not result in additive effects on potency or selectivity.</div><div class="NLM_p">At the 5-HT<sub>2B</sub> receptor, the 3-hydroxy analogue <b>40</b> has about a 10-fold higher potency than the corresponding 3-methyl analogue <b>37</b>, while both compounds were essentially equipotent at the 5-HT<sub>2C</sub> receptor. This might indicate a hydrogen bond interaction between compound <b>40</b> and the 5-HT<sub>2B</sub> receptor that is absent in the 5-HT<sub>2C</sub>-<b>40</b> complex, making compound <b>37</b> one of the most selective compounds in the current series.</div><div class="NLM_p">5-HT<sub>2A</sub> potencies of most tested compounds were above or around 0.5 μM, resulting in a generally good 5-HT<sub>2A</sub> over 5-HT<sub>2C</sub> selectivity. Additionally, most compounds were partial agonists at the 5-HT<sub>2A</sub> receptor but full agonists at the 5-HT<sub>2C</sub> receptor. 2-Chloro and 2-bromo substitutions resulted in increased 5-HT<sub>2A</sub> potency, a trend also seen at the other two receptors.</div><div class="NLM_p">We also prepared and tested the biphenyl and heteroaryl-phenyl derivatives <b>66</b>−<b>74</b>, the 2- and 3-acetamido, 2- and 3-benzamido, 2-benzylamino, and 2-(4-chlorophenyl)urea analogues <b>78</b>, <b>80</b>−<b>84</b>, and a series of extended alkynyl derivatives <b>86</b>−<b>90</b> (<a class="ref internalNav" href="#si1" aria-label="Table S1, Supporting Information">Table S1, Supporting Information</a>). Most of these compounds were inactive or had potencies above 1 μM at all tested receptors. None of these compounds had a 5-HT<sub>2C</sub> potency below 100 nM.</div><div class="NLM_p">The basic ring-monosubstituted derivatives presented in this publication do not reach the same level of selectivity as the 5-HT<sub>2C</sub> agonists that are currently in clinical trials; in our hands the potent compound (+)-<b>29</b> displayed about 5-fold less 5-HT<sub>2C</sub> over 5-HT<sub>2B</sub> selectivity as compared to <b>7</b>.</div><div class="NLM_p">A molecular overlay of several of the new selective 5-HT<sub>2C</sub> agonists prepared by other research groups with one of our more selective compounds <b>37</b> reveals the molecular features common to all these compounds, which include a similarly aligned positively charged nitrogen atom (blue) positioned above the plane of an aromatic ring, which is substituted with hydrophobic group(s), such as chloro, methyl, ethyl, or trifluoromethyl (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Overlay of the 3-methyl bearing analogue <b>37</b> (orange) with <b>7</b> (purple) and the BMS pyrazinoisoindoline (<b>8</b>)<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (light blue) shows the expected similarities in structure. See Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> for structures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">A selection of compounds was then subjected to binding experiments together with <b>7</b> as a reference compound (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Compounds <b>37</b> (3-Me), <b>41</b> (4-F), and <b>53</b> (2-Cl, 4-F) had comparable 5-HT<sub>2C</sub> binding affinities. Compound <b>41</b> was as 5-HT<sub>2C</sub>-selective as <b>7</b>, while <b>29</b>, (+)-<b>29</b>, and <b>37</b> where less selective. Since earlier data suggested sympathomimetic effects for the unsubstituted parent compound <b>14a</b>,<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> we also tested these compounds on all three monoamine reuptake transporters. None of the compounds had submicromolar binding affinities at SERT (5-HT transporter), NET (norepinephrine transporter), and DAT (dopamine transporter).</div></div><div id="sec1_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8"> In Vivo Studies: Evaluation of a 5-HT<sub>2C</sub> Agonist for Antidepressant Potential</h4><div class="NLM_p">5-HT<sub>2C</sub> agonists have been reported to have antidepressant-like properties in multiple animal models, indicating that the 5-HT<sub>2C</sub> receptor may be a desired target for CNS therapeutic effects. Compound <b>37</b> is one of the most potent and selective ligands for the 5-HT<sub>2C</sub> receptor in the current series (120-fold selectivity over 2A and 14-fold selectivity over 2B, EC<sub>50</sub> = 585, 65, and 4.8 nM at the 2A, 2B, and 2C subtypes, respectively, see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). On the basis of this in vitro profile, compound <b>37</b> was chosen for an initial in vivo profiling in the mouse forced swim test, which is a commonly used assay to validate antidepressant-like properties of compounds.</div><div class="NLM_p">In the mouse forced swim test, compound <b>37</b> (10−60 mg/kg) produced a dose-dependent decrease in immobility time compared to vehicle (<i>F</i>(4.45) = 8.865, <i>p</i> < 0.001). Posthoc analysis indicated that compound <b>37</b> produced a significant decrease in immobility at all three doses tested (28%, 38%, and 38% decrease in the 10, 30, and 60 mg/kg groups, respectively, (<i>p</i> < 0.05)). For comparison, the reference selective serotonin reuptake inhibitor sertraline (<b>92</b>) (10 mg/kg) was used as a positive control in the same study. Both <b>92</b> (<i>p</i> < 0.001) and compound <b>37</b> significantly reduced the immobility time, indicative of an antidepressant-like effect (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The results also demonstrate that compound <b>37</b> possesses drug-like properties in vivo and that it is centrally active. The antidepressant-like effects together with the absence of monoamine reuptake transporter binding are in agreement with previous studies, which demonstrated that 5-HT<sub>2C</sub> agonists have antidepressant-like properties in both acute and chronic preclinical models used to predict antidepressant efficacy.<a onclick="showRef(event, 'ref20 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref22">(20, 22)</a></div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. The effect of compounds <b>37</b> and <b>92</b> in the mouse forced swim test. Compound <b>37</b> (10−60 mg/kg, ip) or the reference compound <b>92</b> (10 mg/kg, ip) was administered 30 min prior to testing. Both compounds <b>92</b> and <b>37</b> produced a significant decrease in immobility, which reached significance at all doses tested. These data are indicative of an antidepressant-like effect and in vivo drug-like central activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02845" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02845" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">5-HT<sub>2C</sub> agonists have demonstrated efficacy in preclinical models of depression, obesity, and psychosis.<a onclick="showRef(event, 'ref23 ref55'); return false;" href="javascript:void(0);" class="ref ref23 ref55">(23, 55)</a> The present work reports the chemical synthesis of 67 new side-chain analogues of the monoamine oxidase inhibitor <b>9</b>, which were identified as a new class of 5-HT<sub>2C</sub> agonists. Starting from compound <b>9</b>, a selective but only moderately potent 5-HT<sub>2C</sub> agonist, we have undertaken a structural optimization campaign that has led to a potent and moderately selective agonist that demonstrates antidepressant-like effects in a commonly used behavioral assay. Moreover, preliminary results based on the work presented in this article suggest the possibility of compounds with improved selectivity profiles comparable to drugs currently in clinical trials. This study therefore presents a new scaffold for 5-HT<sub>2C</sub> drug discovery, which may in turn lead to novel therapeutics for use in a variety of CNS related disorders.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80281" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80281" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Chemistry</h3><div class="NLM_p last"><sup>1</sup>H and <sup>13</sup>C NMR spectra were obtained with a Bruker Avance spectrometer at 300 and 75 MHz or a Bruker Avance spectrometer at 400 and 100 MHz, respectively. <sup>1</sup>H chemical shifts (δ) were reported in ppm downfield from internal Me<sub>4</sub>Si. Mass spectra were measured in positive mode electrospray ionization (ESI). The HRMS data were obtained on a Micromass Q-TOF-2TM, ThermoFinnigan LTQFT. and Shimadzu LCMSITTOF instruments. Optical rotations were measured with an AUTOPOL IV (Rudolph Research Analytical) instrument. TLC was performed on silica gel 60F<sub>254</sub> glass plates; column chromatography was performed using Merck silica gel (230−400 mesh). Analytical HPLC was performed using a Shimadzu LC-10AD system equipped with the following columns: Column 1: ACE 5 AQ C<sub>18</sub> UltraInert column (4.6 mm × 250 mm; 5 μm). Column 2: Waters μ-Bondapak C<sub>18</sub> column (3.9 mm × 300 mm; 5 μm). Column 3: ACE 3 AQ C<sub>18</sub> UltraInert column (4.6 mm × 100 mm; 3.5 μm). Chiralcel OJ (4.6 mm × 250 mm, DAICEL) and Chiralpak AD (10.0 mm × 250 mm, DAICEL) were used for Chiral HPLC analysis. HPLC data were recorded using following methods. Method A: H<sub>2</sub>O/MeCN (0.1% TFA), 90/10 → 0/100 in 18 min, + 2 min isocratic, flow rate of 1.6 mL/min, λ = 254, 280 nm. Method B: H<sub>2</sub>O/MeCN (0.1% TFA), 100/0 → 0/100 in 20 min, + 2 min isocratic, flow rate of 1.6 mL/min, λ = 254, 280 nm. Method C: H<sub>2</sub>O/MeCN (0.1% TFA), 70/30 → 0/100 in 21 min, + 7 min isocratic, flow rate of 1.3 mL/min, λ = 254, 280 nm. Method D: H<sub>2</sub>O/MeCN (0.1% TFA), 90/10 → 0/100 in 20 min, + 7 min isocratic, flow rate of 1 mL/min, λ = 254, 280 nm. Method E: H<sub>2</sub>O/MeCN (0.1% TFA), 100/0 → 0/100 in 30 min, + 3 min isocratic, flow rate of 1.3 mL/min, λ = 254, 280 nm. Starting materials were obtained from Aldrich, Alfa Aesar, or Acros. Solvents were obtained from Fisher Scientific or Aldrich and were used without further purification unless noted otherwise.</div></div><div id="sec3_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Procedure for the Synthesis of <i>trans</i>- and <i>cis</i>-(2-Phenylcyclopropyl)methylamine Hydrochloride (<b>14a</b> and <b>14b</b>)</h3><div id="sec3_1_99" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Step A: <i>trans</i>- and <i>cis</i>-2-Phenylcyclopropanecarboxylic Acid Ethyl Ester (<b>11a</b> and <b>11b</b>)</h4><div class="NLM_p last">Under dry conditions, Cu(acac)<sub>2</sub> (78 mg, 0.3 mmol) was dissolved in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (20 mL). After the solution was stirred for 5 min, a few drops of phenylhydrazine were added and stirring was continued. To this solution was added styrene (1.15 mL, 10 mmol). The mixture was stirred at 40 °C for 5 min, and a solution of ethyl diazoacetate (1.56 mL, 15 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added via syringe pump over 5 h at 40 °C. After stirring for one more hour followed by the addition of CH<sub>2</sub>Cl<sub>2</sub> (50 mL), the mixture was washed successively with sat. aq NaHCO<sub>3</sub> (×2) and H<sub>2</sub>O (×2). The organic portion was dried over Na<sub>2</sub>SO<sub>4</sub> and all volatiles were removed in vacuo. The isomers were separated by silica gel chromatography (hexane/Et<sub>2</sub>O 20:1) to afford the title compounds as colorless oils (<i>trans-</i>isomer <b>11a</b>: 1.19 g, 67% yield) and (<i>cis-</i>isomer <b>11b</b>: 490 mg, 27% yield). <b>11a</b>: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.30 (m, 2 H), 7.24 (m, 1 H), 7.13 (d, <i>J</i> = 7.1 Hz, 2 H), 4.20 (q, <i>J</i> = 7.1 Hz, 2 H), 2.54 (m, 1 H), 1.93 (m, 1 H), 1.63 (m, 1 H), 1.37−1.29 (m, 4 H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 173.3, 140.0, 128.4, 126.4, 126.1, 60.6, 26.1, 24.1, 17.0, 14.2. <b>11b</b>: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.29−7.21 (m, 5 H), 3.90 (q, <i>J</i> = 7.1 Hz, 2 H), 2.60 (m, 1 H), 2.10 (m, 1 H), 1.74 (m, 1 H), 1.35 (m, 1 H), 0.99 (t, <i>J</i> = 7.1 Hz, 3 H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 170.1, 136.5, 129.2, 127.8, 126.6, 60.1, 25.4, 21.7, 14.0, 11.0.</div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Step B: <i>trans</i>-2-Phenylcyclopropanecarboxylic Acid (<b>12a</b>)</h4><div class="NLM_p last">A solution of <b>11a</b> (128 mg, 0.726 mmol) in MeOH (1 mL) was added to KOH (406 mg, 7.26 mmol) in MeOH (3 mL) at 0 °C. The mixture was stirred at rt overnight, and then poured into water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was discarded, and the aqueous phase was acidified with 10% HCl and extracted with CH<sub>2</sub>Cl<sub>2</sub> (×2). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub> and all volatiles were removed in vacuo. The acid was isolated as white powders and further purified by recrystallization from hexane (80 mg, 68% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 10.3 (br s, 1 H), 7.34−7.22 (m, 3 H), 7.14 (d, <i>J</i> = 7.0 Hz, 2 H), 2.64 (m, 1 H), 1.93 (m, 1 H), 1.70 (m, 1 H), 1.44 (m, 1 H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 180.2, 139.9, 128.9, 127.1, 126.7, 27.5, 24.4, 17.9.</div></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> <i>cis</i>-2-Phenylcyclopropanecarboxylic Acid (<b>12b</b>)</h4><div class="NLM_p last">Prepared by the same procedure as described for <b>12a</b> (233 mg, 77% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.29−7.20 (m, 5 H), 2.65 (m, 1 H), 2.05 (m, 1 H), 1.68 (m, 1 H), 1.40 (m, 1 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 177.2, 135.8, 129.2, 127.9, 126.8, 26.6, 21.4, 12.0.</div></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Step C: <i>trans</i>-2-Phenylcyclopropanecarboxylic Acid Amide (<b>13a</b>)</h4><div class="NLM_p last">Several drops of dimethylformamide and thionyl chloride (13.5 mL, 185 mmol) were added dropwise to a solution of <b>12a</b> (2.0 g, 12.3 mmol) in toluene (40 mL). After stirring at 80 °C for 3 h, the reaction mixture was concentrated under vacuum. The resulting residue was dissolved in toluene (10 mL), and the resulting solution was added to liquid ammonia at <b>−</b>78 °C. After stirring at <b>−</b>78 °C for 30 min and then at rt for 30 min, CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was added to the mixture at <b>−</b>78 °C and the resulting mixture was stirred at rt overnight. After addition of EtOAc, the mixture was washed with sat. aq NH<sub>4</sub>Cl (×2), dried over Na<sub>2</sub>SO<sub>4</sub>, and all volatiles were removed in vacuo. The title compound was isolated as a pearly yellow powder and further purified by recrystallization from hexane/EtOAc (1.72 g, 87% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.60 (br s, 1 H), 7.29−7.10 (m, 5 H), 6.91 (br s, 1 H), 2.21 (m, 1 H), 1.82 (m, 1 H), 1.32 (m, 1 H), 1.18 (m, 1 H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 173.8, 142.1, 129.2, 126.8, 126.6, 26.4, 24.8, 16.1.</div></div><div id="sec3_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> <i>cis</i>-2-Phenylcyclopropanecarboxylic Acid Amide (<b>13b</b>)</h4><div class="NLM_p last">Prepared by the same procedure as described for <b>13a</b> (128 mg, 56% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.40 (br s, 1 H), 7.21−7.20 (m, 4 H), 7.13 (m, 1 H), 6.59 (br s, 1 H), 2.36 (m, 1 H), 1.97 (m, 1 H), 1.45 (m, 1 H), 1.13 (m, 1 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.9, 138.2, 129.4, 127.9, 126.2, 24.3, 23.4, 9.9.</div></div><div id="sec3_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Step D: <i>trans</i>-(2-Phenylcyclopropyl)methylamine Hydrochloride (<b>14a</b>)</h4><div class="NLM_p last">To a solution of <b>13a</b> (1.6 g, 9.93 mmol) in anhydrous THF (40 mL) was added dropwise 1 M borane/THF solution (39.7 mL) at 0 °C. The mixture was heated under reflux at 70 °C overnight and then was quenched by the careful addition of 10% aq HCl. After stirring at rt for 1 h, the THF was removed by evaporation and the residual aqueous solution was washed with Et<sub>2</sub>O (×2), neutralized with 10% NaOH, and then extracted with Et<sub>2</sub>O (×4). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated until the volume was reduced to about 20 mL. To the solution was added 1 M HCl in Et<sub>2</sub>O (20 mL, 20 mmol) at 0 °C. After stirring at 0 °C for 15 min and at rt for 1 h, the mixture was concentrated under vacuum. The resulting residue was purified by recrystallization from ethanol/Et<sub>2</sub>O to afford the title compound as a white solid (1.54 g, 86% yield). HPLC purity: 11.9 min, 95.4% (column 1, method C). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.29−7.24 (m, 2 H), 7.18−7.13 (m, 3 H), 3.01 (d, <i>J</i> = 7.4 Hz, 2 H), 2.03 (m, 1 H), 1.41 (m, 1 H), 1.14<b>−</b>1.05 (m, 2 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 141.6, 128.4, 126.0, 125.9, 43.9, 22.2, 19.8, 14.0. MS (ESI) <i>m</i>/<i>z</i> 148.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>14</sub>N<sup>+</sup> [MH<sup>+</sup>] 148.1126, found 148.1127.</div></div><div id="sec3_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>cis</i>-(2-Phenylcyclopropyl)methylamine Hydrochloride (<b>14b</b>)</h4><div class="NLM_p last">Prepared by the same procedure as described for <b>14a</b> (26.8 mg, 47% yield). HPLC purity: 12.4 min, 95.5% (column 1, method C). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.35−7.24 (m, 5 H), 2.99−2.94 (m, 1 H), 2.20 (m, 1 H), 1.49 (m, 1 H), 1.25−1.18 (m, 1 H), 1.08 (m, 1 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 137.3, 129.1, 128.5, 126.8, 40.5, 21.1, 15.5, 8.3. MS (ESI) <i>m</i>/<i>z</i> 148.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>14</sub>N<sup>+</sup> [MH<sup>+</sup>] 148.1126, found 148.1123.</div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure for the Preparation of Optically Pure Ligand ((+)- and (−)-<b>14a</b>)</h3><div id="sec3_2_99" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Step A: (+)- and (−)-<i>trans</i>-2-Phenylcyclopropanecarboxylic Acid (2-Hydroxy-1-phenylethyl)amide ((+)- and (−)-<b>91</b>)</h4><div class="NLM_p last">To a stirred solution of <b>12a</b> (1.62 g, 10.0 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) were added (<i>R</i>)-(−)-2-phenylglycinol (2.06 g, 15.0 mmol), HOBT (1.35 g, 10.0 mmol), and EDC·HCl (2.88 g, 15.0 mmol). The mixture was stirred at 0 °C for 1 h followed at rt overnight. The reaction mixture was washed with 5% aq citric acid, sat. aq NaHCO<sub>3</sub>, and sat. NaCl. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude residue was purified by silica gel column chromatography (EtOAc/Et<sub>2</sub>O 1:2) to afford the (−)-isomer with a higher <i>R</i><sub>f</sub> value (650 mg, 23% yield) and the (+)-isomer with a lower <i>R</i><sub>f</sub> value (703 mg, 25% yield) as colorless solids. (+)-<b>91</b>: <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.35−7.10 (m, 9 H), 5.02 (t, <i>J</i> = 6.3 Hz, 1 H), 3.75 (m, 2 H), 2.34 (m, 1 H), 2.03 (m, 1 H), 1.53 (m, 1 H), 1.27 (m, 1 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 173.6, 141.2, 140.4, 128.5, 128.4, 127.4, 127.0, 126.3, 126.1, 65.3, 56.4, 25.8, 24.8, 15.2. (−)-<b>91</b>: <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.36−7.13 (m, 9 H), 5.03 (t, <i>J</i> = 6.3 Hz, 1 H), 3.75 (m, 2 H), 2.42 (m, 1 H), 2.03 (m, 1 H), 1.46 (m, 1 H), 1.24 (m, 1 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 173.6, 141.2, 140.4, 128.5, 128.4, 127.4, 127.0, 126.2, 126.0, 65.2, 56.3, 25.7, 24.8, 15.4.</div></div><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Step B: (+)-<i>trans</i>-2-Phenylcyclopropanecarboxylic Acid ((+)-<b>12a</b>)</h4><div class="NLM_p last">A solution of (+)-<b>91</b> (150 mg, 0.534 mmol) in dioxane (5 mL) was added to 3 N H<sub>2</sub>SO<sub>4</sub> (5 mL). The mixture was stirred at 100 °C for 24 h and then poured into water and extracted with CH<sub>2</sub>Cl<sub>2</sub> (×3). The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude residue was purified by silica gel column chromatography (EtOAc/hexane 1:2) to afford the title compound as a colorless solid (73 mg, 84% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 10.3 (br s, 1 H), 7.34−7.22 (m, 3 H), 7.14 (d, <i>J</i> = 7.0 Hz, 2 H), 2.64 (m, 1 H), 1.93 (m, 1 H), 1.70 (m, 1 H), 1.44 (m, 1 H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 180.2, 139.9, 128.9, 127.1, 126.7, 27.5, 24.4, 17.9; [α]<sub>D</sub> +389° (c 0.61, CHCl<sub>3</sub>) [lit. 405° (c 1.0, CHCl<sub>3</sub>)<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a><sub></sub>].</div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (−)-<i>trans</i>-2-Phenylcyclopropanecarboxylic Acid ((−)-<b>12a</b>)</h4><div class="NLM_p last">Prepared by the same procedure as described for (+)-<b>12a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.76 (br s, 1 H), 7.34−7.22 (m, 3 H), 7.14 (d, <i>J</i> = 7.0 Hz, 2 H), 2.64 (m, 1 H), 1.93 (m, 1 H), 1.70 (m, 1 H), 1.44 (m, 1 H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 180.2, 139.9, 128.9, 127.1, 126.7, 27.5, 24.4, 17.9; [α]<sub>D</sub> −396° (c 0.72, CHCl<sub>3</sub>) [lit. −410° (c 1.0, CHCl<sub>3</sub>)<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a>].</div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Step C: (+)-<i>trans</i>-(<i>S</i>,<i>S</i>)-(2-Phenylcyclopropyl)methylamine Hydrochloride ((+)-<b>14a</b>)</h4><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above with substituting (+)-<i>trans</i>-2-phenyl-cyclopropanecarboxylic acid (+)-<b>12a</b> for (±)-<b>12a</b> in Step C. HPLC purity: 12.8 min, 97.9% (column 1, method C). <sup>1</sup>H NMR (MeOD-<i>d</i><sub>4</sub>) δ 7.29−7.24 (m, 2 H), 7.18−7.13 (m, 3 H), 3.01 (d, <i>J</i> = 7.4 Hz, 2 H), 2.02 (m, 1 H), 1.41 (m, 1 H), 1.14−1.06 (m, 2 H). <sup>13</sup>C NMR (MeOD-<i>d</i><sub>4</sub>) δ 141.6, 128.4, 126.0, 125.9, 43.9, 22.2, 19.8, 14.0. MS (ESI) <i>m</i>/<i>z</i> 148.2 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>14</sub>N<sup>+</sup> [MH<sup>+</sup>] 148.1126, found 148.11202; [α]<sub>D</sub> +72.9° (c 0.45, MeOH).</div></div><div id="sec3_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (−)-<i>trans</i>-(<i>R</i>,<i>R</i>)-(2-Phenylcyclopropyl)methylamine Hydrochloride ((−)-<b>14a</b>)</h4><div class="NLM_p last">Prepared by the same procedure as described for (+)-<b>14a</b>. HPLC purity: 12.6 min, 98.1% (column 1, method C). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.29−7.24 (m, 2 H), 7.18−7.13 (m, 3 H), 3.01 (d, <i>J</i> = 7.4 Hz, 2 H), 2.06−2.02 (m, 1 H), 1.42 (m, 1 H), 1.13−1.05 (m, 2 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 141.6, 128.4, 126.0, 125.9, 43.9, 22.2, 19.8, 14.0. MS (ESI) <i>m</i>/<i>z</i> 148.2 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>14</sub>N<sup>+</sup> [MH<sup>+</sup>] 148.1126, found 148.11200; [α]<sub>D</sub><b>−</b>71.3° (c 0.45, MeOH).</div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>trans</i>-<i>N</i>-Methyl-(2-phenylcyclopropyl)amine (<b>15</b>)</h3><div class="NLM_p last">Acetic formic anhydride was generated by dropwise addition of formic acid (0.36 mL, 9.6 mmol) to acetic anhydride (0.73 mL, 7.8 mmol). The mixture was kept on ice and then heated at 50 °C for 2 h. The mixture was cooled to rt, and THF (5 mL) was added. This mixture (0.6 mL, 0.3 mmol) was added to a solution of <b>9</b> (50 mg, 0.3 mmol) in THF (1 mL) at −15 °C, followed by addition of <i>N</i>-methylmorpholine (45 μL, 0.3 mmol). The resulting mixture was stirred at −15 °C for 30 min and at rt for 1 h, insoluble materials were filtered out, and the solution was concentrated in vacuo. The crude residue (65 mg) was dissolved in THF (1.2 mL), and to the solution was added 1.0 M solution of borane dimethylsulfide complex in THF (0.75 mL). After the mixture was stirred at 65 °C overnight, the reaction was quenched by 10% aq HCl. The mixture was concentrated under reduced pressure to remove THF, and the residual aqueous solution was washed with Et<sub>2</sub>O (×1), neutralized with 10% aq NaOH, and then extracted with Et<sub>2</sub>O (×3). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by preparative TLC (EtOAc/Et<sub>3</sub>N/MeOH 8:1:1) to afford the title compound as a colorless oil (21 mg, 47% yield). HPLC purity: 24.8 min, 95.2% (column 2, method C). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.30−7.25 (m, 2 H), 7.20−7.16 (m, 1 H), 7.09−7.06 (m, 2 H), 2.54 (br s, 3 H), 2.34 (m, 1 H), 1.92 (m, 1 H), 1.76 (br s, 1 H), 1.12−1.06 (m, 1 H), 1.02−0.98 (m, 1 H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 142.8, 128.6, 126.3, 125.9, 43.7, 36.2, 25.3, 17.5. MS (ESI) <i>m</i>/<i>z</i> 148.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>14</sub>N<sup>+</sup> [MH<sup>+</sup>] 148.1126, found 148.1124.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>trans</i>-<i>N</i>-Methyl-(2-phenylcyclopropylmethyl)amine (<b>16</b>)</h3><div class="NLM_p last">Acetic formic anhydride was generated as described above for <b>15</b> from formic acid (0.18 mL, 4.8 mmol) and acetic anhydride (0.365 mL, 3.9 mmol) and THF (4.5 mL). This mixture (0.53 mL, 0.408 mmol) was added to a solution of <b>14a</b> (30 mg, 0.163 mmol) in THF (1 mL) at −15 °C, followed by addition of <i>N</i>-methylmorpholine (17.9 μL, 0.163 mmol). The resulting mixture was stirred at −15 °C for 30 min and at rt for 1 h, insoluble materials were filtered out, and the mixture was concentrated in vacuo. The crude residue (42 mg) was dissolved in THF (1.2 mL), and to the solution was added 1.0 M borane dimethylsulfide complex in THF (0.41 mL). After the mixture was stirred at 65 °C overnight, the reaction was quenched by 10% aq HCl. The mixture was concentrated in vacuo to remove THF, and the residual aqueous solution was washed with Et<sub>2</sub>O (×1), neutralized with 10% aq NaOH, and then extracted with Et<sub>2</sub>O (×3). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by preparative TLC (EtOAc/Et<sub>3</sub>N/MeOH 8:1:1) to afford the title compound as a colorless oil (14.0 mg, 53% yield). HPLC purity: 21.0 min, 96.8% (column 2, method C). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.29−7.24 (m, 2 H), 7.18−7.15 (m, 1 H), 7.10−7.07 (m, 2 H), 2.66 (br d, 2 H), 2.49 (br s, 3 H), 2.37 (br s, 1 H), 1.77 (m, 1 H), 1.38−1.32 (m, 1 H), 0.99−0.85 (m, 2 H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 143.3, 128.7, 126.2, 125.9, 56.5, 36.5, 23.3, 22.5, 15.1. MS (ESI) <i>m</i>/<i>z</i> 162.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>11</sub>H<sub>16</sub>N<sup>+</sup> [MH<sup>+</sup>] 162.1283, found 162.1285.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>trans</i>-<i>N</i>,<i>N</i>-Dimethyl-(2-phenylcyclopropyl)amine (<b>17</b>)</h3><div class="NLM_p last">To a stirred solution of <b>9</b> (34 mg, 0.2 mmol) in acetonitrile/H<sub>2</sub>O (1:1, v/v) (5 mL) were added <i>N</i>-methylmorpholine (45 μL, 0.4 mmol), 37% aq formaldehyde (0.16 mL, 2.0 mmol), and sodium cyanoborohydride (40 mg, 0.6 mmol). Glacial acetic acid (40 μL) was added to the mixture over 10 min, and the reaction was stirred at rt for 30 min. To the reaction mixture was added crushed ice, and the acetonitrile was removed in vacuo. The aqueous residue was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by preparative TLC (EtOAc/Et<sub>3</sub>N 95:5) to afford the title compound as a colorless oil (19.7 mg, 61% yield). HPLC purity: 19.8 min, 94.8% (column 1, method C). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.34−7.26 (m, 2 H), 7.18 (t, <i>J</i> = 7.3 Hz, 1 H), 7.09 (d, <i>J</i> = 7.2 Hz, 2 H), 2.74 (d, <i>J</i> = 3.6 Hz, 2 H), 2.42 (s, 6 H), 2.00 (m, 1 H), 1.83 (m, 1 H), 1.13 (m, 1 H), 0.99 (m, 1 H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 142.5, 128.6, 126.5, 126.0, 50.6, 45.4, 25.7, 17.6. MS (ESI) <i>m</i>/<i>z</i> 162.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>11</sub>H<sub>16</sub>N<sup>+</sup> [MH<sup>+</sup>] 162.1283, found 162.1279.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>trans</i>-<i>N</i>-Isopropyl-(2-phenylcyclopropyl)amine (<b>18</b>)</h3><div class="NLM_p last">To a stirred solution of <b>9</b> (50 mg, 0.295 mmol) in MeOH (1 mL) were added acetone (21.7 μL, 0.295 mmol) and sodium cyanoborohydride (22 mg, 0.354 mmol). The mixture was stirred at 0 °C for 1 h and at rt overnight. Crushed ice was added to the reaction mixture, and the MeOH was removed in vacuo. The aqueous residue was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by preparative TLC (EtOAc/Et<sub>3</sub>N 95:5) to afford the title compound as a colorless oil (16.7 mg, 32% yield). HPLC purity: 8.6 min, 97.4% (column 1, method C). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.30−7.25 (m, 2 H), 7.19−7.14 (m, 1 H), 7.06 (d, <i>J</i> = 7.3 Hz, 2 H), 3.01 (m, 1 H), 2.31 (m, 1 H), 1.90 (m, 1 H), 1.87 (br s, 1 H), 1.12 (d, <i>J</i> = 6.3 Hz, 6 H), 1.07 (m, 2 H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 142.8, 128.6, 126.1, 125.8, 49.7, 40.7, 25.9, 23.7, 23.6, 17.2. MS (ESI) <i>m</i>/<i>z</i> 176.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>12</sub>H<sub>18</sub>N<sup>+</sup> [MH<sup>+</sup>] 176.1439, found 176.1437.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>trans</i>-<i>N</i>-Benzyl-(2-phenylcyclopropyl)amine (<b>19</b>)</h3><div class="NLM_p last">Prepared by the same procedure as described for <b>18</b> with benzaldehyde (27 μL, 0.266 mmol) as the starting material (15.4 mg, 23% yield). HPLC purity: 14.6 min, 96.8% (column 1, method C). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.40−7.25 (m, 9 H), 7.18 (m, 1 H), 7.03 (d, <i>J</i> = 7.3 Hz, 2 H), 3.92 (s, 2 H), 2.42 (m, 1 H), 2.25 (m, br s, 1 H), 1.97 (m, 1 H), 1.14 (m, 1 H), 1.01 (m, 1 H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 142.7, 140.7, 128.8, 128.7, 128.6, 127.4, 126.3, 125.9, 54.0, 41.6, 25.8, 17.5. MS (ESI) <i>m</i>/<i>z</i> 224.1 [MH<sup>+</sup>]. HRMS, (ESI) calculated for C<sub>16</sub>H<sub>18</sub>N<sup>+</sup> [MH<sup>+</sup>] 224.1439, found 224.1440.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>trans</i>-<i>N</i>-Benzyl-(2-phenylcyclopropylmethyl)amine (<b>20</b>)</h3><div class="NLM_p last">Prepared by the same procedure as described for <b>18</b> with <b>14a</b> (30 mg, 0.163 mmol) and benzaldehyde (14.9 μL, 0.147 mmol) as the starting materials (20.8 mg, 54% yield). HPLC purity: 15.7 min, 95.1% (column 1, method C). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.36−7.25 (m, 7 H), 7.19−7.16 (m, 1 H), 7.10−7.07 (m, 2 H), 3.87 (s, 2 H), 2.71 (m, 1 H), 1.73 (m, 1 H), 1.69 (br s, 1 H), 0.95 (m, 1 H), 0.85 (m, 1 H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 143.4, 140.8, 128.8, 128.7, 128.5, 127.4, 126.1, 125.9, 54.1, 54.0, 23.8, 22.5, 15.3. MS (ESI) <i>m</i>/<i>z</i> 238.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>17</sub>H<sub>20</sub>N<sup>+</sup> [MH<sup>+</sup>] 238.1596, found 238.1589.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> General Procedure for the Synthesis of Substituted Styrene (<b>22</b>)</h3><div class="NLM_p last">To a stirred suspension of benzaldehyde <b>21</b> (10 mmol) and methyltriphenylphosphonium bromide (4.28 g, 12 mmol) in THF (50 mL) was added sodium hydride (1.08 g, 45.10 mmol) under argon purge at 0 °C. After the mixture was stirred at rt overnight, the organic layer was washed three times with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was purified by silica gel column chromatography (hexane/Et<sub>2</sub>O 20:1) to afford the title compound as a colorless oil (90−99% yield).</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>trans</i>-(2-Naphthalen-2-ylcyclopropyl)methylamine Hydrochloride (<b>26</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 2-vinylnaphthalene as the starting material. HPLC purity: 14.8 min, 97.7% (column 1, method C). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.81−7.77 (m, 3 H), 7.63 (s, 1 H), 7.48−7.38 (m, 2 H), 7.28 (m, 1 H), 3.06 (d, <i>J</i> = 7.4 Hz, 2 H), 2.20 (m, 1 H), 1.55 (m, 1 H), 1.24 (m, 1 H), 1.15 (m, 1 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 139.1, 134.0, 132.7, 128.1, 127.6, 127.4, 126.2, 125.3, 124.7, 124.3, 43.9, 22.4, 19.9, 14.1. MS (ESI) <i>m</i>/<i>z</i> 198.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>14</sub>H<sub>16</sub>N<sup>+</sup> [MH<sup>+</sup>] 198.1283, found 198.1290.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>trans</i>-[2-(2-Fluorophenyl)cyclopropyl]methylamine Hydrochloride (<b>27</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 2-fluorostyrene as the starting material. HPLC purity: 12.3 min, 95.8% (column 1, method C). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.21 (m, 1 H), 7.13−7.02 (m, 3 H), 3.07−3.03 (m, 2 H), 2.16 (m, 1 H), 1.49 (m, 1 H), 1.17−1.09 (m, 2 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 162.1 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 243.9 Hz), 128.3 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 14.2 Hz), 127.81 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 8.3 Hz), 127.2 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 3.9 Hz), 124.4 (d, <sup>4</sup><i>J</i><sub>CF</sub> = 3.5 Hz), 115.0 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 22.1 Hz), 43.8, 18.3, 15.7, 12.7. MS (ESI) <i>m</i>/<i>z</i> 166.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>13</sub>NF<sup>+</sup> [MH<sup>+</sup>] 166.1032, found 166.1029.</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>trans</i>-[2-(2-Chlorophenyl)cyclopropyl]methylamine Hydrochloride (<b>28</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 2-chlorostyrene as the starting material. HPLC purity: 6.8 min, 96.2% (column 3, method A). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.38 (dd, <i>J</i> = 7.4, 1.2 Hz, 1 H), 7.26−7.11 (m, 3 H), 3.25 (m, 1 H), 2.93 (m, 1 H), 2.22 (m, 1 H), 1.37 (m, 1 H), 1.12 (t, <i>J</i> = 6.8 Hz, 2 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 139.8, 136.4, 130.4, 129.0, 128.7, 128.4, 44.9, 21.6, 19.7, 14.9. MS (ESI) <i>m</i>/<i>z</i> 182.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>13</sub>NCl<sup>+</sup> [MH<sup>+</sup>] 182.0731, found 182.0738.</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>trans</i>-[2-(2-Bromophenyl)cyclopropyl]methylamine Hydrochloride (<b>29</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 2-bromostyrene as the starting material. HPLC purity: 14.8 min, 96.1% (column 1, method C). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.57 (d, <i>J</i> = 8.1 Hz, 1 H), 7.29 (t, <i>J</i> = 7.0 Hz, 1 H), 7.13 (m, 2 H), 3.33 (m, 1 H), 2.89 (m, 1 H), 2.17 (m, 1 H), 1.39 (m, 1 H), 1.13 (m, 2 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 140.3, 132.5, 128.2, 127.9, 127.8, 125.8, 43.8, 23.3, 18.7, 12.9. MS (ESI) <i>m</i>/<i>z</i> 226.0 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>13</sub>NBr<sup>+</sup> [MH<sup>+</sup>] 226.0231, found 226.0228.</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>trans</i>-[2-(2-Methylphenyl)cyclopropyl]methylamine Hydrochloride (<b>30</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 2-methylstyrene as the starting material. HPLC purity: 9.4 min, 98.5% (column 1, method E). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.13 (t, <i>J</i> = 7.8 Hz, 1 H), 6.96−6.91 (m, 3 H), 7.13 (m, 2 H), 3.00 (m, 1 H), 2.28 (s, 3 H), 2.89 (m, 1 H), 2.01−1.96 (m, 1 H), 1.44 (m, 1 H), 1.05 (t, <i>J</i> = 6.7 Hz, 1 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 142.6, 139.0, 129.4, 127.8, 127.7, 124.1, 45.1, 23.2, 21.6, 20.8, 15.2. MS (ESI) <i>m</i>/<i>z</i> 162.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>11</sub>H<sub>16</sub>N<sup>+</sup> [MH<sup>+</sup>] 161.1277, found 162.1270.</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>trans</i>-[2-(2-Trifluoromethylphenyl)cyclopropyl]methylamine Hydrochloride (<b>31</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 2-trifluoromethylstyrene as the starting material. HPLC purity: 7.9 min, 99.3% (column 3, method A). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.20 (s, 3 H), 7.67 (d, <i>J</i> = 6.4 Hz, 1 H), 7.58 (m, 1 H), 7.40 (m, 1 H), 7.29 (d, <i>J</i> = 5.8 Hz, 1 H), 3.00 (m, 1 H), 2.75 (m, 1 H), 2.15 (m, 1 H), 1.50 (m, 1 H), 1.09 (m, 2 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 140.0, 133.2, 128.6 (q, <sup>2</sup><i>J</i><sub>CF</sub> = 30.0 Hz), 128.0, 127.0, 126.1 (q, <sup>3</sup><i>J</i><sub>CF</sub> = 5.5 Hz), 125.1 (q, <sup>1</sup><i>J</i><sub>CF</sub> = 273.7 Hz), 42.7, 19.3, 19.2, 14.3. MS (ESI) <i>m</i>/<i>z</i> 216.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>11</sub>H<sub>13</sub>NF<sub>3</sub><sup>+</sup> [MH<sup>+</sup>] 216.0995, found 216.0990.</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>trans</i>-[2-(2-Methoxyphenyl)cyclopropyl]methylamine Hydrochloride (<b>32</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 2-methoxystyrene as the starting material. HPLC purity: 7.3 min, 97.7% (column 3, method A). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.17−7.13 (m, 1 H), 6.94−6.82 (m, 3 H), 3.86 (s, 3 H), 2.79 (m, 2 H), 2.07−2.02 (m, 1 H), 1.29−1.25 (m, 1 H), 1.09−1.02 (m, 1 H), 0.97−0.90 (m, 1 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 159.8, 130.7, 128.5, 127.3, 121.7, 111.4, 56.1, 45.8, 20.8, 18.2, 13.3. MS (ESI) <i>m</i>/<i>z</i> 178.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>11</sub>H<sub>16</sub>NO<sup>+</sup> [MH<sup>+</sup>] 178.1226, found 178.1228.</div></div><div id="sec3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>trans</i>-[2-(2-Hydroxyphenyl)cyclopropyl]methylamine Hydrochloride (<b>33</b>)</h3><div class="NLM_p last">To a solution of <b>32</b> (80 mg, 0.451 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (2 mL) under a nitrogen atmosphere at −78 °C was slowly added a solution of boron tribromide (1.0 M in CH<sub>2</sub>Cl<sub>2</sub>, 1 mL). The reaction mixture was allowed to warm to rt and stirred for 4 h. The brown solution was cooled with an ice bath, and to the solution was slowly added water (2 mL). The organic layer was separated, and the water layer was extracted with EtOAc (×4). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated until the volume was reduced to about 1 mL. To the solution was added 1 M HCl in Et<sub>2</sub>O (1 mL, 1 mmol) at 0 °C. After stirring at 0 °C for 15 min and at rt for 1 h, the mixture was concentrated in vacuo. The resulting residue was purified by recrystallization from ethanol/Et<sub>2</sub>O to afford the title compound as a white solid (50 mg, 68% yield). HPLC purity: 7.7 min, 97.7% (column 3, method B). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.03−6.99 (m, 1 H), 6.91 (d, <i>J</i> = 7.5 Hz, 1 H), 6.79−6.73 (m, 2 H), 3.15−3.10 (m, 1 H), 2.91−2.86 (m, 1 H), 2.07−2.02 (m, 1 H), 1.24−1.20 (m, 1 H), 1.75−1.11 (m, 1 H), 1.00−0.95 (m, 1 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 157.3, 128.4, 128.4, 127.8, 120.8, 115.7, 45.5, 19.5, 18.4, 12.6. MS (ESI) <i>m</i>/<i>z</i> 164.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>14</sub>NO<sup>+</sup> [MH<sup>+</sup>] 164.1070, found 164.1068.</div></div><div id="sec3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>trans</i>-[2-(3-Fluorophenyl)cyclopropyl]methylamine Hydrochloride (<b>34</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 3-fluorostyrene as the starting material. HPLC purity: 12.6 min, 95.9% (column 1, method C). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.27 (m, 1 H), 6.98 (d, <i>J</i> = 7.7 Hz, 1 H), 6.90 (m, 2 H), 3.01 (m, 2 H), 2.06 (m, 1 H), 1.44 (m, 1 H), 1.12 (m, 2 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 163.5 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 243.0 Hz), 144.8 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 6.0 Hz), 130.1 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 8.8 Hz), 122.0, 112.7 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 22.0 Hz), 43.7, 22.0, 20.3, 14.4. MS (ESI) <i>m</i>/<i>z</i> 166.0 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>13</sub>NF<sup>+</sup> [MH<sup>+</sup>] 166.1032, found 166.1032.</div></div><div id="sec3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>trans</i>-[2-(3-Chlorophenyl)cyclopropyl]methylamine Hydrochloride (<b>35</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 3-chlorostyrene as the starting material. HPLC purity: 7.4 min, 98.6% (column 3, method A). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.27−7.05 (m, 4 H), 3.00 (d, <i>J</i> = 4.1 Hz, 2 H), 2.03 (m, 1 H), 1.43 (m, 1 H), 1.11 (m, 2 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 145.4, 135.4, 131.1, 127.3, 127.2, 125.6, 44.9, 23.0, 21.3, 15.4. MS (ESI) <i>m</i>/<i>z</i> 182.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>13</sub>NCl<sup>+</sup> [MH<sup>+</sup>] 182.0731, found 182.0732.</div></div><div id="sec3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>trans</i>-[2-(3-Bromophenyl)cyclopropyl]methylamine Hydrochloride (<b>36</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 3-bromostyrene as the starting material. HPLC purity: 16.3 min, 95.9% (column 1, method C). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.33 (d, <i>J</i> = 7.8 Hz, 2 H), 7.26−7.11 (m, 2 H), 3.08−2.95 (m, 2 H), 2.07−2.01 (m, 1 H), 1.50−1.39 (m, 1 H), 1.17−1.07 (m, 2 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 144.5, 130.2, 129.2, 129.1, 124.8, 122.4, 43.7, 21.8, 20.2, 14.2. MS (ESI) <i>m</i>/<i>z</i> 226.0 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>13</sub>NBr<sup>+</sup> [MH<sup>+</sup>] 226.0231, found 226.0235.</div></div><div id="sec3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>trans</i>-[2-(3-Methylphenyl)cyclopropyl]methylamine Hydrochloride (<b>37</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 3-methylstyrene as the starting material. HPLC purity: 9.5 min, 99.2% (column 1, method E). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.13−7.05 (m, 3 H), 7.02−7.00 (m, 1 H), 3.25−3.21 (m, 1 H), 2.94−2.88 (m, 1 H), 2.40 (s, 3 H), 2.04−1.99 (m, 1 H), 1.46−1.41 (m, 1 H), 1.09−1.04 (m, 1 H), 0.97−0.93 (m, 1 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 140.2, 138.8, 130.8, 127.5, 127.1, 126.8, 45.1, 21.6, 20.0, 18.7, 13.9. MS (ESI) <i>m</i>/<i>z</i> 162.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>11</sub>H<sub>16</sub>N<sup>+</sup> [MH<sup>+</sup>] 162.1277, found 162.1270.</div></div><div id="sec3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>trans</i>-[2-(3-Trifluoromethylphenyl)cyclopropyl]methylamine Hydrochloride (<b>38</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 3-trifluorostyrene as the starting material. HPLC purity: 8.4 min, 98.3% (column 3, method A). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.94 (s, 3 H), 7.50−7.39 (m, 4 H), 2.96 (m, 1 H), 2.74 (m, 1 H), 2.12 (m, 1 H), 1.34 (m, 1 H), 1.15−1.05 (m, 2 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 143.2, 129.6, 129.3, 129.0 (q, <sup>2</sup><i>J</i><sub>CF</sub> = 31.0 Hz), 124.2 (q, <sup>1</sup><i>J</i><sub>CF</sub> = 272.6 Hz), 122.6 (q, <sup>3</sup><i>J</i><sub>CF</sub> = 3.5 Hz), 122.4 (q, <sup>3</sup><i>J</i><sub>CF</sub> = 3.5 Hz), 42.7, 21.3, 20.4, 14.4. MS (ESI) <i>m</i>/<i>z</i> 216.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>11</sub>H<sub>13</sub>NF<sub>3</sub><sup>+</sup> [MH<sup>+</sup>] 216.0995, found 216.0991.</div></div><div id="sec3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>trans</i>-[2-(3-Methoxyphenyl)cyclopropyl]methylamine Hydrochloride (<b>39</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 3-methoxystyrene as the starting material. HPLC purity: 6.9 min, 98.5% (column 3, method A). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.18−7.13 (m, 1 H), 6.72−6.69 (m, 3 H), 3.76 (s, 3 H), 2.99 (d, <i>J</i> = 7.3 Hz, 2 H), 2.03−1.97 (m, 1 H), 1.44−1.39 (m, 1 H), 1.11−1.01 (m, 2 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 161.4, 144.5, 130.5, 119.3, 113.1, 112.5, 55.8, 45.0, 23.4, 21.0, 15.2. MS (ESI) <i>m</i>/<i>z</i> 178.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>11</sub>H<sub>16</sub>NO<sup>+</sup> [MH<sup>+</sup>] 178.1226, found 178.1226.</div></div><div id="sec3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>trans</i>-[2-(3-Hydroxyphenyl)cyclopropyl]methylamine Hydrochloride (<b>40</b>)</h3><div class="NLM_p last">Prepared by the same procedure as described for <b>33</b> with <b>39</b> as the starting material (45 mg, 70% yield). HPLC purity: 7.5 min, 97.2% (column 1, method E). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 6.95 (t, <i>J</i> = 7.7 Hz, 1 H), 6.51−6.45 (m, 3 H), 2.87 (m, 2 H), 1.83 (m, 1 H), 1.28 (m, 1 H), 0.96−0.91 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 158.6, 144.4, 130.5, 118.4, 114.1, 113.8, 45.1, 23.3, 20.9, 15.2. MS (ESI) <i>m</i>/<i>z</i> 164.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>14</sub>NO<sup>+</sup> [MH<sup>+</sup>] 164.1070, found 164.1073.</div></div><div id="sec3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>trans</i>-[2-(4-Fluorophenyl)cyclopropyl]methylamine Hydrochloride (<b>41</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 4-fluorostyrene as the starting material. HPLC purity: 12.7 min, 95.4% (column 1, method C). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.16 (m, 2 H), 7.00 (m, 2 H), 3.01 (d, <i>J</i> = 7.4 Hz, 2 H), 2.04 (m, 1 H), 1.39 (m, 1 H), 1.08 (m, 2 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 161.8 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 243.0 Hz), 137.6, 127.8 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 7.9 Hz), 115.0 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 21.7 Hz), 43.8, 21.5, 19.7, 13.9. MS (ESI) <i>m</i>/<i>z</i> 166.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>13</sub>NF<sup>+</sup> [MH<sup>+</sup>] 166.1032, found 166.1034.</div></div><div id="sec3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>trans</i>-[2-(4-Chlorophenyl)cyclopropyl]methylamine Hydrochloride (<b>42</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 4-chlorostyrene as the starting material. HPLC purity: 7.4 min, 98.2% (column 3, method A). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.25 (d, <i>J</i> = 8.4 Hz, 2 H), 7.12 (d, <i>J</i> = 8.5 Hz, 2 H), 3.00 (d, <i>J</i> = 7.2 Hz, 2 H), 2.05−1.99 (m, 1 H), 1.44−1.38 (m, 1 H), 1.09 (t, <i>J</i> = 6.9 Hz, 2 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 141.7, 132.8, 129.6, 128.8, 44.9, 22.8, 21.2, 15.3. MS (ESI) <i>m</i>/<i>z</i> 182.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>13</sub>NCl<sup>+</sup> [MH<sup>+</sup>] 182.0731, found 182.0736.</div></div><div id="sec3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>trans</i>-[2-(4-Bromophenyl)cyclopropyl]methylamine Hydrochloride (<b>43</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 4-bromostyrene as the starting material. HPLC purity: 14.3 min, 97.4% (column 1, method C). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.41 (d, <i>J</i> = 8.5 Hz, 2 H), 7.08 (d, <i>J</i> = 8.4 Hz, 2 H), 3.05−2.96 (m, 2 H), 2.04−1.99 (m, 1 H), 1.44−1.39 (m, 1 H), 1.14−1.07 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 140.6, 131.0, 127.6, 119.1, 21.3, 19.6, 13.7. MS (ESI) <i>m</i>/<i>z</i> 225.9 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>13</sub>NBr<sup>+</sup> [MH<sup>+</sup>] 226.0231, found 226.0233.</div></div><div id="sec3_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>trans</i>-[2-(4-Methylphenyl)cyclopropyl]methylamine Hydrochloride (<b>44</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 4-methylstyrene as the starting material. HPLC purity: 6.5 min, 98.8% (column 1, method D). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 6.92 (d, <i>J</i> = 7.9 Hz, 2 H), 6.86 (d, <i>J</i> = 7.9 Hz, 2 H), 2.78 (d, <i>J</i> = 7.4 Hz, 2 H), 2.13 (s, 3 H), 1.81−1.76 (m, 1 H), 1.22−1.18 (m, 1 H), 0.90−0.82 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 139.9, 136.6, 130.1, 127.0, 45.4, 23.0, 21.7, 21.1, 15.0. MS (ESI) <i>m</i>/<i>z</i> 162.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>11</sub>H<sub>16</sub>N<sup>+</sup> [MH<sup>+</sup>] 161.1277, found 162.1272.</div></div><div id="sec3_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>trans</i>-[2-(4-Trifluoromethylphenyl)cyclopropyl]methylamine Hydrochloride (<b>45</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 4-trifluorostyrene as the starting material. HPLC purity: 8.4 min, 99.3% (column 3, method A). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.17 (s, 3 H), 7.61 (d, <i>J</i> = 8.0 Hz, 2 H), 7.33 (d, <i>J</i> = 8.0 Hz, 2 H), 2.96 (m, 1 H), 2.75 (m, 1 H), 2.14 (m, 1 H), 1.40 (m, 1 H), 1.12 (t, <i>J</i> = 7.0 Hz, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 147.6, 129.0 (q, <sup>2</sup><i>J</i><sub>CF</sub> = 32.3 Hz), 127.7, 126.2 (q, <sup>3</sup><i>J</i><sub>CF</sub> = 3.3 Hz), 125.7 (q, <sup>1</sup><i>J</i><sub>CF</sub> = 270.8 Hz), 45.1, 23.2, 21.7, 16.1. MS (ESI) <i>m</i>/<i>z</i> 216.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>11</sub>H<sub>13</sub>NF<sub>3</sub><sup>+</sup> [MH<sup>+</sup>] 216.0995, found 216.0989.</div></div><div id="sec3_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>trans</i>-[2-(4-Methoxyphenyl)cyclopropyl]methylamine Hydrochloride (<b>46</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 4-methoxystyrene as the starting material. HPLC purity: 5.7 min, 99.1% (column 3, method A). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.05 (d, <i>J</i> = 8.3 Hz, 2 H), 6.81 (d, <i>J</i> = 8.3 Hz, 2 H), 3.74 (s, 3 H), 2.98 (d, <i>J</i> = 6.8 Hz, 2 H), 1.95 (m, 1 H), 1.31 (m, 1 H), 1.01 (m, 2 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 159.7, 134.6, 128.3, 115.0, 55.8, 45.1, 22.7, 20.5, 14.7. MS (ESI) <i>m</i>/<i>z</i> 178.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>11</sub>H<sub>16</sub>NO<sup>+</sup> [MH<sup>+</sup>] 178.1226, found 178.1226.</div></div><div id="sec3_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>trans</i>-[2-(4-Hydroxyphenyl)cyclopropyl]methylamine Hydrochloride (<b>47</b>)</h3><div class="NLM_p last">Prepared by the same procedure as described for <b>33</b> with <b>46</b> as the starting material (38 mg, 72% yield). HPLC purity: 6.1 min, 99.2% (column 3, method B). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 6.96 (d, <i>J</i> = 8.4 Hz, 2 H), 6.68 (d, <i>J</i> = 8.4 Hz, 2 H), 2.96 (d, <i>J</i> = 7.3 Hz, 2 H), 1.95−1.89 (m, 1 H), 1.29 (m, 1 H), 1.03−0.92 (m, 2 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 157.0, 133.3, 128.4, 116.3, 45.2, 22.7, 20.4, 14.5. MS (ESI) <i>m</i>/<i>z</i> 164.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>14</sub>NO<sup>+</sup> [MH<sup>+</sup>] 164.1070, found 164.1069.</div></div><div id="sec3_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>trans</i>-[2-(2,3-Difluorophenyl)cyclopropyl]methylamine Hydrochloride (<b>48</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of substituted styrene <b>14a</b> described above by using 2,3-difluorobenzaldehyde as the starting material. HPLC purity: 8.7 min, 95.1% (column 1, method C). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.08−7.05 (m, 2 H), 6.87−6.86 (m, 1 H), 3.08−3.02 (m, 2 H), 2.21−2.16 (m, 1 H), 1.58−1.51 (m, 1 H), 1.16 (t, <i>J</i> = 6.9 Hz, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 151.9 (dd, <sup>1</sup><i>J</i><sub>CF</sub> = 246.0, <sup>2</sup><i>J</i><sub>CF</sub> = 13.0 Hz), 150.9 (dd, <sup>1</sup><i>J</i><sub>CF</sub> = 245.4, <sup>2</sup><i>J</i><sub>CF</sub> = 13.0 Hz), 132.3 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 10.9 Hz), 125.6 (dd, <sup>2</sup><i>J</i><sub>CF</sub> = 7.2, <sup>3</sup><i>J</i><sub>CF</sub> = 4.8 Hz), 123.2 (m), 116.0 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 17.3 Hz), 44.7, 19.8, 16.7, 14.3. MS (ESI) <i>m</i>/<i>z</i> 184.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>12</sub>NF<sub>2</sub><sup>+</sup> [MH<sup>+</sup>] 184.0932, found 184.0931.</div></div><div id="sec3_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>trans</i>-[2-(2,4-Difluorophenyl)cyclopropyl]methylamine Hydrochloride (<b>49</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of substituted styrene and <b>14a</b> described above by using 2,4-difluorobenzaldehyde as the starting material. HPLC purity: 8.5 min, 95.5% (column 1, method C). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.11 (dd, <i>J</i> = 15.4, 8.4 Hz, 1 H), 6.93−6.86 (m, 2 H), 3.02 (m, 2 H), 2.11−2.06 (m, 1 H), 1.43−1.40 (m, 1 H), 1.14−1.05 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 163.1 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 258 Hz), 163.0 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 258 Hz), 129.7 (dd, <sup>3</sup><i>J</i><sub>CF</sub> = 9.5, <sup>3</sup><i>J</i><sub>CF</sub> = 5.4 Hz), 112.3 (dd, <sup>2</sup><i>J</i><sub>CF</sub> = 21.4, <sup>3</sup><i>J</i><sub>CF</sub> = 3.7 Hz), 104.5 (dd, <sup>2</sup><i>J</i><sub>CF</sub> = 26.1, <sup>2</sup><i>J</i><sub>CF</sub> = 26.1 Hz), 44.8, 19.3, 16.5, 13.5. MS (ESI) <i>m</i>/<i>z</i> 184.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>12</sub>NF<sub>2</sub><sup>+</sup> [MH<sup>+</sup>] 184.0932, found 184.0930.</div></div><div id="sec3_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>trans</i>-[2-(2,6-Difluorophenyl)cyclopropyl]methylamine Hydrochloride (<b>50</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of substituted styrene <b>14a</b> described above by using 2,6-difluorobenzaldehyde as the starting material. HPLC purity: 5.4 min, 96.5% (column 3, method A). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.31−7.21 (m, 1 H), 6.98−6.89 (m, 2 H), 3.06−3.03 (m, 2 H), 1.93 (m, 1 H), 1.64 (m, 1 H), 1.26 (m, 1 H), 1.13 (m, 1 H). <sup>13</sup>C NMR (75 MHz, MeOD-<i>d</i><sub>4</sub>) δ 162.5 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 246.5 Hz), 128.5 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 10.7 Hz), 116.5, 111.4 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 26.1 Hz), 43.9, 17.0, 11.7, 11.6. MS (ESI) <i>m</i>/<i>z</i> 184.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>12</sub>NF<sub>2</sub><sup>+</sup> [MH<sup>+</sup>] 184.09323; found 184.09316.</div></div><div id="sec3_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>trans</i>-[2-(3,4-Difluorophenyl)cyclopropyl]methylamine Hydrochloride (<b>51</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of substituted styrene and <b>14a</b> described above by using 3,4-difluorobenzaldehyde as the starting material. HPLC purity: 8.6 min, 96.4% (column 1, method C). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.17−7.05 (m, 2 H), 6.98−5.97 (m, 1 H), 2.98 (m, 2 H), 2.10−2.06 (m, 1 H), 1.44 (m, 1 H), 1.12−1.09 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 151.6 (dd, <sup>1</sup><i>J</i><sub>CF</sub> = 245.7, <sup>2</sup><i>J</i><sub>CF</sub> = 12.8 Hz), 150.0 (dd, <sup>1</sup><i>J</i><sub>CF</sub> = 244.1, <sup>2</sup><i>J</i><sub>CF</sub> = 12.7 Hz), 140.6 (dd, <sup>3</sup><i>J</i><sub>CF</sub> = 5.9, <sup>4</sup><i>J</i><sub>CF</sub> = 3.6 Hz), 123.7 (dd, <sup>3</sup><i>J</i><sub>CF</sub> = 6.1, <sup>4</sup><i>J</i><sub>CF</sub> = 3.3 Hz), 118.2 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 17.3 Hz), 116.1 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 17.9 Hz), 44.9, 22.6, 21.3, 15.3. MS (ESI) <i>m</i>/<i>z</i> 184.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>12</sub>NF<sub>2</sub><sup>+</sup> [MH<sup>+</sup>] 184.0932, found 184.0930.</div></div><div id="sec3_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>trans</i>-[2-(4-Chloro-2-fluorophenyl)cyclopropyl]methylamine Hydrochloride (<b>52</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of substituted styrene and <b>14a</b> described above by using 4-chloro-2-fluorobenzaldehyde as the starting material. HPLC purity: 7.4 min, 94.4% (column 3, method A). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.13−7.07 (m, 3 H), 3.13−3.00 (m, 2 H), 2.16−2.12 (m, 1 H), 1.57−1.52 (m, 1 H), 1.17−1.11 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 162.8 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 247.9 Hz), 133.4 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 10.4 Hz), 129.6 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 4.9 Hz), 128.6 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 14.4 Hz), 125.7 (d, <sup>4</sup><i>J</i><sub>CF</sub> = 3.6 Hz), 116.7 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 25.9 Hz), 44.7, 19.5, 16.6, 14.1. MS (ESI) <i>m</i>/<i>z</i> 200.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>12</sub>NFCl<sup>+</sup> [MH<sup>+</sup>] 200.0637, found 200.0639.</div></div><div id="sec3_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>trans</i>-[2-(2-Chloro-4-fluorophenyl)cyclopropyl]methylamine Hydrochloride (<b>53</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of substituted styrene and <b>14a</b> described above by using 2-chloro-4-fluorobenzaldehyde as the starting material. HPLC purity: 7.2 min, 98.2% (column 3, method A). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.20−7.17 (m, 2 H), 7.03−6.99 (m, 1 H), 3.27−3.22 (m, 1 H), 2.96−2.91 (m, 1 H), 2.19−2.14 (m, 1 H), 1.44−1.39 (m, 1 H), 1.17−1.07 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 162.6 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 247.0 Hz), 137.0 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 10.3 Hz), 136.0, 130.3 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 8.8 Hz), 117.4 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 25.2 Hz), 115.2 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 21.2 Hz), 44.8, 21.1, 19.5, 13.8. MS (ESI) <i>m</i>/<i>z</i> 200.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>12</sub>NFCl<sup>+</sup> [MH<sup>+</sup>] 200.0637, found 200.0633.</div></div><div id="sec3_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>trans</i>-[2-(2,3-Dichlorophenyl)cyclopropyl]methylamine Hydrochloride (<b>54</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of substituted styrene and <b>14a</b> described above by using 2,3-dichlorobenzaldehyde as the starting material. HPLC purity: 8.7 min, 98.7% (column 3, method A). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.37 (d, <i>J</i> = 6.9 Hz, 1 H), 7.22 (dd, <i>J</i> = 7.9, 7.9 Hz, 1 H), 7.10 (d, <i>J</i> = 7.8 Hz, 1 H), 3.32−3.25 (m, 1 H), 2.98−2.93 (m, 1 H), 2.29−2.24 (m, 1 H), 1.49−1.45 (m, 1 H), 1.21−1.10 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 142.4, 134.5, 133.9, 129.7, 128.9, 127.2, 44.8, 22.5, 19.8, 14.2. MS (ESI) <i>m</i>/<i>z</i> 216.0 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>12</sub>NCl<sub>2</sub><sup>+</sup> [MH<sup>+</sup>] 216.0341, found 216.0338.</div></div><div id="sec3_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>trans</i>-[2-(2,4-Dichlorophenyl)cyclopropyl]methylamine Hydrochloride (<b>55</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of substituted styrene and <b>14a</b> described above by using 2,4-dichlorobenzaldehyde as the starting material. HPLC purity: 8.3 min, 93.7% (column 3, method A). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.43 (d, <i>J</i> = 1.9 Hz, 1 H), 7.26 (dd, <i>J</i> = 8.3, 1.9 Hz, 1 H), 7.12 (d, <i>J</i> = 8.4 Hz, 1 H), 3.25−3.20 (m, 1 H), 2.96−2.91 (m, 1 H), 2.22−2.17 (m, 1 H), 1.45−1.40 (m, 1 H), 1.18−1.09 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 138.9, 137.1, 133.8, 130.0, 129.9, 128.5, 44.7, 21.1, 19.7, 14.0. MS (ESI) <i>m</i>/<i>z</i> 216.0 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>10</sub>H<sub>12</sub>NCl<sub>2</sub><sup>+</sup> [MH<sup>+</sup>] 216.0341, found 216.0338.</div></div><div id="sec3_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>trans</i>-[2-(4-Fluoro-3-methylphenyl)cyclopropyl]methylamine Hydrochloride (<b>56</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 1-fluoro-2-methyl-4-vinylbenzene as the starting material. HPLC purity: 11.69 min, 99.6% (column 1, method E). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.08−6.84 (m, 3 H), 3.07−2.91 (m, 1 H), 2.22 (s, 3 H), 2.04−1.92 (m, 1 H), 1.42−1.28 (m, 1 H), 1.12−0.96 (m, 2 H).<sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ δ161.0 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 241.4 Hz), 136.7, 128.8, 124.6 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 7.9 Hz), 124.2, 114.2 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 25.5 Hz), 43.4, 21.1, 19.2, 13.3, 13.0. MS (ESI) <i>m</i>/<i>z</i> 163.0 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>11</sub>H<sub>15</sub>NF<sup>+</sup> [MH<sup>+</sup>] 180.1183, found 180.1187.</div></div><div id="sec3_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> <i>trans</i>-[2-(2-Chloro-6-methylphenyl)cyclopropyl]methylamine Hydrochloride (<b>57</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 1-chloro-3-methyl-2-vinylbenzene as the starting material. HPLC purity: 13.76 min, 96.7% (column 1, method E). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.24−7.18 (m, 1 H), 7.14−7.09 (m, 2 H), 3.56−3.45 (m, 1H), 2.81−2.70 (m, 1H), 2.44 (s, 3H), 1.86−1.77 (m, 1H), 1.48−1.35 (m, 1 H), 1.27−1.17 (m, 1 H), 1.02−0.92 (m, 1H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 140.8, 135.7, 135.6, 128.7, 127.5, 127.0, 43.6, 19.3, 18.9, 18.8, 14.2. MS (ESI) <i>m</i>/<i>z</i> 179.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>11</sub>H<sub>15</sub>NCl<sup>+</sup> [MH<sup>+</sup>] 196.0888, found 196.0892.</div></div><div id="sec3_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> <i>trans</i>-[2-(2-Bromo-4-methylphenyl)cyclopropyl]methylamine Hydrochloride (<b>58</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 2-bromo-4-methyl-1-vinylbenzene as the starting material. HPLC purity: 16.41 min, 96.8% (column 1, method E). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.41 (s, 1 H), 7.09 (d, <i>J</i> = 7.9 Hz, 1 H), 7.0 (d, <i>J</i> = 7.9 Hz, 1 H), 3.37−3.24 (m, 1 H), 2.92−2.81 (m, 1 H), 2.29 (s, 3 H), 2.17−2.06 (m, 1 H), 1.40−1.26 (m, 1 H), 1.13−1.02 (m, 2H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 136.5, 135.1, 130.9, 126.5, 125.3, 123.6, 41.9, 20.9, 17.6, 16.6, 10.8. MS (ESI) <i>m</i>/<i>z</i> 224.0 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>11</sub>H<sub>15</sub>NBr<sup>+</sup> [MH<sup>+</sup>] 240.0382, found 240.0388.</div></div><div id="sec3_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>trans</i>-[2-(2,3-Dimethylphenyl)cyclopropyl]methylamine Hydrochloride (<b>59</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 1,2-dimethyl-3-vinylbenzene as the starting material. HPLC purity: 12.92 min, 98.4% (column 1, method E). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.03−6.80 (m, 3 H), 3.27−3.15 (m, 1H), 2.97−2.83 (m, 1 H), 2.33 (s, 3H), 2.27 (s, 3 H), 2.08−1.94 (m, 1H), 1.46−1.32 (m, 1 H), 1.11−1.0 (m, 1H), 0.95−0.88 (m, 1 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 138.4, 136.0, 135.7, 127.7, 125.0, 123.9, 43.6, 20.8, 19.1, 17.1, 14.0, 12.2. MS (ESI) <i>m</i>/<i>z</i> 159.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>12</sub>H<sub>18</sub>N<sup>+</sup> [MH<sup>+</sup>] 176.1434, found 176.1436.</div></div><div id="sec3_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>trans</i>-[2-(3,4-Dimethylphenyl)cyclopropyl]methylamine Hydrochloride (<b>60</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 1,2-dimethyl-4-vinylbenzene as the starting material. HPLC purity: 13.03 min, 99.2% (column 1, method E). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.0 (d, <i>J</i> = 7.8 Hz, 1 H), 6.89 (s, 1 H), 6.82 (d, <i>J</i> = 7.8 Hz, 1 H), 3.02 (m, 2 H), 2.25 (s, 3 H), 2.21 (s, 3 H), 1.97−1.89 (m, 1 H), 1.40−1.29 (m, 1H), 1.08−0.95 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 138.4, 136.0, 133.7, 129.11, 126.8, 122.8, 43.5, 21.4, 19.1, 18.3, 17.9, 13.2. MS (ESI) <i>m</i>/<i>z</i> 159.1[MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>12</sub>H<sub>18</sub>N<sup>+</sup> [MH<sup>+</sup>] 176.1434, found 176.1433.</div></div><div id="sec3_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>trans</i>-[2-(6-Chloro-2-fluoro-3-methylphenyl)cyclopropyl]methylamine Hydrochloride (<b>61</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>14a</b> described above by using 1-chloro-3-fluoro-4-methyl-2-vinylbenzene (1 g, 5.8 mmol) as the starting material. HPLC purity: 13.03 min, 95.6% (column 1, method D). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.16−7.04 (m, 2 H), 3.22−3.11 (m, 1 H), 3.0−2.91 (m, 1 H), 2.22 (s, 3 H), 1.88−181 (m, 1 H), 1.56−1.45 (m, 1 H), 1.21−1.11 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 161.6 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 245.4 Hz), 133.5, 129.8, 125.8 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 16.4 Hz), 125.2, 123.8, 43.5, 17.5, 15.2, 12.9, 12.5. MS (ESI) <i>m</i>/<i>z</i> 214.1[MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>11</sub>H<sub>14</sub>NFCl<sup>+</sup> [MH<sup>+</sup>] 214.0793, found 214.0786.</div></div><div id="sec3_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>trans</i>-[2-(2-Bromophenyl)cyclopropylmethyl]carbamic Acid <i>tert</i>-Butyl Ester (<b>62</b>)</h3><div class="NLM_p last">To a solution of <b>29</b> (1.63 g, 6.21 mmol) and Boc<sub>2</sub>O (1.35 g, 8.07 mmol) in Et<sub>2</sub>O (75 mL) was added 10% aq NaOH (14.9 mL, 37.2 mmol) at 0 °C. The mixture was stirred at 0 °C for 30 min and then at rt for 7 h. To the resulting mixture were added crushed ice and Et<sub>2</sub>O. The organic layer was further washed with water (×1), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was purified by silica gel chromatography (hexane/EtOAc 10:1) to afford the title compounds as colorless oils (1.71 g, 84% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.44 (d, <i>J</i> = 8.5 Hz, 2 H), 7.40 (d, <i>J</i> = 8.5 Hz, 2 H), 7.30−7.19 (m, 3 H), 7.00 (d, <i>J</i> = 7.2 H, 1 Hz), 4.45 (br s, 1 H), 3.05−2.95 (m, 2 H), 1.76 (m, 1 H), 1.46 (s, 9 H), 1.26 (m, 1 H), 0.94 (m, 1 H), 0.77 (m, 1 H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 156.2, 141.6, 140.5, 139.6, 133.4, 131.2, 130.0, 128.8, 128.2, 126.1, 125.3, 79.6, 44.9, 28.8, 23.3, 20.6, 14.3.</div></div><div id="sec3_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>trans</i>-[2-(3-Bromophenyl)cyclopropylmethyl]carbamic Acid <i>tert</i>-Butyl Ester (<b>63</b>)</h3><div class="NLM_p last">Prepared by the same procedure as described for <b>62</b> (1.59 g, 99% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.29 (d, <i>J</i> = 6.8 Hz, 1 H), 7.20 (s, 1 H), 7.12 (t, <i>J</i> = 7.8 Hz, 1 H), 6.99 (d, <i>J</i> = 7.6 Hz, 1 H), 4.70 (br s, 1 H), 3.22−3.11 (m, 2 H), 1.80−1.76 (m, 1 H), 1.47 (s, 9 H), 1.33−1.27 (m, 1 H), 0.94 (t, <i>J</i> = 6.9 Hz, 2 H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 156.5, 145.5, 130.2, 129.3, 129.1, 124.9, 122.9, 28.8, 23.8, 22.0, 14.8.</div></div><div id="sec3_47_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>trans</i>-[2-(4-Bromophenyl)cyclopropylmethyl]carbamic Acid <i>tert</i>-Butyl Ester (<b>64</b>)</h3><div class="NLM_p last">Prepared by the same procedure as described for <b>62</b> (356 mg, 82% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.38 (d, <i>J</i> = 8.3 Hz, 2 H), 6.93 (d, <i>J</i> = 8.3 Hz, 2 H), 4.69 (br s, 1 H), 3.18−3.11 (m, 2 H), 1.79−1.76 (m, 2 H), 1.47 (s, 9 H), 1.28 (m, 2 H), 0.94−0.90 (m, 2 H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 156.0, 142.0, 131.7, 128.0, 127.0, 79.9, 45.0, 28.8, 23.7, 21.9, 14.8.</div></div><div id="sec3_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> <i>trans</i>-[2-(4′-Fluorobiphenyl-2-yl)cyclopropyl]methylamine Hydrochloride (<b>66</b>)</h3><div id="sec3_98" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Step A:</h4><div class="NLM_p last">Compound <b>62</b> (30 mg, 0.092 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (10.4 mg, 0.009 mmol), and 4-fluorophenylboronic acid (32.2 mg, 0.23 mmol) were dissolved in dimethoxyethane (DME) (4 mL), and the mixture was degassed for 1 min and stirred for 10 min at rt. To the mixture was added 2 M aq K<sub>2</sub>CO<sub>3</sub> (0.115 mL, 0.23 mmol). The mixture was degassed again for 1 min and stirred at 85 °C overnight. The resulting mixture was cooled to ambient temperature and poured into a mixture of 0.1 N HCl/EtOAc (15 mL/15 mL). After partition, the organic layer was washed with water, filtered, and concentrated. The residue was purified by preparative TLC (hexane/EtOAc 4:1) to afford the title compound as a colorless oil (31 mg, 99% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.38 (dd, <i>J</i> = 8.6, 5.5 Hz, 2 H), 7.32−7.12 (m, 5 H), 7.01 (d, <i>J</i> = 7.7 Hz, 1 H), 4.38 (br s, 1 H), 3.07 (m, 1 H), 2.92 (m, 1 H), 1.77 (m, 1 H), 1.46 (s, 9 H), 1.20 (m, 1 H), 0.95 (m, 1 H), 0.76 (m, 1 H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 162.4 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 246 Hz), 156.2, 142.0, 139.7, 138.0 (d, <sup>4</sup><i>J</i><sub>CF</sub> = 3.3 Hz), 131.4 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 7.9 Hz), 130.2, 128.1, 126.1, 125.6, 115.6 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 21.3 Hz), 79.6, 45.0, 28.8, 23.1, 20.8, 14.0.</div></div><div id="sec3_99" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Step B:</h4><div class="NLM_p last">To a solution of <i>trans</i>-[2-(4′-fluorobiphenyl-4-yl)cyclopropylmethyl]carbamic acid <i>tert</i>-butyl ester (30 mg) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was added TFA (0.1 mL) at 0 °C. After standing at 0 °C for 30 min and at rt for 1 h, the mixture was concentrated. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (1 mL), and 1 M HCl in Et<sub>2</sub>O (0.3 mL) was added to the solution. The mixture was let stand at 0 °C for 30 min, and concentrated. The resulting white solid was purified by recrystallization from ethanol/Et<sub>2</sub>O to afford the title compound as a white solid (16 mg, 66% yield). HPLC purity: 7.8 min, 97.7% (column 3, method A). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.43−7.39 (m, 2 H), 7.33−7.24 (m, 2 H), 7.22−7.13 (m, 4 H), 2.96 (m, 1 H), 2.54 (m, 1 H), 1.96 (m, 1 H), 1.31 (m, 1 H), 1.00 (m, 1 H), 0.93 (m, 1 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 163.6 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 245 Hz), 143.3, 139.6, 139.3 (d, <sup>4</sup><i>J</i><sub>CF</sub> = 3.4 Hz), 132.4 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 8.0 Hz), 130.9, 129.0, 127.5, 127.2, 116.1 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 21.5 Hz), 44.8, 22.3, 20.3, 15.2. MS (ESI) <i>m</i>/<i>z</i> 242.2 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>16</sub>H<sub>17</sub>NF<sup>+</sup> [MH<sup>+</sup>] 242.13395, found 242.13373.</div></div></div><div id="sec3_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>trans</i>-<i>C</i>-[2-(2-Benzofuran-2-ylphenyl)cyclopropyl]methylamine Hydrochloride (<b>67</b>)</h3><div class="NLM_p last">Prepared by the same procedure as described for <b>66</b> with 2-benzofuranboronic acid (37.3 mg, 0.23 mmol) as the starting material (22 mg, 111% and 76% yields). HPLC purity: 10.5 min, 98.9% (column 3, method A). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.77 (d, <i>J</i> = 7.2 Hz, 1 H), 7.66 (d, <i>J</i> = 7.5 H, 1 Hz), 7.55 (d, <i>J</i> = 8.0 Hz, 1 H), 7.39−7.25 (m, 5 H), 7.14 (s, 1 H), 3.21 (m, 1 H), 2.84 (m, 1 H), 2.42 (m, 1 H), 1.50 (m, 1 H), 1.15 (m, 1 H), 1.05 (m, 1 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 157.0, 156.2, 139.9, 132.5, 130.6, 130.2, 129.8, 128.7, 127.9, 125.7, 124.2, 122.3, 112.0, 106.8, 45.1, 23.1, 19.8, 14.8. MS (ESI) <i>m</i>/<i>z</i> 264.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>18</sub>H<sub>18</sub>NO<sup>+</sup> [MH<sup>+</sup>] 264.13829, found 264.13814.</div></div><div id="sec3_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> <i>trans</i>-[2-(4′-Fluorobiphenyl-3-yl)cyclopropyl]methylamine Hydrochloride (<b>68</b>)</h3><div class="NLM_p last">Prepared by the same procedure as described for <b>66</b> with <b>63</b> (30 mg, 0.092 mmol) and 4-fluorophenylboronic acid (32.2 mg, 0.23 mmol) as the starting materials (18 mg, 115% and 63% yields). HPLC purity: 18.2 min, 97.3% (column 3, method A). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.63−7.60 (m, 1 H), 7.40−7.33 (m, 3 H), 7.17 (t, <i>J</i> = 8.8 Hz, 1 H), 7.11 (d, <i>J</i> = 7.5 Hz, 1 H), 3.09−3.00 (m, 2 H), 2.14−2.09 (m, 1 H), 1.52−1.47 (m, 1 H), 1.21−1.16 (m, 1 H), 1.14−1.09 (m, 1 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 164.0 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 245 Hz), 143.5, 141.7, 138.8 (d, <sup>4</sup><i>J</i><sub>CF</sub> = 3.2 Hz), 130.2, 130.0 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 8.1 Hz), 126.0, 125.9, 125.8, 116.6 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 21.7 Hz), 45.0, 23.4, 21.1, 15.2. MS (ESI) <i>m</i>/<i>z</i> 242.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>16</sub>H<sub>17</sub>NF<sup>+</sup> [MH<sup>+</sup>] 242.13395, found 242.13373.</div></div><div id="sec3_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> <i>trans</i>-[2-(4′-Chlorobiphenyl-3-yl)cyclopropyl]methylamine Hydrochloride (<b>69</b>)</h3><div class="NLM_p last">Prepared by the same procedure as described for <b>68</b> with 4-chlorophenylboronic acid (36.0 mg, 0.23 mmol) as the starting material (17 mg, 82% and 83% yields). HPLC purity: 17.9 min, 97.7% (column 1, method C). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.58 (d, <i>J</i> = 8.4 Hz, 2 H), 7.43 (d, <i>J</i> = 8.1 Hz, 2 H), 7.40−7.33 (m, 3 H), 7.12 (d, <i>J</i> = 7.5 Hz, 2 H), 3.02 (m, 2 H), 2.09 (m, 2 H), 1.46 (m, 1 H), 1.18 (m, 1 H), 1.10 (m, 1 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 143.6, 141.5, 141.2, 134.6, 130.3, 130.1, 129.7, 126.3, 126.0, 125.9, 45.0, 23.4, 21.1, 15.2. MS (ESI) <i>m</i>/<i>z</i> 258.2 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>16</sub>H<sub>17</sub>NCl<sup>+</sup> [MH<sup>+</sup>] 258.10440, found 258.10422.</div></div><div id="sec3_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> <i>trans</i>-[2-(4′-Trifluoromethybiphenyl-3-yl)cyclopropyl]methylamine Hydrochloride (<b>70</b>)</h3><div class="NLM_p last">Prepared by the same procedure as described for <b>68</b> with 4-trifluoromethylphenylboronic acid (43.7 mg, 0.23 mmol) as the starting material (15 mg, 66% and 81% yields). HPLC purity: 17.6 min, 95.6% (column 1, method C). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.81 (d, <i>J</i> = 8.2 Hz, 2 H), 7.75 (d, <i>J</i> = 8.4 Hz, 2 H), 7.51−7.47 (m, 2 H), 7.41 (t, <i>J</i> = 7.7 Hz, 1 H), 7.19 (d, <i>J</i> = 7.7 Hz, 1 H), 3.07−3.00 (m, 2 H), 2.16−2.11 (m, 1 H), 1.52−1.48 (m, 1 H), 1.24−1.20 (m, 1 H), 1.16−1.11 (m, 1 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 144.4, 141.8, 139.2, 128.4, 126.8, 125.0, 124.9, 124.9, 124.4, 124.3, 43.1, 21.5, 19.2, 13.3. MS (ESI) <i>m</i>/<i>z</i> 292.2 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>17</sub>H<sub>17</sub>NF<sub>3</sub><sup>+</sup> [MH<sup>+</sup>] 292.13076, found 292.13050.</div></div><div id="sec3_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> <i>trans</i>-[2-(4′-Cyanobiphenyl-3-yl)cyclopropyl]methylamine Hydrochloride (<b>71</b>)</h3><div class="NLM_p last">Prepared by the same procedure as described for <b>68</b> with 4-cyanophenylboronic acid (33.8 mg, 0.23 mmol) as the starting material (20 mg, 94% and 75% yields). HPLC purity: 13.6 min, 97.9% (column 3, method A). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.81 (s, 4 H), 7.49 (m, 1 H), 7.48 (s, 1 H), 7.41 (t, <i>J</i> = 7.6 Hz, 1 H), 7.21 (d, <i>J</i> = 7.6 Hz, 1 H), 3.10−3.01 (m, 2 H), 2.17−2.12 (m, 1 H), 1.55−1.47 (m, 1 H), 1.24−1.19 (m, 1 H), 1.16−1.11 (m, 1 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 147.2, 144.0, 140.7, 133.9, 130.5, 129.1, 127.3, 126.3, 126.2, 119.9, 112.0, 45.0, 23.4, 21.2, 15.3. MS (ESI) <i>m</i>/<i>z</i> 249.2 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>17</sub>H<sub>17</sub>N<sub>2</sub><sup>+</sup> [MH<sup>+</sup>] 249.13863, found 249.13861.</div></div><div id="sec3_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> <i>trans</i>-<i>C</i>-[2-(3-Benzofuran-2-ylphenyl)cyclopropyl]methylamine Hydrochloride (<b>72</b>)</h3><div class="NLM_p last">Prepared by the same procedure as described for <b>68</b> with 2-benzofuranboronic acid (37.3 mg, 0.23 mmol) as the starting material (21 mg, 101% and 85% yields). HPLC purity: 12.5 min, 98.4% (column 3, method A). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.71 (d, <i>J</i> = 6.5 Hz, 2 H), 7.61 (d, <i>J</i> = 7.5 Hz, 1 H), 7.52 (d, <i>J</i> = 7.8 Hz, 1 H), 7.37 (t, <i>J</i> = 8.0 Hz, 1 H), 7.29 (d, <i>J</i> = 7.3 Hz, 1 H), 7.23 (t, <i>J</i> = 7.6 Hz, 1 H), 7.19 (br s, 1 H), 7.15 (d, <i>J</i> = 7.8 Hz, 1 H), 3.05 (m, 2 H), 2.13 (m, 1 H), 1.51 (m, 1 H), 1.21 (m, 1 H), 1.14 (m, 1 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 157.2, 156.4, 143.6, 132.0, 130.7, 130.2, 127.4, 125.7, 124.3, 123.8, 123.7, 122.2, 112.0, 102.7, 79.3, 45.0, 23.4, 21.1, 15.2. MS (ESI) <i>m</i>/<i>z</i> 264.2 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>18</sub>H<sub>18</sub>NO<sup>+</sup> [MH<sup>+</sup>] 264.13829, found 264.13811.</div></div><div id="sec3_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> <i>trans</i>-[2-(4′-Fluorobiphenyl-4-yl)cyclopropyl]methylamine Hydrochloride (<b>73</b>)</h3><div class="NLM_p last">Prepared by the same procedure as described for <b>66</b> with <b>64</b> (34 mg, 0.104 mmol) and 4-fluorophenylboronic acid (36.5 mg, 0.261 mmol) as the starting materials (14 mg, 62% and 86% yields). HPLC purity: 18.0 min, 96.4% (column 1, method C). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.70 (m, 2 H), 7.51 (d, <i>J</i> = 8.1 Hz, 2 H), 7.22 (d, <i>J</i> = 8.1 Hz, 2 H), 7.16 (m, 2 H), 3.03 (d, <i>J</i> = 7.4 Hz, 2 H), 2.06 (m, 1 H), 1.49 (m, 1 H), 1.13 (m, 2 H) (ppm). <sup>13</sup>C NMR δ 157.0, 140.9, 138.2, 137.5, 128.6, 128.5, 126.9, 126.5, 115.6, 115.3, 43.9, 21.9, 20.0, 14.1. MS (ESI) <i>m</i>/<i>z</i> 242.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>16</sub>H<sub>17</sub>NF<sup>+</sup> [MH<sup>+</sup>] 242.1345, found 242.1344.</div></div><div id="sec3_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> <i>trans</i>-[2-(4-Furan-2-ylphenyl)cyclopropyl]methylamine Hydrochloride (<b>74</b>)</h3><div class="NLM_p last">Prepared by the same procedure as described for <b>66</b> with <b>64</b> (30 mg, 0.092 mmol) and 2-furanboronic acid (25.7 mg, 0.23 mmol) as the starting materials (18 mg, 98% and 82% yields). HPLC purity: 13.6 min, 96.5% (column 3, method A). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.60 (d, <i>J</i> = 8.2 Hz, 2 H), 7.53 (s, 1 H), 7.17 (d, <i>J</i> = 8.1 Hz, 2 H), 6.70 (m, 1 H), 6.50 (s, 1 H), 3.02 (d, <i>J</i> = 7.4 Hz, 2 H), 2.07−2.01 (m, 1 H), 1.44 (m, 1 H), 1.18−1.08 (m, 2 H). <sup>13</sup>C NMR δ 154.2, 142.1, 140.9, 129.3, 126.3, 123.8, 111.7, 104.6, 43.8, 22.0, 20.0, 14.1. MS (ESI) <i>m</i>/<i>z</i> 214.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>14</sub>H<sub>16</sub>NO<sup>+</sup> [MH<sup>+</sup>] 214.1232, found 214.1228.</div></div><div id="sec3_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> <i>trans</i>-[2-(2-Aminophenyl)cyclopropylmethyl]carbamic Acid <i>tert</i>-Butyl Ester (<b>75</b>)</h3><div id="sec3_57_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Step A:</h4><div class="NLM_p last">To a mixture of Pd(OAc)<sub>2</sub> (3.4 mg, 0.015 mmol), BINAP (19.1 mg, 0.031 mmol), and <b>62</b> (50 mg, 0.153 mmol) in toluene (3 mL) were added benzophenone imine (0.051 mL, 0.306 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (125 mg, 0.383 mmol) under nitrogen. The resulting mixture was stirred at 100 °C overnight, diluted with EtOAc, filtered, and concentrated. The residue was purified by preparative TLC (hexane/EtOAc 3:1) to afford the corresponding diphenyl ketimine compound as a colorless oil (51.9 mg, a mixture of starting material and the product). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.50 (d, <i>J</i> = 6.9 Hz, 2 H), 7.46 (m, 3 H), 7.28 (m, 3 H), 7.16 (m, 2 H), 6.86 (m, 2 H), 6.79 (m, 1 H), 6.39 (m, 1 H), 4.88 (br s, 1 H), 3.34−3.23 (m, 2 H), 1.87 (m, 1 H), 1.45 (s, 9 H), 1.28 (m, 1 H), 0.93 (m, 1 H), 0.85 (m, 1 H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 168.3, 156.2, 150.9, 139.9, 136.7, 131.1, 129.8, 129.5, 129.1, 128.7, 128.3, 127.8, 126.1, 123.8, 119.8, 79.4, 45.4, 28.9, 22.9, 18.8, 12.9.</div></div><div id="sec3_57_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Step B:</h4><div class="NLM_p last">To a solution of the ketimine adduct (35 mg, 0.188 mmol) in MeOH (0.8 mL) at rt were added NaOAc (16.2 mg, 0.197 mmol) and NH<sub>2</sub>OH·HCl (10.3 mg, 0.148 mmol). The mixture was stirred at rt for 2 h, diluted with CH<sub>2</sub>Cl<sub>2</sub>, and purified by preparative TLC (hexane/EtOAc 2:1) to afford the title compound as a colorless oil (20.5 mg, 95% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.05 (m, 1 H), 6.98 (d, <i>J</i> = 7.3 Hz, 1 H), 6.69 (m, 2 H), 4.89 (br s, 1 H), 3.42−3.36 (m, 1 H), 3.16−3.11 (m, 1 H), 1.65 (m, 1 H), 1.48 (s, 9 H), 1.14 (m, 1 H), 0.94 (m, 1 H), 0.80 (m, 1 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 156.3, 146.3, 127.8, 127.2, 125.5, 117.9, 114.6, 79.4, 44.2, 28.4, 20.2, 14.1, 9.7.</div></div></div><div id="sec3_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> <i>trans</i>-[2-(3-Aminophenyl)cyclopropylmethyl]carbamic Acid <i>tert</i>-Butyl Ester (<b>76</b>)</h3><div class="NLM_p last">Prepared by the same procedure as described for <b>75</b> with <b>63</b> (120 mg, 0.368 mmol) as the starting material (33 mg, 67% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.07 (t, <i>J</i> = 7.8 Hz, 1 H), 6.56 (dd, <i>J</i> = 1.4 Hz, 7.9 Hz, 1 H), 6.52 (d, <i>J</i> = 7.6 Hz, 1 H), 6.46 (s, 1 H), 4.70 (br s, 1 H), 3.22 (m, 1 H), 3.10 (m, 1 H), 1.73 (m, 1 H), 1.47 (s, 9 H), 1.28 (m, 1 H), 0.91 (m, 1 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.5, 144.9, 143.6, 128.9, 116.4, 112.7, 44.4, 28.0, 22.4, 21.5, 13.8.</div></div><div id="sec3_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> <i>trans</i>-[3-(2-Aminomethylcyclopropyl)phenyl]benzylamine Hydrochloride (<b>78</b>)</h3><div id="sec3_59_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Step A:</h4><div class="NLM_p last">Compound <b>76</b> (15 mg, 0.0572 mmol) was dissolved in MeOH (0.5 mL) containing benzaldehyde (0.0052 mL, 0.0512 mmol) at 0 °C. To the mixture was added NaCNBH<sub>3</sub> (4.3 mg, 0.0686 mmol). The resulting mixture was stirred at 0 °C for 1 h and at rt overnight and directly purified by preparative TLC (hexane/EtOAc 1:1) to afford the title compound as a colorless oil (9.9 mg, 49% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.38−7.35 (m, 4 H), 7.32−7.28 (m, 1 H), 7.08 (t, <i>J</i> = 7.8 Hz, 1 H), 6.47−6.42 (m, 2 H), 6.37 (s, 1 H), 4.68 (br s, 1 H), 4.33 (s, 2 H), 4.07 (br s, 1 H), 3.26−3.23 (m, 1 H), 3.12−3.05 (m, 1 H), 1.72 (m, 1 H), 1.47 (s, 9 H), 1.28 (m, 1 H), 0.89 (m, 2 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.8, 148.2, 143.7, 139.4, 129.2, 128.6, 127.5, 127.2, 114.9, 110.4, 110.2, 79.1, 48.3, 44.8, 28.4, 22.7, 22.1, 14.2.</div></div><div id="sec3_59_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Step B:</h4><div class="NLM_p last">Prepared by the same deprotection procedure as described for <b>66</b> (5.6 mg, 76% yield). HPLC purity: 4.4 min, 94.4% (column 3, method A). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.45−7.41 (m, 6 H), 7.28 (d, <i>J</i> = 8.0 Hz, 1 H), 7.20−7.18 (m, 2 H), 4.60 (s, 2 H), 3.03 (m, 2 H), 2.11 (m, 1 H), 1.48 (m, 1 H), 1.17−1.12 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 146.0, 132.4, 131.6, 131.4, 130.9, 130.3, 128.3, 121.7, 121.5, 56.8, 44.7, 23.1, 21.6, 15.6. MS (ESI) <i>m</i>/<i>z</i> 253.2 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>17</sub>H<sub>21</sub>N<sub>2</sub><sup>+</sup> [MH<sup>+</sup>] 253.16993, found 253.16979.</div></div></div><div id="sec3_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> <i>trans</i>-<i>N</i>-[2-(2-Aminomethylcyclopropyl)phenyl]acetamide Hydrochloride (<b>80</b>)</h3><div id="sec3_60_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Step A:</h4><div class="NLM_p last">To compound <b>75</b> (7.0 mg, 0.0267 mmol) and DMAP (3.3 mg, 0.0267 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.3 mL) was added acetic anhydride (0.004 mL, 0.0423 mmol) at 0 °C. The resulting mixture was stirred at 0 °C for 1 h and rt overnight and directly purified by preparative TLC (hexane/EtOAc 1:1) to afford the title compound as a colorless oil (7.2 mg, 89% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.63 (br. s, 1 H), 8.09 (d, <i>J</i> = 7.9 Hz, 1 H), 7.21 (t, <i>J</i> = 7.6 Hz, 1 H), 7.06−6.96 (m, 2 H), 4.89 (br s, 1 H), 3.58 (m, 1 H), 3.05 (m, 1 H), 1.84 (m, 1 H), 1.46 (s, 9 H), 1.27 (m, 1 H), 1.24 (m, 1 H), 0.83 (m, 1 H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 169.7, 157.4, 138.0, 131.5, 127.1, 126.5, 124.4, 122.5, 80.4, 43.7, 30.1, 28.8, 24.8, 22.4, 18.1.</div></div><div id="sec3_60_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Step B:</h4><div class="NLM_p last">Prepared by the same deprotection procedure as described for <b>66</b> (3.6 mg, 77% yield). HPLC purity: 4.8 min, 97.0% (column 3, method A). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.22−7.20 (m, 3 H), 6.99 ((m, 3 H), 3.08 (m, 1 H), 2.94 (m, 1 H), 1.96 (m, 1 H), 1.32 (m, 1 H), 1.16 (m, 1 H), 1.08 (m, 1 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 172.6, 138.1, 137.2, 128.1, 127.6, 127.2, 126.0, 45.0, 23.1, 21.2, 19.8, 14.0. MS (ESI) <i>m</i>/<i>z</i> 205.2 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>12</sub>H<sub>17</sub>N<sub>2</sub>O<sup>+</sup> [MH<sup>+</sup>] 205.13354, found 205.13345.</div></div></div><div id="sec3_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> <i>trans</i>-<i>N</i>-[2-(2-Aminomethylcyclopropyl)phenyl]benzamide Hydrochloride (<b>81</b>)</h3><div class="NLM_p last">Prepared by the same procedure as described for <b>80</b> with <b>75</b> (5.8 mg, 0.0221 mmol) and benzoyl chloride (0.0039 mL, 0.0332 mmol) as the starting materials (3.5 mg, 100% and 53% yields). HPLC purity: 6.48 min, 99.2% (column 3, method A). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 8.05 (d, <i>J</i> = 7.3 Hz, 2 H), 7.64 (t, <i>J</i> = 7.3 Hz, 1 H), 7.56 (t, <i>J</i> = 7.4 Hz, 2 H), 7.33−7.27 (m, 3 H), 7.07 (m, 1 H), 3.01 (m, 1 H), 2.86 (m, 1 H), 2.01 (m, 1 H), 1.38 (m, 1 H), 1.21 (m, 1 H), 1.05 (m, 1 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 169.4, 138.7, 137.5, 135.3, 133.3, 129.8, 128.8, 128.4, 127.7, 127.6, 126.3, 45.0, 21.2, 20.2, 13.7. MS (ESI) <i>m</i>/<i>z</i> 267.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>17</sub>H<sub>19</sub>N<sub>2</sub>O<sup>+</sup> [MH<sup>+</sup>] 267.14919, found 267.14900.</div></div><div id="sec3_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> <i>trans</i>-1-[2-(2-Aminomethylcyclopropyl)phenyl]-3-(4-chlorophenyl)urea Hydrochloride (<b>82</b>)</h3><div id="sec3_62_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> Step A:</h4><div class="NLM_p last">To a solution of <b>75</b> (30.0 mg, 0.114 mmol) in THF (5 mL) were added DMAP (2.8 mg, 0.023 mmol) and 4-chlorophenyl isocyanate (0.022 mL, 0.172 mmol) at rt. The mixture was stirred at 50 °C overnight and directly purified by preparative TLC (hexane/EtOAc 1:1) to afford the title compound as a colorless oil (29.1 mg, 61% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.42 (br s, 1 H), 8.32 (d, <i>J</i> = 8.2 Hz, 1 H), 8.08 (br s, 1 H), 7.53 (d, <i>J</i> = 8.8 Hz, 2 H), 7.29−7.22 (m, 3 H), 7.04 (t, <i>J</i> = 6.9 Hz, 1 H), 6.90 (d, <i>J</i> = 6.9 Hz, 1 H), 6.95 (t, <i>J</i> = 7.2 Hz, 1 H), 4.98 (br t, <i>J</i> = 6.2 Hz, 1 H), 3.93 (m, 1 H), 3.23 (m, 1 H), 1.61 (m, 1 H), 1.50 (s, 9 H), 1.19 (m, 1 H), 0.83−0.72 (m, 2 H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 158.5, 153.3, 139.7, 138.8, 129.2, 128.9, 127.6, 127.4, 127.1, 122.3, 120.2, 119.3, 81.5, 40.6, 28.8, 21.2, 16.2, 6.5.</div></div><div id="sec3_62_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> Step B:</h4><div class="NLM_p last">Prepared by the same deprotection procedure as described for <b>66</b> (18 mg, 79% yield). HPLC purity: 8.1 min, 99.5% (column 3, method A). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.48 (d, <i>J</i> = 8.8 Hz, 2 H), 7.29 (d, <i>J</i> = 8.9 Hz, 2 H), 7.24−7.12 (m, 2 H), 7.03 (d, <i>J</i> = 7.6 Hz, 1 H), 3.11−2.95 (m, 2 H), 2.12−2.05 (m, 1 H), 1.44−1.38 (m, 1 H), 1.14−1.09 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 155.1, 138.5, 137.1, 135.0, 128.8, 127.6, 126.7, 125.6, 125.5, 124.8, 120.5, 44.0, 19.3, 18.7, 13.0. MS (ESI) <i>m</i>/<i>z</i> 316.2 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>17</sub>H<sub>19</sub>N<sub>3</sub>OCl<sup>+</sup> [MH<sup>+</sup>] 316.12112, found 316.12080.</div></div></div><div id="sec3_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> <i>trans</i>-<i>N</i>-[3-(2-Aminomethylcyclopropyl)phenyl]acetamide Hydrochloride (<b>83</b>)</h3><div class="NLM_p last">Prepared by the same procedure as described for <b>80</b> with <b>75</b> (5.8 mg, 0.0221 mmol) and benzoyl chloride (0.0039 mL, 0.0332 mmol) as the starting materials (3.3 mg, 94% and 60% yields). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.47 (s, 1 H), 7.25−7.19 (m, 2 H), 6.90 (d, <i>J</i> = 6.4 Hz, 1 H), 3.01 (d, <i>J</i> = 7.4 Hz, 2 H), 2.13 (s, 3 H), 2.01 (m, 1 H), 1.42 (m, 1 H), 1.10 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 171.9, 143.6, 140.2, 130.0, 123.0, 119.0, 118.9, 45.0, 24.0, 23.4, 21.1, 15.2. MS (ESI) <i>m</i>/<i>z</i> 205.2 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>12</sub>H<sub>17</sub>N<sub>2</sub>O<sup>+</sup> [MH<sup>+</sup>] 205.13354, found 205.13341.</div></div><div id="sec3_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> <i>trans</i>-<i>N</i>-[3-(2-Aminomethylcyclopropyl)phenyl]benzamide Hydrochloride (<b>84</b>)</h3><div class="NLM_p last">Prepared by the same procedure as described for <b>80</b> with <b>76</b> (7.0 mg, 0.0234 mmol) and benzoyl chloride (0.0047 mL, 0.040 mmol) as the starting materials (4.3 mg, 97% and 74% yields). HPLC purity: 4.8 min, 99.6% (column 3, method A). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.94 (d, <i>J</i> = 7.2 Hz, 2 H), 7.62−7.51 (m, 4 H), 7.13−7.09 (m, 2 H), 7.41 (d, <i>J</i> = 8.1 Hz, 1 H), 7.28 (t, <i>J</i> = 7.8 Hz, 1 H), 6.97 (d, <i>J</i> = 7.6 Hz, 1 H), 3.02 (d, <i>J</i> = 7.4 Hz, 2 H), 2.06 (m, 1 H), 1.46 (m, 1 H), 1.17 (m, 1 H), 1.10 (m, 1 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 169.1, 143.6, 140.1, 136.4, 133.1, 130.0, 129.8, 128.7, 123.6, 120.2, 120.0, 45.0, 23.4, 21.1, 15.2. MS (ESI) <i>m</i>/<i>z</i> 267.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>17</sub>H<sub>19</sub>N<sub>2</sub>O<sup>+</sup> [MH<sup>+</sup>] 267.14919, found 267.14899.</div></div><div id="sec3_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> General Procedure for <i>t</i>-Boc Deprotection</h3><div class="NLM_p last">The protected amine was dissolved in a 2 N HCl solution in diethyl ether, and the reaction mixture was stirred at ambient temperature for 12−24 h. A white precipitate formed after several minutes to hours. The mixture was stirred until the reaction was complete by TLC and worked up as described below.</div></div><div id="sec3_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> <i>trans</i>-{2-[2-(6-Hydroxyhex-1-ynyl)phenyl]cyclopropyl}methylamine Hydrochloride (<b>86</b>)</h3><div id="sec3_66_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> Step A:</h4><div class="NLM_p last">Compound <b>62</b> (50 mg, 0.153 mmol), Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (8.6 mg, 0.012 mmol), PPh<sub>3</sub> (6.4 mg, 0.024 mmol), CuI (4.7 mg, 0.024 mmol), and 5-hexyn-1-ol (0.037 mL, 0.337 mmol) were dissolved in triethylamine (TEA) (1.4 mL), and the mixture was degassed for 1 min and stirred at 85 °C overnight. The resulting mixture was cooled to ambient temperature and poured into a mixture of 0.1 N HCl/EtOAc (3 mL/3 mL). After partition, the organic layer was washed with water, filtered, and concentrated. The residue was purified by silica gel chromatography (hexane/Et<sub>2</sub>O 4:1) to afford the title compound as a colorless oil (30 mg, 57% yield).</div></div><div id="sec3_66_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> Step B:</h4><div class="NLM_p last"> Refer to the general procedure for <i>t</i>-Boc deprotection described above. The mixture was concentrated and washed with ethanol/Et<sub>2</sub>O to afford the title compound as a brown oil (22 mg, 90% yield). HPLC purity: 7.9 min, 94.7% (column 3, method A). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.24−7.08 (m, 3 H), 6.94 (d, <i>J</i> = 7.6 Hz, 1 H), 5.74 (t, <i>J</i> = 7.1 Hz, 1 H), 3.52 (t, <i>J</i> = 6.1 Hz, 2 H), 2.62 (m, 1 H), 2.38−2.33 (m, 1 H), 2.09−2.06 (m, 1 H), 1.57−1.50 (m, 4 H), 1.29 (m, 1 H), 1.02−0.95 (m, 3 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 143.3, 140.8, 132.3, 130.8, 127.5, 126.7, 90.5, 81.2, 62.8, 45.1, 33.4, 30.0, 26.1, 21.7, 20.3, 12.3. MS (ESI) <i>m</i>/<i>z</i> 244.2 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>16</sub>H<sub>22</sub>NO<sup>+</sup> [MH<sup>+</sup>] 244.1696, found 244.1688.</div></div></div><div id="sec3_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> <i>trans</i>-[2-(3-Ethynylphenyl)cyclopropyl]methylamine Hydrochloride (<b>87</b>)</h3><div class="NLM_p last">Pd(PhCN)<sub>2</sub>Cl<sub>2</sub> (1.8 mg, 0.0045 mmol) and CuI (0.6 mg, 0.003 mmol) were added to a dry vial, which was then sparged with argon and charged with dioxane (0.3 mL). P(<i>t</i>-Bu)<sub>3</sub> (1.0 M in dioxane, 9.2 μL, 0.009 mmol), HN(<i>i</i>-Pr)<sub>2</sub> (13.3 μL, 0.184 mol), <b>63</b> (50 mg, 0.153 mmol), and ethynyltrimethylsilane (26 μL, 0.184 mmol) were added to the stirred reaction mixture. During the reaction, precipitation of [H<sub>2</sub>N(<i>i</i>-Pr)<sub>2</sub>]Br was observed. After stirring at 50 °C overnight, the reaction mixture was diluted with EtOAc (5 mL), filtered through a small pad of silica gel, concentrated, and purified by silica gel chromatography (hexane/Et<sub>2</sub>O 4:1) to afford the title compound as brown powder (58 mg, 57% yield). To a stirred solution of <i>trans</i>-[2-(3-trimethylsilanylethynylphenyl)cyclopropylmethyl]carbamic acid <i>tert</i>-butyl ester (58 mg, 0.17 mmol) in THF (1.5 mL) was added TBAF solution (1.0 M in THF, 0.255 mL, 0.255 mmol) slowly under argon purge to give a deep-dark solution. After 1 h, the reaction mixture was diluted with EtOAc (5 mL). The organic layer was washed with water, filtered and concentrated, and purified by silica gel chromatography (hexane/Et<sub>2</sub>O 4:1) to afford the title compound as brown powder (58 mg, 57% yield). Refer to the general procedure for <i>t</i>-Boc deprotection described above. The crude precipitate was filtered and purified by recrystallization from ethanol/Et<sub>2</sub>O to afford the title compound as a white solid (22 mg, 90% yield). HPLC purity: 9.3 min, 99.4% (column 1, method D). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.28−7.22 (m, 3 H), 7.13 (d, <i>J</i> = 6.8 Hz, 1 H), 3.45 (s, 1 H), 3.04−2.93 (m, 2 H), 2.02−1.97 (m, 1 H), 1.42−1.38 (m, 1 H), 1.33−1.04 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 143.3, 130.8, 130.7, 129.7, 127.6, 124.0, 78.7, 44.9, 23.0, 21.1, 15.2. MS (ESI) <i>m</i>/<i>z</i> 272.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>12</sub>H<sub>14</sub>N<sup>+</sup> [MH<sup>+</sup>] 172.1121, found 172.1122.</div></div><div id="sec3_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> <i>trans</i>-{2-[3-(6-Hydroxyhex-1-ynyl)phenyl]cyclopropyl}methylamine Hydrochloride (<b>88</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>86</b> described above with substitution of <b>63</b> for <b>62</b>. The crude precipitate was filtered and purified by recrystallization from ethanol/Et<sub>2</sub>O to afford the title compound as a white solid (21 mg, 86% yield). HPLC purity: 5.8 min, 94.8% (column 1, method C). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.19−7.05 (m, 3 H), 6.97 (d, <i>J</i> = 7.2 Hz, 1 H), 3.51 (t, <i>J</i> = 5.9 Hz, 2 H), 2.90 (m, 2 H), 2.34 (t, <i>J</i> = 6.7 Hz, 2 H), 1.93−1.88 (m, 1 H), 1.63−1.55 (m, 4 H), 1.34−1.29 (m, 1 H), 1.02−0.96 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 143.1, 130.3, 130.1, 129.5, 126.6, 125.6, 90.7, 81.9, 62.6, 44.9, 32.9, 26.4, 23.1, 21.7, 19.9, 15.2. MS (ESI) <i>m</i>/<i>z</i> 244.2 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>16</sub>H<sub>22</sub>NO<sup>+</sup> [MH<sup>+</sup>] 244.1696, found 244.1688.</div></div><div id="sec3_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> <i>trans</i>-{2-[3-(3-Hydroxy-3-methylbut-1-ynyl)phenyl]cyclopropyl}methylamine Hydrochloride (<b>89</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>86</b> described above with substitution of <b>63</b> for <b>62</b> and 2-methylbut-3-yn-2-ol for 5-hexyn-1-ol (17 mg, 98% and 85% yields). HPLC purity: 8.5 min, 95.4% (column 3, method A). <sup>1</sup>H NMR (400 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.26−7.16 (m, 3 H), 7.12−7.10 (m, 1 H), 3.04−2.95 (m, 2 H), 2.01−1.98 (m, 1 H), 1.51−1.38 (m, 7 H), 1.13−1.05 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 143.3, 130.4, 130.3, 129.7, 127.4, 124.2, 91.6, 85.6, 65.9, 44.9, 31.5, 28.9, 23.0, 21.1, 15.1. MS (ESI) <i>m</i>/<i>z</i> 230.1 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>15</sub>H<sub>20</sub>NO<sup>+</sup> [MH<sup>+</sup>] 230.1539, found 230.1537.</div></div><div id="sec3_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> <i>trans</i>-{2-[4-(6-Hydroxyhex-1-ynyl)phenyl]cyclopropyl}methylamine Hydrochloride (<b>90</b>)</h3><div class="NLM_p last">Refer to the general procedure for the synthesis of <b>76</b> described above with substitution of <b>64</b> for <b>62</b>. The crude precipitate was filtered and purified by recrystallization from ethanol/Et<sub>2</sub>O to afford the title compound as a white solid (21 mg, 86% yield). HPLC purity: 7.7 min, 99.0% (column 3, method A). <sup>1</sup>H NMR (300 MHz, MeOD-<i>d</i><sub>4</sub>) δ 7.25 (d, <i>J</i> = 8.2 Hz, 2 H), 7.04 (d, <i>J</i> = 8.2 Hz, 2 H), 3.60 (t, <i>J</i> = 6.1 Hz, 2 H), 2.98 (m, 2 H), 2.47−2.40 (m, 2 H), 2.00−1.95 (m, 1 H), 1.71−1.63 (m, 4 H), 1.39 (m, 1 H), 1.11−1.04 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD-<i>d</i><sub>4</sub>) δ 142.5, 132.7, 127.0, 123.2, 90.5, 81.8, 62.6, 44.9, 33.0, 26.5, 23.2, 21.3, 19.9, 15.4. MS (ESI) <i>m</i>/<i>z</i> 244.2 [MH<sup>+</sup>]. HRMS (ESI) calculated for C<sub>16</sub>H<sub>22</sub>NO<sup>+</sup> [MH<sup>+</sup>] 244.1696, found 244.1689.</div></div><div id="sec3_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> Biological Methods</h3><div id="sec3_71_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> Calcium Flux Assays</h4><div class="NLM_p last">Calcium flux assays were performed essentially as described earlier.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> HEK 293 cells stably expressing the human 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, or 5-HT<sub>2C (INI)</sub> receptor were seeded and incubated for 20 h in serum-free DMEM containing 50 U/mL penicillin and 50 μg/mL streptomycin sulfate in tissue culture-treated black clear-bottom 384-well plates (Greiner, Germany); plates were coated with 20 μL/well of 50 mg/L poly <span class="smallcaps smallerCapital">l</span>-lysine (Sigma, P-1524) in PBS. The cells were preincubated for 75 min at 37 °C in a humidified incubator with 20 μL of reconstituted fura-4 based calcium dye (Calcium Plus Assay Kit, Molecular Devices) in assay buffer (Hanks’ balanced salt solution containing calcium and magnesium (Invitrogen, 14065-056), 50 mM HEPES, 2.5 mM probenecid, 100 mg/L ascorbic acid, pH 7.4). The plates were allowed to cool to rt over 10 min and were transferred to a FLIPR Tetra fluorescence image plate reader (Molecular Devices). The test compounds in 15 μL assay buffer were automatically added and fluorescence (excitation: 470−495 nm, emission: 515−575 nm) was measured every second for 3 min. The baseline was averaged from 10 data points immediately before the additions and results were exported as the maximal response over baseline during 60 s after addition. Compounds were measured at seven concentrations from 10 μM to 10 pM in triplicate. EC<sub>50</sub> values and <i>E</i><sub>max</sub> values were obtained from nonlinear curve fitting against a sigmoidal dose−response model using Prism (Graphpad).</div></div></div><div id="sec3_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> Behavior</h3><div id="sec3_72_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> Animals</h4><div class="NLM_p last">C57BL/6J male mice (9 weeks of age at testing) were obtained from Jackson Laboratory (Bar Harbor, ME). Mice were housed four to a cage in a colony room maintained at 22 °C on a 12 h light−dark cycle. All animal experiments were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals and the PsychoGenics Animal Care and Use Committee.</div></div><div id="sec3_72_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> Mouse Forced Swim Test</h4><div class="NLM_p last">Procedures were based on those previously described.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Mice were individually placed into clear glass cylinders (i.e., 15 cm tall × 10 cm wide, 1 L beakers) containing 23 ± 1 °C water 12 cm deep (approximately 800 mL). The time the animal spent immobile was recorded every 1 min over a 6 min trial. Immobility was described as the postural position of floating in the water. After testing, mice were dried and returned to their home cage.</div></div></div><div id="sec3_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> Drugs</h3><div class="NLM_p last">Sertraline was purchased from a commercial vendor (Sigma, St. Louis, MO). All compounds were dissolved in 10% DMSO vehicle in saline 30 min prior to testing. All compounds were administered ip, 1 mL/kg dosing volume.</div></div><div id="sec3_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> Statistics</h3><div class="NLM_p last">ANOVA was performed to determine the effects of test treatment, followed by posthoc analysis using Fisher’s PLSC.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i115"><a href="/doi/suppl/10.1021/jm801354e">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65672" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65672" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Functional activity of compounds <b>66</b>−<b>74</b>, <b>78</b>, <b>80</b>−<b>84</b>, and <b>86</b>−<b>90</b>. Copy of original spectroscopic data and purity assessment of key compounds <b>29</b> and <b>37</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm801354e/suppl_file/jm801354e_si_001.pdf">jm801354e_si_001.pdf (810.34 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm801354e" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66662" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66662" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryan L. Roth</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy (M/C781), University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612-7230, Department of Pharmacology, Psychiatry, Comprehensive Cancer Center, Center for Neurobiology Division of Medicinal Chemistry and Natural Products, and NIMH Psychoactive Drug Screening Program, University of North Carolina Medical School, Chapel Hill, CB 7365, North Carolina 27599, Psychogenics, Inc., Tarrytown, New York 10591</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0d6f7f746c63527f6279654d6068692378636e236869782d6662776466627a6c4d78646e23686978"><span class="__cf_email__" data-cfemail="abc9d9d2cac5f4d9c4dfc3ebc6cecf85dec5c885cecfde">[email protected]</span> <span class="__cf_email__" data-cfemail="056e6a7f6c6e6a726445706c662b606170">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan P. Kozikowski</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy (M/C781), University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612-7230, Department of Pharmacology, Psychiatry, Comprehensive Cancer Center, Center for Neurobiology Division of Medicinal Chemistry and Natural Products, and NIMH Psychoactive Drug Screening Program, University of North Carolina Medical School, Chapel Hill, CB 7365, North Carolina 27599, Psychogenics, Inc., Tarrytown, New York 10591</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5c3e2e253d32032e3328341c3139387229323f723938297c3733263537332b3d1c29353f72393829"><span class="__cf_email__" data-cfemail="7517070c141b2a071a011d351810115b001b165b101100">[email protected]</span> <span class="__cf_email__" data-cfemail="42292d382b292d352302372b216c272637">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sung Jin Cho</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy (M/C781), University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612-7230, Department of Pharmacology, Psychiatry, Comprehensive Cancer Center, Center for Neurobiology Division of Medicinal Chemistry and Natural Products, and NIMH Psychoactive Drug Screening Program, University of North Carolina Medical School, Chapel Hill, CB 7365, North Carolina 27599, Psychogenics, Inc., Tarrytown, New York 10591</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Niels H. Jensen</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy (M/C781), University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612-7230, Department of Pharmacology, Psychiatry, Comprehensive Cancer Center, Center for Neurobiology Division of Medicinal Chemistry and Natural Products, and NIMH Psychoactive Drug Screening Program, University of North Carolina Medical School, Chapel Hill, CB 7365, North Carolina 27599, Psychogenics, Inc., Tarrytown, New York 10591</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Toru Kurome</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy (M/C781), University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612-7230, Department of Pharmacology, Psychiatry, Comprehensive Cancer Center, Center for Neurobiology Division of Medicinal Chemistry and Natural Products, and NIMH Psychoactive Drug Screening Program, University of North Carolina Medical School, Chapel Hill, CB 7365, North Carolina 27599, Psychogenics, Inc., Tarrytown, New York 10591</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sudhakar Kadari</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy (M/C781), University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612-7230, Department of Pharmacology, Psychiatry, Comprehensive Cancer Center, Center for Neurobiology Division of Medicinal Chemistry and Natural Products, and NIMH Psychoactive Drug Screening Program, University of North Carolina Medical School, Chapel Hill, CB 7365, North Carolina 27599, Psychogenics, Inc., Tarrytown, New York 10591</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael L. Manzano</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy (M/C781), University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612-7230, Department of Pharmacology, Psychiatry, Comprehensive Cancer Center, Center for Neurobiology Division of Medicinal Chemistry and Natural Products, and NIMH Psychoactive Drug Screening Program, University of North Carolina Medical School, Chapel Hill, CB 7365, North Carolina 27599, Psychogenics, Inc., Tarrytown, New York 10591</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jessica E. Malberg</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy (M/C781), University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612-7230, Department of Pharmacology, Psychiatry, Comprehensive Cancer Center, Center for Neurobiology Division of Medicinal Chemistry and Natural Products, and NIMH Psychoactive Drug Screening Program, University of North Carolina Medical School, Chapel Hill, CB 7365, North Carolina 27599, Psychogenics, Inc., Tarrytown, New York 10591</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Caldarone</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy (M/C781), University of Illinois at Chicago, 833 South Wood Street, Chicago, Illinois 60612-7230, Department of Pharmacology, Psychiatry, Comprehensive Cancer Center, Center for Neurobiology Division of Medicinal Chemistry and Natural Products, and NIMH Psychoactive Drug Screening Program, University of North Carolina Medical School, Chapel Hill, CB 7365, North Carolina 27599, Psychogenics, Inc., Tarrytown, New York 10591</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i114">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45507" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45507" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported in part by NIH grant (R01 DA022317, grantee Alan P. Kozikowski), (RO1MH61887, NO1MH80032, and U19MH82441, grantee Bryan L. Roth) and NIDA fellowship (2006−2007). This work was supported by the Korea Research Foundation Grant funded by the Korean Government (KRF-2007-357-C00071). We thank Dr. Rong He for help with the preparative of the manuscript and Dr. Arsen Gaysin for help with generating the data reported. S. J. Cho expresses appreciation to Dr. Suresh Tipparaju, Dr. Annamaria Lilienkampf, Dr. Sophie Gaudrel-Grosay, and Dr. Ki Duk Park for helpful discussions.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i116">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70857" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70857" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 55 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hoyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, G.</span><span> </span><span class="NLM_article-title">5-HT receptor classification and nomenclature: towards a harmonization with the human genome</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=419-428&author=D.+Hoyerauthor=G.+Martin&title=5-HT+receptor+classification+and+nomenclature%3A+towards+a+harmonization+with+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DG.%26atitle%3D5-HT%2520receptor%2520classification%2520and%2520nomenclature%253A%2520towards%2520a%2520harmonization%2520with%2520the%2520human%2520genome%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D419%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Multiple serotonin receptors: clinical and experimental aspects</span> <span class="citation_source-journal">Ann. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.3109%2F10401239409148985" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=7804391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A280%3ADyaK2M7gt1Orsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1994&pages=67-78&author=B.+L.+Roth&title=Multiple+serotonin+receptors%3A+clinical+and+experimental+aspects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple serotonin receptors: clinical and experimental aspects</span></div><div class="casAuthors">Roth B L</div><div class="citationInfo"><span class="NLM_cas:title">Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-78</span>
        ISSN:<span class="NLM_cas:issn">1040-1237</span>.
    </div><div class="casAbstract">Serotonin (5-hydroxytryptamine; 5-HT) has been implicated in a large number of psychophysiologic processes including the regulation of sleep, appetite, mood, aggression, perception, memory, and anxiety.  To mediate this large array of physiologic processes, at least 14 separate 5-HT receptors have evolved, which are divided into seven main families.  Not surprisingly, alterations of 5-HT receptor activity have been shown to occur in many psychiatric diseases including anxiety, depression, eating disorders, schizophrenia, personality disorders, and many drug-induced psychotic states.  Additionally, a number of effective psychopharmacologic agents for diseases as diverse as schizophrenia and anxiety have been developed which either specifically alter brain levels of serotonin or bind to 5-HT receptor subtypes.  This review article summarizes recent advances in the burgeoning field of serotonin receptor pharmacology and integrates this information into a coherent perspective on the importance of serotonergic agents for clinical psychiatry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6F454_VHydK91pGlMMoT5fW6udTcc2ebmzOYh-CFporntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M7gt1Orsw%253D%253D&md5=163a37829cc21c21c5a81e6c256cbc35</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3109%2F10401239409148985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10401239409148985%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DMultiple%2520serotonin%2520receptors%253A%2520clinical%2520and%2520experimental%2520aspects%26jtitle%3DAnn.%2520Clin.%2520Psychiatry%26date%3D1994%26volume%3D6%26spage%3D67%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Kroeze, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1128</span><span class="NLM_x">–</span> <span class="NLM_lpage">1142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1016%2FS0006-3223%2898%2900132-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=9836016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADyaK1cXnvFKqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1998&pages=1128-1142&author=W.+K.+Kroezeauthor=B.+L.+Roth&title=The+molecular+biology+of+serotonin+receptors%3A+therapeutic+implications+for+the+interface+of+mood+and+psychosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis</span></div><div class="casAuthors">Kroeze, Wesley K.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1128-1142</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with 152 refs., which summarizes the mol. biol. of serotonin (5-HT; 5-hydroxytryptamine) receptors and indicates the potential relevance of this information for the treatment of mood and psychotic disorders.  At least 15 sep. subtypes of 5-HT receptors have been identified by mol. cloning techniques to be distinct genetic entities.  Subtle differences in the primary amino acid sequences of these receptors can yield large differences in ligand selectivity.  Addnl., it has recently been discovered that drugs such as atypical antipsychotic drugs and serotonin-selective reuptake inhibitors may interact with a large no. of heretofore unknown 5-HT receptors.  Thus clozapine, for instance, has high affinity for at least four sep. 5-HT receptors, and it is unknown which of these receptors is essential for its unique therapeutic efficacy.  One way to approach these questions is to test subtype-selective agents, although there are few of these currently available.  Approaches to the design of subtype-selective ligands are described, including structure-based drug design and combinatorial approaches.  Modes of regulation of 5-HT receptors are also summarized, and it is emphasized that antipsychotic drugs and antidepressants likely exert their effects via nontranscriptional and posttranslational means.  Understanding the cellular mechanisms by which 5-HT receptors are regulated by psychopharmacol. agents is likely to yield novel insights into drug action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBEIwmClT3vbVg90H21EOLACvtfcHk0ljdZgh06_UKfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvFKqurc%253D&md5=daae7df1a87e737a3cd49d844135a687</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2898%2900132-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252898%252900132-2%26sid%3Dliteratum%253Aachs%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DThe%2520molecular%2520biology%2520of%2520serotonin%2520receptors%253A%2520therapeutic%2520implications%2520for%2520the%2520interface%2520of%2520mood%2520and%2520psychosis%26jtitle%3DBiol.%2520Psychiatry%26date%3D1998%26volume%3D44%26spage%3D1128%26epage%3D1142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kroeze, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">G-protein-coupled receptors at a glance</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">4867</span><span class="NLM_x">–</span> <span class="NLM_lpage">4869</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1242%2Fjcs.00902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=14625380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFOntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2003&pages=4867-4869&author=W.+K.+Kroezeauthor=D.+J.+Shefflerauthor=B.+L.+Roth&title=G-protein-coupled+receptors+at+a+glance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">G-protein-coupled receptors at a glance</span></div><div class="casAuthors">Kroeze, Wesley K.; Sheffler, Douglas J.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4867-4869</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review discusses how G-protein-coupled receptors (GPCRs) work, the different types of GPCR, and the importance of these receptors as drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoICG4Zs6PITbVg90H21EOLACvtfcHk0lgtITiI1fH2rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFOntQ%253D%253D&md5=c32c6d5103b50e89182a7ea9ee5a2c78</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1242%2Fjcs.00902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.00902%26sid%3Dliteratum%253Aachs%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DG-protein-coupled%2520receptors%2520at%2520a%2520glance%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2003%26volume%3D116%26spage%3D4867%26epage%3D4869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Kroeze, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristiansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Molecular biology of serotonin receptors structure and function at the molecular level</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.2174%2F1568026023393796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=12052191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD38Xksl2jt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=507-528&author=W.+K.+Kroezeauthor=K.+Kristiansenauthor=B.+L.+Roth&title=Molecular+biology+of+serotonin+receptors+structure+and+function+at+the+molecular+level"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular biology of serotonin receptors - structure and function at the molecular level</span></div><div class="casAuthors">Kroeze, Wesley K.; Kristiansen, Kurt; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">507-528</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review summarizing current understanding of the structure and function of the G-protein coupled 5-HT receptors.  The following topics were discussed: overall structure of the G-protein-coupled 5-HT receptors; cloning of 5-HT receptors; sequence conservation of 5-HT receptors; mutagenesis of 5-HT receptors; alternative splicing of 5-HT receptors; mRNA editing of 5-HT receptors; oligomerization; and targeting and trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE_gk0dnNzOrVg90H21EOLACvtfcHk0lgtITiI1fH2rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xksl2jt70%253D&md5=5453cbcd55b910d6eaa714830157b0fd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F1568026023393796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026023393796%26sid%3Dliteratum%253Aachs%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26aulast%3DKristiansen%26aufirst%3DK.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DMolecular%2520biology%2520of%2520serotonin%2520receptors%2520structure%2520and%2520function%2520at%2520the%2520molecular%2520level%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2002%26volume%3D2%26spage%3D507%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Nichols, D. E.</span><span> </span><span class="NLM_article-title">Hallucinogens</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1016%2Fj.pharmthera.2003.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=14761703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFCmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=131-181&author=D.+E.+Nichols&title=Hallucinogens"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Hallucinogens</span></div><div class="casAuthors">Nichols, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-181</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Hallucinogens (psychedelics) are psychoactive substances that powerfully alter perception, mood, and a host of cognitive processes.  They are considered physiol. safe and do not produce dependence or addiction.  Their origin predates written history, and they were employed by early cultures in a variety of sociocultural and ritual contexts.  In the 1950s, after the virtually contemporaneous discovery of both serotonin (5-HT) and lysergic acid diethylamide (LSD-25), early brain research focused intensely on the possibility that LSD or other hallucinogens had a serotonergic basis of action and reinforced the idea that 5-HT was an important neurotransmitter in brain.  These ideas were eventually proven, and today it is believed that hallucinogens stimulate 5-HT2A receptors, esp. those expressed on neocortical pyramidal cells.  Activation of 5-HT2A receptors also leads to increased cortical glutamate levels presumably by a presynaptic receptor-mediated release from thalamic afferents.  These findings have led to comparisons of the effects of classical hallucinogens with certain aspects of acute psychosis and to a focus on thalamocortical interactions as key to understanding both the action of these substances and the neuroanatomical sites involved in altered states of consciousness (ASC).  In vivo brain imaging in humans using [18F]fluorodeoxyglucose has shown that hallucinogens increase prefrontal cortical metab., and correlations have been developed between activity in specific brain areas and psychol. elements of the ASC produced by hallucinogens.  The 5-HT2A receptor clearly plays an essential role in cognitive processing, including working memory, and ligands for this receptor may be extremely useful tools for future cognitive neuroscience research.  In addn., it appears entirely possible that utility may still emerge for the use of hallucinogens in treating alcoholism, substance abuse, and certain psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRl6lKmZ_4Y7Vg90H21EOLACvtfcHk0lgtITiI1fH2rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFCmsg%253D%253D&md5=7b5246f6479d76736c5a7223c60a9e99</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2003.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2003.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DD.%2BE.%26atitle%3DHallucinogens%26jtitle%3DPharmacol.%2520Ther.%26date%3D2004%26volume%3D101%26spage%3D131%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauser, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hufeisen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Evidence for possible involvement of 5-HT<sub>2B</sub> receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">2836</span><span class="NLM_x">–</span> <span class="NLM_lpage">2841</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1161%2F01.CIR.102.23.2836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=11104741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptVSjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=2836-2841&author=R.+B.+Rothmanauthor=M.+H.+Baumannauthor=J.+E.+Savageauthor=L.+Rauserauthor=A.+McBrideauthor=S.+J.+Hufeisenauthor=B.+L.+Roth&title=Evidence+for+possible+involvement+of+5-HT2B+receptors+in+the+cardiac+valvulopathy+associated+with+fenfluramine+and+other+serotonergic+medications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications</span></div><div class="casAuthors">Rothman, Richard B.; Baumann, Michael H.; Savage, Jason E.; Rauser, Laura; McBride, Ace; Hufeisen, Sandra J.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2836-2841</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Serotonergic medications with various mechanisms of action are used to treat psychiatric disorders and are being investigated as treatments for drug dependence.  The occurrence of fenfluramine-assocd. valvular heart disease (VHD) has raised concerns that other serotonergic medications might also increase the risk of developing VHD.  We hypothesized that fenfluramine or its metabolite norfenfluramine and other medications known to produce VHD have preferentially high affinities for a particular serotonin receptor subtype capable of stimulating mitogenesis.  Medications known or suspected to cause VHD (pos. controls) and medications not assocd. with VHD (neg. controls) were screened for activity at 11 cloned serotonin receptor subtypes by use of ligand-binding methods and functional assays.  The pos. control drugs were (±)-fenfluramine; (+)-fenfluramine; (-)-fenfluramine; its metabolites (±)-norfenfluramine, (+)-norfenfluramine, and (-)-norfenfluramine; ergotamine; and methysergide and its metabolite methylergonovine.  The neg. control drugs were phentermine, fluoxetine, its metabolite norfluoxetine, and trazodone and its active metabolite m-chlorophenylpiperazine.  (±)-, (+)-, And (-)-Norfenfluramine, ergotamine, and methylergonovine all had preferentially high affinities for the cloned human serotonin 5-HT2B receptor and were partial to full agonists at the 5-HT2B receptor.  Our data imply that activation of 5-HT2B receptors is necessary to produce VHD and that serotonergic medications that do not activate 5-HT2B receptors are unlikely to produce VHD.  We suggest that all clin. available medications with serotonergic activity and their active metabolites be screened for agonist activity at 5-HT2B receptors and that clinicians should consider suspending their use of medications with significant activity at 5-HT2B receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6spUXOCLtLrVg90H21EOLACvtfcHk0li-E782X8ZJzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptVSjtrs%253D&md5=6b8c6059885dd9b058859089914c61b3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.102.23.2836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.102.23.2836%26sid%3Dliteratum%253Aachs%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DSavage%26aufirst%3DJ.%2BE.%26aulast%3DRauser%26aufirst%3DL.%26aulast%3DMcBride%26aufirst%3DA.%26aulast%3DHufeisen%26aufirst%3DS.%2BJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DEvidence%2520for%2520possible%2520involvement%2520of%25205-HT2B%2520receptors%2520in%2520the%2520cardiac%2520valvulopathy%2520associated%2520with%2520fenfluramine%2520and%2520other%2520serotonergic%2520medications%26jtitle%3DCirculation%26date%3D2000%26volume%3D102%26spage%3D2836%26epage%3D2841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Drugs and valvular heart disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1056%2FNEJMp068265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=17202450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitlCitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2007&pages=6-9&author=B.+L.+Roth&title=Drugs+and+valvular+heart+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs and valvular heart disease</span></div><div class="casAuthors">Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">6-9</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOaFEwabTP8rVg90H21EOLACvtfcHk0li-E782X8ZJzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitlCitQ%253D%253D&md5=e5161a25f1a2596cef68030f0f8a7b61</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1056%2FNEJMp068265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMp068265%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DDrugs%2520and%2520valvular%2520heart%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2007%26volume%3D356%26spage%3D6%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Loke, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard-Copley, A.</span><span> </span><span class="NLM_article-title">Appetite suppressants and valvular heart disease—a systematic review</span> <span class="citation_source-journal">BMC Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1186%2F1472-6904-2-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=12194699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A280%3ADC%252BD2czlt1yisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=6&author=Y.+K.+Lokeauthor=S.+Derryauthor=A.+Pritchard-Copley&title=Appetite+suppressants+and+valvular+heart+disease%E2%80%94a+systematic+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Appetite suppressants and valvular heart disease - a systematic review</span></div><div class="casAuthors">Loke Yoon K; Derry Sheena; Pritchard-Copley Angharad</div><div class="citationInfo"><span class="NLM_cas:title">BMC clinical pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Although appetite suppressants have been implicated in the development of valvular heart disease, the exact level of risk is still uncertain.  Initial studies suggested that as many as 1 in 3 exposed patients were affected, but subsequent research has yielded substantially different figures.  Our objective was to systematically assess the risk of valvular heart disease with appetite suppressants.  METHODS:  We accepted studies involving obese patients treated with any of the following appetite suppressants: fenfluramine, dexfenfluramine, and phentermine.  Three types of studies were reviewed: controlled and uncontrolled observational studies, and randomized controlled trials.  Outcomes of interest were echocardiographically detectable aortic regurgitation of mild or greater severity, or mitral regurgitation of moderate or greater severity.  RESULTS:  Of the 1279 patients evaluated in seven uncontrolled cohort studies, 236 (18%) and 60 (5%) were found to have aortic and mitral regurgitation, respectively.  Pooled data from six controlled cohort studies yielded, for aortic regurgitation, a relative risk ratio of 2.32 (95% confidence intervals 1.79 to 3.01, p < 0.00001) and an attributable rate of 4.9%, and for mitral regurgitation, a relative risk ratio of 1.55 (95% confidence intervals 1.06 to 2.25, p = 0.02) with an attributable rate of 1.0%.  Only one case of valvular heart disease was detected in 57 randomized controlled trials, but this was judged unrelated to drug therapy.  CONCLUSIONS:  The risk of valvular heart disease is significantly increased by the appetite suppressants reviewed here.  Nevertheless, when considering all the evidence, valvulopathy is much less common than suggested by the initial, less methodologically rigorous studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnTGf8uIGluvxQvRxYU81tfW6udTcc2eb30vKIFvt03Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czlt1yisQ%253D%253D&md5=87f6f43f022174efacf782e8552b1aa4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1186%2F1472-6904-2-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1472-6904-2-6%26sid%3Dliteratum%253Aachs%26aulast%3DLoke%26aufirst%3DY.%2BK.%26aulast%3DDerry%26aufirst%3DS.%26aulast%3DPritchard-Copley%26aufirst%3DA.%26atitle%3DAppetite%2520suppressants%2520and%2520valvular%2520heart%2520disease%25E2%2580%2594a%2520systematic%2520review%26jtitle%3DBMC%2520Clin.%2520Pharmacol.%26date%3D2002%26volume%3D2%26spage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Rocha, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulding, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Dell, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mead, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coufal, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tecott, L. H.</span><span> </span><span class="NLM_article-title">Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">10039</span><span class="NLM_x">–</span> <span class="NLM_lpage">10045</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=12427861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD38XovF2ktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=10039-10045&author=B.+A.+Rochaauthor=E.+H.+Gouldingauthor=L.+E.+O%E2%80%99Dellauthor=A.+N.+Meadauthor=N.+G.+Coufalauthor=L.+H.+Parsonsauthor=L.+H.+Tecott&title=Enhanced+locomotor%2C+reinforcing%2C+and+neurochemical+effects+of+cocaine+in+serotonin+5-hydroxytryptamine+2C+receptor+mutant+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice</span></div><div class="casAuthors">Rocha, Beatriz A.; Goulding, Evan H.; O'Dell, Laura E.; Mead, Andy N.; Coufal, Nicole G.; Parsons, Loren H.; Tecott, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10039-10045</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Brain serotonin [5-hydroxytryptamine (5-HT)] systems substantially influence the effects of cocaine; however, the contributions of individual 5-HT receptor subtypes to the regulation of cocaine responses are unclear.  A line of mutant mice devoid of 5-HT2C receptors was used to examine the contribution of this receptor subtype to the serotonergic modulation of cocaine responses.  Mutants display enhanced exploration of a novel environment and increased sensitivity to the locomotor stimulant effects of cocaine.  In an operant i.v. self-administration model under a progressive ratio schedule of reinforcement, mutants display elevated levels of lever pressing for cocaine injections, indicating that the drug is more reinforcing in these mice.  Moreover, mutants exhibit enhanced cocaine-induced elevations of dopamine (DA) levels in the nucleus accumbens, a brain region implicated in the stimulant and rewarding properties of cocaine.  In contrast, phenotypic differences in dorsal striatal DA levels were not produced by cocaine treatment.  These findings strongly implicate 5-HT2C receptors in the serotonergic suppression of DA-mediated behavioral responses to cocaine and as a potential therapeutic target for cocaine abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqap24jrSmDe7Vg90H21EOLACvtfcHk0liXwrWuf3IVAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovF2ktrw%253D&md5=d834faafa5977fc6914c732af667c849</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRocha%26aufirst%3DB.%2BA.%26aulast%3DGoulding%26aufirst%3DE.%2BH.%26aulast%3DO%25E2%2580%2599Dell%26aufirst%3DL.%2BE.%26aulast%3DMead%26aufirst%3DA.%2BN.%26aulast%3DCoufal%26aufirst%3DN.%2BG.%26aulast%3DParsons%26aufirst%3DL.%2BH.%26aulast%3DTecott%26aufirst%3DL.%2BH.%26atitle%3DEnhanced%2520locomotor%252C%2520reinforcing%252C%2520and%2520neurochemical%2520effects%2520of%2520cocaine%2520in%2520serotonin%25205-hydroxytryptamine%25202C%2520receptor%2520mutant%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D10039%26epage%3D10045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Tecott, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akana, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strack, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowenstein, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallman, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julius, D.</span><span> </span><span class="NLM_article-title">Eating disorder and epilepsy in mice lacking 5-HT<sub>2C</sub> serotonin receptors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1038%2F374542a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=7700379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADyaK2MXkvVKqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=1995&pages=542-546&author=L.+H.+Tecottauthor=L.+M.+Sunauthor=S.+F.+Akanaauthor=A.+M.+Strackauthor=D.+H.+Lowensteinauthor=M.+F.+Dallmanauthor=D.+Julius&title=Eating+disorder+and+epilepsy+in+mice+lacking+5-HT2C+serotonin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors</span></div><div class="casAuthors">Tecott, Laurence H.; Sun, Linda M.; Akana, Susan F.; Strack, Alison M.; Lowenstein, Daniel H.; Dallman, Mary F.; Julius, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">374</span>
        (<span class="NLM_cas:issue">6522</span>),
    <span class="NLM_cas:pages">542-6</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Serotonin (5-hydroxytryptamine, 5-HT) is a monoaminergic neurotransmitter that is believed to modulate numerous sensory, motor and behavioral processes in the mammalian nervous system.  These diverse responses are elicited through the activation of a large family of receptor subtypes.  The complexity of this signalling system and the paucity of selective drugs have made it difficult to define specific roles for 5-HT receptor subtypes, or to det. how serotonergic drugs modulate mood and behavior.  To address these issues, we have generated mutant mice lacking functional 5-HT2C receptors (previously termed 5-HT1C), prominent G-protein-coupled receptors that are widely expressed throughout the brain and spinal cord and which have been proposed to mediate numerous central nervous system (CNS) actions of serotonin.  Here we show that 5-HT2C receptor-deficient mice are overweight as a result of abnormal control of feeding behavior, establishing a role for this receptor in the serotonergic control of appetite.  Mutant animals are also prone to spontaneous death from seizures, suggesting that 5-HT2C receptors mediate tonic inhibition of neuronal network excitability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyfCSY65mvybVg90H21EOLACvtfcHk0liXwrWuf3IVAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkvVKqtr4%253D&md5=e87d8eac0789c2c012c34717d1fdbfe0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2F374542a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F374542a0%26sid%3Dliteratum%253Aachs%26aulast%3DTecott%26aufirst%3DL.%2BH.%26aulast%3DSun%26aufirst%3DL.%2BM.%26aulast%3DAkana%26aufirst%3DS.%2BF.%26aulast%3DStrack%26aufirst%3DA.%2BM.%26aulast%3DLowenstein%26aufirst%3DD.%2BH.%26aulast%3DDallman%26aufirst%3DM.%2BF.%26aulast%3DJulius%26aufirst%3DD.%26atitle%3DEating%2520disorder%2520and%2520epilepsy%2520in%2520mice%2520lacking%25205-HT2C%2520serotonin%2520receptors%26jtitle%3DNature%26date%3D1995%26volume%3D374%26spage%3D542%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Chou-Green, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holscher, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallman, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akana, S. F.</span><span> </span><span class="NLM_article-title">Compulsive behavior in the 5-HT<sub>2C</sub> receptor knockout mouse</span> <span class="citation_source-journal">Physiol. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">649</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1016%2FS0031-9384%2803%2900047-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=12782219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFGlsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2003&pages=641-649&author=J.+M.+Chou-Greenauthor=T.+D.+Holscherauthor=M.+F.+Dallmanauthor=S.+F.+Akana&title=Compulsive+behavior+in+the+5-HT2C+receptor+knockout+mouse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Compulsive behavior in the 5-HT2C receptor knockout mouse</span></div><div class="casAuthors">Chou-Green, Jennifer M.; Holscher, Todd D.; Dallman, Mary F.; Akana, Susan F.</div><div class="citationInfo"><span class="NLM_cas:title">Physiology & Behavior</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">641-649</span>CODEN:
                <span class="NLM_cas:coden">PHBHA4</span>;
        ISSN:<span class="NLM_cas:issn">0031-9384</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">We hypothesized that 5-HT2C receptor knockout (KO) mice may display compulsive-like behavior.  This paper describes characterization of several distinct, highly organized behaviors in mice lacking functional 5-HT2C receptors, which supports a compulsive-like syndrome.  Compulsive-like behavior was assessed in male 5-HTC receptor KO and wildtype (WT) mice.  Chewing of non-nutritive clay, chewing patterns on plastic-mesh screens, and the frequency of head dipping were measured.  5-HTC receptor KO mice chewed more clay, produced a distinct pattern of neat chewing of plastic screens and exhibited reduced habituation of head dipping activity compared to WT mice.  We conclude that the 5-HT2C receptor null mutant mouse provides a promising model of compulsive behavior and a means to further explore the role of 5-HT in obsession-compulsion disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnAGeAB6uFJLVg90H21EOLACvtfcHk0ljBTrY26Gro9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFGlsbo%253D&md5=a6daf407955decc087c2ead152669814</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0031-9384%2803%2900047-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0031-9384%252803%252900047-7%26sid%3Dliteratum%253Aachs%26aulast%3DChou-Green%26aufirst%3DJ.%2BM.%26aulast%3DHolscher%26aufirst%3DT.%2BD.%26aulast%3DDallman%26aufirst%3DM.%2BF.%26aulast%3DAkana%26aufirst%3DS.%2BF.%26atitle%3DCompulsive%2520behavior%2520in%2520the%25205-HT2C%2520receptor%2520knockout%2520mouse%26jtitle%3DPhysiol.%2520Behav.%26date%3D2003%26volume%3D78%26spage%3D641%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Delgado, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, F. A.</span><span> </span><span class="NLM_article-title">Hallucinogens, serotonin and obsessive-compulsive disorder</span> <span class="citation_source-journal">J. Psychoactive Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1080%2F02791072.1998.10399711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=9924841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A280%3ADyaK1M7it1ahuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1998&pages=359-366&author=P.+L.+Delgadoauthor=F.+A.+Moreno&title=Hallucinogens%2C+serotonin+and+obsessive-compulsive+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Hallucinogens, serotonin and obsessive-compulsive disorder</span></div><div class="casAuthors">Delgado P L; Moreno F A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychoactive drugs</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">359-66</span>
        ISSN:<span class="NLM_cas:issn">0279-1072</span>.
    </div><div class="casAbstract">The serotonin (5-HT) neurotransmitter system has been implicated in the pathophysiology of several neuropsychiatric disorders, especially obsessive-compulsive disorder (OCD).  Blockade of 5-HT reuptake appears to be an important initial neurobiological event in the therapeutic mechanism of action of antiobsessional drugs.  However, for reasons that continue to be poorly understood, clinical improvement following initiation of treatment with 5-HT reuptake inhibitors can take up to eight to 12 weeks, and most patients do not fully improve.  Recent data suggest that activation of 5-HT2A and/or 5-HT2C receptors may be important for the improvement of OCD symptoms.  Most psychedelic drugs are potent agonists at 5-HT2A and 5-HT2C receptors and their binding potency to these receptors is strongly correlated with their human potency as hallucinogens.  This article will briefly review the relevant clinical and preclinical studies relating to the effects of hallucinogens on OCD.  These data suggest that activation of 5-HT2 receptors by hallucinogens may lead to acute reduction of, as well as possible longer-lasting beneficial effects on, the symptoms of OCD.  Evidence for and against involvement of 5-HT2A and/or 5-HT2C receptors in the therapeutic effects of drug therapies for OCD are reviewed.  Issues related to the pharmacological properties and safety of psychedelic drugs, when considered as potential treatments for patients with OCD, are summarized.  The authors suggest that controlled trials of potent 5-HT2 agonists in people suffering from OCD are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTTnZEdidVmckQ0lWbKiCflfW6udTcc2eagLMLIy2XFoLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7it1ahuw%253D%253D&md5=c078396bacf436bf8be058c3ee579131</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1080%2F02791072.1998.10399711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F02791072.1998.10399711%26sid%3Dliteratum%253Aachs%26aulast%3DDelgado%26aufirst%3DP.%2BL.%26aulast%3DMoreno%26aufirst%3DF.%2BA.%26atitle%3DHallucinogens%252C%2520serotonin%2520and%2520obsessive-compulsive%2520disorder%26jtitle%3DJ.%2520Psychoactive%2520Drugs%26date%3D1998%26volume%3D30%26spage%3D359%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Martin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleight, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berendsen, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broekkamp, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruigt, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delft, A. M.</span><span> </span><span class="NLM_article-title">5-HT<sub>2C</sub> receptor agonists: pharmacological characteristics and therapeutic potential</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=9694950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADyaK1cXlsVWhs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1998&pages=913-924&author=J.+R.+Martinauthor=M.+Bosauthor=F.+Jenckauthor=J.+Moreauauthor=V.+Mutelauthor=A.+J.+Sleightauthor=J.+Wichmannauthor=J.+S.+Andrewsauthor=H.+H.+Berendsenauthor=C.+L.+Broekkampauthor=G.+S.+Ruigtauthor=C.+Kohlerauthor=A.+M.+Delft&title=5-HT2C+receptor+agonists%3A+pharmacological+characteristics+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential</span></div><div class="casAuthors">Martin, J. R.; Bos, M.; Jenck, F.; Moreau, J.-L.; Mutel, V.; Sleight, A. J.; Wichmann, J.; Andrews, J. S.; Berendsen, H. H. G.; Broekkamp, C. L. E.; Ruigt, G. S. F.; Kohler, C.; Van Delft, A. M. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">913-924</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">In vitro, (S)-2-(chloro-5-fluoro-indol-1-yl)-1-methylethylamine 1:1 C4H4O4 and (S)-2-(4,4,7-trimethyl-1,4-dihydro-indeno[1,2-b]pyrrol-1-yl)-methylethylamine 1:1 C4H4O4 exhibited high-affinity binding to the serotonin2C (5HT2C) receptors and stimulated turnover of inositol 1,4,5-triphosphate.  Affinity to several of the other 5-HT receptor subtypes and to numerous nonserotonergic receptors was much lower.  In rats, both compds. elicited behavioral signs of 5-HT2C receptor agonism but not 5-HT2A receptor agonism.  Hypomotility induced in rats by high doses of these compds. was reversed by the 5-HT2C receptor antagonist N-(2-naphthyl)-N'-(3-pyridyl)-urea 1:1 HCl.  In addn., these compds. were active in tests used to demonstrate anticompulsive effects: reducing schedule-induced polydipsia in rats (prevented by the 5-HT2C/2B receptor antagonist N-(1-methyl-5'-indolyl)-(3-pyridyl)urea 1:1 HCl), reversing increased scratching induced with 8-hydroxy-dipropylaminotetralin 1:1 HCl in squirrel monkeys (no tolerance developed), decreasing responding in the marble-burying task in mice, and decreasing excessive eating of palatable food in rats.  In contrast to these compds., fluoxetine was much less potent, and in some tasks less efficacious, in reducing excessive behavior in these models.  These two 5-HT2C receptor agonists do not show anxiogenic effects in the plus-maze in rats.  (S)-2-(4,4,7-trimethyl-1,4-dihydro-indeno[1,2-b]pyrrol-1-yl)-1-methylethylamine 1:1 C4H4O4 reduced the olfactory bulbectomy-induced passive avoidance impairment in rats, a result that indicates antidepressant potential.  Similarly, in the differential-reinforcement-of-low rate 72-s operant schedule task in rats, (S)-2-(chloro-5-fluoro-indol-1-yl)-1-methylethylamine 1:1 C4H4O4 increased (and (S)-2-(4,4,7-trimethyl-1,4-dihydro-indeno[1,2-b]pyrrol-1-yl)-1-methylethylamine 1:1 C4H4O4 showed a tendency to increase) total reinforcements received, which is suggestive of antidepressant activity.  The electroencephalog. defined sleep-waking pattern in rats produced by these two 5-HT2C agonists, as well as fluoxetine, included increased quiet-waking and decreased rapid-eye-movement sleep, which is characteristic of antidepressant drugs.  These results suggest that 5-HT2C receptor agonism is assocd. with therapeutic potential in obsessive compulsive disorder and depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohW8KKOgYeubVg90H21EOLACvtfcHk0ljBTrY26Gro9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsVWhs7g%253D&md5=82d744eb5a21ff6a0db4f9f29071bac1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DJ.%2BR.%26aulast%3DBos%26aufirst%3DM.%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DMoreau%26aufirst%3DJ.%26aulast%3DMutel%26aufirst%3DV.%26aulast%3DSleight%26aufirst%3DA.%2BJ.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DAndrews%26aufirst%3DJ.%2BS.%26aulast%3DBerendsen%26aufirst%3DH.%2BH.%26aulast%3DBroekkamp%26aufirst%3DC.%2BL.%26aulast%3DRuigt%26aufirst%3DG.%2BS.%26aulast%3DKohler%26aufirst%3DC.%26aulast%3DDelft%26aufirst%3DA.%2BM.%26atitle%3D5-HT2C%2520receptor%2520agonists%253A%2520pharmacological%2520characteristics%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1998%26volume%3D286%26spage%3D913%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, D. A.</span><span> </span><span class="NLM_article-title">Insights into the structure and function of 5-HT<sub>2</sub> family serotonin receptors reveal novel strategies for therapeutic target development</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1517%2F14728222.5.6.685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=12540278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFWgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2001&pages=685-695&author=B.+L.+Rothauthor=D.+A.+Shapiro&title=Insights+into+the+structure+and+function+of+5-HT2+family+serotonin+receptors+reveal+novel+strategies+for+therapeutic+target+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the structure and function of 5-HT2 family serotonin receptors reveal novel strategies for therapeutic target development</span></div><div class="casAuthors">Roth, Bryan L.; Shapiro, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">685-695</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  5-HT2 family serotonin receptors, principal sites of action of serotonin in the brain, represent major mol. targets for drugs used in treating a variety of diseases including schizophrenia, depression, anxiety, eating disorders, obsessive-compulsive disorder, chronic pain conditions and obesity.  The 5-HT2 family of receptors has three members: 5-HT2A, 5-HT2B and 5-HT2C.  Therefore, it is likely that subtype-selective compds. will be needed to avoid serious side effects and to enhance therapeutic indexes.  Unfortunately, recent insights into the structure and function of 5-HT2A receptors have revealed that structurally-diverse agonists and antagonists have distinct modes of interacting with 5-HT2A receptors, complicating efforts at structure-based drug-design.  These distinct binding modes would not have been predicted based on conventional structure-activity relationships or static docking models.  Fortunately, these complicated binding modes can be predicted and simulated using mol. dynamics, allowing for the possibility of structure-based drug design.  Thus, provided appropriately sophisticated drug design strategies are employed, it is likely that uniquely valuable medications will result which could have great potential for treating a variety of mental and phys. illnesses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzVQ9Bi3a_u7Vg90H21EOLACvtfcHk0lgNWe_A4waF7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFWgsA%253D%253D&md5=dce9ef4a4033267a8d2f9a78ee625748</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F14728222.5.6.685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.5.6.685%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DShapiro%26aufirst%3DD.%2BA.%26atitle%3DInsights%2520into%2520the%2520structure%2520and%2520function%2520of%25205-HT2%2520family%2520serotonin%2520receptors%2520reveal%2520novel%2520strategies%2520for%2520therapeutic%2520target%2520development%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2001%26volume%3D5%26spage%3D685%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Miller, K. J.</span><span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>2C</sub> receptor agonists: potential for the treatment of obesity</span> <span class="citation_source-journal">Mol. Interv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">282</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=282-291&author=K.+J.+Miller&title=Serotonin+5-HT2C+receptor+agonists%3A+potential+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DK.%2BJ.%26atitle%3DSerotonin%25205-HT2C%2520receptor%2520agonists%253A%2520potential%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DMol.%2520Interv.%26date%3D2005%26volume%3D5%26spage%3D282%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroeze, W. K.</span><span> </span><span class="NLM_article-title">The multiplicity of serotonin receptors: Uselessly diverse molecules or an embarrassment of riches?</span> <span class="citation_source-journal">Neuroscientist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=252-262&author=B.+L.+Rothauthor=E.+Lopezauthor=S.+Patelauthor=W.+K.+Kroeze&title=The+multiplicity+of+serotonin+receptors%3A+Uselessly+diverse+molecules+or+an+embarrassment+of+riches%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DLopez%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26atitle%3DThe%2520multiplicity%2520of%2520serotonin%2520receptors%253A%2520Uselessly%2520diverse%2520molecules%2520or%2520an%2520embarrassment%2520of%2520riches%253F%26jtitle%3DNeuroscientist%26date%3D2000%26volume%3D6%26spage%3D252%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Isaac, M.</span><span> </span><span class="NLM_article-title">Serotonergic 5-HT<sub>2C</sub> receptors as a potential therapeutic target for the design antiepileptic drugs</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.2174%2F1568026053386980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=15638778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFOgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=59-67&author=M.+Isaac&title=Serotonergic+5-HT2C+receptors+as+a+potential+therapeutic+target+for+the+design+antiepileptic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonergic 5-HT2C receptors as a potential therapeutic target for the design antiepileptic drugs</span></div><div class="casAuthors">Isaac, Methvin</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-67</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A variety of clin. observations suggest that certain forms of epilepsy are due to long-term, progressive changes in neural networks that eventually provoke spontaneous and recurring seizures.  Recently, there has been growing evidence that serotonergic neurotransmission modulates exptl. induced seizures and is involved in the enhanced seizure susceptibility obsd. in some genetically epilepsy-prone animals.  Generally, agents that elevate extracellular serotonin (5-Hydroxytryptamine, 5-HT) levels, such as 5-hydroxytryptophan, and 5-HT reuptake blockers inhibit both limbic and generalized seizures.  Conversely, depletion of brain 5-HT lowers the threshold to audiogenically, chem. and elec.-evoked convulsions.  More specifically, the recent finding that the 5-HT2B/2C receptor agonist, 1-(m-chlorophenyl)-piperazine (mCPP) is anticonvulsant has kindled an interest into the investigation of the serotonergic 5-HT2C receptor subtype as a potential target for the treatment of epilepsy.  Further pharmacol. evaluation of selective activation or inactivation of the 5-HT2C receptor subtype with selective agonist/pos. modulators and antagonists will provide important information about the therapeutic contribution of this receptor to the epileptic circuitry in the brain.  Future development of serotonergic antiepileptic drugs will be a significant addn. to the therapeutic armamentarium against epilepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCeBhoy3zffLVg90H21EOLACvtfcHk0lgNWe_A4waF7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFOgtg%253D%253D&md5=7857cc5504f944828dd910855b598547</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F1568026053386980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053386980%26sid%3Dliteratum%253Aachs%26aulast%3DIsaac%26aufirst%3DM.%26atitle%3DSerotonergic%25205-HT2C%2520receptors%2520as%2520a%2520potential%2520therapeutic%2520target%2520for%2520the%2520design%2520antiepileptic%2520drugs%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D59%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peglion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavielle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin-Monneyron, S.</span><span> </span><span class="NLM_article-title">5-HT<sub>2C</sub> receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1016%2FS0014-2999%2897%2989962-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=9151932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADyaK2sXivFynurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=1997&pages=9-12&author=M.+J.+Millanauthor=J.+L.+Peglionauthor=G.+Lavielleauthor=S.+Perrin-Monneyron&title=5-HT2C+receptors+mediate+penile+erections+in+rats%3A+actions+of+novel+and+selective+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists</span></div><div class="casAuthors">Millan, Mark J.; Peglion, Jean-Louis; Lavielle, Gilbert; Perrin-Monneyron, Sabine</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-12</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The mixed 5-HT2A/5-HT2B/5-HT2C receptor agonist, m-(chlorophenyl)piperazine (mCPP), elicited penile erections in rats, an action mimicked by the selective 5-HT2C receptor agonist, RO 60-0175 ((S)-2-(6-chloro-5-fluoroindol-1-yl)-1-methylethylamine), whereas the preferential 5-HT2B receptor agonist, BW 723C86 (1-[5-(thienylmethoxy)-1H-3-indolyl] propan-2-amine) was ineffective.  The actions of mCPP and RO 60-0175 were dose-dependently abolished by the novel 5-HT2B/5-HT2C receptor antagonists, SB 200,646 ((1-(1-methylindol-5-yl)-3-pyridyl) urea) and SB 206,553 (5 methyl-1-(3-pyridil-carbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole).  In contrast, penile erections were not significantly affected by the selective 5-HT2B receptor antagonist, SB 204,741 (1-(1-methylindol-5-yl)-3-(3-methylisothiazol-5-yl)-urea) nor by the selective 5-HT2A receptor antagonist, MDL 100,907 ([R(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidine-methanol]).  These data provide rigorous pharmacol. evidence that activation of 5-HT2C receptor elicits penile erections in the rat.  This model should, thus, be of use for characterizing novel ligands at this site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouGTT-meFlpLVg90H21EOLACvtfcHk0lh2K1J7bMINAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFynurY%253D&md5=24b45ce46f14e74c350dfd35223447c6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2897%2989962-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252897%252989962-1%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DPeglion%26aufirst%3DJ.%2BL.%26aulast%3DLavielle%26aufirst%3DG.%26aulast%3DPerrin-Monneyron%26aufirst%3DS.%26atitle%3D5-HT2C%2520receptors%2520mediate%2520penile%2520erections%2520in%2520rats%253A%2520actions%2520of%2520novel%2520and%2520selective%2520agonists%2520and%2520antagonists%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D325%26spage%3D9%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Cryan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucki, I.</span><span> </span><span class="NLM_article-title">Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine<sub>2C</sub> receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">1120</span><span class="NLM_x">–</span> <span class="NLM_lpage">1126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=11082448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVKisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2000&pages=1120-1126&author=J.+F.+Cryanauthor=I.+Lucki&title=Antidepressant-like+behavioral+effects+mediated+by+5-hydroxytryptamine2C+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine2C receptors</span></div><div class="casAuthors">Cryan, John F.; Lucki, Irwin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1120-1126</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The role of the 5-HT2C receptor in mediating active behaviors in the modified rat forced swim test was examd.  Three novel selective 5-HT2C receptor agonists, WAY 161503 (0.1-3.0 mg/kg), RO 60-0175 (2-20 mg/kg), and RO 60-0332 (20 mg/kg), all decreased immobility and increased swimming, a pattern of behavior similar to that which occurs with the selective serotonin reuptake inhibitor fluoxetine (5-20 mg/kg).  However, the prototypical but nonselective 5-HT2C receptor agonist m-chlorophenylpiperazine (1-10 mg/kg) increased immobility scores in the forced swim test.  The selective 5-HT2C receptor antagonist SB 206533 was inactive when given alone (1-20 mg/kg).  However, SB 206533 (20 mg/kg) blocked the antidepressant-like effects of both WAY 161503 (1 mg/kg) and fluoxetine (20 mg/kg).  The atypical antidepressant (noradrenergic α2 and 5-HT2C receptor antagonist) mianserin reduced immobility and increased climbing at 30 mg/kg.  At a behaviorally subactive dose (10 mg/kg), mianserin abolished the effects of WAY 161503 (1 mg/kg) on both swimming and immobility scores.  Mianserin blocked the effects of fluoxetine (20 mg/kg) on swimming only; mianserin plus fluoxetine reduced immobility and induced a switch to climbing behavior, suggesting activation of noradrenergic transmission.  These data exemplify the benefits of using the modified rat forced swim test, which was sensitive to serotonergic compds. and distinguished behavioral changes assocd. with serotonergic and noradrenergic effects.  Taken together, the results strongly implicate a role for 5-HT2C receptors in the behavioral effects of antidepressant drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgnstIvZMyE7Vg90H21EOLACvtfcHk0lh2K1J7bMINAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVKisLs%253D&md5=ba187197751b56006b91fef9357a96af</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCryan%26aufirst%3DJ.%2BF.%26aulast%3DLucki%26aufirst%3DI.%26atitle%3DAntidepressant-like%2520behavioral%2520effects%2520mediated%2520by%25205-hydroxytryptamine2C%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D295%26spage%3D1120%26epage%3D1126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Giorgetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tecott, L. H.</span><span> </span><span class="NLM_article-title">Contributions of 5-HT<sub>2C</sub> receptors to multiple actions of central serotonin systems</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">1−9</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2004&pages=1%E2%88%929&author=M.+Giorgettiauthor=L.+H.+Tecott&title=Contributions+of+5-HT2C+receptors+to+multiple+actions+of+central+serotonin+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiorgetti%26aufirst%3DM.%26aulast%3DTecott%26aufirst%3DL.%2BH.%26atitle%3DContributions%2520of%25205-HT2C%2520receptors%2520to%2520multiple%2520actions%2520of%2520central%2520serotonin%2520systems%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D488%26spage%3D1%25E2%2588%25929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malberg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cryan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff Rizzo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span> </span><span class="NLM_article-title">Antidepressant-like effects of the novel, selective, 5-HT<sub>2C</sub> receptor agonist WAY-163909 in rodents</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">192</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1007%2Fs00213-007-0710-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=17297636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslWgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2007&pages=159-170&author=S.+Rosenzweig-Lipsonauthor=A.+Sabbauthor=G.+Stackauthor=P.+Mitchellauthor=I.+Luckiauthor=J.+E.+Malbergauthor=S.+Grauerauthor=J.+Brennanauthor=J.+F.+Cryanauthor=S.+J.+Sukoff+Rizzoauthor=J.+Dunlopauthor=J.+E.+Barrettauthor=K.+L.+Marquis&title=Antidepressant-like+effects+of+the+novel%2C+selective%2C+5-HT2C+receptor+agonist+WAY-163909+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents</span></div><div class="casAuthors">Rosenzweig-Lipson, Sharon; Sabb, Annmarie; Stack, Gary; Mitchell, Paul; Lucki, Irwin; Malberg, Jessica E.; Grauer, Steve; Brennan, Julie; Cryan, John F.; Sukoff Rizzo, Stacey J.; Dunlop, John; Barrett, James E.; Marquis, Karen L.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-170</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Rationale Activation of one or more of the serotonin (5-HT) receptors may play a role in mediating the antidepressant effects of SSRIs.  Objective The present studies were conducted to evaluate the effects of the novel 5-HT2C receptor agonist WAY-163909 in animal models of antidepressant activity (forced swim test (FST), resident-intruder, olfactory bulbectomy (BULB)), in a schedule-induced polydipsia (SIP) model of obsessive-compulsive disorder and in a model for evaluating sexual dysfunction.  Results WAY-163909 (10 mg/kg, i.p. or s.c.) decreased immobility time in Wistar-Kyoto rats in the FST, effects that were reversed by the 5-HT2C/2B receptor antagonist SB 206553.  Moreover, in Sprague-Dawley rats, the profile of WAY-163909 (decreased immobility, increased swimming) in the FST was comparable to the effects of SSRIs.  Acute treatment with WAY-163909 (0.33 mg/kg, s.c.) decreased rodent aggression at doses lower than those required for decreasing total behavior.  Administration of WAY-163909 (3 mg/kg, i.p.) for 5 or 21 days decreased the BULB-induced hyperactivity in rats.  Addnl., acute administration of WAY-163909 (3 mg/kg, i.p.) decreased adjunctive drinking in a SIP model.  The effects of WAY-163909 were reversed by the 5-HT2C/2B receptor antagonist SB 206553 and the selective 5-HT2C receptor antagonist SB 242084.  Chronic administration of WAY-163909 produced deficits in sexual function at doses higher (10 mg/kg, i.p.) than those required for antidepressant-like effects in the BULB model.  Conclusions Taken together, these results demonstrate that the novel 5-HT2C receptor agonist WAY-163909 produces rapid onset antidepressant-like effects in animal models and may be a novel treatment for depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWDasPaMjxzrVg90H21EOLACvtfcHk0lh2K1J7bMINAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslWgtro%253D&md5=c659bfb0d2e22f169e22b8fd605d970a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs00213-007-0710-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-007-0710-6%26sid%3Dliteratum%253Aachs%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DSabb%26aufirst%3DA.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DMitchell%26aufirst%3DP.%26aulast%3DLucki%26aufirst%3DI.%26aulast%3DMalberg%26aufirst%3DJ.%2BE.%26aulast%3DGrauer%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DJ.%26aulast%3DCryan%26aufirst%3DJ.%2BF.%26aulast%3DSukoff%2BRizzo%26aufirst%3DS.%2BJ.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DBarrett%26aufirst%3DJ.%2BE.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26atitle%3DAntidepressant-like%2520effects%2520of%2520the%2520novel%252C%2520selective%252C%25205-HT2C%2520receptor%2520agonist%2520WAY-163909%2520in%2520rodents%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D2007%26volume%3D192%26spage%3D159%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Marquis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabb, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logue, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piesla, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span> </span><span class="NLM_article-title">WAY-163909 [(7b<i>R</i>,10a<i>R</i>)-1,2,3,4,8,9,10,10a-octahydro-7b<i>H</i>-cyclopenta-[<i>b</i>][1,4]diazepino[6,7,1<i>hi</i>]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1124%2Fjpet.106.106989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=17038512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFCgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=486-496&author=K.+L.+Marquisauthor=A.+L.+Sabbauthor=S.+F.+Logueauthor=J.+A.+Brennanauthor=M.+J.+Pieslaauthor=T.+A.+Comeryauthor=S.+M.+Grauerauthor=C.+R.+Ashbyauthor=H.+Q.+Nguyenauthor=L.+A.+Dawsonauthor=J.+E.+Barrettauthor=G.+Stackauthor=H.+Y.+Meltzerauthor=B.+L.+Harrisonauthor=S.+Rosenzweig-Lipson&title=WAY-163909+%5B%287bR%2C10aR%29-1%2C2%2C3%2C4%2C8%2C9%2C10%2C10a-octahydro-7bH-cyclopenta-%5Bb%5D%5B1%2C4%5Ddiazepino%5B6%2C7%2C1hi%5Dindole%5D%3A+A+novel+5-hydroxytryptamine+2C+receptor-selective+agonist+with+preclinical+antipsychotic-like+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: a novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity</span></div><div class="casAuthors">Marquis, Karen L.; Sabb, Annmarie L.; Logue, Sheree F.; Brennan, Julie A.; Piesla, Michael J.; Comery, Tom A.; Grauer, Steven M.; Ashby, Charles R., Jr.; Nguyen, Huy Q.; Dawson, Lee A.; Barrett, James E.; Stack, Gary; Meltzer, Herbert Y.; Harrison, Boyd L.; Rosenzweig-Lipson, Sharon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">486-496</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Serotonin-2C (5-HT2C) receptor antagonists and agonists have been shown to affect dopamine (DA) neurotransmission, with agonists selectively decreasing mesolimbic DA.  As antipsychotic efficacy is proposed to be assocd. with decreased mesolimbic DA neurotransmission by virtue of DA D2 receptor antagonism, the 5-HT2C-selective receptor agonist, WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], was evaluated in animal models of schizophrenia and in vivo microdialysis and electrophysiol. to det. the effects on mesolimbic and nigrostriatal DA neurotransmission.  Similar to clozapine, WAY-163909 (1.7-30 mg/kg i.p.) decreased apomorphine-induced climbing with little effect on stereotypy and no significant induction of catalepsy.  WAY-163909 (0.3-3 mg/kg s.c.) more potently reduced phencyclidine-induced locomotor activity compared with d-amphetamine with no effect on spontaneous activity.  WAY-163909 (1.7-17 mg/kg i.p.) reversed MK-801 (5H-dibenzo[a,d]cyclohepten-5,10-imine (dizocilpine maleate)- and DOI [1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane]-disrupted prepulse inhibition of startle (PPI) and improved PPI in DBA/2N mice.  In conditioned avoidance responding, WAY-163909 (0.3-3 mg/kg i.p.; 1-17 mg/kg p.o.) reduced avoidance responding, an effect blocked by the 5-HT2B/2C receptor antagonist SB 206553 [5-methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole].  WAY-163909 (10 mg/kg s.c.) selectively decreased extracellular levels of DA in the nucleus accumbens without affecting the striatum.  Likewise, in vivo electrophysiol. recordings showed a decrease in the no. of spontaneously firing DA neurons in the ventral tegmental area but not in the substantia nigra with both acute and chronic (21-day) administration of WAY-163909 (1-10 mg/kg i.p.).  Thus, the profile of the 5-HT2C selective receptor agonist WAY-163909 is similar to that of an atypical antipsychotic and addnl. may have rapid onset properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoemOaXlISXJrVg90H21EOLACvtfcHk0ljyhZiqFdYrEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFCgtg%253D%253D&md5=f70bb5a91c306aa208b5a19cd2e21937</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.106989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.106989%26sid%3Dliteratum%253Aachs%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DSabb%26aufirst%3DA.%2BL.%26aulast%3DLogue%26aufirst%3DS.%2BF.%26aulast%3DBrennan%26aufirst%3DJ.%2BA.%26aulast%3DPiesla%26aufirst%3DM.%2BJ.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DGrauer%26aufirst%3DS.%2BM.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DNguyen%26aufirst%3DH.%2BQ.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DBarrett%26aufirst%3DJ.%2BE.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DMeltzer%26aufirst%3DH.%2BY.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DWAY-163909%2520%255B%25287bR%252C10aR%2529-1%252C2%252C3%252C4%252C8%252C9%252C10%252C10a-octahydro-7bH-cyclopenta-%255Bb%255D%255B1%252C4%255Ddiazepino%255B6%252C7%252C1hi%255Dindole%255D%253A%2520A%2520novel%25205-hydroxytryptamine%25202C%2520receptor-selective%2520agonist%2520with%2520preclinical%2520antipsychotic-like%2520activity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D486%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Berger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">The Expanded Biology of Serotonin</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1146%2Fannurev.med.60.042307.110802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=19630576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlyntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=355-366&author=M.+Bergerauthor=J.+A.+Grayauthor=B.+L.+Roth&title=The+Expanded+Biology+of+Serotonin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The expanded biology of serotonin</span></div><div class="casAuthors">Berger, Miles; Gray, John A.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">355-366</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Serotonin is perhaps best known as a neurotransmitter that modulates neural activity and a wide range of neuropsychol. processes, and drugs that target serotonin receptors are used widely in psychiatry and neurol.  However, most serotonin is found outside the central nervous system, and virtually all of the 15 serotonin receptors are expressed outside as well as within the brain.  Serotonin regulates numerous biol. processes including cardiovascular function, bowel motility, ejaculatory latency, and bladder control.  Addnl., new work suggests that serotonin may regulate some processes, including platelet aggregation, by receptor-independent, transglutaminase-dependent covalent linkage to cellular proteins.  We review this new expanded serotonin biol. and discuss how drugs targeting specific serotonin receptors are beginning to help treat a wide range of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoz0HW5hdNOrVg90H21EOLACvtfcHk0ljyhZiqFdYrEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlyntb8%253D&md5=0557e01e6b79dbfb50559aca03f8b31f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1146%2Fannurev.med.60.042307.110802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.med.60.042307.110802%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DGray%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DThe%2520Expanded%2520Biology%2520of%2520Serotonin%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2009%26volume%3D60%26spage%3D355%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span> </span><span class="NLM_article-title">Selective agents for serotonin<sub>2C</sub> (5-HT<sub>2C</sub>) receptor</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1927</span><span class="NLM_x">–</span> <span class="NLM_lpage">1970</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.2174%2F156802606778522168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=17017967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFens7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1927-1970&author=E.+Lacivitaauthor=M.+Leopoldo&title=Selective+agents+for+serotonin2C+%285-HT2C%29+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Selective agents for serotonin2C (5-HT2C) receptor</span></div><div class="casAuthors">Lacivita, Enza; Leopoldo, Marcello</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1927-1970</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The serotonin2C (5-HT2C) receptor has attracted a lot of attention owing to its role in appetite regulation, depression, obsessive-compulsive disorder (OCD), panic disorders, and substance abuse.  This review summarizes non-patent and patent literature up to Nov. 2005 that deals with the synthesis and characterization of selective 5-HT2C receptor agonists and antagonists.  Highlights on structure-activity relationships were included, when possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXHlktCIyYFbVg90H21EOLACvtfcHk0ljyhZiqFdYrEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFens7fN&md5=9d6414a68db4d393319800d4cc19e8f1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F156802606778522168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606778522168%26sid%3Dliteratum%253Aachs%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26atitle%3DSelective%2520agents%2520for%2520serotonin2C%2520%25285-HT2C%2529%2520receptor%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1927%26epage%3D1970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Nilsson, B. M.</span><span> </span><span class="NLM_article-title">5-Hydroxytryptamine 2C (5-HT<sub>2C</sub>) receptor agonists as potential antiobesity agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4023</span><span class="NLM_x">–</span> <span class="NLM_lpage">4034</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058240i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVSisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4023-4034&author=B.+M.+Nilsson&title=5-Hydroxytryptamine+2C+%285-HT2C%29+receptor+agonists+as+potential+antiobesity+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents</span></div><div class="casAuthors">Nilsson, Bjoern M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4023-4034</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review of 5-HT 2C receptor agonists as potential antiobesity agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr39FDBz-7CqrVg90H21EOLACvtfcHk0lhacV3FjjASTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVSisrs%253D&md5=ec5788cfe273b9cf7ccbdfc39fc8a7b2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm058240i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058240i%26sid%3Dliteratum%253Aachs%26aulast%3DNilsson%26aufirst%3DB.%2BM.%26atitle%3D5-Hydroxytryptamine%25202C%2520%25285-HT2C%2529%2520receptor%2520agonists%2520as%2520potential%2520antiobesity%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4023%26epage%3D4034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Siuciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanowsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iredale, P. A.</span><span> </span><span class="NLM_article-title">CP-809,101, a selective 5-HT<sub>2C</sub> agonist, shows activity in animal models of antipsychotic activity</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1016%2Fj.neuropharm.2006.07.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=16949622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=279-290&author=J.+A.+Siuciakauthor=D.+S.+Chapinauthor=S.+A.+McCarthyauthor=V.+Guanowskyauthor=J.+Brownauthor=P.+Chiangauthor=R.+Maralaauthor=T.+Pattersonauthor=P.+A.+Seymourauthor=A.+Swickauthor=P.+A.+Iredale&title=CP-809%2C101%2C+a+selective+5-HT2C+agonist%2C+shows+activity+in+animal+models+of+antipsychotic+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity</span></div><div class="casAuthors">Siuciak, Judith A.; Chapin, Douglas S.; McCarthy, Sheryl A.; Guanowsky, Victor; Brown, Janice; Chiang, Phoebe; Marala, Ravi; Patterson, Terrell; Seymour, Patricia A.; Swick, Andrew; Iredale, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">279-290</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">CP-809,101 is a potent, functionally selective 5-HT2C agonist that displays approx. 100% efficacy in vitro.  The aim of the present studies was to assess the efficacy of a selective 5-HT2C agonist in animal models predictive of antipsychotic-like efficacy and side-effect liability.  Similar to currently available antipsychotic drugs, CP-809,101 dose-dependently inhibited conditioned avoidance responding (CAR, ED50 = 4.8 mg/kg, s.c.).  The efficacy of CP-809,101 in CAR was completely antagonized by the concurrent administration of the 5-HT2C receptor antagonist, SB-224,282.  CP-809,101 antagonized both PCP- and d-amphetamine-induced hyperactivity with ED50 values of 2.4 and 2.9 mg/kg (s.c.), resp. and also reversed an apomorphine induced-deficit in prepulse inhibition.  At doses up to 56 mg/kg, CP-809,101 did not produce catalepsy.  Thus, the present results demonstrate that the 5-HT2C agonist, CP-809,101, has a pharmacol. profile similar to that of the atypical antipsychotics with low extrapyramidal symptom liability.  CP-809,101 was inactive in two animal models of antidepressant-like activity, the forced swim test and learned helplessness.  However, CP-809,101 was active in novel object recognition, an animal model of cognitive function.  These data suggest that 5-HT2C agonists may be a novel approach in the treatment of psychosis as well as for the improvement of cognitive dysfunction assocd. with schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHuHmkKSf1jrVg90H21EOLACvtfcHk0lhacV3FjjASTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCqtbk%253D&md5=5b422611bae3df8a9bcf71f84f1bbc37</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2006.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2006.07.024%26sid%3Dliteratum%253Aachs%26aulast%3DSiuciak%26aufirst%3DJ.%2BA.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DMcCarthy%26aufirst%3DS.%2BA.%26aulast%3DGuanowsky%26aufirst%3DV.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DP.%26aulast%3DMarala%26aufirst%3DR.%26aulast%3DPatterson%26aufirst%3DT.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DSwick%26aufirst%3DA.%26aulast%3DIredale%26aufirst%3DP.%2BA.%26atitle%3DCP-809%252C101%252C%2520a%2520selective%25205-HT2C%2520agonist%252C%2520shows%2520activity%2520in%2520animal%2520models%2520of%2520antipsychotic%2520activity%26jtitle%3DNeuropharmacology%26date%3D2007%26volume%3D52%26spage%3D279%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Welmaker, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabalski, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabb, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potoski, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coupet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazandarani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Synthesis and 5-hydroxytryptamine (5-HT) activity of 2,3,4,4a-tetrahydro-1<i>H</i>-pyrazino[1,2-<i>a</i>]quinoxalin-5-(6<i>H</i>)ones and 2,3,4,4a,5,6-hexahydro-1<i>H</i>-pyrazino[1,2-<i>a</i>]quinoxalines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1991</span><span class="NLM_x">–</span> <span class="NLM_lpage">1994</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1991-1994&author=G.+S.+Welmakerauthor=J.+A.+Nelsonauthor=J.+E.+Sabalskiauthor=A.+L.+Sabbauthor=J.+R.+Potoskiauthor=D.+Grazianoauthor=M.+Kaganauthor=J.+Coupetauthor=J.+Dunlopauthor=H.+Mazandaraniauthor=S.+Rosenzweig-Lipsonauthor=S.+Sukoffauthor=Y.+Zhang&title=Synthesis+and+5-hydroxytryptamine+%285-HT%29+activity+of+2%2C3%2C4%2C4a-tetrahydro-1H-pyrazino%5B1%2C2-a%5Dquinoxalin-5-%286H%29ones+and+2%2C3%2C4%2C4a%2C5%2C6-hexahydro-1H-pyrazino%5B1%2C2-a%5Dquinoxalines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWelmaker%26aufirst%3DG.%2BS.%26aulast%3DNelson%26aufirst%3DJ.%2BA.%26aulast%3DSabalski%26aufirst%3DJ.%2BE.%26aulast%3DSabb%26aufirst%3DA.%2BL.%26aulast%3DPotoski%26aufirst%3DJ.%2BR.%26aulast%3DGraziano%26aufirst%3DD.%26aulast%3DKagan%26aufirst%3DM.%26aulast%3DCoupet%26aufirst%3DJ.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DMazandarani%26aufirst%3DH.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DSukoff%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DSynthesis%2520and%25205-hydroxytryptamine%2520%25285-HT%2529%2520activity%2520of%25202%252C3%252C4%252C4a-tetrahydro-1H-pyrazino%255B1%252C2-a%255Dquinoxalin-5-%25286H%2529ones%2520and%25202%252C3%252C4%252C4a%252C5%252C6-hexahydro-1H-pyrazino%255B1%252C2-a%255Dquinoxalines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D1991%26epage%3D1994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Sabb, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welmaker, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabalski, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coupet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B.</span><span> </span><span class="NLM_article-title">Cycloalkyl[<i>b</i>][1,4]benzodiazepinoindoles are agonists at the human 5-HT<sub>2C</sub> receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2603</span><span class="NLM_x">–</span> <span class="NLM_lpage">2607</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2603-2607&author=A.+L.+Sabbauthor=R.+L.+Vogelauthor=G.+S.+Welmakerauthor=J.+E.+Sabalskiauthor=J.+Coupetauthor=J.+Dunlopauthor=S.+Rosenzweig-Lipsonauthor=B.+Harrison&title=Cycloalkyl%5Bb%5D%5B1%2C4%5Dbenzodiazepinoindoles+are+agonists+at+the+human+5-HT2C+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSabb%26aufirst%3DA.%2BL.%26aulast%3DVogel%26aufirst%3DR.%2BL.%26aulast%3DWelmaker%26aufirst%3DG.%2BS.%26aulast%3DSabalski%26aufirst%3DJ.%2BE.%26aulast%3DCoupet%26aufirst%3DJ.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DHarrison%26aufirst%3DB.%26atitle%3DCycloalkyl%255Bb%255D%255B1%252C4%255Dbenzodiazepinoindoles%2520are%2520agonists%2520at%2520the%2520human%25205-HT2C%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2603%26epage%3D2607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Smith, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieto, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallardo, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dosa, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covel, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beeley, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espitia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saldana, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjenning, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelan, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grottick, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzaghi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, W. J.</span><span> </span><span class="NLM_article-title">Discovery and structure−activity relationship of (1<i>R</i>)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1<i>H</i>-3-benzazepine (Lorcaserin), a selective serotonin 5-HT<sub>2C</sub> receptor agonist for the treatment of obesity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0709034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=305-313&author=B.+M.+Smithauthor=J.+M.+Smithauthor=J.+H.+Tsaiauthor=J.+A.+Schultzauthor=C.+A.+Gilsonauthor=S.+A.+Estradaauthor=R.+R.+Chenauthor=D.+M.+Parkauthor=E.+B.+Prietoauthor=C.+S.+Gallardoauthor=D.+Senguptaauthor=P.+I.+Dosaauthor=J.+A.+Covelauthor=A.+Renauthor=R.+R.+Webbauthor=N.+R.+Beeleyauthor=M.+Martinauthor=M.+Morganauthor=S.+Espitiaauthor=H.+R.+Saldanaauthor=C.+Bjenningauthor=K.+T.+Whelanauthor=A.+J.+Grottickauthor=F.+Menzaghiauthor=W.+J.+Thomsen&title=Discovery+and+structure%E2%88%92activity+relationship+of+%281R%29-8-chloro-2%2C3%2C4%2C5-tetrahydro-1-methyl-1H-3-benzazepine+%28Lorcaserin%29%2C+a+selective+serotonin+5-HT2C+receptor+agonist+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm0709034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0709034%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BM.%26aulast%3DSmith%26aufirst%3DJ.%2BM.%26aulast%3DTsai%26aufirst%3DJ.%2BH.%26aulast%3DSchultz%26aufirst%3DJ.%2BA.%26aulast%3DGilson%26aufirst%3DC.%2BA.%26aulast%3DEstrada%26aufirst%3DS.%2BA.%26aulast%3DChen%26aufirst%3DR.%2BR.%26aulast%3DPark%26aufirst%3DD.%2BM.%26aulast%3DPrieto%26aufirst%3DE.%2BB.%26aulast%3DGallardo%26aufirst%3DC.%2BS.%26aulast%3DSengupta%26aufirst%3DD.%26aulast%3DDosa%26aufirst%3DP.%2BI.%26aulast%3DCovel%26aufirst%3DJ.%2BA.%26aulast%3DRen%26aufirst%3DA.%26aulast%3DWebb%26aufirst%3DR.%2BR.%26aulast%3DBeeley%26aufirst%3DN.%2BR.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DEspitia%26aufirst%3DS.%26aulast%3DSaldana%26aufirst%3DH.%2BR.%26aulast%3DBjenning%26aufirst%3DC.%26aulast%3DWhelan%26aufirst%3DK.%2BT.%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26aulast%3DMenzaghi%26aufirst%3DF.%26aulast%3DThomsen%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520and%2520structure%25E2%2588%2592activity%2520relationship%2520of%2520%25281R%2529-8-chloro-2%252C3%252C4%252C5-tetrahydro-1-methyl-1H-3-benzazepine%2520%2528Lorcaserin%2529%252C%2520a%2520selective%2520serotonin%25205-HT2C%2520receptor%2520agonist%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D305%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Wacker, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varnes, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malmstrom, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuvich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohrbach, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janovitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehman-McKeeman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malley, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devenny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelleymounter, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span> </span><span class="NLM_article-title">Discovery of (<i>R</i>)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol- 6(2<i>H</i>)-one, a selective, orally active agonist of the 5-HT<sub>2C</sub> receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1365</span><span class="NLM_x">–</span> <span class="NLM_lpage">1379</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0612968" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1365-1379&author=D.+A.+Wackerauthor=J.+G.+Varnesauthor=S.+E.+Malmstromauthor=X.+Caoauthor=C.+P.+Hungauthor=T.+Ungauthor=G.+Wuauthor=G.+Zhangauthor=E.+Zuvichauthor=M.+A.+Thomasauthor=W.+J.+Keimauthor=M.+J.+Cullenauthor=K.+W.+Rohrbachauthor=Q.+Quauthor=R.+Narayananauthor=K.+Rossiauthor=E.+Janovitzauthor=L.+Lehman-McKeemanauthor=M.+F.+Malleyauthor=J.+Devennyauthor=M.+A.+Pelleymounterauthor=K.+J.+Millerauthor=J.+A.+Robl&title=Discovery+of+%28R%29-9-ethyl-1%2C3%2C4%2C10b-tetrahydro-7-trifluoromethylpyrazino%5B2%2C1-a%5Disoindol-+6%282H%29-one%2C+a+selective%2C+orally+active+agonist+of+the+5-HT2C+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm0612968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0612968%26sid%3Dliteratum%253Aachs%26aulast%3DWacker%26aufirst%3DD.%2BA.%26aulast%3DVarnes%26aufirst%3DJ.%2BG.%26aulast%3DMalmstrom%26aufirst%3DS.%2BE.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DHung%26aufirst%3DC.%2BP.%26aulast%3DUng%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DZuvich%26aufirst%3DE.%26aulast%3DThomas%26aufirst%3DM.%2BA.%26aulast%3DKeim%26aufirst%3DW.%2BJ.%26aulast%3DCullen%26aufirst%3DM.%2BJ.%26aulast%3DRohrbach%26aufirst%3DK.%2BW.%26aulast%3DQu%26aufirst%3DQ.%26aulast%3DNarayanan%26aufirst%3DR.%26aulast%3DRossi%26aufirst%3DK.%26aulast%3DJanovitz%26aufirst%3DE.%26aulast%3DLehman-McKeeman%26aufirst%3DL.%26aulast%3DMalley%26aufirst%3DM.%2BF.%26aulast%3DDevenny%26aufirst%3DJ.%26aulast%3DPelleymounter%26aufirst%3DM.%2BA.%26aulast%3DMiller%26aufirst%3DK.%2BJ.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520%2528R%2529-9-ethyl-1%252C3%252C4%252C10b-tetrahydro-7-trifluoromethylpyrazino%255B2%252C1-a%255Disoindol-%25206%25282H%2529-one%252C%2520a%2520selective%252C%2520orally%2520active%2520agonist%2520of%2520the%25205-HT2C%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1365%26epage%3D1379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Wacker, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. J.</span><span> </span><span class="NLM_article-title">Agonists of the serotonin 5-HT<sub>2C</sub> receptor: preclinical and clinical progression in multiple diseases</span> <span class="citation_source-journal">Curr. Opin. Drug. Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">438</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=18600561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosFWmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=438-445&author=D.+A.+Wackerauthor=K.+J.+Miller&title=Agonists+of+the+serotonin+5-HT2C+receptor%3A+preclinical+and+clinical+progression+in+multiple+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Agonists of the serotonin 5-HT2C receptor: preclinical and clinical progression in multiple diseases</span></div><div class="casAuthors">Wacker, Dean A.; Miller, Keith J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">438-445</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  The serotonin 5-HT2C receptor is a G-protein-coupled receptor and is 1 of the 14 subtypes that constitute the serotonin receptor family.  Agonists of 5-HT2C have been implicated as potential treatments for diseases of significant unmet medical need, including obesity and schizophrenia.  Despite approx. 10 years of discovery efforts, 5-HT2C agonists have only recently advanced into the clinic, likely because many of the early drug discovery efforts experienced significant difficulties with attaining receptor selectivity.  Several of these issues related to receptor selectivity have now been overcome, resulting in the entry of compds. into advanced clin. trials.  This review summarizes the progress in 5-HT2C agonist discovery and clin. development over the last 3 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1eDgqANEVarVg90H21EOLACvtfcHk0ljngXVmXpU7bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosFWmtbk%253D&md5=cd06a22cee150e5a0c658a4ce8876151</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWacker%26aufirst%3DD.%2BA.%26aulast%3DMiller%26aufirst%3DK.%2BJ.%26atitle%3DAgonists%2520of%2520the%2520serotonin%25205-HT2C%2520receptor%253A%2520preclinical%2520and%2520clinical%2520progression%2520in%2520multiple%2520diseases%26jtitle%3DCurr.%2520Opin.%2520Drug.%2520Discovery%2520Dev.%26date%3D2008%26volume%3D11%26spage%3D438%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thian, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">High-resolution crystal structure of an engineered human β<sub>2</sub>-adrenergic G protein-coupled receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1258</span><span class="NLM_x">–</span> <span class="NLM_lpage">1265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1126%2Fscience.1150577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=17962520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=1258-1265&author=V.+Cherezovauthor=D.+M.+Rosenbaumauthor=M.+A.+Hansonauthor=S.+G.+Rasmussenauthor=F.+S.+Thianauthor=T.+S.+Kobilkaauthor=H.+J.+Choiauthor=P.+Kuhnauthor=W.+I.+Weisauthor=B.+K.+Kobilkaauthor=R.+C.+Stevens&title=High-resolution+crystal+structure+of+an+engineered+human+%CE%B22-adrenergic+G+protein-coupled+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein-Coupled Receptor</span></div><div class="casAuthors">Cherezov, Vadim; Rosenbaum, Daniel M.; Hanson, Michael A.; Rasmussen, Soren G. F.; Thian, Foon Sun; Kobilka, Tong Sun; Choi, Hee-Jung; Kuhn, Peter; Weis, William I.; Kobilka, Brian K.; Stevens, Raymond C.; Takeda, S.; Kadowaki, S.; Haga, T.; Takaesu, H.; Mitaku, S.; Fredriksson, R.; Lagerstrom, M. C.; Lundin, L. G.; Schioth, H. B.; Pierce, K. L.; Premont, R. T.; Lefkowitz, R. J.; Lefkowitz, R. J.; Shenoy, S. K.; Rosenbaum, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">5854</span>),
    <span class="NLM_cas:pages">1258-1265</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Second extracellular loop, which in the β2-adrenergic receptor contains an unusual pair of disulfide bonds and an extra helix.  This loop and the absence Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors constitute the largest family of eukaryotic signal transduction proteins that communicate across the membrane.  We report the crystal structure of a human β2-adrenergic receptor-T4 lysozyme fusion protein bound to the partial inverse agonist carazolol at 2.4 angstrom resoln.  The structure provides a high-resoln. view of a human G protein-coupled receptor bound to a diffusible ligand.  Ligand-binding site accessibility is enabled by the second extracellular loop, which is held out of the binding cavity by a pair of closely spaced disulfide bridges and a short helical segment within the loop.  Cholesterol, a necessary component for crystn., mediates an intriguing parallel assocn. of receptor mols. in the crystal lattice.  Although the location of carazolol in the β2-adrenergic receptor is very similar to that of retinal in rhodopsin, structural differences in the ligand-binding site and other regions highlight the challenges in using rhodopsin as a template model for this large receptor family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC-8wZ2k2GHLVg90H21EOLACvtfcHk0ljngXVmXpU7bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmur7I&md5=12c5bacb8464a4b243fe9341192b5b3b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1126%2Fscience.1150577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1150577%26sid%3Dliteratum%253Aachs%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DRasmussen%26aufirst%3DS.%2BG.%26aulast%3DThian%26aufirst%3DF.%2BS.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DChoi%26aufirst%3DH.%2BJ.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DHigh-resolution%2520crystal%2520structure%2520of%2520an%2520engineered%2520human%2520%25CE%25B22-adrenergic%2520G%2520protein-coupled%2520receptor%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D1258%26epage%3D1265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Rasmussen, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thian, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burghammer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnala, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanishvili, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischetti, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schertler, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span> </span><span class="NLM_article-title">Crystal structure of the human β<sub>2</sub> adrenergic G-protein-coupled receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1038%2Fnature06325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=17952055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlajs77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2007&pages=383-387&author=S.+G.+Rasmussenauthor=H.+J.+Choiauthor=D.+M.+Rosenbaumauthor=T.+S.+Kobilkaauthor=F.+S.+Thianauthor=P.+C.+Edwardsauthor=M.+Burghammerauthor=V.+R.+Ratnalaauthor=R.+Sanishviliauthor=R.+F.+Fischettiauthor=G.+F.+Schertlerauthor=W.+I.+Weisauthor=B.+K.+Kobilka&title=Crystal+structure+of+the+human+%CE%B22+adrenergic+G-protein-coupled+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the human β2 adrenergic G-protein-coupled receptor</span></div><div class="casAuthors">Rasmussen, Soren G. F.; Choi, Hee-Jung; Rosenbaum, Daniel M.; Kobilka, Tong Sun; Thian, Foon Sun; Edwards, Patricia C.; Burghammer, Manfred; Ratnala, Venkata R. P.; Sanishvili, Ruslan; Fischetti, Robert F.; Schertler, Gebhard F. X.; Weis, William I.; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">450</span>
        (<span class="NLM_cas:issue">7168</span>),
    <span class="NLM_cas:pages">383-387</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Structural anal. of G-protein-coupled receptors (GPCRs) for hormones and neurotransmitters has been hindered by their low natural abundance, inherent structural flexibility, and instability in detergent solns.  Here we report a structure of the human β2 adrenoceptor (β2AR), which was crystd. in a lipid environment when bound to an inverse agonist and in complex with a Fab that binds to the third intracellular loop.  Diffraction data were obtained by high-brilliance microcrystallog. and the structure detd. at 3.4 Å/3.7 Å resoln.  The cytoplasmic ends of the β2AR transmembrane segments and the connecting loops are well resolved, whereas the extracellular regions of the β2AR are not seen.  The β2AR structure differs from rhodopsin in having weaker interactions between the cytoplasmic ends of transmembrane (TM)3 and TM6, involving the conserved E/DRY sequences.  These differences may be responsible for the relatively high basal activity and structural instability of the β2AR, and contribute to the challenges in obtaining diffraction-quality crystals of non-rhodopsin GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTx0B_3Vn2M7Vg90H21EOLACvtfcHk0ljngXVmXpU7bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlajs77N&md5=79026a0a69ddb4b0ea25063e409ad2cd</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnature06325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06325%26sid%3Dliteratum%253Aachs%26aulast%3DRasmussen%26aufirst%3DS.%2BG.%26aulast%3DChoi%26aufirst%3DH.%2BJ.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DThian%26aufirst%3DF.%2BS.%26aulast%3DEdwards%26aufirst%3DP.%2BC.%26aulast%3DBurghammer%26aufirst%3DM.%26aulast%3DRatnala%26aufirst%3DV.%2BR.%26aulast%3DSanishvili%26aufirst%3DR.%26aulast%3DFischetti%26aufirst%3DR.%2BF.%26aulast%3DSchertler%26aufirst%3DG.%2BF.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520%25CE%25B22%2520adrenergic%2520G-protein-coupled%2520receptor%26jtitle%3DNature%26date%3D2007%26volume%3D450%26spage%3D383%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Rosenbaum, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thian, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span> </span><span class="NLM_article-title">GPCR engineering yields high-resolution structural insights into β<sub>2</sub>-adrenergic receptor function</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1266</span><span class="NLM_x">–</span> <span class="NLM_lpage">1273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1126%2Fscience.1150609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=17962519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=1266-1273&author=D.+M.+Rosenbaumauthor=V.+Cherezovauthor=M.+A.+Hansonauthor=S.+G.+Rasmussenauthor=F.+S.+Thianauthor=T.+S.+Kobilkaauthor=H.+J.+Choiauthor=X.+J.+Yaoauthor=W.+I.+Weisauthor=R.+C.+Stevensauthor=B.+K.+Kobilka&title=GPCR+engineering+yields+high-resolution+structural+insights+into+%CE%B22-adrenergic+receptor+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">GPCR Engineering Yields High-Resolution Structural Insights into β2-Adrenergic Receptor Function</span></div><div class="casAuthors">Rosenbaum, Daniel M.; Cherezov, Vadim; Hanson, Michael A.; Rasmussen, Soren G. F.; Thian, Foon Sun; Kobilka, Tong Sun; Choi, Hee-Jung; Yao, Xiao-Jie; Weis, William I.; Stevens, Raymond C.; Kobilka, Brian K.; Pierce, K. L.; Premont, R. T.; Lefkowitz, R. J.; Kobilka, B. K.; Deupi, X.; Cherezov, V.; Rasmussen, S. G. F.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">5854</span>),
    <span class="NLM_cas:pages">1266-1273</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The β2-adrenergic receptor (β2AR) is a well-studied prototype for heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) that respond to diffusible hormones and neurotransmitters.  To overcome the structural flexibility of the β2AR and to facilitate its crystn., we engineered a β2AR fusion protein in which T4 lysozyme (T4L) replaces most of the third intracellular loop of the GPCR ("β2AR-T4L") and showed that this protein retains near-native pharmacol. properties.  Anal. of adrenergic receptor ligand-binding mutants within the context of the reported high-resoln. structure of β2AR-T4L provides insights into inverse-agonist binding and the structural changes required to accommodate catecholamine agonists.  Amino acids known to regulate receptor function are linked through packing interactions and a network of hydrogen bonds, suggesting a conformational pathway from the ligand-binding pocket to regions that interact with G proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6gmrMhXnVl7Vg90H21EOLACvtfcHk0lhyjHdnLq0j1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmur7J&md5=d422ff1e7a28719848c0e16fede045db</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1126%2Fscience.1150609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1150609%26sid%3Dliteratum%253Aachs%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DRasmussen%26aufirst%3DS.%2BG.%26aulast%3DThian%26aufirst%3DF.%2BS.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DChoi%26aufirst%3DH.%2BJ.%26aulast%3DYao%26aufirst%3DX.%2BJ.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DGPCR%2520engineering%2520yields%2520high-resolution%2520structural%2520insights%2520into%2520%25CE%25B22-adrenergic%2520receptor%2520function%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D1266%26epage%3D1273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Rohl, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chivian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span> </span><span class="NLM_article-title">Modeling structurally variable regions in homologous proteins with rosetta</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">656</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=656-677&author=C.+A.+Rohlauthor=C.+E.+Straussauthor=D.+Chivianauthor=D.+Baker&title=Modeling+structurally+variable+regions+in+homologous+proteins+with+rosetta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRohl%26aufirst%3DC.%2BA.%26aulast%3DStrauss%26aufirst%3DC.%2BE.%26aulast%3DChivian%26aufirst%3DD.%26aulast%3DBaker%26aufirst%3DD.%26atitle%3DModeling%2520structurally%2520variable%2520regions%2520in%2520homologous%2520proteins%2520with%2520rosetta%26jtitle%3DProteins%26date%3D2004%26volume%3D55%26spage%3D656%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ferrara, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gohlke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, C. L.,  III.</span><span> </span><span class="NLM_article-title">Assessing scoring functions for protein−ligand interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3032</span><span class="NLM_x">–</span> <span class="NLM_lpage">3047</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030489h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3032-3047&author=P.+Ferraraauthor=H.+Gohlkeauthor=D.+J.+Priceauthor=G.+Klebeauthor=C.+L.+Brooks&title=Assessing+scoring+functions+for+protein%E2%88%92ligand+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm030489h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030489h%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DP.%26aulast%3DGohlke%26aufirst%3DH.%26aulast%3DPrice%26aufirst%3DD.%2BJ.%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DBrooks%26aufirst%3DC.%2BL.%26atitle%3DAssessing%2520scoring%2520functions%2520for%2520protein%25E2%2588%2592ligand%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3032%26epage%3D3047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Burger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennet, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, L. B.</span><span> </span><span class="NLM_article-title">Arylcycloalkylamines</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1950</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1950&pages=306&author=A.+Burgerauthor=C.+R.+Walterauthor=W.+B.+Bennetauthor=L.+B.+Turnbull&title=Arylcycloalkylamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DA.%26aulast%3DWalter%26aufirst%3DC.%2BR.%26aulast%3DBennet%26aufirst%3DW.%2BB.%26aulast%3DTurnbull%26aufirst%3DL.%2BB.%26atitle%3DArylcycloalkylamines%26jtitle%3DScience%26date%3D1950%26volume%3D112%26spage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Burger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yost, W. L.</span><span> </span><span class="NLM_article-title">Arylcycloalkylamines. I. 2-Phenylcyclopropylamine</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1948</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">2198</span><span class="NLM_x">–</span> <span class="NLM_lpage">2201</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01186a062" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1948&pages=2198-2201&author=A.+Burgerauthor=W.+L.+Yost&title=Arylcycloalkylamines.+I.+2-Phenylcyclopropylamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fja01186a062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01186a062%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DA.%26aulast%3DYost%26aufirst%3DW.%2BL.%26atitle%3DArylcycloalkylamines.%2520I.%25202-Phenylcyclopropylamine%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1948%26volume%3D70%26spage%3D2198%26epage%3D2201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span>Prestwick Drug Library; <span class="NLM_publisher-name">Prestwick Chemical</span>: <span class="NLM_publisher-loc">Illkirch, France</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span><a href="http://www.prestwickchemical.fr/" class="extLink">http://www.prestwickchemical.fr/</a> (accessed <span class="NLM_access-date">March 3, 2009</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prestwick+Drug+Library%3B+Prestwick+Chemical%3A+Illkirch%2C+France%2C+2006%3B+http%3A%2F%2Fwww.prestwickchemical.fr%2F+%28accessed+March+3%2C+2009%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DPrestwick%2520Drug%2520Library%26pub%3DPrestwick%2520Chemical%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Teotino, U. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bella, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benelli, G.</span><span> </span><span class="NLM_article-title">Chemical and biological properties of some aminomethyl-2-phenylcyclopropane derivatives. Pharmacological comparison with tranylcypromine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1096</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00318a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1967&pages=1091-1096&author=U.+M.+Teotinoauthor=D.+D.+Bellaauthor=A.+Gandiniauthor=G.+Benelli&title=Chemical+and+biological+properties+of+some+aminomethyl-2-phenylcyclopropane+derivatives.+Pharmacological+comparison+with+tranylcypromine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm00318a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00318a024%26sid%3Dliteratum%253Aachs%26aulast%3DTeotino%26aufirst%3DU.%2BM.%26aulast%3DBella%26aufirst%3DD.%2BD.%26aulast%3DGandini%26aufirst%3DA.%26aulast%3DBenelli%26aufirst%3DG.%26atitle%3DChemical%2520and%2520biological%2520properties%2520of%2520some%2520aminomethyl-2-phenylcyclopropane%2520derivatives.%2520Pharmacological%2520comparison%2520with%2520tranylcypromine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1967%26volume%3D10%26spage%3D1091%26epage%3D1096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Zirkle, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedeschi, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedeschi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, A.</span><span> </span><span class="NLM_article-title">2-Substituted Cyclopropylamines. II. Effect of Structure Upon Monoamine Oxidase-Inhibitory Activity as Measured in Vivo by Potentiation of Tryptamine Convulsions</span> <span class="citation_source-journal">J. Med. Pharm. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1265</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm01241a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1962&pages=1265-1284&author=C.+L.+Zirkleauthor=C.+Kaiserauthor=D.+H.+Tedeschiauthor=R.+E.+Tedeschiauthor=A.+Burger&title=2-Substituted+Cyclopropylamines.+II.+Effect+of+Structure+Upon+Monoamine+Oxidase-Inhibitory+Activity+as+Measured+in+Vivo+by+Potentiation+of+Tryptamine+Convulsions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm01241a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm01241a018%26sid%3Dliteratum%253Aachs%26aulast%3DZirkle%26aufirst%3DC.%2BL.%26aulast%3DKaiser%26aufirst%3DC.%26aulast%3DTedeschi%26aufirst%3DD.%2BH.%26aulast%3DTedeschi%26aufirst%3DR.%2BE.%26aulast%3DBurger%26aufirst%3DA.%26atitle%3D2-Substituted%2520Cyclopropylamines.%2520II.%2520Effect%2520of%2520Structure%2520Upon%2520Monoamine%2520Oxidase-Inhibitory%2520Activity%2520as%2520Measured%2520in%2520Vivo%2520by%2520Potentiation%2520of%2520Tryptamine%2520Convulsions%26jtitle%3DJ.%2520Med.%2520Pharm.%2520Chem.%26date%3D1962%26volume%3D5%26spage%3D1265%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haufe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirk, K. L.</span><span> </span><span class="NLM_article-title">Fluorinated phenylcyclopropylamines. 1. Synthesis and effect of fluorine substitution at the cyclopropane ring on inhibition of microbial tyramine oxidase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1796</span><span class="NLM_x">–</span> <span class="NLM_lpage">1806</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030398k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1796-1806&author=S.+Yoshidaauthor=O.+G.+Meyerauthor=T.+C.+Rosenauthor=G.+Haufeauthor=S.+Yeauthor=M.+J.+Sloanauthor=K.+L.+Kirk&title=Fluorinated+phenylcyclopropylamines.+1.+Synthesis+and+effect+of+fluorine+substitution+at+the+cyclopropane+ring+on+inhibition+of+microbial+tyramine+oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm030398k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030398k%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DMeyer%26aufirst%3DO.%2BG.%26aulast%3DRosen%26aufirst%3DT.%2BC.%26aulast%3DHaufe%26aufirst%3DG.%26aulast%3DYe%26aufirst%3DS.%26aulast%3DSloan%26aufirst%3DM.%2BJ.%26aulast%3DKirk%26aufirst%3DK.%2BL.%26atitle%3DFluorinated%2520phenylcyclopropylamines.%25201.%2520Synthesis%2520and%2520effect%2520of%2520fluorine%2520substitution%2520at%2520the%2520cyclopropane%2520ring%2520on%2520inhibition%2520of%2520microbial%2520tyramine%2520oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1796%26epage%3D1806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Krishnamurthy, S.</span><span> </span><span class="NLM_article-title">A highly efficient and general <i>N</i>-monomethylation of functionalized primary amines via formylation—borane:methyl sulfide reduction</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3315</span><span class="NLM_x">–</span> <span class="NLM_lpage">3318</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1982&pages=3315-3318&author=S.+Krishnamurthy&title=A+highly+efficient+and+general+N-monomethylation+of+functionalized+primary+amines+via+formylation%E2%80%94borane%3Amethyl+sulfide+reduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnamurthy%26aufirst%3DS.%26atitle%3DA%2520highly%2520efficient%2520and%2520general%2520N-monomethylation%2520of%2520functionalized%2520primary%2520amines%2520via%2520formylation%25E2%2580%2594borane%253Amethyl%2520sulfide%2520reduction%26jtitle%3DTetrahedron%2520Lett.%26date%3D1982%26volume%3D23%26spage%3D3315%26epage%3D3318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Balboni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jinsmaa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarus, L. H.</span><span> </span><span class="NLM_article-title">Synthesis and opioid activity of <i>N</i>,<i>N</i>-dimethyl-Dmt-Tic-NH-CH(R)-R′ analogues: acquisition of potent δ antagonism</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">5435</span><span class="NLM_x">–</span> <span class="NLM_lpage">5441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=5435-5441&author=G.+Balboniauthor=S.+Salvadoriauthor=R.+Guerriniauthor=L.+Negriauthor=E.+Gianniniauthor=S.+D.+Bryantauthor=Y.+Jinsmaaauthor=L.+H.+Lazarus&title=Synthesis+and+opioid+activity+of+N%2CN-dimethyl-Dmt-Tic-NH-CH%28R%29-R%E2%80%B2+analogues%3A+acquisition+of+potent+%CE%B4+antagonism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBalboni%26aufirst%3DG.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DNegri%26aufirst%3DL.%26aulast%3DGiannini%26aufirst%3DE.%26aulast%3DBryant%26aufirst%3DS.%2BD.%26aulast%3DJinsmaa%26aufirst%3DY.%26aulast%3DLazarus%26aufirst%3DL.%2BH.%26atitle%3DSynthesis%2520and%2520opioid%2520activity%2520of%2520N%252CN-dimethyl-Dmt-Tic-NH-CH%2528R%2529-R%25E2%2580%25B2%2520analogues%253A%2520acquisition%2520of%2520potent%2520%25CE%25B4%2520antagonism%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D5435%26epage%3D5441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Arvidsson, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacksell, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjorth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, B.</span><span> </span><span class="NLM_article-title"><i>N</i>,<i>N</i>-Dialkylated monophenolic <i>trans</i>-2-phenylcyclopropylamines: novel central 5-hydroxytryptamine receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00396a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=92-99&author=L.+E.+Arvidssonauthor=A.+M.+Johanssonauthor=U.+Hacksellauthor=J.+L.+Nilssonauthor=K.+Svenssonauthor=S.+Hjorthauthor=T.+Magnussonauthor=A.+Carlssonauthor=P.+Lindbergauthor=B.+Andersson&title=N%2CN-Dialkylated+monophenolic+trans-2-phenylcyclopropylamines%3A+novel+central+5-hydroxytryptamine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm00396a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00396a014%26sid%3Dliteratum%253Aachs%26aulast%3DArvidsson%26aufirst%3DL.%2BE.%26aulast%3DJohansson%26aufirst%3DA.%2BM.%26aulast%3DHacksell%26aufirst%3DU.%26aulast%3DNilsson%26aufirst%3DJ.%2BL.%26aulast%3DSvensson%26aufirst%3DK.%26aulast%3DHjorth%26aufirst%3DS.%26aulast%3DMagnusson%26aufirst%3DT.%26aulast%3DCarlsson%26aufirst%3DA.%26aulast%3DLindberg%26aufirst%3DP.%26aulast%3DAndersson%26aufirst%3DB.%26atitle%3DN%252CN-Dialkylated%2520monophenolic%2520trans-2-phenylcyclopropylamines%253A%2520novel%2520central%25205-hydroxytryptamine%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D92%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Kawamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyaji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span> </span><span class="NLM_article-title">Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3<i>R</i>,4<i>R</i>)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2<i>H</i>-benzimidazol-2-one (J-113397)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5061</span><span class="NLM_x">–</span> <span class="NLM_lpage">5063</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990517p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5061-5063&author=H.+Kawamotoauthor=S.+Ozakiauthor=Y.+Itohauthor=M.+Miyajiauthor=S.+Araiauthor=H.+Nakashimaauthor=T.+Katoauthor=H.+Ohtaauthor=Y.+Iwasawa&title=Discovery+of+the+first+potent+and+selective+small+molecule+opioid+receptor-like+%28ORL1%29+antagonist%3A+1-%5B%283R%2C4R%29-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl%5D-3-ethyl-1%2C3-dihydro-2H-benzimidazol-2-one+%28J-113397%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm990517p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990517p%26sid%3Dliteratum%253Aachs%26aulast%3DKawamoto%26aufirst%3DH.%26aulast%3DOzaki%26aufirst%3DS.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DMiyaji%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DS.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DH.%26aulast%3DIwasawa%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520the%2520first%2520potent%2520and%2520selective%2520small%2520molecule%2520opioid%2520receptor-like%2520%2528ORL1%2529%2520antagonist%253A%25201-%255B%25283R%252C4R%2529-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl%255D-3-ethyl-1%252C3-dihydro-2H-benzimidazol-2-one%2520%2528J-113397%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5061%26epage%3D5063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Chandrasekhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, M.</span><span> </span><span class="NLM_article-title">A single step reductive amination of carbonyl compounds with polymethylhydrosiloxane-Ti((OPr)-Pr-i)(4)</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">1657</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=1655-1657&author=S.+Chandrasekharauthor=C.+R.+Reddyauthor=M.+Ahmed&title=A+single+step+reductive+amination+of+carbonyl+compounds+with+polymethylhydrosiloxane-Ti%28%28OPr%29-Pr-i%29%284%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChandrasekhar%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DC.%2BR.%26aulast%3DAhmed%26aufirst%3DM.%26atitle%3DA%2520single%2520step%2520reductive%2520amination%2520of%2520carbonyl%2520compounds%2520with%2520polymethylhydrosiloxane-Ti%2528%2528OPr%2529-Pr-i%2529%25284%2529%26jtitle%3DSynlett%26date%3D2000%26spage%3D1655%26epage%3D1657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Miyaura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2457</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00039a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2457-2483&author=N.+Miyauraauthor=A.+Suzuki&title=Palladium-Catalyzed+Cross-Coupling+Reactions+of+Organoboron+Compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span></div><div class="casAuthors">Miyaura, Norio; Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2457-83</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with >250 refs. including title reactions and their mechanisms, prepn. of organoboron reagents, alkoxycarbonylation and dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwupBJT1UCbVg90H21EOLACvtfcHk0liw8odKoiO6nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D&md5=d127b414a75161652876eebc3ed0c486</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fcr00039a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00039a007%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DPalladium-Catalyzed%2520Cross-Coupling%2520Reactions%2520of%2520Organoboron%2520Compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26spage%3D2457%26epage%3D2483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">DeVasher, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaughnessy, K. H.</span><span> </span><span class="NLM_article-title">Aqueous-phase, palladium-catalyzed cross-coupling of aryl bromides under mild conditions, using water-soluble, sterically demanding alkylphosphines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">7919</span><span class="NLM_x">–</span> <span class="NLM_lpage">7927</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo048910c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=7919-7927&author=R.+B.+DeVasherauthor=L.+R.+Mooreauthor=K.+H.+Shaughnessy&title=Aqueous-phase%2C+palladium-catalyzed+cross-coupling+of+aryl+bromides+under+mild+conditions%2C+using+water-soluble%2C+sterically+demanding+alkylphosphines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjo048910c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo048910c%26sid%3Dliteratum%253Aachs%26aulast%3DDeVasher%26aufirst%3DR.%2BB.%26aulast%3DMoore%26aufirst%3DL.%2BR.%26aulast%3DShaughnessy%26aufirst%3DK.%2BH.%26atitle%3DAqueous-phase%252C%2520palladium-catalyzed%2520cross-coupling%2520of%2520aryl%2520bromides%2520under%2520mild%2520conditions%252C%2520using%2520water-soluble%252C%2520sterically%2520demanding%2520alkylphosphines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D7919%26epage%3D7927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Overberger, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimokawa, Y.</span><span> </span><span class="NLM_article-title">Synthesis and Optical Properties of Asymmetric Polyamides Derived from Optically Active Cyclic Dicarboxylic Acids</span> <span class="citation_source-journal">Macromolecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">718</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span></span><div class="citationLinks">[<a href="/doi/10.1021/ma60024a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1971&pages=718-725&author=C.+G.+Overbergerauthor=Y.+Shimokawa&title=Synthesis+and+Optical+Properties+of+Asymmetric+Polyamides+Derived+from+Optically+Active+Cyclic+Dicarboxylic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fma60024a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fma60024a010%26sid%3Dliteratum%253Aachs%26aulast%3DOverberger%26aufirst%3DC.%2BG.%26aulast%3DShimokawa%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520Optical%2520Properties%2520of%2520Asymmetric%2520Polyamides%2520Derived%2520from%2520Optically%2520Active%2520Cyclic%2520Dicarboxylic%2520Acids%26jtitle%3DMacromolecules%26date%3D1971%26volume%3D4%26spage%3D718%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgetts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasley, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craven, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodbeck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieltyka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacolod, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurkauf, A.</span><span> </span><span class="NLM_article-title"><i>trans</i>-1-[(2-Phenylcyclopropyl)methyl]-4-arylpiperazines: mixed dopamine D<sub>2</sub>/D<sub>4</sub> receptor antagonists as potential antipsychotic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3923</span><span class="NLM_x">–</span> <span class="NLM_lpage">3932</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990562x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3923-3932&author=X.+Zhangauthor=K.+Hodgettsauthor=S.+Rachwalauthor=H.+Zhaoauthor=J.+W.+Wasleyauthor=K.+Cravenauthor=R.+Brodbeckauthor=A.+Kieltykaauthor=D.+Hoffmanauthor=M.+D.+Bacolodauthor=B.+Girardauthor=J.+Tranauthor=A.+Thurkauf&title=trans-1-%5B%282-Phenylcyclopropyl%29methyl%5D-4-arylpiperazines%3A+mixed+dopamine+D2%2FD4+receptor+antagonists+as+potential+antipsychotic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm990562x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990562x%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHodgetts%26aufirst%3DK.%26aulast%3DRachwal%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DWasley%26aufirst%3DJ.%2BW.%26aulast%3DCraven%26aufirst%3DK.%26aulast%3DBrodbeck%26aufirst%3DR.%26aulast%3DKieltyka%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DD.%26aulast%3DBacolod%26aufirst%3DM.%2BD.%26aulast%3DGirard%26aufirst%3DB.%26aulast%3DTran%26aufirst%3DJ.%26aulast%3DThurkauf%26aufirst%3DA.%26atitle%3Dtrans-1-%255B%25282-Phenylcyclopropyl%2529methyl%255D-4-arylpiperazines%253A%2520mixed%2520dopamine%2520D2%252FD4%2520receptor%2520antagonists%2520as%2520potential%2520antipsychotic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3923%26epage%3D3932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Jensen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguiz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetsel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title"><i>N</i>-Desalkylquetiapine, a Potent Norepinephrine Reuptake Inhibitor and Partial 5-HT<sub>1A</sub> Agonist, as a Putative Mediator of Quetiapine’s Antidepressant Activity</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2303</span><span class="NLM_x">–</span> <span class="NLM_lpage">2312</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2007&pages=2303-2312&author=N.+H.+Jensenauthor=R.+M.+Rodriguizauthor=M.+G.+Caronauthor=W.+C.+Wetselauthor=R.+B.+Rothmanauthor=B.+L.+Roth&title=N-Desalkylquetiapine%2C+a+Potent+Norepinephrine+Reuptake+Inhibitor+and+Partial+5-HT1A+Agonist%2C+as+a+Putative+Mediator+of+Quetiapine%E2%80%99s+Antidepressant+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DN-Desalkylquetiapine%252C%2520a%2520Potent%2520Norepinephrine%2520Reuptake%2520Inhibitor%2520and%2520Partial%25205-HT1A%2520Agonist%252C%2520as%2520a%2520Putative%2520Mediator%2520of%2520Quetiapine%25E2%2580%2599s%2520Antidepressant%2520Activity%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D33%26spage%3D2303%26epage%3D2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Egan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinde, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrick-Davis, K.</span><span> </span><span class="NLM_article-title">Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT<sub>2A</sub> and 5-HT<sub>2C</sub> receptors</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2000&pages=144-150&author=C.+Eganauthor=E.+Grindeauthor=A.+Dupreauthor=B.+L.+Rothauthor=M.+Hakeauthor=M.+Teitlerauthor=K.+Herrick-Davis&title=Agonist+high+and+low+affinity+state+ratios+predict+drug+intrinsic+activity+and+a+revised+ternary+complex+mechanism+at+serotonin+5-HT2A+and+5-HT2C+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEgan%26aufirst%3DC.%26aulast%3DGrinde%26aufirst%3DE.%26aulast%3DDupre%26aufirst%3DA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHake%26aufirst%3DM.%26aulast%3DTeitler%26aufirst%3DM.%26aulast%3DHerrick-Davis%26aufirst%3DK.%26atitle%3DAgonist%2520high%2520and%2520low%2520affinity%2520state%2520ratios%2520predict%2520drug%2520intrinsic%2520activity%2520and%2520a%2520revised%2520ternary%2520complex%2520mechanism%2520at%2520serotonin%25205-HT2A%2520and%25205-HT2C%2520receptors%26jtitle%3DSynapse%26date%3D2000%26volume%3D35%26spage%3D144%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheesman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span> </span><span class="NLM_article-title">Pharmacological profile of the 5-HT<sub>2C</sub> receptor agonist WAY-163909; therapeutic potential in multiple indications</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=167-177&author=J.+Dunlopauthor=K.+L.+Marquisauthor=H.+K.+Limauthor=L.+Leungauthor=J.+Kaoauthor=C.+Cheesmanauthor=S.+Rosenzweig-Lipson&title=Pharmacological+profile+of+the+5-HT2C+receptor+agonist+WAY-163909%3B+therapeutic+potential+in+multiple+indications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DLim%26aufirst%3DH.%2BK.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DKao%26aufirst%3DJ.%26aulast%3DCheesman%26aufirst%3DC.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DPharmacological%2520profile%2520of%2520the%25205-HT2C%2520receptor%2520agonist%2520WAY-163909%253B%2520therapeutic%2520potential%2520in%2520multiple%2520indications%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2006%26volume%3D12%26spage%3D167%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 43 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Liang Tan, Qingtong Zhou, Wenzhong Yan, Jian Sun, Alan P. Kozikowski, Suwen Zhao, Xi-Ping Huang, <span class="NLM_string-name hlFld-ContribAuthor">Jianjun Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Bitopic 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as Selective Dopamine D3 Receptor Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (9)
                                     , 4579-4602. <a href="https://doi.org/10.1021/acs.jmedchem.9b01835" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01835</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01835%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BBitopic%252B2-Phenylcyclopropylmethylamine%252B%252528PCPMA%252529%252BDerivatives%252Bas%252BSelective%252BDopamine%252BD3%252BReceptor%252BLigands%26aulast%3DTan%26aufirst%3DLiang%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D18112019%26date%3D23042020%26date%3D13042020%26volume%3D63%26issue%3D9%26spage%3D4579%26epage%3D4602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kevin M. Peese, Christopher W. Allard, Timothy Connolly, Barry L. Johnson, Chen Li, Manoj Patel, Margaret E. Sorensen, Michael A. Walker, Nicholas A. Meanwell, Brian McAuliffe, Beatrice Minassian, Mark Krystal, Dawn D. Parker, Hal A. Lewis, Kevin Kish, Ping Zhang, Robert T. Nolte, Jean Simmermacher, Susan Jenkins, Christopher Cianci, <span class="NLM_string-name hlFld-ContribAuthor">B. Narasimhulu Naidu</span>. </span><span class="cited-content_cbyCitation_article-title">5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (3)
                                     , 1348-1361. <a href="https://doi.org/10.1021/acs.jmedchem.8b01473" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01473%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D5%25252C6%25252C7%25252C8-Tetrahydro-1%25252C6-naphthyridine%252BDerivatives%252Bas%252BPotent%252BHIV-1-Integrase-Allosteric-Site%252BInhibitors%26aulast%3DPeese%26aufirst%3DKevin%2BM.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D21092018%26date%3D18012019%26date%3D04012019%26volume%3D62%26issue%3D3%26spage%3D1348%26epage%3D1361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher
T. Wild, Joanna M. Miszkiel, Eric A. Wold, Claudia A. Soto, Chunyong Ding, Rachel M. Hartley, Mark A. White, Noelle C. Anastasio, Kathryn A. Cunningham, <span class="NLM_string-name hlFld-ContribAuthor">Jia Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT2C Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (1)
                                     , 288-305. <a href="https://doi.org/10.1021/acs.jmedchem.8b00401" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00401</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00401%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BCharacterization%252Bof%252B4-Undecylpiperidine-2-carboxamides%252Bas%252BPositive%252BAllosteric%252BModulators%252Bof%252Bthe%252BSerotonin%252B%2525285-HT%252529%252B5-HT2C%252BReceptor%26aulast%3DWild%26aufirst%3DChristopher%2BT.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D12032018%26date%3D13042018%26date%3D05042018%26volume%3D62%26issue%3D1%26spage%3D288%26epage%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guiping  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianjun  Cheng</span>, <span class="hlFld-ContribAuthor ">John D.  McCorvy</span>, <span class="hlFld-ContribAuthor ">Paul J.  Lorello</span>, <span class="hlFld-ContribAuthor ">Barbara J.  Caldarone</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, and <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (14)
                                     , 6273-6288. <a href="https://doi.org/10.1021/acs.jmedchem.7b00584" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00584</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00584%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-Substituted%252B%2525282-Phenylcyclopropyl%252529methylamines%252Bas%252BFunctionally%252BSelective%252BSerotonin%252B2C%252BReceptor%252BAgonists%252Bfor%252BPotential%252BUse%252Bas%252BAntipsychotic%252BMedications%26aulast%3DZhang%26aufirst%3DGuiping%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D17042017%26date%3D18072017%26date%3D27072017%26date%3D28062017%26volume%3D60%26issue%3D14%26spage%3D6273%26epage%3D6288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianjun  Cheng</span>, <span class="hlFld-ContribAuthor ">John D.  McCorvy</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Giguere</span>, <span class="hlFld-ContribAuthor ">Hu  Zhu</span>, <span class="hlFld-ContribAuthor ">Terry  Kenakin</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, and <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Discovery of Functionally Selective Serotonin 2C (5-HT2C) Receptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (21)
                                     , 9866-9880. <a href="https://doi.org/10.1021/acs.jmedchem.6b01194" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01194%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BDiscovery%252Bof%252BFunctionally%252BSelective%252BSerotonin%252B2C%252B%2525285-HT2C%252529%252BReceptor%252BAgonists%26aulast%3DCheng%26aufirst%3DJianjun%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D10082016%26date%3D25102016%26date%3D10112016%26date%3D11102016%26volume%3D59%26issue%3D21%26spage%3D9866%26epage%3D9880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianjun  Cheng</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Giguere</span>, <span class="hlFld-ContribAuthor ">Claire M.  Schmerberg</span>, <span class="hlFld-ContribAuthor ">Vladimir M.  Pogorelov</span>, <span class="hlFld-ContribAuthor ">Ramona M.  Rodriguiz</span>, <span class="hlFld-ContribAuthor ">Xi-Ping  Huang</span>, <span class="hlFld-ContribAuthor ">Hu  Zhu</span>, <span class="hlFld-ContribAuthor ">John D.  McCorvy</span>, <span class="hlFld-ContribAuthor ">William C.  Wetsel</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, and <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition Models. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (2)
                                     , 578-591. <a href="https://doi.org/10.1021/acs.jmedchem.5b01153" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01153%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFurther%252BAdvances%252Bin%252BOptimizing%252B%2525282-Phenylcyclopropyl%252529methylamines%252Bas%252BNovel%252BSerotonin%252B2C%252BAgonists%25253A%252BEffects%252Bon%252BHyperlocomotion%25252C%252BPrepulse%252BInhibition%25252C%252Band%252BCognition%252BModels%26aulast%3DCheng%26aufirst%3DJianjun%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D22072015%26date%3D13012016%26date%3D28012016%26date%3D24122015%26volume%3D59%26issue%3D2%26spage%3D578%26epage%3D591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianjun  Cheng</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Giguère</span>, <span class="hlFld-ContribAuthor ">Oluseye K.  Onajole</span>, <span class="hlFld-ContribAuthor ">Wei  Lv</span>, <span class="hlFld-ContribAuthor ">Arsen  Gaisin</span>, <span class="hlFld-ContribAuthor ">Hendra  Gunosewoyo</span>, <span class="hlFld-ContribAuthor ">Claire M.  Schmerberg</span>, <span class="hlFld-ContribAuthor ">Vladimir M.  Pogorelov</span>, <span class="hlFld-ContribAuthor ">Ramona M.  Rodriguiz</span>, <span class="hlFld-ContribAuthor ">Giulio  Vistoli</span>, <span class="hlFld-ContribAuthor ">William C.  Wetsel</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, and <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimization of 2-Phenylcyclopropylmethylamines as Selective Serotonin 2C Receptor Agonists and Their Evaluation as Potential Antipsychotic Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (4)
                                     , 1992-2002. <a href="https://doi.org/10.1021/jm5019274" title="DOI URL">https://doi.org/10.1021/jm5019274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5019274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5019274%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252B2-Phenylcyclopropylmethylamines%252Bas%252BSelective%252BSerotonin%252B2C%252BReceptor%252BAgonists%252Band%252BTheir%252BEvaluation%252Bas%252BPotential%252BAntipsychotic%252BAgents%26aulast%3DCheng%26aufirst%3DJianjun%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D12122014%26date%3D10022015%26date%3D26022015%26date%3D29012015%26volume%3D58%26issue%3D4%26spage%3D1992%26epage%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R. Ian  Storer</span>, <span class="hlFld-ContribAuthor ">Paul E.  Brennan</span>, <span class="hlFld-ContribAuthor ">Alan D.  Brown</span>, <span class="hlFld-ContribAuthor ">Peter J.  Bungay</span>, <span class="hlFld-ContribAuthor ">Kelly M.  Conlon</span>, <span class="hlFld-ContribAuthor ">Matthew S.  Corbett</span>, <span class="hlFld-ContribAuthor ">Robert P.  DePianta</span>, <span class="hlFld-ContribAuthor ">Paul V.  Fish</span>, <span class="hlFld-ContribAuthor ">Alexander  Heifetz</span>, <span class="hlFld-ContribAuthor ">Danny K. H.  Ho</span>, <span class="hlFld-ContribAuthor ">Alan S.  Jessiman</span>, <span class="hlFld-ContribAuthor ">Gordon  McMurray</span>, <span class="hlFld-ContribAuthor ">Cesar Augusto F.  de Oliveira</span>, <span class="hlFld-ContribAuthor ">Lee R.  Roberts</span>, <span class="hlFld-ContribAuthor ">James A.  Root</span>, <span class="hlFld-ContribAuthor ">Veerabahu  Shanmugasundaram</span>, <span class="hlFld-ContribAuthor ">Michael J.  Shapiro</span>, <span class="hlFld-ContribAuthor ">Melanie  Skerten</span>, <span class="hlFld-ContribAuthor ">Dominique  Westbrook</span>, <span class="hlFld-ContribAuthor ">Simon  Wheeler</span>, <span class="hlFld-ContribAuthor ">Gavin A.  Whitlock</span>, and <span class="hlFld-ContribAuthor ">John  Wright</span>  . </span><span class="cited-content_cbyCitation_article-title">Multiparameter Optimization in CNS Drug Discovery: Design of Pyrimido[4,5-d]azepines as Potent 5-Hydroxytryptamine 2C (5-HT2C) Receptor Agonists with Exquisite Functional Selectivity over 5-HT2A and 5-HT2B Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (12)
                                     , 5258-5269. <a href="https://doi.org/10.1021/jm5003292" title="DOI URL">https://doi.org/10.1021/jm5003292</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5003292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5003292%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMultiparameter%252BOptimization%252Bin%252BCNS%252BDrug%252BDiscovery%25253A%252BDesign%252Bof%252BPyrimido%25255B4%25252C5-d%25255Dazepines%252Bas%252BPotent%252B5-Hydroxytryptamine%252B2C%252B%2525285-HT2C%252529%252BReceptor%252BAgonists%252Bwith%252BExquisite%252BFunctional%252BSelectivity%252Bover%252B5-HT2A%252Band%252B5-HT2B%252BReceptors%26aulast%3DStorer%26aufirst%3DR.%2BIan%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D01032014%26date%3D17062014%26date%3D26062014%26date%3D30052014%26volume%3D57%26issue%3D12%26spage%3D5258%26epage%3D5269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yubo  Cui</span>, <span class="hlFld-ContribAuthor ">Raghavan  Balachandran</span>, <span class="hlFld-ContribAuthor ">Billy W.  Day</span>, and <span class="hlFld-ContribAuthor ">Paul E.  Floreancig</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Neopeltolide and Analogs. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2012,</strong> <em>77 </em>
                                    (5)
                                     , 2225-2235. <a href="https://doi.org/10.1021/jo2023685" title="DOI URL">https://doi.org/10.1021/jo2023685</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo2023685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo2023685%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNeopeltolide%252Band%252BAnalogs%26aulast%3DCui%26aufirst%3DYubo%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D30112011%26date%3D22022012%26date%3D02032012%26date%3D13022012%26volume%3D77%26issue%3D5%26spage%3D2225%26epage%3D2235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gang  Chen</span>, <span class="hlFld-ContribAuthor ">Sung Jin  Cho</span>, <span class="hlFld-ContribAuthor ">Xi-Ping  Huang</span>, <span class="hlFld-ContribAuthor ">Niels H.  Jensen</span>, <span class="hlFld-ContribAuthor ">Andreas  Svennebring</span>, <span class="hlFld-ContribAuthor ">Maria F.  Sassano</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, and <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Rational Drug Design Leading to the Identification of a Potent 5-HT2C Agonist Lacking 5-HT2B Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>2 </em>
                                    (12)
                                     , 929-932. <a href="https://doi.org/10.1021/ml200206z" title="DOI URL">https://doi.org/10.1021/ml200206z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml200206z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml200206z%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRational%252BDrug%252BDesign%252BLeading%252Bto%252Bthe%252BIdentification%252Bof%252Ba%252BPotent%252B5-HT2C%252BAgonist%252BLacking%252B5-HT2B%252BActivity%26aulast%3DChen%26aufirst%3DGang%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D22082011%26date%3D10102011%26date%3D18102011%26date%3D08122011%26date%3D10102011%26volume%3D2%26issue%3D12%26spage%3D929%26epage%3D932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabina  Podlewska</span>, <span class="hlFld-ContribAuthor ">Ryszard  Bugno</span>, <span class="hlFld-ContribAuthor ">Enza  Lacivita</span>, <span class="hlFld-ContribAuthor ">Marcello  Leopoldo</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>, <span class="hlFld-ContribAuthor ">Jadwiga  Handzlik</span>. </span><span class="cited-content_cbyCitation_article-title">Low Basicity as a Characteristic for Atypical Ligands of Serotonin Receptor 5-HT2. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (3)
                                     , 1035. <a href="https://doi.org/10.3390/ijms22031035" title="DOI URL">https://doi.org/10.3390/ijms22031035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22031035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22031035%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DLow%252BBasicity%252Bas%252Ba%252BCharacteristic%252Bfor%252BAtypical%252BLigands%252Bof%252BSerotonin%252BReceptor%252B5-HT2%26aulast%3DPodlewska%26aufirst%3DSabina%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D3%26spage%3D1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gerard J.  Marek</span>, <span class="hlFld-ContribAuthor ">Darryle D.  Schoepp</span>. </span><span class="cited-content_cbyCitation_article-title">Cortical influences of serotonin and glutamate on layer V pyramidal neurons. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 341-378. <a href="https://doi.org/10.1016/bs.pbr.2020.11.002" title="DOI URL">https://doi.org/10.1016/bs.pbr.2020.11.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pbr.2020.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pbr.2020.11.002%26sid%3Dliteratum%253Aachs%26atitle%3DCortical%252Binfluences%252Bof%252Bserotonin%252Band%252Bglutamate%252Bon%252Blayer%252BV%252Bpyramidal%252Bneurons%26aulast%3DMarek%26aufirst%3DGerard%2BJ.%26date%3D2021%26spage%3D341%26epage%3D378%26pub%3DElsevier%26atitle%3D5-HT%252BInteraction%252Bwith%252BOther%252BNeurotransmitters%25253A%252BExperimental%252BEvidence%252Band%252BTherapeutic%252BRelevance%252B-%252BPart%252BB%26date%3D2021%26volume%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Kreibich</span>, <span class="hlFld-ContribAuthor ">Manuel  Gemander</span>, <span class="hlFld-ContribAuthor ">David  Peter</span>, <span class="hlFld-ContribAuthor ">Dharmendra B.  Yadav</span>, <span class="hlFld-ContribAuthor ">Charles B.  de Koning</span>, <span class="hlFld-ContribAuthor ">Manuel A.  Fernandes</span>, <span class="hlFld-ContribAuthor ">Ivan R.  Green</span>, <span class="hlFld-ContribAuthor ">Willem A. L.  van Otterlo</span>, <span class="hlFld-ContribAuthor ">Reinhard  Brückner</span>. </span><span class="cited-content_cbyCitation_article-title">6,7‐Benzotropolone Syntheses Based on Ring‐Closing Metatheses and Four‐Electron Oxidations. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (19)
                                     , 2929-2955. <a href="https://doi.org/10.1002/ejoc.202000256" title="DOI URL">https://doi.org/10.1002/ejoc.202000256</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202000256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202000256%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D6%25252C7%2525E2%252580%252590Benzotropolone%252BSyntheses%252BBased%252Bon%252BRing%2525E2%252580%252590Closing%252BMetatheses%252Band%252BFour%2525E2%252580%252590Electron%252BOxidations%26aulast%3DKreibich%26aufirst%3DMichael%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D19%26spage%3D2929%26epage%3D2955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rossella  Fioravanti</span>, <span class="hlFld-ContribAuthor ">Annalisa  Romanelli</span>, <span class="hlFld-ContribAuthor ">Nicola  Mautone</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Di Bello</span>, <span class="hlFld-ContribAuthor ">Annarita  Rovere</span>, <span class="hlFld-ContribAuthor ">Davide  Corinti</span>, <span class="hlFld-ContribAuthor ">Clemens  Zwergel</span>, <span class="hlFld-ContribAuthor ">Sergio  Valente</span>, <span class="hlFld-ContribAuthor ">Dante  Rotili</span>, <span class="hlFld-ContribAuthor ">Oronza A.  Botrugno</span>, <span class="hlFld-ContribAuthor ">Paola  Dessanti</span>, <span class="hlFld-ContribAuthor ">Stefania  Vultaggio</span>, <span class="hlFld-ContribAuthor ">Paola  Vianello</span>, <span class="hlFld-ContribAuthor ">Anna  Cappa</span>, <span class="hlFld-ContribAuthor ">Claudia  Binda</span>, <span class="hlFld-ContribAuthor ">Andrea  Mattevi</span>, <span class="hlFld-ContribAuthor ">Saverio  Minucci</span>, <span class="hlFld-ContribAuthor ">Ciro  Mercurio</span>, <span class="hlFld-ContribAuthor ">Mario  Varasi</span>, <span class="hlFld-ContribAuthor ">Antonello  Mai</span>. </span><span class="cited-content_cbyCitation_article-title">Tranylcypromine‐Based LSD1 Inhibitors: Structure‐Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (7)
                                     , 643-658. <a href="https://doi.org/10.1002/cmdc.201900730" title="DOI URL">https://doi.org/10.1002/cmdc.201900730</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900730%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTranylcypromine%2525E2%252580%252590Based%252BLSD1%252BInhibitors%25253A%252BStructure%2525E2%252580%252590Activity%252BRelationships%25252C%252BAntiproliferative%252BEffects%252Bin%252BLeukemia%25252C%252Band%252BGene%252BTarget%252BModulation%26aulast%3DFioravanti%26aufirst%3DRossella%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D7%26spage%3D643%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oleksandr V.  Hryschuk</span>, <span class="hlFld-ContribAuthor ">Yevhen  Yurov</span>, <span class="hlFld-ContribAuthor ">Andriy V.  Tymtsunik</span>, <span class="hlFld-ContribAuthor ">Volodymyr O.  Kovtunenko</span>, <span class="hlFld-ContribAuthor ">Igor V.  Komarov</span>, <span class="hlFld-ContribAuthor ">Oleksandr O.  Grygorenko</span>. </span><span class="cited-content_cbyCitation_article-title">Multigram Synthesis and C−C/C−N Couplings of Functionalized 1,2‐Disubstituted Cyclopropyltrifluoroborates. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2019,</strong> <em>361 </em>
                                    (23)
                                     , 5428-5439. <a href="https://doi.org/10.1002/adsc.201900879" title="DOI URL">https://doi.org/10.1002/adsc.201900879</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201900879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201900879%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DMultigram%252BSynthesis%252Band%252BC%2525E2%252588%252592C%25252FC%2525E2%252588%252592N%252BCouplings%252Bof%252BFunctionalized%252B1%25252C2%2525E2%252580%252590Disubstituted%252BCyclopropyltrifluoroborates%26aulast%3DHryschuk%26aufirst%3DOleksandr%2BV.%26date%3D2019%26date%3D2019%26volume%3D361%26issue%3D23%26spage%3D5428%26epage%3D5439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guiping  Zhang</span>, <span class="hlFld-ContribAuthor ">John D.  McCorvy</span>, <span class="hlFld-ContribAuthor ">Sida  Shen</span>, <span class="hlFld-ContribAuthor ">Jianjun  Cheng</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>. </span><span class="cited-content_cbyCitation_article-title">Design of fluorinated cyclopropane derivatives of 2-phenylcyclopropylmethylamine leading to identification of a selective serotonin 2C (5-HT2C) receptor agonist without 5-HT2B agonism. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111626. <a href="https://doi.org/10.1016/j.ejmech.2019.111626" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111626</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111626%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252Bfluorinated%252Bcyclopropane%252Bderivatives%252Bof%252B2-phenylcyclopropylmethylamine%252Bleading%252Bto%252Bidentification%252Bof%252Ba%252Bselective%252Bserotonin%252B2C%252B%2525285-HT2C%252529%252Breceptor%252Bagonist%252Bwithout%252B5-HT2B%252Bagonism%26aulast%3DZhang%26aufirst%3DGuiping%26date%3D2019%26volume%3D182%26spage%3D111626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ariel  Carreño-Montero</span>, <span class="hlFld-ContribAuthor ">Luis A.  Maldonado</span>, <span class="hlFld-ContribAuthor ">María Isabel  Chávez</span>, <span class="hlFld-ContribAuthor ">Simón  Hernández-Ortega</span>, <span class="hlFld-ContribAuthor ">Guillermo  Delgado</span>. </span><span class="cited-content_cbyCitation_article-title">An unexpected Pummerer rearrangement in the synthetic route to ethyl (2′-hydroxy-4′,5′-methylenedioxyphenyl)acetate: An alternative approach to 2,3-dimethylthio benzofurans. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (48)
                                     , 151282. <a href="https://doi.org/10.1016/j.tetlet.2019.151282" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.151282</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.151282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.151282%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAn%252Bunexpected%252BPummerer%252Brearrangement%252Bin%252Bthe%252Bsynthetic%252Broute%252Bto%252Bethyl%252B%2525282%2525E2%252580%2525B2-hydroxy-4%2525E2%252580%2525B2%25252C5%2525E2%252580%2525B2-methylenedioxyphenyl%252529acetate%25253A%252BAn%252Balternative%252Bapproach%252Bto%252B2%25252C3-dimethylthio%252Bbenzofurans%26aulast%3DCarre%25C3%25B1o-Montero%26aufirst%3DAriel%26date%3D2019%26volume%3D60%26issue%3D48%26spage%3D151282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabian  Heider</span>, <span class="hlFld-ContribAuthor ">Francesco  Ansideri</span>, <span class="hlFld-ContribAuthor ">Roberta  Tesch</span>, <span class="hlFld-ContribAuthor ">Tatu  Pantsar</span>, <span class="hlFld-ContribAuthor ">Urs  Haun</span>, <span class="hlFld-ContribAuthor ">Eva  Döring</span>, <span class="hlFld-ContribAuthor ">Mark  Kudolo</span>, <span class="hlFld-ContribAuthor ">Antti  Poso</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Albrecht</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>, <span class="hlFld-ContribAuthor ">Pierre  Koch</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridinylimidazoles as dual glycogen synthase kinase 3β/p38α mitogen-activated protein kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>175 </em>, 309-329. <a href="https://doi.org/10.1016/j.ejmech.2019.04.035" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.04.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.04.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.04.035%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyridinylimidazoles%252Bas%252Bdual%252Bglycogen%252Bsynthase%252Bkinase%252B3%2525CE%2525B2%25252Fp38%2525CE%2525B1%252Bmitogen-activated%252Bprotein%252Bkinase%252Binhibitors%26aulast%3DHeider%26aufirst%3DFabian%26date%3D2019%26volume%3D175%26spage%3D309%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liming  Xie</span>, <span class="hlFld-ContribAuthor ">Xueying  Xiong</span>, <span class="hlFld-ContribAuthor ">Qiaowen  Chang</span>, <span class="hlFld-ContribAuthor ">Xiaolian  Chen</span>, <span class="hlFld-ContribAuthor ">Changting  Wei</span>, <span class="hlFld-ContribAuthor ">Xia  Li</span>, <span class="hlFld-ContribAuthor ">Meng  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenming  Su</span>, <span class="hlFld-ContribAuthor ">Zheng  Cui</span>. </span><span class="cited-content_cbyCitation_article-title">Inkjet‐Printed High‐Efficiency Multilayer QLEDs Based on a Novel Crosslinkable Small‐Molecule Hole Transport Material. </span><span class="cited-content_cbyCitation_journal-name">Small</span><span> <strong>2019,</strong> <em>15 </em>
                                    (16)
                                     , 1900111. <a href="https://doi.org/10.1002/smll.201900111" title="DOI URL">https://doi.org/10.1002/smll.201900111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/smll.201900111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fsmll.201900111%26sid%3Dliteratum%253Aachs%26jtitle%3DSmall%26atitle%3DInkjet%2525E2%252580%252590Printed%252BHigh%2525E2%252580%252590Efficiency%252BMultilayer%252BQLEDs%252BBased%252Bon%252Ba%252BNovel%252BCrosslinkable%252BSmall%2525E2%252580%252590Molecule%252BHole%252BTransport%252BMaterial%26aulast%3DXie%26aufirst%3DLiming%26date%3D2019%26date%3D2019%26volume%3D15%26issue%3D16%26spage%3D1900111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin-Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Jia-Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Shau-Wei  Tsai</span>. </span><span class="cited-content_cbyCitation_article-title">Lipase-catalyzed hydrolytic resolution of trans-2-(3,4-difluorophenyl)cyclopropyl azolides, a key building block for Ticagrelor synthesis. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Taiwan Institute of Chemical Engineers</span><span> <strong>2019,</strong> <em>97 </em>, 112-118. <a href="https://doi.org/10.1016/j.jtice.2019.02.026" title="DOI URL">https://doi.org/10.1016/j.jtice.2019.02.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jtice.2019.02.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jtice.2019.02.026%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Taiwan%2520Institute%2520of%2520Chemical%2520Engineers%26atitle%3DLipase-catalyzed%252Bhydrolytic%252Bresolution%252Bof%252Btrans-2-%2525283%25252C4-difluorophenyl%252529cyclopropyl%252Bazolides%25252C%252Ba%252Bkey%252Bbuilding%252Bblock%252Bfor%252BTicagrelor%252Bsynthesis%26aulast%3DWang%26aufirst%3DXin-Yu%26date%3D2019%26volume%3D97%26spage%3D112%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kartikey  Singh</span>, <span class="hlFld-ContribAuthor ">Chandan  Sona</span>, <span class="hlFld-ContribAuthor ">Vikash  Ojha</span>, <span class="hlFld-ContribAuthor ">Maninder  Singh</span>, <span class="hlFld-ContribAuthor ">Ankita  Mishra</span>, <span class="hlFld-ContribAuthor ">Ajeet  Kumar</span>, <span class="hlFld-ContribAuthor ">Mohammad Imran  Siddiqi</span>, <span class="hlFld-ContribAuthor ">Rama P.  Tripathi</span>, <span class="hlFld-ContribAuthor ">Prem N.  Yadav</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of dual role of piperazine-linked phenyl cyclopropyl methanone as positive allosteric modulator of 5-HT2C and negative allosteric modulator of 5-HT2B receptors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 499-516. <a href="https://doi.org/10.1016/j.ejmech.2018.12.070" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.070%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bdual%252Brole%252Bof%252Bpiperazine-linked%252Bphenyl%252Bcyclopropyl%252Bmethanone%252Bas%252Bpositive%252Ballosteric%252Bmodulator%252Bof%252B5-HT2C%252Band%252Bnegative%252Ballosteric%252Bmodulator%252Bof%252B5-HT2B%252Breceptors%26aulast%3DSingh%26aufirst%3DKartikey%26date%3D2019%26volume%3D164%26spage%3D499%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iris  Elser</span>, <span class="hlFld-ContribAuthor ">Benjamin R.  Kordes</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Frey</span>, <span class="hlFld-ContribAuthor ">Katharina  Herz</span>, <span class="hlFld-ContribAuthor ">Roman  Schowner</span>, <span class="hlFld-ContribAuthor ">Laura  Stöhr</span>, <span class="hlFld-ContribAuthor ">Hagen J.  Altmann</span>, <span class="hlFld-ContribAuthor ">Michael R.  Buchmeiser</span>. </span><span class="cited-content_cbyCitation_article-title">Latent and Air-Stable Pre-Catalysts for the Polymerization of Dicyclopentadiene: From Penta- to Hexacoordination in Molybdenum Imido Alkylidene N-Heterocyclic Carbene Complexes. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2018,</strong> <em>24 </em>
                                    (48)
                                     , 12652-12659. <a href="https://doi.org/10.1002/chem.201801862" title="DOI URL">https://doi.org/10.1002/chem.201801862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201801862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201801862%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DLatent%252Band%252BAir-Stable%252BPre-Catalysts%252Bfor%252Bthe%252BPolymerization%252Bof%252BDicyclopentadiene%25253A%252BFrom%252BPenta-%252Bto%252BHexacoordination%252Bin%252BMolybdenum%252BImido%252BAlkylidene%252BN-Heterocyclic%252BCarbene%252BComplexes%26aulast%3DElser%26aufirst%3DIris%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D48%26spage%3D12652%26epage%3D12659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan‐Ru  Yeh</span>, <span class="hlFld-ContribAuthor ">Yi‐Jia  Tzeng</span>, <span class="hlFld-ContribAuthor ">Shau‐Wei  Tsai</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative Improvements and Insights into CALB‐Catalyzed Resolution of
              trans
              ‐ and
              cis
              ‐2‐Phenylcyclopropyl Azolides. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (19)
                                     , 5353-5360. <a href="https://doi.org/10.1002/slct.201800578" title="DOI URL">https://doi.org/10.1002/slct.201800578</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201800578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201800578%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DQuantitative%252BImprovements%252Band%252BInsights%252Binto%252BCALB%2525E2%252580%252590Catalyzed%252BResolution%252Bof%252Btrans%252B%2525E2%252580%252590%252Band%252Bcis%252B%2525E2%252580%2525902%2525E2%252580%252590Phenylcyclopropyl%252BAzolides%26aulast%3DYeh%26aufirst%3DYan%25E2%2580%2590Ru%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D19%26spage%3D5353%26epage%3D5360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eswar K.  Aratikatla</span>, <span class="hlFld-ContribAuthor ">Tushar R.  Valkute</span>, <span class="hlFld-ContribAuthor ">Sunil K.  Puri</span>, <span class="hlFld-ContribAuthor ">Kumkum  Srivastava</span>, <span class="hlFld-ContribAuthor ">Asish K.  Bhattacharya</span>. </span><span class="cited-content_cbyCitation_article-title">Norepinephrine alkaloids as antiplasmodial agents: Synthesis of syncarpamide and insight into the structure-activity relationships of its analogues as antiplasmodial agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>138 </em>, 1089-1105. <a href="https://doi.org/10.1016/j.ejmech.2017.07.052" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.052%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNorepinephrine%252Balkaloids%252Bas%252Bantiplasmodial%252Bagents%25253A%252BSynthesis%252Bof%252Bsyncarpamide%252Band%252Binsight%252Binto%252Bthe%252Bstructure-activity%252Brelationships%252Bof%252Bits%252Banalogues%252Bas%252Bantiplasmodial%252Bagents%26aulast%3DAratikatla%26aufirst%3DEswar%2BK.%26date%3D2017%26volume%3D138%26spage%3D1089%26epage%3D1105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lara  Fakhouri</span>, <span class="hlFld-ContribAuthor ">Christopher D.  Cook</span>, <span class="hlFld-ContribAuthor ">Mohammed H.  Al-Huniti</span>, <span class="hlFld-ContribAuthor ">Linda M.  Console-Bram</span>, <span class="hlFld-ContribAuthor ">Dow P.  Hurst</span>, <span class="hlFld-ContribAuthor ">Michael B.S.  Spano</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Nasrallah</span>, <span class="hlFld-ContribAuthor ">Marc G.  Caron</span>, <span class="hlFld-ContribAuthor ">Larry S.  Barak</span>, <span class="hlFld-ContribAuthor ">Patricia H.  Reggio</span>, <span class="hlFld-ContribAuthor ">Mary E.  Abood</span>, <span class="hlFld-ContribAuthor ">Mitchell P.  Croatt</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of GPR55 agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (16)
                                     , 4355-4367. <a href="https://doi.org/10.1016/j.bmc.2017.06.016" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.06.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.06.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BGPR55%252Bagonists%26aulast%3DFakhouri%26aufirst%3DLara%26date%3D2017%26volume%3D25%26issue%3D16%26spage%3D4355%26epage%3D4367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Milica  Radan</span>, <span class="hlFld-ContribAuthor ">Katarina  Nikolić</span>, <span class="hlFld-ContribAuthor ">Jelica  Vučićević</span>, <span class="hlFld-ContribAuthor ">Slavica  Oljačić</span>, <span class="hlFld-ContribAuthor ">Danica  Agbaba</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR study and development of pharmacophore for serotonin 5-HT2A receptors agonists. </span><span class="cited-content_cbyCitation_journal-name">Arhiv za farmaciju</span><span> <strong>2017,</strong> <em>67 </em>
                                    (3)
                                     , 165-179. <a href="https://doi.org/10.5937/arhfarm1703165R" title="DOI URL">https://doi.org/10.5937/arhfarm1703165R</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5937/arhfarm1703165R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5937%2Farhfarm1703165R%26sid%3Dliteratum%253Aachs%26jtitle%3DArhiv%2520za%2520farmaciju%26atitle%3D3D-QSAR%252Bstudy%252Band%252Bdevelopment%252Bof%252Bpharmacophore%252Bfor%252Bserotonin%252B5-HT2A%252Breceptors%252Bagonists%26aulast%3DRadan%26aufirst%3DMilica%26date%3D2017%26volume%3D67%26issue%3D3%26spage%3D165%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad Hadi  Ghasemi</span>, <span class="hlFld-ContribAuthor ">Elaheh  Kowsari</span>. </span><span class="cited-content_cbyCitation_article-title">The synergistic effect of copper chromite spinel nanoparticles (CuCr2O4) and basic ionic liquid on the synthesis of cyclopropanecarboxylic acids. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2016,</strong> <em>42 </em>
                                    (12)
                                     , 7963-7975. <a href="https://doi.org/10.1007/s11164-016-2572-1" title="DOI URL">https://doi.org/10.1007/s11164-016-2572-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-016-2572-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-016-2572-1%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DThe%252Bsynergistic%252Beffect%252Bof%252Bcopper%252Bchromite%252Bspinel%252Bnanoparticles%252B%252528CuCr2O4%252529%252Band%252Bbasic%252Bionic%252Bliquid%252Bon%252Bthe%252Bsynthesis%252Bof%252Bcyclopropanecarboxylic%252Bacids%26aulast%3DGhasemi%26aufirst%3DMohammad%2BHadi%26date%3D2016%26date%3D2016%26volume%3D42%26issue%3D12%26spage%3D7963%26epage%3D7975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giannamaria  Annunziato</span>, <span class="hlFld-ContribAuthor ">Andrea  Angeli</span>, <span class="hlFld-ContribAuthor ">Francesca  D'Alba</span>, <span class="hlFld-ContribAuthor ">Agostino  Bruno</span>, <span class="hlFld-ContribAuthor ">Marco  Pieroni</span>, <span class="hlFld-ContribAuthor ">Daniela  Vullo</span>, <span class="hlFld-ContribAuthor ">Viviana  De Luca</span>, <span class="hlFld-ContribAuthor ">Clemente  Capasso</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Gabriele  Costantino</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (17)
                                     , 1904-1914. <a href="https://doi.org/10.1002/cmdc.201600180" title="DOI URL">https://doi.org/10.1002/cmdc.201600180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600180%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDiscovery%252Bof%252BNew%252BPotential%252BAnti-Infective%252BCompounds%252BBased%252Bon%252BCarbonic%252BAnhydrase%252BInhibitors%252Bby%252BRational%252BTarget-Focused%252BRepurposing%252BApproaches%26aulast%3DAnnunziato%26aufirst%3DGiannamaria%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D17%26spage%3D1904%26epage%3D1914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi Sing  Gee</span>, <span class="hlFld-ContribAuthor ">Neils J. M.  Goertz</span>, <span class="hlFld-ContribAuthor ">Michael G.  Gardiner</span>, <span class="hlFld-ContribAuthor ">Christopher J. T.  Hyland</span>. </span><span class="cited-content_cbyCitation_article-title">Oxidative ring-opening of ferrocenylcyclopropylamines to N-ferrocenylmethyl β-hydroxyamides. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (8)
                                     , 2498-2503. <a href="https://doi.org/10.1039/C5OB02577J" title="DOI URL">https://doi.org/10.1039/C5OB02577J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB02577J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB02577J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DOxidative%252Bring-opening%252Bof%252Bferrocenylcyclopropylamines%252Bto%252BN-ferrocenylmethyl%252B%2525CE%2525B2-hydroxyamides%26aulast%3DGee%26aufirst%3DYi%2BSing%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D8%26spage%3D2498%26epage%3D2503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianjun  Cheng</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>. </span><span class="cited-content_cbyCitation_article-title">We Need 2C but Not 2B: Developing Serotonin 2C (5-HT
              2C
              ) Receptor Agonists for the Treatment of CNS Disorders. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2015,</strong> <em>10 </em>
                                    (12)
                                     , 1963-1967. <a href="https://doi.org/10.1002/cmdc.201500437" title="DOI URL">https://doi.org/10.1002/cmdc.201500437</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500437%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DWe%252BNeed%252B2C%252Bbut%252BNot%252B2B%25253A%252BDeveloping%252BSerotonin%252B2C%252B%2525285-HT%252B2C%252B%252529%252BReceptor%252BAgonists%252Bfor%252Bthe%252BTreatment%252Bof%252BCNS%252BDisorders%26aulast%3DCheng%26aufirst%3DJianjun%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D12%26spage%3D1963%26epage%3D1967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shingo  Ishikawa</span>, <span class="hlFld-ContribAuthor ">Reuben  Hudson</span>, <span class="hlFld-ContribAuthor ">Mitra  Masnadi</span>, <span class="hlFld-ContribAuthor ">Mary  Bateman</span>, <span class="hlFld-ContribAuthor ">Annie  Castonguay</span>, <span class="hlFld-ContribAuthor ">Nadi  Braidy</span>, <span class="hlFld-ContribAuthor ">Audrey  Moores</span>, <span class="hlFld-ContribAuthor ">Chao-Jun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclopropanation of diazoesters with styrene derivatives catalyzed by magnetically recoverable copper-plated iron nanoparticles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (46)
                                     , 8952-8958. <a href="https://doi.org/10.1016/j.tet.2014.09.011" title="DOI URL">https://doi.org/10.1016/j.tet.2014.09.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.09.011%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DCyclopropanation%252Bof%252Bdiazoesters%252Bwith%252Bstyrene%252Bderivatives%252Bcatalyzed%252Bby%252Bmagnetically%252Brecoverable%252Bcopper-plated%252Biron%252Bnanoparticles%26aulast%3DIshikawa%26aufirst%3DShingo%26date%3D2014%26volume%3D70%26issue%3D46%26spage%3D8952%26epage%3D8958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shingo  Ishikawa</span>, <span class="hlFld-ContribAuthor ">Reuben  Hudson</span>, <span class="hlFld-ContribAuthor ">Mitra  Masnadi</span>, <span class="hlFld-ContribAuthor ">Mary  Bateman</span>, <span class="hlFld-ContribAuthor ">Annie  Castonguay</span>, <span class="hlFld-ContribAuthor ">Nadi  Braidy</span>, <span class="hlFld-ContribAuthor ">Audrey  Moores</span>, <span class="hlFld-ContribAuthor ">Chao-Jun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclopropanation of diazoesters with styrene derivatives catalyzed by magnetically recoverable copper-plated iron nanoparticles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (36)
                                     , 6162-6168. <a href="https://doi.org/10.1016/j.tet.2014.03.090" title="DOI URL">https://doi.org/10.1016/j.tet.2014.03.090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.03.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.03.090%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DCyclopropanation%252Bof%252Bdiazoesters%252Bwith%252Bstyrene%252Bderivatives%252Bcatalyzed%252Bby%252Bmagnetically%252Brecoverable%252Bcopper-plated%252Biron%252Bnanoparticles%26aulast%3DIshikawa%26aufirst%3DShingo%26date%3D2014%26volume%3D70%26issue%3D36%26spage%3D6162%26epage%3D6168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Basavaraj M  Budanur</span>, <span class="hlFld-ContribAuthor ">Faiz Ahmed  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Superoxide chemistry revisited: synthesis of tetrachloro-substituted methylenenortricyclenes. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>10 </em>, 2531-2538. <a href="https://doi.org/10.3762/bjoc.10.264" title="DOI URL">https://doi.org/10.3762/bjoc.10.264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.10.264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.10.264%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSuperoxide%252Bchemistry%252Brevisited%25253A%252Bsynthesis%252Bof%252Btetrachloro-substituted%252Bmethylenenortricyclenes%26aulast%3DBudanur%26aufirst%3DBasavaraj%2BM%26date%3D2014%26date%3D2014%26volume%3D10%26spage%3D2531%26epage%3D2538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammed Naseer Ahmed  Khan</span>, <span class="hlFld-ContribAuthor ">Takayoshi  Suzuki</span>, <span class="hlFld-ContribAuthor ">Naoki  Miyata</span>. </span><span class="cited-content_cbyCitation_article-title">An Overview of Phenylcyclopropylamine Derivatives: Biochemical and Biological Significance and Recent Developments. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2013,</strong> <em>33 </em>
                                    (4)
                                     , 873-910. <a href="https://doi.org/10.1002/med.21269" title="DOI URL">https://doi.org/10.1002/med.21269</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21269%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DAn%252BOverview%252Bof%252BPhenylcyclopropylamine%252BDerivatives%25253A%252BBiochemical%252Band%252BBiological%252BSignificance%252Band%252BRecent%252BDevelopments%26aulast%3DKhan%26aufirst%3DMohammed%2BNaseer%2BAhmed%26date%3D2013%26date%3D2012%26volume%3D33%26issue%3D4%26spage%3D873%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathryn M.  Chepiga</span>, <span class="hlFld-ContribAuthor ">Changming  Qin</span>, <span class="hlFld-ContribAuthor ">Joshua S.  Alford</span>, <span class="hlFld-ContribAuthor ">Spandan  Chennamadhavuni</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Gregg</span>, <span class="hlFld-ContribAuthor ">Jeremy P.  Olson</span>, <span class="hlFld-ContribAuthor ">Huw M.L.  Davies</span>. </span><span class="cited-content_cbyCitation_article-title">Guide to enantioselective dirhodium(II)-catalyzed cyclopropanation with aryldiazoacetates. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2013,</strong> <em>69 </em>
                                    (27-28)
                                     , 5765-5771. <a href="https://doi.org/10.1016/j.tet.2013.04.075" title="DOI URL">https://doi.org/10.1016/j.tet.2013.04.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.04.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.04.075%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DGuide%252Bto%252Benantioselective%252Bdirhodium%252528II%252529-catalyzed%252Bcyclopropanation%252Bwith%252Baryldiazoacetates%26aulast%3DChepiga%26aufirst%3DKathryn%2BM.%26date%3D2013%26volume%3D69%26issue%3D27-28%26spage%3D5765%26epage%3D5771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abhisek  Banerjee</span>, <span class="hlFld-ContribAuthor ">Pravin S.  Yadav</span>, <span class="hlFld-ContribAuthor ">Malini  Bajpai</span>, <span class="hlFld-ContribAuthor ">Ramachandra Rao  Sangana</span>, <span class="hlFld-ContribAuthor ">Srinivas  Gullapalli</span>, <span class="hlFld-ContribAuthor ">Girish S.  Gudi</span>, <span class="hlFld-ContribAuthor ">Laxmikant A.  Gharat</span>. </span><span class="cited-content_cbyCitation_article-title">Isothiazole and isoxazole fused pyrimidones as PDE7 inhibitors: SAR and pharmacokinetic evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (9)
                                     , 3223-3228. <a href="https://doi.org/10.1016/j.bmcl.2012.03.025" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.03.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.03.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIsothiazole%252Band%252Bisoxazole%252Bfused%252Bpyrimidones%252Bas%252BPDE7%252Binhibitors%25253A%252BSAR%252Band%252Bpharmacokinetic%252Bevaluation%26aulast%3DBanerjee%26aufirst%3DAbhisek%26date%3D2012%26volume%3D22%26issue%3D9%26spage%3D3223%26epage%3D3228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niall G.  McCreanor</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Cook</span>. </span><span class="cited-content_cbyCitation_article-title">4-Fluorostyrene. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,<a href="https://doi.org/10.1002/047084289X.rn01450" title="DOI URL">https://doi.org/10.1002/047084289X.rn01450</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/047084289X.rn01450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F047084289X.rn01450%26sid%3Dliteratum%253Aachs%26atitle%3D4-Fluorostyrene%26aulast%3DMcCreanor%26aufirst%3DNiall%2BG.%26date%3D2012%26date%3D2012%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DEncyclopedia%252Bof%252BReagents%252Bfor%252BOrganic%252BSynthesis%26date%3D2001%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark G.  McLaughlin</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Cook</span>. </span><span class="cited-content_cbyCitation_article-title">4-Trifluoromethylstyrene. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,<a href="https://doi.org/10.1002/047084289X.rn01451" title="DOI URL">https://doi.org/10.1002/047084289X.rn01451</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/047084289X.rn01451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F047084289X.rn01451%26sid%3Dliteratum%253Aachs%26atitle%3D4-Trifluoromethylstyrene%26aulast%3DMcLaughlin%26aufirst%3DMark%2BG.%26date%3D2012%26date%3D2012%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DEncyclopedia%252Bof%252BReagents%252Bfor%252BOrganic%252BSynthesis%26date%3D2001%26date%3D2001%26volume%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>. </span><span class="cited-content_cbyCitation_article-title">Irving Page Lecture: 5-HT2A serotonin receptor biology: Interacting proteins, kinases and paradoxical regulation. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2011,</strong> <em>61 </em>
                                    (3)
                                     , 348-354. <a href="https://doi.org/10.1016/j.neuropharm.2011.01.012" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2011.01.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2011.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2011.01.012%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DIrving%252BPage%252BLecture%25253A%252B5-HT2A%252Bserotonin%252Breceptor%252Bbiology%25253A%252BInteracting%252Bproteins%25252C%252Bkinases%252Band%252Bparadoxical%252Bregulation%26aulast%3DRoth%26aufirst%3DBryan%2BL.%26date%3D2011%26volume%3D61%26issue%3D3%26spage%3D348%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark D.  Andrews</span>, <span class="hlFld-ContribAuthor ">Paul V.  Fish</span>, <span class="hlFld-ContribAuthor ">Julian  Blagg</span>, <span class="hlFld-ContribAuthor ">Tiffini K.  Brabham</span>, <span class="hlFld-ContribAuthor ">Paul E.  Brennan</span>, <span class="hlFld-ContribAuthor ">Alison  Bridgeland</span>, <span class="hlFld-ContribAuthor ">Alan D.  Brown</span>, <span class="hlFld-ContribAuthor ">Peter J.  Bungay</span>, <span class="hlFld-ContribAuthor ">Kelly M.  Conlon</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Edmunds</span>, <span class="hlFld-ContribAuthor ">Kerry  af Forselles</span>, <span class="hlFld-ContribAuthor ">Colleen P.  Gibbons</span>, <span class="hlFld-ContribAuthor ">Martin P.  Green</span>, <span class="hlFld-ContribAuthor ">Giles  Hanton</span>, <span class="hlFld-ContribAuthor ">Mark  Holbrook</span>, <span class="hlFld-ContribAuthor ">Alan S.  Jessiman</span>, <span class="hlFld-ContribAuthor ">Karin  McIntosh</span>, <span class="hlFld-ContribAuthor ">Gordon  McMurray</span>, <span class="hlFld-ContribAuthor ">Carly L.  Nichols</span>, <span class="hlFld-ContribAuthor ">James A.  Root</span>, <span class="hlFld-ContribAuthor ">R. Ian  Storer</span>, <span class="hlFld-ContribAuthor ">Michael R.  Sutton</span>, <span class="hlFld-ContribAuthor ">Robin V.  Ward</span>, <span class="hlFld-ContribAuthor ">Dominique  Westbrook</span>, <span class="hlFld-ContribAuthor ">Gavin A.  Whitlock</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (9)
                                     , 2715-2720. <a href="https://doi.org/10.1016/j.bmcl.2010.11.120" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.11.120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.11.120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.11.120%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPyrimido%25255B4%25252C5-d%25255Dazepines%252Bas%252Bpotent%252Band%252Bselective%252B5-HT2C%252Breceptor%252Bagonists%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252BPF-3246799%252Bas%252Ba%252Btreatment%252Bfor%252Burinary%252Bincontinence%26aulast%3DAndrews%26aufirst%3DMark%2BD.%26date%3D2011%26volume%3D21%26issue%3D9%26spage%3D2715%26epage%3D2720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keith J  Miller</span>, <span class="hlFld-ContribAuthor ">Dean A  Wacker</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and development of 5-HT
              2C
              receptor agonists for obesity: is there light at the end of the tunnel?. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2010,</strong> <em>2 </em>
                                    (12)
                                     , 1761-1775. <a href="https://doi.org/10.4155/fmc.10.261" title="DOI URL">https://doi.org/10.4155/fmc.10.261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.10.261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.10.261%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bdevelopment%252Bof%252B5-HT%252B2C%252Breceptor%252Bagonists%252Bfor%252Bobesity%25253A%252Bis%252Bthere%252Blight%252Bat%252Bthe%252Bend%252Bof%252Bthe%252Btunnel%25253F%26aulast%3DMiller%26aufirst%3DKeith%2BJ%26date%3D2010%26volume%3D2%26issue%3D12%26spage%3D1761%26epage%3D1775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junwon  Lee</span>, <span class="hlFld-ContribAuthor ">Myung Eun  Jung</span>, <span class="hlFld-ContribAuthor ">Jinhwa  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">5-HT2C receptor modulators: a patent survey. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2010,</strong> <em>20 </em>
                                    (11)
                                     , 1429-1455. <a href="https://doi.org/10.1517/13543776.2010.518956" title="DOI URL">https://doi.org/10.1517/13543776.2010.518956</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2010.518956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2010.518956%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3D5-HT2C%252Breceptor%252Bmodulators%25253A%252Ba%252Bpatent%252Bsurvey%26aulast%3DLee%26aufirst%3DJunwon%26date%3D2010%26date%3D2010%26volume%3D20%26issue%3D11%26spage%3D1429%26epage%3D1455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>, <span class="hlFld-ContribAuthor ">Sung Jin  Cho</span>, <span class="hlFld-ContribAuthor ">Niels H.  Jensen</span>, <span class="hlFld-ContribAuthor ">John A.  Allen</span>, <span class="hlFld-ContribAuthor ">Andreas M.  Svennebring</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>. </span><span class="cited-content_cbyCitation_article-title">HTS and Rational Drug Design to Generate a Class of 5-HT2C-Selective Ligands for Possible Use in Schizophrenia.. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2010,</strong> <em>5 </em>
                                    (8)
                                     , 1221-1225. <a href="https://doi.org/10.1002/cmdc.201000186" title="DOI URL">https://doi.org/10.1002/cmdc.201000186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201000186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201000186%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DHTS%252Band%252BRational%252BDrug%252BDesign%252Bto%252BGenerate%252Ba%252BClass%252Bof%252B5-HT2C-Selective%252BLigands%252Bfor%252BPossible%252BUse%252Bin%252BSchizophrenia.%26aulast%3DKozikowski%26aufirst%3DAlan%25E2%2580%2585P.%26date%3D2010%26date%3D2010%26volume%3D5%26issue%3D8%26spage%3D1221%26epage%3D1225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. The classical 5-HT<sub>2C</sub> receptor agonist <i>m</i>-CPP and several more recently developed 5-HT<sub>2C</sub> ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of <b>9</b> and its analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0004.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) N<sub>2</sub>CHCO<sub>2</sub>Et, Cu(acac)<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, reflux, 5 h. (b) 2 N KOH, MeOH. (c) (i) SOCl<sub>2</sub>, toluene, 80 °C, 3 h; (ii) NH<sub>3</sub> (liquid), toluene/CH<sub>2</sub>Cl<sub>2</sub>. (d) (i) BH<sub>3</sub>/THF, reflux, 20 h; (ii) 1 M HCl, 0 °C.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0005.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) acetic formic anhydride, BH<sub>3</sub>·SMe<sub>2</sub>/THF. (b) HCHO (excess), NaBH<sub>3</sub>CN, acetonitrile/H<sub>2</sub>O. (c) acetone or benzaldehyde, NaBH<sub>3</sub>CN, MeOH.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Aromatic substitution screening of <i>trans</i>-(2-phenylcyclopropyl)methylamine hydrochloride analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0007.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyltriphenylphosphonium bromide, NaH, THF, 20 h. (b) N<sub>2</sub>CHCO<sub>2</sub>Et, Cu(acac)<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, reflux, 5 h. (c) 2 N KOH, MeOH. (d) (i) SOCl<sub>2</sub>, toluene, 80 °C, 3 h; (ii) NH<sub>3</sub> (liquid), toluene/CH<sub>2</sub>Cl<sub>2</sub>. (e) (i) BH<sub>3</sub>/THF, reflux, 20 h; (ii) 1 M HCl, 0 °C; (f) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0008.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Boc<sub>2</sub>O, triethylamine, CH<sub>2</sub>Cl<sub>2</sub>. (b) Ar−B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dimethoxyethane, 80 °C, 20 h. (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt. (d) (i) benzophenone imine, Pd(OAc)<sub>2</sub>, BINAP, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 80 °C; (ii) NaOAc, NH<sub>2</sub>OH·HCl, MeOH, rt, 2 h. (e) RCHO, NaBH<sub>3</sub>CN, MeOH. (f) various anhydrides, DMAP, CH<sub>2</sub>Cl<sub>2</sub>. (g) R′C≡CH, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, PPh<sub>3</sub>, CuI, triethylamine, reflux. (h) 2 M HCl, rt.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0009.jpeg" id="rightTab-gs5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (<i>R</i>)-phenylglycinol, EDCI, HOBT, CH<sub>2</sub>Cl<sub>2</sub>. (b) H<sub>2</sub>SO<sub>4</sub>, 100 °C.</p></p></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Overlay of the 3-methyl bearing analogue <b>37</b> (orange) with <b>7</b> (purple) and the BMS pyrazinoisoindoline (<b>8</b>)<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (light blue) shows the expected similarities in structure. See Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> for structures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/medium/jm-2008-01354e_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. The effect of compounds <b>37</b> and <b>92</b> in the mouse forced swim test. Compound <b>37</b> (10−60 mg/kg, ip) or the reference compound <b>92</b> (10 mg/kg, ip) was administered 30 min prior to testing. Both compounds <b>92</b> and <b>37</b> produced a significant decrease in immobility, which reached significance at all doses tested. These data are indicative of an antidepressant-like effect and in vivo drug-like central activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-7/jm801354e/production/images/large/jm-2008-01354e_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801354e&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i116">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18607" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18607" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 55 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hoyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, G.</span><span> </span><span class="NLM_article-title">5-HT receptor classification and nomenclature: towards a harmonization with the human genome</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=419-428&author=D.+Hoyerauthor=G.+Martin&title=5-HT+receptor+classification+and+nomenclature%3A+towards+a+harmonization+with+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DG.%26atitle%3D5-HT%2520receptor%2520classification%2520and%2520nomenclature%253A%2520towards%2520a%2520harmonization%2520with%2520the%2520human%2520genome%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D419%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Multiple serotonin receptors: clinical and experimental aspects</span> <span class="citation_source-journal">Ann. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.3109%2F10401239409148985" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=7804391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A280%3ADyaK2M7gt1Orsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1994&pages=67-78&author=B.+L.+Roth&title=Multiple+serotonin+receptors%3A+clinical+and+experimental+aspects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple serotonin receptors: clinical and experimental aspects</span></div><div class="casAuthors">Roth B L</div><div class="citationInfo"><span class="NLM_cas:title">Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-78</span>
        ISSN:<span class="NLM_cas:issn">1040-1237</span>.
    </div><div class="casAbstract">Serotonin (5-hydroxytryptamine; 5-HT) has been implicated in a large number of psychophysiologic processes including the regulation of sleep, appetite, mood, aggression, perception, memory, and anxiety.  To mediate this large array of physiologic processes, at least 14 separate 5-HT receptors have evolved, which are divided into seven main families.  Not surprisingly, alterations of 5-HT receptor activity have been shown to occur in many psychiatric diseases including anxiety, depression, eating disorders, schizophrenia, personality disorders, and many drug-induced psychotic states.  Additionally, a number of effective psychopharmacologic agents for diseases as diverse as schizophrenia and anxiety have been developed which either specifically alter brain levels of serotonin or bind to 5-HT receptor subtypes.  This review article summarizes recent advances in the burgeoning field of serotonin receptor pharmacology and integrates this information into a coherent perspective on the importance of serotonergic agents for clinical psychiatry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6F454_VHydK91pGlMMoT5fW6udTcc2ebP8TQv31mqQbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M7gt1Orsw%253D%253D&md5=163a37829cc21c21c5a81e6c256cbc35</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3109%2F10401239409148985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10401239409148985%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DMultiple%2520serotonin%2520receptors%253A%2520clinical%2520and%2520experimental%2520aspects%26jtitle%3DAnn.%2520Clin.%2520Psychiatry%26date%3D1994%26volume%3D6%26spage%3D67%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Kroeze, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1128</span><span class="NLM_x">–</span> <span class="NLM_lpage">1142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1016%2FS0006-3223%2898%2900132-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=9836016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADyaK1cXnvFKqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1998&pages=1128-1142&author=W.+K.+Kroezeauthor=B.+L.+Roth&title=The+molecular+biology+of+serotonin+receptors%3A+therapeutic+implications+for+the+interface+of+mood+and+psychosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis</span></div><div class="casAuthors">Kroeze, Wesley K.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1128-1142</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with 152 refs., which summarizes the mol. biol. of serotonin (5-HT; 5-hydroxytryptamine) receptors and indicates the potential relevance of this information for the treatment of mood and psychotic disorders.  At least 15 sep. subtypes of 5-HT receptors have been identified by mol. cloning techniques to be distinct genetic entities.  Subtle differences in the primary amino acid sequences of these receptors can yield large differences in ligand selectivity.  Addnl., it has recently been discovered that drugs such as atypical antipsychotic drugs and serotonin-selective reuptake inhibitors may interact with a large no. of heretofore unknown 5-HT receptors.  Thus clozapine, for instance, has high affinity for at least four sep. 5-HT receptors, and it is unknown which of these receptors is essential for its unique therapeutic efficacy.  One way to approach these questions is to test subtype-selective agents, although there are few of these currently available.  Approaches to the design of subtype-selective ligands are described, including structure-based drug design and combinatorial approaches.  Modes of regulation of 5-HT receptors are also summarized, and it is emphasized that antipsychotic drugs and antidepressants likely exert their effects via nontranscriptional and posttranslational means.  Understanding the cellular mechanisms by which 5-HT receptors are regulated by psychopharmacol. agents is likely to yield novel insights into drug action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBEIwmClT3vbVg90H21EOLACvtfcHk0ljl2OervyO5Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnvFKqurc%253D&md5=daae7df1a87e737a3cd49d844135a687</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2898%2900132-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252898%252900132-2%26sid%3Dliteratum%253Aachs%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DThe%2520molecular%2520biology%2520of%2520serotonin%2520receptors%253A%2520therapeutic%2520implications%2520for%2520the%2520interface%2520of%2520mood%2520and%2520psychosis%26jtitle%3DBiol.%2520Psychiatry%26date%3D1998%26volume%3D44%26spage%3D1128%26epage%3D1142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kroeze, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">G-protein-coupled receptors at a glance</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">4867</span><span class="NLM_x">–</span> <span class="NLM_lpage">4869</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1242%2Fjcs.00902" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=14625380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFOntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2003&pages=4867-4869&author=W.+K.+Kroezeauthor=D.+J.+Shefflerauthor=B.+L.+Roth&title=G-protein-coupled+receptors+at+a+glance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">G-protein-coupled receptors at a glance</span></div><div class="casAuthors">Kroeze, Wesley K.; Sheffler, Douglas J.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4867-4869</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review discusses how G-protein-coupled receptors (GPCRs) work, the different types of GPCR, and the importance of these receptors as drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoICG4Zs6PITbVg90H21EOLACvtfcHk0ljl2OervyO5Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFOntQ%253D%253D&md5=c32c6d5103b50e89182a7ea9ee5a2c78</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1242%2Fjcs.00902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.00902%26sid%3Dliteratum%253Aachs%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DG-protein-coupled%2520receptors%2520at%2520a%2520glance%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2003%26volume%3D116%26spage%3D4867%26epage%3D4869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Kroeze, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristiansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Molecular biology of serotonin receptors structure and function at the molecular level</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.2174%2F1568026023393796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=12052191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD38Xksl2jt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=507-528&author=W.+K.+Kroezeauthor=K.+Kristiansenauthor=B.+L.+Roth&title=Molecular+biology+of+serotonin+receptors+structure+and+function+at+the+molecular+level"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular biology of serotonin receptors - structure and function at the molecular level</span></div><div class="casAuthors">Kroeze, Wesley K.; Kristiansen, Kurt; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">507-528</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review summarizing current understanding of the structure and function of the G-protein coupled 5-HT receptors.  The following topics were discussed: overall structure of the G-protein-coupled 5-HT receptors; cloning of 5-HT receptors; sequence conservation of 5-HT receptors; mutagenesis of 5-HT receptors; alternative splicing of 5-HT receptors; mRNA editing of 5-HT receptors; oligomerization; and targeting and trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE_gk0dnNzOrVg90H21EOLACvtfcHk0ljl2OervyO5Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xksl2jt70%253D&md5=5453cbcd55b910d6eaa714830157b0fd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F1568026023393796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026023393796%26sid%3Dliteratum%253Aachs%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26aulast%3DKristiansen%26aufirst%3DK.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DMolecular%2520biology%2520of%2520serotonin%2520receptors%2520structure%2520and%2520function%2520at%2520the%2520molecular%2520level%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2002%26volume%3D2%26spage%3D507%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Nichols, D. E.</span><span> </span><span class="NLM_article-title">Hallucinogens</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1016%2Fj.pharmthera.2003.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=14761703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFCmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=131-181&author=D.+E.+Nichols&title=Hallucinogens"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Hallucinogens</span></div><div class="casAuthors">Nichols, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-181</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Hallucinogens (psychedelics) are psychoactive substances that powerfully alter perception, mood, and a host of cognitive processes.  They are considered physiol. safe and do not produce dependence or addiction.  Their origin predates written history, and they were employed by early cultures in a variety of sociocultural and ritual contexts.  In the 1950s, after the virtually contemporaneous discovery of both serotonin (5-HT) and lysergic acid diethylamide (LSD-25), early brain research focused intensely on the possibility that LSD or other hallucinogens had a serotonergic basis of action and reinforced the idea that 5-HT was an important neurotransmitter in brain.  These ideas were eventually proven, and today it is believed that hallucinogens stimulate 5-HT2A receptors, esp. those expressed on neocortical pyramidal cells.  Activation of 5-HT2A receptors also leads to increased cortical glutamate levels presumably by a presynaptic receptor-mediated release from thalamic afferents.  These findings have led to comparisons of the effects of classical hallucinogens with certain aspects of acute psychosis and to a focus on thalamocortical interactions as key to understanding both the action of these substances and the neuroanatomical sites involved in altered states of consciousness (ASC).  In vivo brain imaging in humans using [18F]fluorodeoxyglucose has shown that hallucinogens increase prefrontal cortical metab., and correlations have been developed between activity in specific brain areas and psychol. elements of the ASC produced by hallucinogens.  The 5-HT2A receptor clearly plays an essential role in cognitive processing, including working memory, and ligands for this receptor may be extremely useful tools for future cognitive neuroscience research.  In addn., it appears entirely possible that utility may still emerge for the use of hallucinogens in treating alcoholism, substance abuse, and certain psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRl6lKmZ_4Y7Vg90H21EOLACvtfcHk0ljl2OervyO5Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFCmsg%253D%253D&md5=7b5246f6479d76736c5a7223c60a9e99</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2003.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2003.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DD.%2BE.%26atitle%3DHallucinogens%26jtitle%3DPharmacol.%2520Ther.%26date%3D2004%26volume%3D101%26spage%3D131%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauser, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hufeisen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Evidence for possible involvement of 5-HT<sub>2B</sub> receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">2836</span><span class="NLM_x">–</span> <span class="NLM_lpage">2841</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1161%2F01.CIR.102.23.2836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=11104741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptVSjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=2836-2841&author=R.+B.+Rothmanauthor=M.+H.+Baumannauthor=J.+E.+Savageauthor=L.+Rauserauthor=A.+McBrideauthor=S.+J.+Hufeisenauthor=B.+L.+Roth&title=Evidence+for+possible+involvement+of+5-HT2B+receptors+in+the+cardiac+valvulopathy+associated+with+fenfluramine+and+other+serotonergic+medications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications</span></div><div class="casAuthors">Rothman, Richard B.; Baumann, Michael H.; Savage, Jason E.; Rauser, Laura; McBride, Ace; Hufeisen, Sandra J.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2836-2841</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Serotonergic medications with various mechanisms of action are used to treat psychiatric disorders and are being investigated as treatments for drug dependence.  The occurrence of fenfluramine-assocd. valvular heart disease (VHD) has raised concerns that other serotonergic medications might also increase the risk of developing VHD.  We hypothesized that fenfluramine or its metabolite norfenfluramine and other medications known to produce VHD have preferentially high affinities for a particular serotonin receptor subtype capable of stimulating mitogenesis.  Medications known or suspected to cause VHD (pos. controls) and medications not assocd. with VHD (neg. controls) were screened for activity at 11 cloned serotonin receptor subtypes by use of ligand-binding methods and functional assays.  The pos. control drugs were (±)-fenfluramine; (+)-fenfluramine; (-)-fenfluramine; its metabolites (±)-norfenfluramine, (+)-norfenfluramine, and (-)-norfenfluramine; ergotamine; and methysergide and its metabolite methylergonovine.  The neg. control drugs were phentermine, fluoxetine, its metabolite norfluoxetine, and trazodone and its active metabolite m-chlorophenylpiperazine.  (±)-, (+)-, And (-)-Norfenfluramine, ergotamine, and methylergonovine all had preferentially high affinities for the cloned human serotonin 5-HT2B receptor and were partial to full agonists at the 5-HT2B receptor.  Our data imply that activation of 5-HT2B receptors is necessary to produce VHD and that serotonergic medications that do not activate 5-HT2B receptors are unlikely to produce VHD.  We suggest that all clin. available medications with serotonergic activity and their active metabolites be screened for agonist activity at 5-HT2B receptors and that clinicians should consider suspending their use of medications with significant activity at 5-HT2B receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6spUXOCLtLrVg90H21EOLACvtfcHk0lgRN8U91F4TkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptVSjtrs%253D&md5=6b8c6059885dd9b058859089914c61b3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.102.23.2836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.102.23.2836%26sid%3Dliteratum%253Aachs%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DSavage%26aufirst%3DJ.%2BE.%26aulast%3DRauser%26aufirst%3DL.%26aulast%3DMcBride%26aufirst%3DA.%26aulast%3DHufeisen%26aufirst%3DS.%2BJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DEvidence%2520for%2520possible%2520involvement%2520of%25205-HT2B%2520receptors%2520in%2520the%2520cardiac%2520valvulopathy%2520associated%2520with%2520fenfluramine%2520and%2520other%2520serotonergic%2520medications%26jtitle%3DCirculation%26date%3D2000%26volume%3D102%26spage%3D2836%26epage%3D2841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Drugs and valvular heart disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1056%2FNEJMp068265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=17202450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitlCitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2007&pages=6-9&author=B.+L.+Roth&title=Drugs+and+valvular+heart+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs and valvular heart disease</span></div><div class="casAuthors">Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">6-9</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOaFEwabTP8rVg90H21EOLACvtfcHk0lgRN8U91F4TkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitlCitQ%253D%253D&md5=e5161a25f1a2596cef68030f0f8a7b61</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1056%2FNEJMp068265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMp068265%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DDrugs%2520and%2520valvular%2520heart%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2007%26volume%3D356%26spage%3D6%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Loke, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard-Copley, A.</span><span> </span><span class="NLM_article-title">Appetite suppressants and valvular heart disease—a systematic review</span> <span class="citation_source-journal">BMC Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1186%2F1472-6904-2-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=12194699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A280%3ADC%252BD2czlt1yisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=6&author=Y.+K.+Lokeauthor=S.+Derryauthor=A.+Pritchard-Copley&title=Appetite+suppressants+and+valvular+heart+disease%E2%80%94a+systematic+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Appetite suppressants and valvular heart disease - a systematic review</span></div><div class="casAuthors">Loke Yoon K; Derry Sheena; Pritchard-Copley Angharad</div><div class="citationInfo"><span class="NLM_cas:title">BMC clinical pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Although appetite suppressants have been implicated in the development of valvular heart disease, the exact level of risk is still uncertain.  Initial studies suggested that as many as 1 in 3 exposed patients were affected, but subsequent research has yielded substantially different figures.  Our objective was to systematically assess the risk of valvular heart disease with appetite suppressants.  METHODS:  We accepted studies involving obese patients treated with any of the following appetite suppressants: fenfluramine, dexfenfluramine, and phentermine.  Three types of studies were reviewed: controlled and uncontrolled observational studies, and randomized controlled trials.  Outcomes of interest were echocardiographically detectable aortic regurgitation of mild or greater severity, or mitral regurgitation of moderate or greater severity.  RESULTS:  Of the 1279 patients evaluated in seven uncontrolled cohort studies, 236 (18%) and 60 (5%) were found to have aortic and mitral regurgitation, respectively.  Pooled data from six controlled cohort studies yielded, for aortic regurgitation, a relative risk ratio of 2.32 (95% confidence intervals 1.79 to 3.01, p < 0.00001) and an attributable rate of 4.9%, and for mitral regurgitation, a relative risk ratio of 1.55 (95% confidence intervals 1.06 to 2.25, p = 0.02) with an attributable rate of 1.0%.  Only one case of valvular heart disease was detected in 57 randomized controlled trials, but this was judged unrelated to drug therapy.  CONCLUSIONS:  The risk of valvular heart disease is significantly increased by the appetite suppressants reviewed here.  Nevertheless, when considering all the evidence, valvulopathy is much less common than suggested by the initial, less methodologically rigorous studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnTGf8uIGluvxQvRxYU81tfW6udTcc2ebzOquilDLecLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czlt1yisQ%253D%253D&md5=87f6f43f022174efacf782e8552b1aa4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1186%2F1472-6904-2-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1472-6904-2-6%26sid%3Dliteratum%253Aachs%26aulast%3DLoke%26aufirst%3DY.%2BK.%26aulast%3DDerry%26aufirst%3DS.%26aulast%3DPritchard-Copley%26aufirst%3DA.%26atitle%3DAppetite%2520suppressants%2520and%2520valvular%2520heart%2520disease%25E2%2580%2594a%2520systematic%2520review%26jtitle%3DBMC%2520Clin.%2520Pharmacol.%26date%3D2002%26volume%3D2%26spage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Rocha, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulding, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Dell, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mead, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coufal, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tecott, L. H.</span><span> </span><span class="NLM_article-title">Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">10039</span><span class="NLM_x">–</span> <span class="NLM_lpage">10045</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=12427861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD38XovF2ktrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=10039-10045&author=B.+A.+Rochaauthor=E.+H.+Gouldingauthor=L.+E.+O%E2%80%99Dellauthor=A.+N.+Meadauthor=N.+G.+Coufalauthor=L.+H.+Parsonsauthor=L.+H.+Tecott&title=Enhanced+locomotor%2C+reinforcing%2C+and+neurochemical+effects+of+cocaine+in+serotonin+5-hydroxytryptamine+2C+receptor+mutant+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice</span></div><div class="casAuthors">Rocha, Beatriz A.; Goulding, Evan H.; O'Dell, Laura E.; Mead, Andy N.; Coufal, Nicole G.; Parsons, Loren H.; Tecott, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10039-10045</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Brain serotonin [5-hydroxytryptamine (5-HT)] systems substantially influence the effects of cocaine; however, the contributions of individual 5-HT receptor subtypes to the regulation of cocaine responses are unclear.  A line of mutant mice devoid of 5-HT2C receptors was used to examine the contribution of this receptor subtype to the serotonergic modulation of cocaine responses.  Mutants display enhanced exploration of a novel environment and increased sensitivity to the locomotor stimulant effects of cocaine.  In an operant i.v. self-administration model under a progressive ratio schedule of reinforcement, mutants display elevated levels of lever pressing for cocaine injections, indicating that the drug is more reinforcing in these mice.  Moreover, mutants exhibit enhanced cocaine-induced elevations of dopamine (DA) levels in the nucleus accumbens, a brain region implicated in the stimulant and rewarding properties of cocaine.  In contrast, phenotypic differences in dorsal striatal DA levels were not produced by cocaine treatment.  These findings strongly implicate 5-HT2C receptors in the serotonergic suppression of DA-mediated behavioral responses to cocaine and as a potential therapeutic target for cocaine abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqap24jrSmDe7Vg90H21EOLACvtfcHk0lgRN8U91F4TkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovF2ktrw%253D&md5=d834faafa5977fc6914c732af667c849</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRocha%26aufirst%3DB.%2BA.%26aulast%3DGoulding%26aufirst%3DE.%2BH.%26aulast%3DO%25E2%2580%2599Dell%26aufirst%3DL.%2BE.%26aulast%3DMead%26aufirst%3DA.%2BN.%26aulast%3DCoufal%26aufirst%3DN.%2BG.%26aulast%3DParsons%26aufirst%3DL.%2BH.%26aulast%3DTecott%26aufirst%3DL.%2BH.%26atitle%3DEnhanced%2520locomotor%252C%2520reinforcing%252C%2520and%2520neurochemical%2520effects%2520of%2520cocaine%2520in%2520serotonin%25205-hydroxytryptamine%25202C%2520receptor%2520mutant%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3D10039%26epage%3D10045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Tecott, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akana, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strack, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowenstein, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallman, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julius, D.</span><span> </span><span class="NLM_article-title">Eating disorder and epilepsy in mice lacking 5-HT<sub>2C</sub> serotonin receptors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1038%2F374542a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=7700379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADyaK2MXkvVKqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=1995&pages=542-546&author=L.+H.+Tecottauthor=L.+M.+Sunauthor=S.+F.+Akanaauthor=A.+M.+Strackauthor=D.+H.+Lowensteinauthor=M.+F.+Dallmanauthor=D.+Julius&title=Eating+disorder+and+epilepsy+in+mice+lacking+5-HT2C+serotonin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors</span></div><div class="casAuthors">Tecott, Laurence H.; Sun, Linda M.; Akana, Susan F.; Strack, Alison M.; Lowenstein, Daniel H.; Dallman, Mary F.; Julius, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">374</span>
        (<span class="NLM_cas:issue">6522</span>),
    <span class="NLM_cas:pages">542-6</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Serotonin (5-hydroxytryptamine, 5-HT) is a monoaminergic neurotransmitter that is believed to modulate numerous sensory, motor and behavioral processes in the mammalian nervous system.  These diverse responses are elicited through the activation of a large family of receptor subtypes.  The complexity of this signalling system and the paucity of selective drugs have made it difficult to define specific roles for 5-HT receptor subtypes, or to det. how serotonergic drugs modulate mood and behavior.  To address these issues, we have generated mutant mice lacking functional 5-HT2C receptors (previously termed 5-HT1C), prominent G-protein-coupled receptors that are widely expressed throughout the brain and spinal cord and which have been proposed to mediate numerous central nervous system (CNS) actions of serotonin.  Here we show that 5-HT2C receptor-deficient mice are overweight as a result of abnormal control of feeding behavior, establishing a role for this receptor in the serotonergic control of appetite.  Mutant animals are also prone to spontaneous death from seizures, suggesting that 5-HT2C receptors mediate tonic inhibition of neuronal network excitability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyfCSY65mvybVg90H21EOLACvtfcHk0ljhJ9qmFX7DAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkvVKqtr4%253D&md5=e87d8eac0789c2c012c34717d1fdbfe0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2F374542a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F374542a0%26sid%3Dliteratum%253Aachs%26aulast%3DTecott%26aufirst%3DL.%2BH.%26aulast%3DSun%26aufirst%3DL.%2BM.%26aulast%3DAkana%26aufirst%3DS.%2BF.%26aulast%3DStrack%26aufirst%3DA.%2BM.%26aulast%3DLowenstein%26aufirst%3DD.%2BH.%26aulast%3DDallman%26aufirst%3DM.%2BF.%26aulast%3DJulius%26aufirst%3DD.%26atitle%3DEating%2520disorder%2520and%2520epilepsy%2520in%2520mice%2520lacking%25205-HT2C%2520serotonin%2520receptors%26jtitle%3DNature%26date%3D1995%26volume%3D374%26spage%3D542%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Chou-Green, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holscher, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallman, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akana, S. F.</span><span> </span><span class="NLM_article-title">Compulsive behavior in the 5-HT<sub>2C</sub> receptor knockout mouse</span> <span class="citation_source-journal">Physiol. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">649</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1016%2FS0031-9384%2803%2900047-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=12782219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFGlsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2003&pages=641-649&author=J.+M.+Chou-Greenauthor=T.+D.+Holscherauthor=M.+F.+Dallmanauthor=S.+F.+Akana&title=Compulsive+behavior+in+the+5-HT2C+receptor+knockout+mouse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Compulsive behavior in the 5-HT2C receptor knockout mouse</span></div><div class="casAuthors">Chou-Green, Jennifer M.; Holscher, Todd D.; Dallman, Mary F.; Akana, Susan F.</div><div class="citationInfo"><span class="NLM_cas:title">Physiology & Behavior</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">641-649</span>CODEN:
                <span class="NLM_cas:coden">PHBHA4</span>;
        ISSN:<span class="NLM_cas:issn">0031-9384</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">We hypothesized that 5-HT2C receptor knockout (KO) mice may display compulsive-like behavior.  This paper describes characterization of several distinct, highly organized behaviors in mice lacking functional 5-HT2C receptors, which supports a compulsive-like syndrome.  Compulsive-like behavior was assessed in male 5-HTC receptor KO and wildtype (WT) mice.  Chewing of non-nutritive clay, chewing patterns on plastic-mesh screens, and the frequency of head dipping were measured.  5-HTC receptor KO mice chewed more clay, produced a distinct pattern of neat chewing of plastic screens and exhibited reduced habituation of head dipping activity compared to WT mice.  We conclude that the 5-HT2C receptor null mutant mouse provides a promising model of compulsive behavior and a means to further explore the role of 5-HT in obsession-compulsion disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnAGeAB6uFJLVg90H21EOLACvtfcHk0ljhJ9qmFX7DAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFGlsbo%253D&md5=a6daf407955decc087c2ead152669814</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0031-9384%2803%2900047-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0031-9384%252803%252900047-7%26sid%3Dliteratum%253Aachs%26aulast%3DChou-Green%26aufirst%3DJ.%2BM.%26aulast%3DHolscher%26aufirst%3DT.%2BD.%26aulast%3DDallman%26aufirst%3DM.%2BF.%26aulast%3DAkana%26aufirst%3DS.%2BF.%26atitle%3DCompulsive%2520behavior%2520in%2520the%25205-HT2C%2520receptor%2520knockout%2520mouse%26jtitle%3DPhysiol.%2520Behav.%26date%3D2003%26volume%3D78%26spage%3D641%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Delgado, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, F. A.</span><span> </span><span class="NLM_article-title">Hallucinogens, serotonin and obsessive-compulsive disorder</span> <span class="citation_source-journal">J. Psychoactive Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1080%2F02791072.1998.10399711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=9924841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A280%3ADyaK1M7it1ahuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1998&pages=359-366&author=P.+L.+Delgadoauthor=F.+A.+Moreno&title=Hallucinogens%2C+serotonin+and+obsessive-compulsive+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Hallucinogens, serotonin and obsessive-compulsive disorder</span></div><div class="casAuthors">Delgado P L; Moreno F A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychoactive drugs</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">359-66</span>
        ISSN:<span class="NLM_cas:issn">0279-1072</span>.
    </div><div class="casAbstract">The serotonin (5-HT) neurotransmitter system has been implicated in the pathophysiology of several neuropsychiatric disorders, especially obsessive-compulsive disorder (OCD).  Blockade of 5-HT reuptake appears to be an important initial neurobiological event in the therapeutic mechanism of action of antiobsessional drugs.  However, for reasons that continue to be poorly understood, clinical improvement following initiation of treatment with 5-HT reuptake inhibitors can take up to eight to 12 weeks, and most patients do not fully improve.  Recent data suggest that activation of 5-HT2A and/or 5-HT2C receptors may be important for the improvement of OCD symptoms.  Most psychedelic drugs are potent agonists at 5-HT2A and 5-HT2C receptors and their binding potency to these receptors is strongly correlated with their human potency as hallucinogens.  This article will briefly review the relevant clinical and preclinical studies relating to the effects of hallucinogens on OCD.  These data suggest that activation of 5-HT2 receptors by hallucinogens may lead to acute reduction of, as well as possible longer-lasting beneficial effects on, the symptoms of OCD.  Evidence for and against involvement of 5-HT2A and/or 5-HT2C receptors in the therapeutic effects of drug therapies for OCD are reviewed.  Issues related to the pharmacological properties and safety of psychedelic drugs, when considered as potential treatments for patients with OCD, are summarized.  The authors suggest that controlled trials of potent 5-HT2 agonists in people suffering from OCD are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTTnZEdidVmckQ0lWbKiCflfW6udTcc2ebjR8EYaPP1c7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7it1ahuw%253D%253D&md5=c078396bacf436bf8be058c3ee579131</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1080%2F02791072.1998.10399711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F02791072.1998.10399711%26sid%3Dliteratum%253Aachs%26aulast%3DDelgado%26aufirst%3DP.%2BL.%26aulast%3DMoreno%26aufirst%3DF.%2BA.%26atitle%3DHallucinogens%252C%2520serotonin%2520and%2520obsessive-compulsive%2520disorder%26jtitle%3DJ.%2520Psychoactive%2520Drugs%26date%3D1998%26volume%3D30%26spage%3D359%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Martin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleight, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berendsen, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broekkamp, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruigt, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delft, A. M.</span><span> </span><span class="NLM_article-title">5-HT<sub>2C</sub> receptor agonists: pharmacological characteristics and therapeutic potential</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=9694950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADyaK1cXlsVWhs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1998&pages=913-924&author=J.+R.+Martinauthor=M.+Bosauthor=F.+Jenckauthor=J.+Moreauauthor=V.+Mutelauthor=A.+J.+Sleightauthor=J.+Wichmannauthor=J.+S.+Andrewsauthor=H.+H.+Berendsenauthor=C.+L.+Broekkampauthor=G.+S.+Ruigtauthor=C.+Kohlerauthor=A.+M.+Delft&title=5-HT2C+receptor+agonists%3A+pharmacological+characteristics+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential</span></div><div class="casAuthors">Martin, J. R.; Bos, M.; Jenck, F.; Moreau, J.-L.; Mutel, V.; Sleight, A. J.; Wichmann, J.; Andrews, J. S.; Berendsen, H. H. G.; Broekkamp, C. L. E.; Ruigt, G. S. F.; Kohler, C.; Van Delft, A. M. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">913-924</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">In vitro, (S)-2-(chloro-5-fluoro-indol-1-yl)-1-methylethylamine 1:1 C4H4O4 and (S)-2-(4,4,7-trimethyl-1,4-dihydro-indeno[1,2-b]pyrrol-1-yl)-methylethylamine 1:1 C4H4O4 exhibited high-affinity binding to the serotonin2C (5HT2C) receptors and stimulated turnover of inositol 1,4,5-triphosphate.  Affinity to several of the other 5-HT receptor subtypes and to numerous nonserotonergic receptors was much lower.  In rats, both compds. elicited behavioral signs of 5-HT2C receptor agonism but not 5-HT2A receptor agonism.  Hypomotility induced in rats by high doses of these compds. was reversed by the 5-HT2C receptor antagonist N-(2-naphthyl)-N'-(3-pyridyl)-urea 1:1 HCl.  In addn., these compds. were active in tests used to demonstrate anticompulsive effects: reducing schedule-induced polydipsia in rats (prevented by the 5-HT2C/2B receptor antagonist N-(1-methyl-5'-indolyl)-(3-pyridyl)urea 1:1 HCl), reversing increased scratching induced with 8-hydroxy-dipropylaminotetralin 1:1 HCl in squirrel monkeys (no tolerance developed), decreasing responding in the marble-burying task in mice, and decreasing excessive eating of palatable food in rats.  In contrast to these compds., fluoxetine was much less potent, and in some tasks less efficacious, in reducing excessive behavior in these models.  These two 5-HT2C receptor agonists do not show anxiogenic effects in the plus-maze in rats.  (S)-2-(4,4,7-trimethyl-1,4-dihydro-indeno[1,2-b]pyrrol-1-yl)-1-methylethylamine 1:1 C4H4O4 reduced the olfactory bulbectomy-induced passive avoidance impairment in rats, a result that indicates antidepressant potential.  Similarly, in the differential-reinforcement-of-low rate 72-s operant schedule task in rats, (S)-2-(chloro-5-fluoro-indol-1-yl)-1-methylethylamine 1:1 C4H4O4 increased (and (S)-2-(4,4,7-trimethyl-1,4-dihydro-indeno[1,2-b]pyrrol-1-yl)-1-methylethylamine 1:1 C4H4O4 showed a tendency to increase) total reinforcements received, which is suggestive of antidepressant activity.  The electroencephalog. defined sleep-waking pattern in rats produced by these two 5-HT2C agonists, as well as fluoxetine, included increased quiet-waking and decreased rapid-eye-movement sleep, which is characteristic of antidepressant drugs.  These results suggest that 5-HT2C receptor agonism is assocd. with therapeutic potential in obsessive compulsive disorder and depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohW8KKOgYeubVg90H21EOLACvtfcHk0lgNOKkHG9Ly8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsVWhs7g%253D&md5=82d744eb5a21ff6a0db4f9f29071bac1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DJ.%2BR.%26aulast%3DBos%26aufirst%3DM.%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DMoreau%26aufirst%3DJ.%26aulast%3DMutel%26aufirst%3DV.%26aulast%3DSleight%26aufirst%3DA.%2BJ.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DAndrews%26aufirst%3DJ.%2BS.%26aulast%3DBerendsen%26aufirst%3DH.%2BH.%26aulast%3DBroekkamp%26aufirst%3DC.%2BL.%26aulast%3DRuigt%26aufirst%3DG.%2BS.%26aulast%3DKohler%26aufirst%3DC.%26aulast%3DDelft%26aufirst%3DA.%2BM.%26atitle%3D5-HT2C%2520receptor%2520agonists%253A%2520pharmacological%2520characteristics%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1998%26volume%3D286%26spage%3D913%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, D. A.</span><span> </span><span class="NLM_article-title">Insights into the structure and function of 5-HT<sub>2</sub> family serotonin receptors reveal novel strategies for therapeutic target development</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1517%2F14728222.5.6.685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=12540278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFWgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2001&pages=685-695&author=B.+L.+Rothauthor=D.+A.+Shapiro&title=Insights+into+the+structure+and+function+of+5-HT2+family+serotonin+receptors+reveal+novel+strategies+for+therapeutic+target+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the structure and function of 5-HT2 family serotonin receptors reveal novel strategies for therapeutic target development</span></div><div class="casAuthors">Roth, Bryan L.; Shapiro, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">685-695</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  5-HT2 family serotonin receptors, principal sites of action of serotonin in the brain, represent major mol. targets for drugs used in treating a variety of diseases including schizophrenia, depression, anxiety, eating disorders, obsessive-compulsive disorder, chronic pain conditions and obesity.  The 5-HT2 family of receptors has three members: 5-HT2A, 5-HT2B and 5-HT2C.  Therefore, it is likely that subtype-selective compds. will be needed to avoid serious side effects and to enhance therapeutic indexes.  Unfortunately, recent insights into the structure and function of 5-HT2A receptors have revealed that structurally-diverse agonists and antagonists have distinct modes of interacting with 5-HT2A receptors, complicating efforts at structure-based drug-design.  These distinct binding modes would not have been predicted based on conventional structure-activity relationships or static docking models.  Fortunately, these complicated binding modes can be predicted and simulated using mol. dynamics, allowing for the possibility of structure-based drug design.  Thus, provided appropriately sophisticated drug design strategies are employed, it is likely that uniquely valuable medications will result which could have great potential for treating a variety of mental and phys. illnesses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzVQ9Bi3a_u7Vg90H21EOLACvtfcHk0lgNOKkHG9Ly8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFWgsA%253D%253D&md5=dce9ef4a4033267a8d2f9a78ee625748</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F14728222.5.6.685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.5.6.685%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DShapiro%26aufirst%3DD.%2BA.%26atitle%3DInsights%2520into%2520the%2520structure%2520and%2520function%2520of%25205-HT2%2520family%2520serotonin%2520receptors%2520reveal%2520novel%2520strategies%2520for%2520therapeutic%2520target%2520development%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2001%26volume%3D5%26spage%3D685%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Miller, K. J.</span><span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>2C</sub> receptor agonists: potential for the treatment of obesity</span> <span class="citation_source-journal">Mol. Interv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">282</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=282-291&author=K.+J.+Miller&title=Serotonin+5-HT2C+receptor+agonists%3A+potential+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DK.%2BJ.%26atitle%3DSerotonin%25205-HT2C%2520receptor%2520agonists%253A%2520potential%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DMol.%2520Interv.%26date%3D2005%26volume%3D5%26spage%3D282%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroeze, W. K.</span><span> </span><span class="NLM_article-title">The multiplicity of serotonin receptors: Uselessly diverse molecules or an embarrassment of riches?</span> <span class="citation_source-journal">Neuroscientist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">252</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=252-262&author=B.+L.+Rothauthor=E.+Lopezauthor=S.+Patelauthor=W.+K.+Kroeze&title=The+multiplicity+of+serotonin+receptors%3A+Uselessly+diverse+molecules+or+an+embarrassment+of+riches%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DLopez%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26atitle%3DThe%2520multiplicity%2520of%2520serotonin%2520receptors%253A%2520Uselessly%2520diverse%2520molecules%2520or%2520an%2520embarrassment%2520of%2520riches%253F%26jtitle%3DNeuroscientist%26date%3D2000%26volume%3D6%26spage%3D252%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Isaac, M.</span><span> </span><span class="NLM_article-title">Serotonergic 5-HT<sub>2C</sub> receptors as a potential therapeutic target for the design antiepileptic drugs</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.2174%2F1568026053386980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=15638778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFOgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=59-67&author=M.+Isaac&title=Serotonergic+5-HT2C+receptors+as+a+potential+therapeutic+target+for+the+design+antiepileptic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonergic 5-HT2C receptors as a potential therapeutic target for the design antiepileptic drugs</span></div><div class="casAuthors">Isaac, Methvin</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-67</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A variety of clin. observations suggest that certain forms of epilepsy are due to long-term, progressive changes in neural networks that eventually provoke spontaneous and recurring seizures.  Recently, there has been growing evidence that serotonergic neurotransmission modulates exptl. induced seizures and is involved in the enhanced seizure susceptibility obsd. in some genetically epilepsy-prone animals.  Generally, agents that elevate extracellular serotonin (5-Hydroxytryptamine, 5-HT) levels, such as 5-hydroxytryptophan, and 5-HT reuptake blockers inhibit both limbic and generalized seizures.  Conversely, depletion of brain 5-HT lowers the threshold to audiogenically, chem. and elec.-evoked convulsions.  More specifically, the recent finding that the 5-HT2B/2C receptor agonist, 1-(m-chlorophenyl)-piperazine (mCPP) is anticonvulsant has kindled an interest into the investigation of the serotonergic 5-HT2C receptor subtype as a potential target for the treatment of epilepsy.  Further pharmacol. evaluation of selective activation or inactivation of the 5-HT2C receptor subtype with selective agonist/pos. modulators and antagonists will provide important information about the therapeutic contribution of this receptor to the epileptic circuitry in the brain.  Future development of serotonergic antiepileptic drugs will be a significant addn. to the therapeutic armamentarium against epilepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCeBhoy3zffLVg90H21EOLACvtfcHk0lgNOKkHG9Ly8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFOgtg%253D%253D&md5=7857cc5504f944828dd910855b598547</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F1568026053386980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026053386980%26sid%3Dliteratum%253Aachs%26aulast%3DIsaac%26aufirst%3DM.%26atitle%3DSerotonergic%25205-HT2C%2520receptors%2520as%2520a%2520potential%2520therapeutic%2520target%2520for%2520the%2520design%2520antiepileptic%2520drugs%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D59%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peglion, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavielle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin-Monneyron, S.</span><span> </span><span class="NLM_article-title">5-HT<sub>2C</sub> receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1016%2FS0014-2999%2897%2989962-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=9151932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADyaK2sXivFynurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=1997&pages=9-12&author=M.+J.+Millanauthor=J.+L.+Peglionauthor=G.+Lavielleauthor=S.+Perrin-Monneyron&title=5-HT2C+receptors+mediate+penile+erections+in+rats%3A+actions+of+novel+and+selective+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists</span></div><div class="casAuthors">Millan, Mark J.; Peglion, Jean-Louis; Lavielle, Gilbert; Perrin-Monneyron, Sabine</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-12</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The mixed 5-HT2A/5-HT2B/5-HT2C receptor agonist, m-(chlorophenyl)piperazine (mCPP), elicited penile erections in rats, an action mimicked by the selective 5-HT2C receptor agonist, RO 60-0175 ((S)-2-(6-chloro-5-fluoroindol-1-yl)-1-methylethylamine), whereas the preferential 5-HT2B receptor agonist, BW 723C86 (1-[5-(thienylmethoxy)-1H-3-indolyl] propan-2-amine) was ineffective.  The actions of mCPP and RO 60-0175 were dose-dependently abolished by the novel 5-HT2B/5-HT2C receptor antagonists, SB 200,646 ((1-(1-methylindol-5-yl)-3-pyridyl) urea) and SB 206,553 (5 methyl-1-(3-pyridil-carbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole).  In contrast, penile erections were not significantly affected by the selective 5-HT2B receptor antagonist, SB 204,741 (1-(1-methylindol-5-yl)-3-(3-methylisothiazol-5-yl)-urea) nor by the selective 5-HT2A receptor antagonist, MDL 100,907 ([R(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidine-methanol]).  These data provide rigorous pharmacol. evidence that activation of 5-HT2C receptor elicits penile erections in the rat.  This model should, thus, be of use for characterizing novel ligands at this site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouGTT-meFlpLVg90H21EOLACvtfcHk0livrVgJS_Se9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFynurY%253D&md5=24b45ce46f14e74c350dfd35223447c6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2897%2989962-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252897%252989962-1%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DPeglion%26aufirst%3DJ.%2BL.%26aulast%3DLavielle%26aufirst%3DG.%26aulast%3DPerrin-Monneyron%26aufirst%3DS.%26atitle%3D5-HT2C%2520receptors%2520mediate%2520penile%2520erections%2520in%2520rats%253A%2520actions%2520of%2520novel%2520and%2520selective%2520agonists%2520and%2520antagonists%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D325%26spage%3D9%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Cryan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucki, I.</span><span> </span><span class="NLM_article-title">Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine<sub>2C</sub> receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">1120</span><span class="NLM_x">–</span> <span class="NLM_lpage">1126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=11082448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVKisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2000&pages=1120-1126&author=J.+F.+Cryanauthor=I.+Lucki&title=Antidepressant-like+behavioral+effects+mediated+by+5-hydroxytryptamine2C+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine2C receptors</span></div><div class="casAuthors">Cryan, John F.; Lucki, Irwin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1120-1126</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The role of the 5-HT2C receptor in mediating active behaviors in the modified rat forced swim test was examd.  Three novel selective 5-HT2C receptor agonists, WAY 161503 (0.1-3.0 mg/kg), RO 60-0175 (2-20 mg/kg), and RO 60-0332 (20 mg/kg), all decreased immobility and increased swimming, a pattern of behavior similar to that which occurs with the selective serotonin reuptake inhibitor fluoxetine (5-20 mg/kg).  However, the prototypical but nonselective 5-HT2C receptor agonist m-chlorophenylpiperazine (1-10 mg/kg) increased immobility scores in the forced swim test.  The selective 5-HT2C receptor antagonist SB 206533 was inactive when given alone (1-20 mg/kg).  However, SB 206533 (20 mg/kg) blocked the antidepressant-like effects of both WAY 161503 (1 mg/kg) and fluoxetine (20 mg/kg).  The atypical antidepressant (noradrenergic α2 and 5-HT2C receptor antagonist) mianserin reduced immobility and increased climbing at 30 mg/kg.  At a behaviorally subactive dose (10 mg/kg), mianserin abolished the effects of WAY 161503 (1 mg/kg) on both swimming and immobility scores.  Mianserin blocked the effects of fluoxetine (20 mg/kg) on swimming only; mianserin plus fluoxetine reduced immobility and induced a switch to climbing behavior, suggesting activation of noradrenergic transmission.  These data exemplify the benefits of using the modified rat forced swim test, which was sensitive to serotonergic compds. and distinguished behavioral changes assocd. with serotonergic and noradrenergic effects.  Taken together, the results strongly implicate a role for 5-HT2C receptors in the behavioral effects of antidepressant drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgnstIvZMyE7Vg90H21EOLACvtfcHk0livrVgJS_Se9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVKisLs%253D&md5=ba187197751b56006b91fef9357a96af</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCryan%26aufirst%3DJ.%2BF.%26aulast%3DLucki%26aufirst%3DI.%26atitle%3DAntidepressant-like%2520behavioral%2520effects%2520mediated%2520by%25205-hydroxytryptamine2C%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D295%26spage%3D1120%26epage%3D1126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Giorgetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tecott, L. H.</span><span> </span><span class="NLM_article-title">Contributions of 5-HT<sub>2C</sub> receptors to multiple actions of central serotonin systems</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">1−9</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2004&pages=1%E2%88%929&author=M.+Giorgettiauthor=L.+H.+Tecott&title=Contributions+of+5-HT2C+receptors+to+multiple+actions+of+central+serotonin+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiorgetti%26aufirst%3DM.%26aulast%3DTecott%26aufirst%3DL.%2BH.%26atitle%3DContributions%2520of%25205-HT2C%2520receptors%2520to%2520multiple%2520actions%2520of%2520central%2520serotonin%2520systems%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D488%26spage%3D1%25E2%2588%25929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malberg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cryan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff Rizzo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span> </span><span class="NLM_article-title">Antidepressant-like effects of the novel, selective, 5-HT<sub>2C</sub> receptor agonist WAY-163909 in rodents</span> <span class="citation_source-journal">Psychopharmacology (Berlin)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">192</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1007%2Fs00213-007-0710-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=17297636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslWgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2007&pages=159-170&author=S.+Rosenzweig-Lipsonauthor=A.+Sabbauthor=G.+Stackauthor=P.+Mitchellauthor=I.+Luckiauthor=J.+E.+Malbergauthor=S.+Grauerauthor=J.+Brennanauthor=J.+F.+Cryanauthor=S.+J.+Sukoff+Rizzoauthor=J.+Dunlopauthor=J.+E.+Barrettauthor=K.+L.+Marquis&title=Antidepressant-like+effects+of+the+novel%2C+selective%2C+5-HT2C+receptor+agonist+WAY-163909+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents</span></div><div class="casAuthors">Rosenzweig-Lipson, Sharon; Sabb, Annmarie; Stack, Gary; Mitchell, Paul; Lucki, Irwin; Malberg, Jessica E.; Grauer, Steve; Brennan, Julie; Cryan, John F.; Sukoff Rizzo, Stacey J.; Dunlop, John; Barrett, James E.; Marquis, Karen L.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-170</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Rationale Activation of one or more of the serotonin (5-HT) receptors may play a role in mediating the antidepressant effects of SSRIs.  Objective The present studies were conducted to evaluate the effects of the novel 5-HT2C receptor agonist WAY-163909 in animal models of antidepressant activity (forced swim test (FST), resident-intruder, olfactory bulbectomy (BULB)), in a schedule-induced polydipsia (SIP) model of obsessive-compulsive disorder and in a model for evaluating sexual dysfunction.  Results WAY-163909 (10 mg/kg, i.p. or s.c.) decreased immobility time in Wistar-Kyoto rats in the FST, effects that were reversed by the 5-HT2C/2B receptor antagonist SB 206553.  Moreover, in Sprague-Dawley rats, the profile of WAY-163909 (decreased immobility, increased swimming) in the FST was comparable to the effects of SSRIs.  Acute treatment with WAY-163909 (0.33 mg/kg, s.c.) decreased rodent aggression at doses lower than those required for decreasing total behavior.  Administration of WAY-163909 (3 mg/kg, i.p.) for 5 or 21 days decreased the BULB-induced hyperactivity in rats.  Addnl., acute administration of WAY-163909 (3 mg/kg, i.p.) decreased adjunctive drinking in a SIP model.  The effects of WAY-163909 were reversed by the 5-HT2C/2B receptor antagonist SB 206553 and the selective 5-HT2C receptor antagonist SB 242084.  Chronic administration of WAY-163909 produced deficits in sexual function at doses higher (10 mg/kg, i.p.) than those required for antidepressant-like effects in the BULB model.  Conclusions Taken together, these results demonstrate that the novel 5-HT2C receptor agonist WAY-163909 produces rapid onset antidepressant-like effects in animal models and may be a novel treatment for depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWDasPaMjxzrVg90H21EOLACvtfcHk0livrVgJS_Se9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslWgtro%253D&md5=c659bfb0d2e22f169e22b8fd605d970a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs00213-007-0710-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-007-0710-6%26sid%3Dliteratum%253Aachs%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DSabb%26aufirst%3DA.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DMitchell%26aufirst%3DP.%26aulast%3DLucki%26aufirst%3DI.%26aulast%3DMalberg%26aufirst%3DJ.%2BE.%26aulast%3DGrauer%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DJ.%26aulast%3DCryan%26aufirst%3DJ.%2BF.%26aulast%3DSukoff%2BRizzo%26aufirst%3DS.%2BJ.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DBarrett%26aufirst%3DJ.%2BE.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26atitle%3DAntidepressant-like%2520effects%2520of%2520the%2520novel%252C%2520selective%252C%25205-HT2C%2520receptor%2520agonist%2520WAY-163909%2520in%2520rodents%26jtitle%3DPsychopharmacology%2520%2528Berlin%2529%26date%3D2007%26volume%3D192%26spage%3D159%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Marquis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabb, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logue, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piesla, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span> </span><span class="NLM_article-title">WAY-163909 [(7b<i>R</i>,10a<i>R</i>)-1,2,3,4,8,9,10,10a-octahydro-7b<i>H</i>-cyclopenta-[<i>b</i>][1,4]diazepino[6,7,1<i>hi</i>]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1124%2Fjpet.106.106989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=17038512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFCgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=486-496&author=K.+L.+Marquisauthor=A.+L.+Sabbauthor=S.+F.+Logueauthor=J.+A.+Brennanauthor=M.+J.+Pieslaauthor=T.+A.+Comeryauthor=S.+M.+Grauerauthor=C.+R.+Ashbyauthor=H.+Q.+Nguyenauthor=L.+A.+Dawsonauthor=J.+E.+Barrettauthor=G.+Stackauthor=H.+Y.+Meltzerauthor=B.+L.+Harrisonauthor=S.+Rosenzweig-Lipson&title=WAY-163909+%5B%287bR%2C10aR%29-1%2C2%2C3%2C4%2C8%2C9%2C10%2C10a-octahydro-7bH-cyclopenta-%5Bb%5D%5B1%2C4%5Ddiazepino%5B6%2C7%2C1hi%5Dindole%5D%3A+A+novel+5-hydroxytryptamine+2C+receptor-selective+agonist+with+preclinical+antipsychotic-like+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: a novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity</span></div><div class="casAuthors">Marquis, Karen L.; Sabb, Annmarie L.; Logue, Sheree F.; Brennan, Julie A.; Piesla, Michael J.; Comery, Tom A.; Grauer, Steven M.; Ashby, Charles R., Jr.; Nguyen, Huy Q.; Dawson, Lee A.; Barrett, James E.; Stack, Gary; Meltzer, Herbert Y.; Harrison, Boyd L.; Rosenzweig-Lipson, Sharon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">486-496</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Serotonin-2C (5-HT2C) receptor antagonists and agonists have been shown to affect dopamine (DA) neurotransmission, with agonists selectively decreasing mesolimbic DA.  As antipsychotic efficacy is proposed to be assocd. with decreased mesolimbic DA neurotransmission by virtue of DA D2 receptor antagonism, the 5-HT2C-selective receptor agonist, WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], was evaluated in animal models of schizophrenia and in vivo microdialysis and electrophysiol. to det. the effects on mesolimbic and nigrostriatal DA neurotransmission.  Similar to clozapine, WAY-163909 (1.7-30 mg/kg i.p.) decreased apomorphine-induced climbing with little effect on stereotypy and no significant induction of catalepsy.  WAY-163909 (0.3-3 mg/kg s.c.) more potently reduced phencyclidine-induced locomotor activity compared with d-amphetamine with no effect on spontaneous activity.  WAY-163909 (1.7-17 mg/kg i.p.) reversed MK-801 (5H-dibenzo[a,d]cyclohepten-5,10-imine (dizocilpine maleate)- and DOI [1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane]-disrupted prepulse inhibition of startle (PPI) and improved PPI in DBA/2N mice.  In conditioned avoidance responding, WAY-163909 (0.3-3 mg/kg i.p.; 1-17 mg/kg p.o.) reduced avoidance responding, an effect blocked by the 5-HT2B/2C receptor antagonist SB 206553 [5-methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole].  WAY-163909 (10 mg/kg s.c.) selectively decreased extracellular levels of DA in the nucleus accumbens without affecting the striatum.  Likewise, in vivo electrophysiol. recordings showed a decrease in the no. of spontaneously firing DA neurons in the ventral tegmental area but not in the substantia nigra with both acute and chronic (21-day) administration of WAY-163909 (1-10 mg/kg i.p.).  Thus, the profile of the 5-HT2C selective receptor agonist WAY-163909 is similar to that of an atypical antipsychotic and addnl. may have rapid onset properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoemOaXlISXJrVg90H21EOLACvtfcHk0lgI_t0XcAoCVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFCgtg%253D%253D&md5=f70bb5a91c306aa208b5a19cd2e21937</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.106989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.106989%26sid%3Dliteratum%253Aachs%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DSabb%26aufirst%3DA.%2BL.%26aulast%3DLogue%26aufirst%3DS.%2BF.%26aulast%3DBrennan%26aufirst%3DJ.%2BA.%26aulast%3DPiesla%26aufirst%3DM.%2BJ.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DGrauer%26aufirst%3DS.%2BM.%26aulast%3DAshby%26aufirst%3DC.%2BR.%26aulast%3DNguyen%26aufirst%3DH.%2BQ.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DBarrett%26aufirst%3DJ.%2BE.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DMeltzer%26aufirst%3DH.%2BY.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DWAY-163909%2520%255B%25287bR%252C10aR%2529-1%252C2%252C3%252C4%252C8%252C9%252C10%252C10a-octahydro-7bH-cyclopenta-%255Bb%255D%255B1%252C4%255Ddiazepino%255B6%252C7%252C1hi%255Dindole%255D%253A%2520A%2520novel%25205-hydroxytryptamine%25202C%2520receptor-selective%2520agonist%2520with%2520preclinical%2520antipsychotic-like%2520activity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D486%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Berger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">The Expanded Biology of Serotonin</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1146%2Fannurev.med.60.042307.110802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=19630576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlyntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=355-366&author=M.+Bergerauthor=J.+A.+Grayauthor=B.+L.+Roth&title=The+Expanded+Biology+of+Serotonin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The expanded biology of serotonin</span></div><div class="casAuthors">Berger, Miles; Gray, John A.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">355-366</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Serotonin is perhaps best known as a neurotransmitter that modulates neural activity and a wide range of neuropsychol. processes, and drugs that target serotonin receptors are used widely in psychiatry and neurol.  However, most serotonin is found outside the central nervous system, and virtually all of the 15 serotonin receptors are expressed outside as well as within the brain.  Serotonin regulates numerous biol. processes including cardiovascular function, bowel motility, ejaculatory latency, and bladder control.  Addnl., new work suggests that serotonin may regulate some processes, including platelet aggregation, by receptor-independent, transglutaminase-dependent covalent linkage to cellular proteins.  We review this new expanded serotonin biol. and discuss how drugs targeting specific serotonin receptors are beginning to help treat a wide range of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoz0HW5hdNOrVg90H21EOLACvtfcHk0lgI_t0XcAoCVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlyntb8%253D&md5=0557e01e6b79dbfb50559aca03f8b31f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1146%2Fannurev.med.60.042307.110802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.med.60.042307.110802%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DGray%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DThe%2520Expanded%2520Biology%2520of%2520Serotonin%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2009%26volume%3D60%26spage%3D355%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span> </span><span class="NLM_article-title">Selective agents for serotonin<sub>2C</sub> (5-HT<sub>2C</sub>) receptor</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1927</span><span class="NLM_x">–</span> <span class="NLM_lpage">1970</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.2174%2F156802606778522168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=17017967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFens7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1927-1970&author=E.+Lacivitaauthor=M.+Leopoldo&title=Selective+agents+for+serotonin2C+%285-HT2C%29+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Selective agents for serotonin2C (5-HT2C) receptor</span></div><div class="casAuthors">Lacivita, Enza; Leopoldo, Marcello</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1927-1970</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The serotonin2C (5-HT2C) receptor has attracted a lot of attention owing to its role in appetite regulation, depression, obsessive-compulsive disorder (OCD), panic disorders, and substance abuse.  This review summarizes non-patent and patent literature up to Nov. 2005 that deals with the synthesis and characterization of selective 5-HT2C receptor agonists and antagonists.  Highlights on structure-activity relationships were included, when possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXHlktCIyYFbVg90H21EOLACvtfcHk0ljhrGoZ2xVotA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFens7fN&md5=9d6414a68db4d393319800d4cc19e8f1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F156802606778522168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606778522168%26sid%3Dliteratum%253Aachs%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26atitle%3DSelective%2520agents%2520for%2520serotonin2C%2520%25285-HT2C%2529%2520receptor%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1927%26epage%3D1970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Nilsson, B. M.</span><span> </span><span class="NLM_article-title">5-Hydroxytryptamine 2C (5-HT<sub>2C</sub>) receptor agonists as potential antiobesity agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4023</span><span class="NLM_x">–</span> <span class="NLM_lpage">4034</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058240i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVSisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4023-4034&author=B.+M.+Nilsson&title=5-Hydroxytryptamine+2C+%285-HT2C%29+receptor+agonists+as+potential+antiobesity+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents</span></div><div class="casAuthors">Nilsson, Bjoern M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4023-4034</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review of 5-HT 2C receptor agonists as potential antiobesity agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr39FDBz-7CqrVg90H21EOLACvtfcHk0ljhrGoZ2xVotA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVSisrs%253D&md5=ec5788cfe273b9cf7ccbdfc39fc8a7b2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm058240i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058240i%26sid%3Dliteratum%253Aachs%26aulast%3DNilsson%26aufirst%3DB.%2BM.%26atitle%3D5-Hydroxytryptamine%25202C%2520%25285-HT2C%2529%2520receptor%2520agonists%2520as%2520potential%2520antiobesity%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4023%26epage%3D4034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Siuciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanowsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iredale, P. A.</span><span> </span><span class="NLM_article-title">CP-809,101, a selective 5-HT<sub>2C</sub> agonist, shows activity in animal models of antipsychotic activity</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1016%2Fj.neuropharm.2006.07.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=16949622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=279-290&author=J.+A.+Siuciakauthor=D.+S.+Chapinauthor=S.+A.+McCarthyauthor=V.+Guanowskyauthor=J.+Brownauthor=P.+Chiangauthor=R.+Maralaauthor=T.+Pattersonauthor=P.+A.+Seymourauthor=A.+Swickauthor=P.+A.+Iredale&title=CP-809%2C101%2C+a+selective+5-HT2C+agonist%2C+shows+activity+in+animal+models+of+antipsychotic+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity</span></div><div class="casAuthors">Siuciak, Judith A.; Chapin, Douglas S.; McCarthy, Sheryl A.; Guanowsky, Victor; Brown, Janice; Chiang, Phoebe; Marala, Ravi; Patterson, Terrell; Seymour, Patricia A.; Swick, Andrew; Iredale, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">279-290</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">CP-809,101 is a potent, functionally selective 5-HT2C agonist that displays approx. 100% efficacy in vitro.  The aim of the present studies was to assess the efficacy of a selective 5-HT2C agonist in animal models predictive of antipsychotic-like efficacy and side-effect liability.  Similar to currently available antipsychotic drugs, CP-809,101 dose-dependently inhibited conditioned avoidance responding (CAR, ED50 = 4.8 mg/kg, s.c.).  The efficacy of CP-809,101 in CAR was completely antagonized by the concurrent administration of the 5-HT2C receptor antagonist, SB-224,282.  CP-809,101 antagonized both PCP- and d-amphetamine-induced hyperactivity with ED50 values of 2.4 and 2.9 mg/kg (s.c.), resp. and also reversed an apomorphine induced-deficit in prepulse inhibition.  At doses up to 56 mg/kg, CP-809,101 did not produce catalepsy.  Thus, the present results demonstrate that the 5-HT2C agonist, CP-809,101, has a pharmacol. profile similar to that of the atypical antipsychotics with low extrapyramidal symptom liability.  CP-809,101 was inactive in two animal models of antidepressant-like activity, the forced swim test and learned helplessness.  However, CP-809,101 was active in novel object recognition, an animal model of cognitive function.  These data suggest that 5-HT2C agonists may be a novel approach in the treatment of psychosis as well as for the improvement of cognitive dysfunction assocd. with schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHuHmkKSf1jrVg90H21EOLACvtfcHk0ljhrGoZ2xVotA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCqtbk%253D&md5=5b422611bae3df8a9bcf71f84f1bbc37</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2006.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2006.07.024%26sid%3Dliteratum%253Aachs%26aulast%3DSiuciak%26aufirst%3DJ.%2BA.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DMcCarthy%26aufirst%3DS.%2BA.%26aulast%3DGuanowsky%26aufirst%3DV.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DP.%26aulast%3DMarala%26aufirst%3DR.%26aulast%3DPatterson%26aufirst%3DT.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DSwick%26aufirst%3DA.%26aulast%3DIredale%26aufirst%3DP.%2BA.%26atitle%3DCP-809%252C101%252C%2520a%2520selective%25205-HT2C%2520agonist%252C%2520shows%2520activity%2520in%2520animal%2520models%2520of%2520antipsychotic%2520activity%26jtitle%3DNeuropharmacology%26date%3D2007%26volume%3D52%26spage%3D279%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Welmaker, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabalski, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabb, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potoski, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coupet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazandarani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Synthesis and 5-hydroxytryptamine (5-HT) activity of 2,3,4,4a-tetrahydro-1<i>H</i>-pyrazino[1,2-<i>a</i>]quinoxalin-5-(6<i>H</i>)ones and 2,3,4,4a,5,6-hexahydro-1<i>H</i>-pyrazino[1,2-<i>a</i>]quinoxalines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1991</span><span class="NLM_x">–</span> <span class="NLM_lpage">1994</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1991-1994&author=G.+S.+Welmakerauthor=J.+A.+Nelsonauthor=J.+E.+Sabalskiauthor=A.+L.+Sabbauthor=J.+R.+Potoskiauthor=D.+Grazianoauthor=M.+Kaganauthor=J.+Coupetauthor=J.+Dunlopauthor=H.+Mazandaraniauthor=S.+Rosenzweig-Lipsonauthor=S.+Sukoffauthor=Y.+Zhang&title=Synthesis+and+5-hydroxytryptamine+%285-HT%29+activity+of+2%2C3%2C4%2C4a-tetrahydro-1H-pyrazino%5B1%2C2-a%5Dquinoxalin-5-%286H%29ones+and+2%2C3%2C4%2C4a%2C5%2C6-hexahydro-1H-pyrazino%5B1%2C2-a%5Dquinoxalines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWelmaker%26aufirst%3DG.%2BS.%26aulast%3DNelson%26aufirst%3DJ.%2BA.%26aulast%3DSabalski%26aufirst%3DJ.%2BE.%26aulast%3DSabb%26aufirst%3DA.%2BL.%26aulast%3DPotoski%26aufirst%3DJ.%2BR.%26aulast%3DGraziano%26aufirst%3DD.%26aulast%3DKagan%26aufirst%3DM.%26aulast%3DCoupet%26aufirst%3DJ.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DMazandarani%26aufirst%3DH.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DSukoff%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DSynthesis%2520and%25205-hydroxytryptamine%2520%25285-HT%2529%2520activity%2520of%25202%252C3%252C4%252C4a-tetrahydro-1H-pyrazino%255B1%252C2-a%255Dquinoxalin-5-%25286H%2529ones%2520and%25202%252C3%252C4%252C4a%252C5%252C6-hexahydro-1H-pyrazino%255B1%252C2-a%255Dquinoxalines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D1991%26epage%3D1994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Sabb, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welmaker, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabalski, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coupet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B.</span><span> </span><span class="NLM_article-title">Cycloalkyl[<i>b</i>][1,4]benzodiazepinoindoles are agonists at the human 5-HT<sub>2C</sub> receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2603</span><span class="NLM_x">–</span> <span class="NLM_lpage">2607</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2603-2607&author=A.+L.+Sabbauthor=R.+L.+Vogelauthor=G.+S.+Welmakerauthor=J.+E.+Sabalskiauthor=J.+Coupetauthor=J.+Dunlopauthor=S.+Rosenzweig-Lipsonauthor=B.+Harrison&title=Cycloalkyl%5Bb%5D%5B1%2C4%5Dbenzodiazepinoindoles+are+agonists+at+the+human+5-HT2C+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSabb%26aufirst%3DA.%2BL.%26aulast%3DVogel%26aufirst%3DR.%2BL.%26aulast%3DWelmaker%26aufirst%3DG.%2BS.%26aulast%3DSabalski%26aufirst%3DJ.%2BE.%26aulast%3DCoupet%26aufirst%3DJ.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DHarrison%26aufirst%3DB.%26atitle%3DCycloalkyl%255Bb%255D%255B1%252C4%255Dbenzodiazepinoindoles%2520are%2520agonists%2520at%2520the%2520human%25205-HT2C%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2603%26epage%3D2607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Smith, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieto, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallardo, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dosa, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covel, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beeley, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espitia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saldana, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjenning, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelan, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grottick, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzaghi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, W. J.</span><span> </span><span class="NLM_article-title">Discovery and structure−activity relationship of (1<i>R</i>)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1<i>H</i>-3-benzazepine (Lorcaserin), a selective serotonin 5-HT<sub>2C</sub> receptor agonist for the treatment of obesity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0709034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=305-313&author=B.+M.+Smithauthor=J.+M.+Smithauthor=J.+H.+Tsaiauthor=J.+A.+Schultzauthor=C.+A.+Gilsonauthor=S.+A.+Estradaauthor=R.+R.+Chenauthor=D.+M.+Parkauthor=E.+B.+Prietoauthor=C.+S.+Gallardoauthor=D.+Senguptaauthor=P.+I.+Dosaauthor=J.+A.+Covelauthor=A.+Renauthor=R.+R.+Webbauthor=N.+R.+Beeleyauthor=M.+Martinauthor=M.+Morganauthor=S.+Espitiaauthor=H.+R.+Saldanaauthor=C.+Bjenningauthor=K.+T.+Whelanauthor=A.+J.+Grottickauthor=F.+Menzaghiauthor=W.+J.+Thomsen&title=Discovery+and+structure%E2%88%92activity+relationship+of+%281R%29-8-chloro-2%2C3%2C4%2C5-tetrahydro-1-methyl-1H-3-benzazepine+%28Lorcaserin%29%2C+a+selective+serotonin+5-HT2C+receptor+agonist+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm0709034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0709034%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BM.%26aulast%3DSmith%26aufirst%3DJ.%2BM.%26aulast%3DTsai%26aufirst%3DJ.%2BH.%26aulast%3DSchultz%26aufirst%3DJ.%2BA.%26aulast%3DGilson%26aufirst%3DC.%2BA.%26aulast%3DEstrada%26aufirst%3DS.%2BA.%26aulast%3DChen%26aufirst%3DR.%2BR.%26aulast%3DPark%26aufirst%3DD.%2BM.%26aulast%3DPrieto%26aufirst%3DE.%2BB.%26aulast%3DGallardo%26aufirst%3DC.%2BS.%26aulast%3DSengupta%26aufirst%3DD.%26aulast%3DDosa%26aufirst%3DP.%2BI.%26aulast%3DCovel%26aufirst%3DJ.%2BA.%26aulast%3DRen%26aufirst%3DA.%26aulast%3DWebb%26aufirst%3DR.%2BR.%26aulast%3DBeeley%26aufirst%3DN.%2BR.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DEspitia%26aufirst%3DS.%26aulast%3DSaldana%26aufirst%3DH.%2BR.%26aulast%3DBjenning%26aufirst%3DC.%26aulast%3DWhelan%26aufirst%3DK.%2BT.%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26aulast%3DMenzaghi%26aufirst%3DF.%26aulast%3DThomsen%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520and%2520structure%25E2%2588%2592activity%2520relationship%2520of%2520%25281R%2529-8-chloro-2%252C3%252C4%252C5-tetrahydro-1-methyl-1H-3-benzazepine%2520%2528Lorcaserin%2529%252C%2520a%2520selective%2520serotonin%25205-HT2C%2520receptor%2520agonist%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D305%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Wacker, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varnes, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malmstrom, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuvich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohrbach, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janovitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehman-McKeeman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malley, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devenny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelleymounter, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span> </span><span class="NLM_article-title">Discovery of (<i>R</i>)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol- 6(2<i>H</i>)-one, a selective, orally active agonist of the 5-HT<sub>2C</sub> receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1365</span><span class="NLM_x">–</span> <span class="NLM_lpage">1379</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0612968" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1365-1379&author=D.+A.+Wackerauthor=J.+G.+Varnesauthor=S.+E.+Malmstromauthor=X.+Caoauthor=C.+P.+Hungauthor=T.+Ungauthor=G.+Wuauthor=G.+Zhangauthor=E.+Zuvichauthor=M.+A.+Thomasauthor=W.+J.+Keimauthor=M.+J.+Cullenauthor=K.+W.+Rohrbachauthor=Q.+Quauthor=R.+Narayananauthor=K.+Rossiauthor=E.+Janovitzauthor=L.+Lehman-McKeemanauthor=M.+F.+Malleyauthor=J.+Devennyauthor=M.+A.+Pelleymounterauthor=K.+J.+Millerauthor=J.+A.+Robl&title=Discovery+of+%28R%29-9-ethyl-1%2C3%2C4%2C10b-tetrahydro-7-trifluoromethylpyrazino%5B2%2C1-a%5Disoindol-+6%282H%29-one%2C+a+selective%2C+orally+active+agonist+of+the+5-HT2C+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm0612968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0612968%26sid%3Dliteratum%253Aachs%26aulast%3DWacker%26aufirst%3DD.%2BA.%26aulast%3DVarnes%26aufirst%3DJ.%2BG.%26aulast%3DMalmstrom%26aufirst%3DS.%2BE.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DHung%26aufirst%3DC.%2BP.%26aulast%3DUng%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DZuvich%26aufirst%3DE.%26aulast%3DThomas%26aufirst%3DM.%2BA.%26aulast%3DKeim%26aufirst%3DW.%2BJ.%26aulast%3DCullen%26aufirst%3DM.%2BJ.%26aulast%3DRohrbach%26aufirst%3DK.%2BW.%26aulast%3DQu%26aufirst%3DQ.%26aulast%3DNarayanan%26aufirst%3DR.%26aulast%3DRossi%26aufirst%3DK.%26aulast%3DJanovitz%26aufirst%3DE.%26aulast%3DLehman-McKeeman%26aufirst%3DL.%26aulast%3DMalley%26aufirst%3DM.%2BF.%26aulast%3DDevenny%26aufirst%3DJ.%26aulast%3DPelleymounter%26aufirst%3DM.%2BA.%26aulast%3DMiller%26aufirst%3DK.%2BJ.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520%2528R%2529-9-ethyl-1%252C3%252C4%252C10b-tetrahydro-7-trifluoromethylpyrazino%255B2%252C1-a%255Disoindol-%25206%25282H%2529-one%252C%2520a%2520selective%252C%2520orally%2520active%2520agonist%2520of%2520the%25205-HT2C%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1365%26epage%3D1379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Wacker, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. J.</span><span> </span><span class="NLM_article-title">Agonists of the serotonin 5-HT<sub>2C</sub> receptor: preclinical and clinical progression in multiple diseases</span> <span class="citation_source-journal">Curr. Opin. Drug. Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">438</span><span class="NLM_x">–</span> <span class="NLM_lpage">445</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=18600561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosFWmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=438-445&author=D.+A.+Wackerauthor=K.+J.+Miller&title=Agonists+of+the+serotonin+5-HT2C+receptor%3A+preclinical+and+clinical+progression+in+multiple+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Agonists of the serotonin 5-HT2C receptor: preclinical and clinical progression in multiple diseases</span></div><div class="casAuthors">Wacker, Dean A.; Miller, Keith J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">438-445</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  The serotonin 5-HT2C receptor is a G-protein-coupled receptor and is 1 of the 14 subtypes that constitute the serotonin receptor family.  Agonists of 5-HT2C have been implicated as potential treatments for diseases of significant unmet medical need, including obesity and schizophrenia.  Despite approx. 10 years of discovery efforts, 5-HT2C agonists have only recently advanced into the clinic, likely because many of the early drug discovery efforts experienced significant difficulties with attaining receptor selectivity.  Several of these issues related to receptor selectivity have now been overcome, resulting in the entry of compds. into advanced clin. trials.  This review summarizes the progress in 5-HT2C agonist discovery and clin. development over the last 3 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1eDgqANEVarVg90H21EOLACvtfcHk0lhS8xcnSrrXaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosFWmtbk%253D&md5=cd06a22cee150e5a0c658a4ce8876151</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWacker%26aufirst%3DD.%2BA.%26aulast%3DMiller%26aufirst%3DK.%2BJ.%26atitle%3DAgonists%2520of%2520the%2520serotonin%25205-HT2C%2520receptor%253A%2520preclinical%2520and%2520clinical%2520progression%2520in%2520multiple%2520diseases%26jtitle%3DCurr.%2520Opin.%2520Drug.%2520Discovery%2520Dev.%26date%3D2008%26volume%3D11%26spage%3D438%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thian, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">High-resolution crystal structure of an engineered human β<sub>2</sub>-adrenergic G protein-coupled receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1258</span><span class="NLM_x">–</span> <span class="NLM_lpage">1265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1126%2Fscience.1150577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=17962520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=1258-1265&author=V.+Cherezovauthor=D.+M.+Rosenbaumauthor=M.+A.+Hansonauthor=S.+G.+Rasmussenauthor=F.+S.+Thianauthor=T.+S.+Kobilkaauthor=H.+J.+Choiauthor=P.+Kuhnauthor=W.+I.+Weisauthor=B.+K.+Kobilkaauthor=R.+C.+Stevens&title=High-resolution+crystal+structure+of+an+engineered+human+%CE%B22-adrenergic+G+protein-coupled+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein-Coupled Receptor</span></div><div class="casAuthors">Cherezov, Vadim; Rosenbaum, Daniel M.; Hanson, Michael A.; Rasmussen, Soren G. F.; Thian, Foon Sun; Kobilka, Tong Sun; Choi, Hee-Jung; Kuhn, Peter; Weis, William I.; Kobilka, Brian K.; Stevens, Raymond C.; Takeda, S.; Kadowaki, S.; Haga, T.; Takaesu, H.; Mitaku, S.; Fredriksson, R.; Lagerstrom, M. C.; Lundin, L. G.; Schioth, H. B.; Pierce, K. L.; Premont, R. T.; Lefkowitz, R. J.; Lefkowitz, R. J.; Shenoy, S. K.; Rosenbaum, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">5854</span>),
    <span class="NLM_cas:pages">1258-1265</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Second extracellular loop, which in the β2-adrenergic receptor contains an unusual pair of disulfide bonds and an extra helix.  This loop and the absence Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors constitute the largest family of eukaryotic signal transduction proteins that communicate across the membrane.  We report the crystal structure of a human β2-adrenergic receptor-T4 lysozyme fusion protein bound to the partial inverse agonist carazolol at 2.4 angstrom resoln.  The structure provides a high-resoln. view of a human G protein-coupled receptor bound to a diffusible ligand.  Ligand-binding site accessibility is enabled by the second extracellular loop, which is held out of the binding cavity by a pair of closely spaced disulfide bridges and a short helical segment within the loop.  Cholesterol, a necessary component for crystn., mediates an intriguing parallel assocn. of receptor mols. in the crystal lattice.  Although the location of carazolol in the β2-adrenergic receptor is very similar to that of retinal in rhodopsin, structural differences in the ligand-binding site and other regions highlight the challenges in using rhodopsin as a template model for this large receptor family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC-8wZ2k2GHLVg90H21EOLACvtfcHk0lhS8xcnSrrXaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmur7I&md5=12c5bacb8464a4b243fe9341192b5b3b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1126%2Fscience.1150577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1150577%26sid%3Dliteratum%253Aachs%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DRasmussen%26aufirst%3DS.%2BG.%26aulast%3DThian%26aufirst%3DF.%2BS.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DChoi%26aufirst%3DH.%2BJ.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DHigh-resolution%2520crystal%2520structure%2520of%2520an%2520engineered%2520human%2520%25CE%25B22-adrenergic%2520G%2520protein-coupled%2520receptor%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D1258%26epage%3D1265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Rasmussen, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thian, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burghammer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnala, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanishvili, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischetti, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schertler, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span> </span><span class="NLM_article-title">Crystal structure of the human β<sub>2</sub> adrenergic G-protein-coupled receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1038%2Fnature06325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=17952055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlajs77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2007&pages=383-387&author=S.+G.+Rasmussenauthor=H.+J.+Choiauthor=D.+M.+Rosenbaumauthor=T.+S.+Kobilkaauthor=F.+S.+Thianauthor=P.+C.+Edwardsauthor=M.+Burghammerauthor=V.+R.+Ratnalaauthor=R.+Sanishviliauthor=R.+F.+Fischettiauthor=G.+F.+Schertlerauthor=W.+I.+Weisauthor=B.+K.+Kobilka&title=Crystal+structure+of+the+human+%CE%B22+adrenergic+G-protein-coupled+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the human β2 adrenergic G-protein-coupled receptor</span></div><div class="casAuthors">Rasmussen, Soren G. F.; Choi, Hee-Jung; Rosenbaum, Daniel M.; Kobilka, Tong Sun; Thian, Foon Sun; Edwards, Patricia C.; Burghammer, Manfred; Ratnala, Venkata R. P.; Sanishvili, Ruslan; Fischetti, Robert F.; Schertler, Gebhard F. X.; Weis, William I.; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">450</span>
        (<span class="NLM_cas:issue">7168</span>),
    <span class="NLM_cas:pages">383-387</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Structural anal. of G-protein-coupled receptors (GPCRs) for hormones and neurotransmitters has been hindered by their low natural abundance, inherent structural flexibility, and instability in detergent solns.  Here we report a structure of the human β2 adrenoceptor (β2AR), which was crystd. in a lipid environment when bound to an inverse agonist and in complex with a Fab that binds to the third intracellular loop.  Diffraction data were obtained by high-brilliance microcrystallog. and the structure detd. at 3.4 Å/3.7 Å resoln.  The cytoplasmic ends of the β2AR transmembrane segments and the connecting loops are well resolved, whereas the extracellular regions of the β2AR are not seen.  The β2AR structure differs from rhodopsin in having weaker interactions between the cytoplasmic ends of transmembrane (TM)3 and TM6, involving the conserved E/DRY sequences.  These differences may be responsible for the relatively high basal activity and structural instability of the β2AR, and contribute to the challenges in obtaining diffraction-quality crystals of non-rhodopsin GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTx0B_3Vn2M7Vg90H21EOLACvtfcHk0lhS8xcnSrrXaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlajs77N&md5=79026a0a69ddb4b0ea25063e409ad2cd</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnature06325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06325%26sid%3Dliteratum%253Aachs%26aulast%3DRasmussen%26aufirst%3DS.%2BG.%26aulast%3DChoi%26aufirst%3DH.%2BJ.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DThian%26aufirst%3DF.%2BS.%26aulast%3DEdwards%26aufirst%3DP.%2BC.%26aulast%3DBurghammer%26aufirst%3DM.%26aulast%3DRatnala%26aufirst%3DV.%2BR.%26aulast%3DSanishvili%26aufirst%3DR.%26aulast%3DFischetti%26aufirst%3DR.%2BF.%26aulast%3DSchertler%26aufirst%3DG.%2BF.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520%25CE%25B22%2520adrenergic%2520G-protein-coupled%2520receptor%26jtitle%3DNature%26date%3D2007%26volume%3D450%26spage%3D383%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Rosenbaum, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thian, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span> </span><span class="NLM_article-title">GPCR engineering yields high-resolution structural insights into β<sub>2</sub>-adrenergic receptor function</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1266</span><span class="NLM_x">–</span> <span class="NLM_lpage">1273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm801354e&amp;key=10.1126%2Fscience.1150609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm801354e&amp;key=17962519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=1266-1273&author=D.+M.+Rosenbaumauthor=V.+Cherezovauthor=M.+A.+Hansonauthor=S.+G.+Rasmussenauthor=F.+S.+Thianauthor=T.+S.+Kobilkaauthor=H.+J.+Choiauthor=X.+J.+Yaoauthor=W.+I.+Weisauthor=R.+C.+Stevensauthor=B.+K.+Kobilka&title=GPCR+engineering+yields+high-resolution+structural+insights+into+%CE%B22-adrenergic+receptor+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">GPCR Engineering Yields High-Resolution Structural Insights into β2-Adrenergic Receptor Function</span></div><div class="casAuthors">Rosenbaum, Daniel M.; Cherezov, Vadim; Hanson, Michael A.; Rasmussen, Soren G. F.; Thian, Foon Sun; Kobilka, Tong Sun; Choi, Hee-Jung; Yao, Xiao-Jie; Weis, William I.; Stevens, Raymond C.; Kobilka, Brian K.; Pierce, K. L.; Premont, R. T.; Lefkowitz, R. J.; Kobilka, B. K.; Deupi, X.; Cherezov, V.; Rasmussen, S. G. F.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">5854</span>),
    <span class="NLM_cas:pages">1266-1273</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The β2-adrenergic receptor (β2AR) is a well-studied prototype for heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) that respond to diffusible hormones and neurotransmitters.  To overcome the structural flexibility of the β2AR and to facilitate its crystn., we engineered a β2AR fusion protein in which T4 lysozyme (T4L) replaces most of the third intracellular loop of the GPCR ("β2AR-T4L") and showed that this protein retains near-native pharmacol. properties.  Anal. of adrenergic receptor ligand-binding mutants within the context of the reported high-resoln. structure of β2AR-T4L provides insights into inverse-agonist binding and the structural changes required to accommodate catecholamine agonists.  Amino acids known to regulate receptor function are linked through packing interactions and a network of hydrogen bonds, suggesting a conformational pathway from the ligand-binding pocket to regions that interact with G proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6gmrMhXnVl7Vg90H21EOLACvtfcHk0ljeajCV7JJypw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmur7J&md5=d422ff1e7a28719848c0e16fede045db</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1126%2Fscience.1150609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1150609%26sid%3Dliteratum%253Aachs%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DRasmussen%26aufirst%3DS.%2BG.%26aulast%3DThian%26aufirst%3DF.%2BS.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DChoi%26aufirst%3DH.%2BJ.%26aulast%3DYao%26aufirst%3DX.%2BJ.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DGPCR%2520engineering%2520yields%2520high-resolution%2520structural%2520insights%2520into%2520%25CE%25B22-adrenergic%2520receptor%2520function%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D1266%26epage%3D1273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Rohl, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chivian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span> </span><span class="NLM_article-title">Modeling structurally variable regions in homologous proteins with rosetta</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">656</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=656-677&author=C.+A.+Rohlauthor=C.+E.+Straussauthor=D.+Chivianauthor=D.+Baker&title=Modeling+structurally+variable+regions+in+homologous+proteins+with+rosetta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRohl%26aufirst%3DC.%2BA.%26aulast%3DStrauss%26aufirst%3DC.%2BE.%26aulast%3DChivian%26aufirst%3DD.%26aulast%3DBaker%26aufirst%3DD.%26atitle%3DModeling%2520structurally%2520variable%2520regions%2520in%2520homologous%2520proteins%2520with%2520rosetta%26jtitle%3DProteins%26date%3D2004%26volume%3D55%26spage%3D656%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ferrara, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gohlke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, C. L.,  III.</span><span> </span><span class="NLM_article-title">Assessing scoring functions for protein−ligand interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3032</span><span class="NLM_x">–</span> <span class="NLM_lpage">3047</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030489h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3032-3047&author=P.+Ferraraauthor=H.+Gohlkeauthor=D.+J.+Priceauthor=G.+Klebeauthor=C.+L.+Brooks&title=Assessing+scoring+functions+for+protein%E2%88%92ligand+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm030489h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030489h%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DP.%26aulast%3DGohlke%26aufirst%3DH.%26aulast%3DPrice%26aufirst%3DD.%2BJ.%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DBrooks%26aufirst%3DC.%2BL.%26atitle%3DAssessing%2520scoring%2520functions%2520for%2520protein%25E2%2588%2592ligand%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3032%26epage%3D3047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Burger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennet, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, L. B.</span><span> </span><span class="NLM_article-title">Arylcycloalkylamines</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1950</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1950&pages=306&author=A.+Burgerauthor=C.+R.+Walterauthor=W.+B.+Bennetauthor=L.+B.+Turnbull&title=Arylcycloalkylamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DA.%26aulast%3DWalter%26aufirst%3DC.%2BR.%26aulast%3DBennet%26aufirst%3DW.%2BB.%26aulast%3DTurnbull%26aufirst%3DL.%2BB.%26atitle%3DArylcycloalkylamines%26jtitle%3DScience%26date%3D1950%26volume%3D112%26spage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Burger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yost, W. L.</span><span> </span><span class="NLM_article-title">Arylcycloalkylamines. I. 2-Phenylcyclopropylamine</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1948</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">2198</span><span class="NLM_x">–</span> <span class="NLM_lpage">2201</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01186a062" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1948&pages=2198-2201&author=A.+Burgerauthor=W.+L.+Yost&title=Arylcycloalkylamines.+I.+2-Phenylcyclopropylamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fja01186a062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01186a062%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DA.%26aulast%3DYost%26aufirst%3DW.%2BL.%26atitle%3DArylcycloalkylamines.%2520I.%25202-Phenylcyclopropylamine%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1948%26volume%3D70%26spage%3D2198%26epage%3D2201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span>Prestwick Drug Library; <span class="NLM_publisher-name">Prestwick Chemical</span>: <span class="NLM_publisher-loc">Illkirch, France</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span><a href="http://www.prestwickchemical.fr/" class="extLink">http://www.prestwickchemical.fr/</a> (accessed <span class="NLM_access-date">March 3, 2009</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prestwick+Drug+Library%3B+Prestwick+Chemical%3A+Illkirch%2C+France%2C+2006%3B+http%3A%2F%2Fwww.prestwickchemical.fr%2F+%28accessed+March+3%2C+2009%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DPrestwick%2520Drug%2520Library%26pub%3DPrestwick%2520Chemical%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Teotino, U. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bella, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benelli, G.</span><span> </span><span class="NLM_article-title">Chemical and biological properties of some aminomethyl-2-phenylcyclopropane derivatives. Pharmacological comparison with tranylcypromine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1096</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00318a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1967&pages=1091-1096&author=U.+M.+Teotinoauthor=D.+D.+Bellaauthor=A.+Gandiniauthor=G.+Benelli&title=Chemical+and+biological+properties+of+some+aminomethyl-2-phenylcyclopropane+derivatives.+Pharmacological+comparison+with+tranylcypromine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm00318a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00318a024%26sid%3Dliteratum%253Aachs%26aulast%3DTeotino%26aufirst%3DU.%2BM.%26aulast%3DBella%26aufirst%3DD.%2BD.%26aulast%3DGandini%26aufirst%3DA.%26aulast%3DBenelli%26aufirst%3DG.%26atitle%3DChemical%2520and%2520biological%2520properties%2520of%2520some%2520aminomethyl-2-phenylcyclopropane%2520derivatives.%2520Pharmacological%2520comparison%2520with%2520tranylcypromine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1967%26volume%3D10%26spage%3D1091%26epage%3D1096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Zirkle, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedeschi, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedeschi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burger, A.</span><span> </span><span class="NLM_article-title">2-Substituted Cyclopropylamines. II. Effect of Structure Upon Monoamine Oxidase-Inhibitory Activity as Measured in Vivo by Potentiation of Tryptamine Convulsions</span> <span class="citation_source-journal">J. Med. Pharm. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1265</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm01241a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1962&pages=1265-1284&author=C.+L.+Zirkleauthor=C.+Kaiserauthor=D.+H.+Tedeschiauthor=R.+E.+Tedeschiauthor=A.+Burger&title=2-Substituted+Cyclopropylamines.+II.+Effect+of+Structure+Upon+Monoamine+Oxidase-Inhibitory+Activity+as+Measured+in+Vivo+by+Potentiation+of+Tryptamine+Convulsions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm01241a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm01241a018%26sid%3Dliteratum%253Aachs%26aulast%3DZirkle%26aufirst%3DC.%2BL.%26aulast%3DKaiser%26aufirst%3DC.%26aulast%3DTedeschi%26aufirst%3DD.%2BH.%26aulast%3DTedeschi%26aufirst%3DR.%2BE.%26aulast%3DBurger%26aufirst%3DA.%26atitle%3D2-Substituted%2520Cyclopropylamines.%2520II.%2520Effect%2520of%2520Structure%2520Upon%2520Monoamine%2520Oxidase-Inhibitory%2520Activity%2520as%2520Measured%2520in%2520Vivo%2520by%2520Potentiation%2520of%2520Tryptamine%2520Convulsions%26jtitle%3DJ.%2520Med.%2520Pharm.%2520Chem.%26date%3D1962%26volume%3D5%26spage%3D1265%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haufe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirk, K. L.</span><span> </span><span class="NLM_article-title">Fluorinated phenylcyclopropylamines. 1. Synthesis and effect of fluorine substitution at the cyclopropane ring on inhibition of microbial tyramine oxidase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1796</span><span class="NLM_x">–</span> <span class="NLM_lpage">1806</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030398k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1796-1806&author=S.+Yoshidaauthor=O.+G.+Meyerauthor=T.+C.+Rosenauthor=G.+Haufeauthor=S.+Yeauthor=M.+J.+Sloanauthor=K.+L.+Kirk&title=Fluorinated+phenylcyclopropylamines.+1.+Synthesis+and+effect+of+fluorine+substitution+at+the+cyclopropane+ring+on+inhibition+of+microbial+tyramine+oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm030398k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030398k%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DMeyer%26aufirst%3DO.%2BG.%26aulast%3DRosen%26aufirst%3DT.%2BC.%26aulast%3DHaufe%26aufirst%3DG.%26aulast%3DYe%26aufirst%3DS.%26aulast%3DSloan%26aufirst%3DM.%2BJ.%26aulast%3DKirk%26aufirst%3DK.%2BL.%26atitle%3DFluorinated%2520phenylcyclopropylamines.%25201.%2520Synthesis%2520and%2520effect%2520of%2520fluorine%2520substitution%2520at%2520the%2520cyclopropane%2520ring%2520on%2520inhibition%2520of%2520microbial%2520tyramine%2520oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1796%26epage%3D1806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Krishnamurthy, S.</span><span> </span><span class="NLM_article-title">A highly efficient and general <i>N</i>-monomethylation of functionalized primary amines via formylation—borane:methyl sulfide reduction</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3315</span><span class="NLM_x">–</span> <span class="NLM_lpage">3318</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1982&pages=3315-3318&author=S.+Krishnamurthy&title=A+highly+efficient+and+general+N-monomethylation+of+functionalized+primary+amines+via+formylation%E2%80%94borane%3Amethyl+sulfide+reduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnamurthy%26aufirst%3DS.%26atitle%3DA%2520highly%2520efficient%2520and%2520general%2520N-monomethylation%2520of%2520functionalized%2520primary%2520amines%2520via%2520formylation%25E2%2580%2594borane%253Amethyl%2520sulfide%2520reduction%26jtitle%3DTetrahedron%2520Lett.%26date%3D1982%26volume%3D23%26spage%3D3315%26epage%3D3318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Balboni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jinsmaa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarus, L. H.</span><span> </span><span class="NLM_article-title">Synthesis and opioid activity of <i>N</i>,<i>N</i>-dimethyl-Dmt-Tic-NH-CH(R)-R′ analogues: acquisition of potent δ antagonism</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">5435</span><span class="NLM_x">–</span> <span class="NLM_lpage">5441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=5435-5441&author=G.+Balboniauthor=S.+Salvadoriauthor=R.+Guerriniauthor=L.+Negriauthor=E.+Gianniniauthor=S.+D.+Bryantauthor=Y.+Jinsmaaauthor=L.+H.+Lazarus&title=Synthesis+and+opioid+activity+of+N%2CN-dimethyl-Dmt-Tic-NH-CH%28R%29-R%E2%80%B2+analogues%3A+acquisition+of+potent+%CE%B4+antagonism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBalboni%26aufirst%3DG.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DNegri%26aufirst%3DL.%26aulast%3DGiannini%26aufirst%3DE.%26aulast%3DBryant%26aufirst%3DS.%2BD.%26aulast%3DJinsmaa%26aufirst%3DY.%26aulast%3DLazarus%26aufirst%3DL.%2BH.%26atitle%3DSynthesis%2520and%2520opioid%2520activity%2520of%2520N%252CN-dimethyl-Dmt-Tic-NH-CH%2528R%2529-R%25E2%2580%25B2%2520analogues%253A%2520acquisition%2520of%2520potent%2520%25CE%25B4%2520antagonism%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D5435%26epage%3D5441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Arvidsson, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacksell, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjorth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, B.</span><span> </span><span class="NLM_article-title"><i>N</i>,<i>N</i>-Dialkylated monophenolic <i>trans</i>-2-phenylcyclopropylamines: novel central 5-hydroxytryptamine receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00396a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=92-99&author=L.+E.+Arvidssonauthor=A.+M.+Johanssonauthor=U.+Hacksellauthor=J.+L.+Nilssonauthor=K.+Svenssonauthor=S.+Hjorthauthor=T.+Magnussonauthor=A.+Carlssonauthor=P.+Lindbergauthor=B.+Andersson&title=N%2CN-Dialkylated+monophenolic+trans-2-phenylcyclopropylamines%3A+novel+central+5-hydroxytryptamine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm00396a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00396a014%26sid%3Dliteratum%253Aachs%26aulast%3DArvidsson%26aufirst%3DL.%2BE.%26aulast%3DJohansson%26aufirst%3DA.%2BM.%26aulast%3DHacksell%26aufirst%3DU.%26aulast%3DNilsson%26aufirst%3DJ.%2BL.%26aulast%3DSvensson%26aufirst%3DK.%26aulast%3DHjorth%26aufirst%3DS.%26aulast%3DMagnusson%26aufirst%3DT.%26aulast%3DCarlsson%26aufirst%3DA.%26aulast%3DLindberg%26aufirst%3DP.%26aulast%3DAndersson%26aufirst%3DB.%26atitle%3DN%252CN-Dialkylated%2520monophenolic%2520trans-2-phenylcyclopropylamines%253A%2520novel%2520central%25205-hydroxytryptamine%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D92%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Kawamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyaji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span> </span><span class="NLM_article-title">Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3<i>R</i>,4<i>R</i>)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2<i>H</i>-benzimidazol-2-one (J-113397)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5061</span><span class="NLM_x">–</span> <span class="NLM_lpage">5063</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990517p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5061-5063&author=H.+Kawamotoauthor=S.+Ozakiauthor=Y.+Itohauthor=M.+Miyajiauthor=S.+Araiauthor=H.+Nakashimaauthor=T.+Katoauthor=H.+Ohtaauthor=Y.+Iwasawa&title=Discovery+of+the+first+potent+and+selective+small+molecule+opioid+receptor-like+%28ORL1%29+antagonist%3A+1-%5B%283R%2C4R%29-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl%5D-3-ethyl-1%2C3-dihydro-2H-benzimidazol-2-one+%28J-113397%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm990517p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990517p%26sid%3Dliteratum%253Aachs%26aulast%3DKawamoto%26aufirst%3DH.%26aulast%3DOzaki%26aufirst%3DS.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DMiyaji%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DS.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DH.%26aulast%3DIwasawa%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520the%2520first%2520potent%2520and%2520selective%2520small%2520molecule%2520opioid%2520receptor-like%2520%2528ORL1%2529%2520antagonist%253A%25201-%255B%25283R%252C4R%2529-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl%255D-3-ethyl-1%252C3-dihydro-2H-benzimidazol-2-one%2520%2528J-113397%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5061%26epage%3D5063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Chandrasekhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, M.</span><span> </span><span class="NLM_article-title">A single step reductive amination of carbonyl compounds with polymethylhydrosiloxane-Ti((OPr)-Pr-i)(4)</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">1657</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=1655-1657&author=S.+Chandrasekharauthor=C.+R.+Reddyauthor=M.+Ahmed&title=A+single+step+reductive+amination+of+carbonyl+compounds+with+polymethylhydrosiloxane-Ti%28%28OPr%29-Pr-i%29%284%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChandrasekhar%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DC.%2BR.%26aulast%3DAhmed%26aufirst%3DM.%26atitle%3DA%2520single%2520step%2520reductive%2520amination%2520of%2520carbonyl%2520compounds%2520with%2520polymethylhydrosiloxane-Ti%2528%2528OPr%2529-Pr-i%2529%25284%2529%26jtitle%3DSynlett%26date%3D2000%26spage%3D1655%26epage%3D1657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Miyaura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2457</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00039a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm801354e&amp;key=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2457-2483&author=N.+Miyauraauthor=A.+Suzuki&title=Palladium-Catalyzed+Cross-Coupling+Reactions+of+Organoboron+Compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span></div><div class="casAuthors">Miyaura, Norio; Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2457-83</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with >250 refs. including title reactions and their mechanisms, prepn. of organoboron reagents, alkoxycarbonylation and dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwupBJT1UCbVg90H21EOLACvtfcHk0lg1LSBgI0GdkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D&md5=d127b414a75161652876eebc3ed0c486</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fcr00039a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00039a007%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DPalladium-Catalyzed%2520Cross-Coupling%2520Reactions%2520of%2520Organoboron%2520Compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26spage%3D2457%26epage%3D2483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">DeVasher, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaughnessy, K. H.</span><span> </span><span class="NLM_article-title">Aqueous-phase, palladium-catalyzed cross-coupling of aryl bromides under mild conditions, using water-soluble, sterically demanding alkylphosphines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">7919</span><span class="NLM_x">–</span> <span class="NLM_lpage">7927</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo048910c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=7919-7927&author=R.+B.+DeVasherauthor=L.+R.+Mooreauthor=K.+H.+Shaughnessy&title=Aqueous-phase%2C+palladium-catalyzed+cross-coupling+of+aryl+bromides+under+mild+conditions%2C+using+water-soluble%2C+sterically+demanding+alkylphosphines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjo048910c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo048910c%26sid%3Dliteratum%253Aachs%26aulast%3DDeVasher%26aufirst%3DR.%2BB.%26aulast%3DMoore%26aufirst%3DL.%2BR.%26aulast%3DShaughnessy%26aufirst%3DK.%2BH.%26atitle%3DAqueous-phase%252C%2520palladium-catalyzed%2520cross-coupling%2520of%2520aryl%2520bromides%2520under%2520mild%2520conditions%252C%2520using%2520water-soluble%252C%2520sterically%2520demanding%2520alkylphosphines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D7919%26epage%3D7927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Overberger, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimokawa, Y.</span><span> </span><span class="NLM_article-title">Synthesis and Optical Properties of Asymmetric Polyamides Derived from Optically Active Cyclic Dicarboxylic Acids</span> <span class="citation_source-journal">Macromolecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">718</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span></span><div class="citationLinks">[<a href="/doi/10.1021/ma60024a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1971&pages=718-725&author=C.+G.+Overbergerauthor=Y.+Shimokawa&title=Synthesis+and+Optical+Properties+of+Asymmetric+Polyamides+Derived+from+Optically+Active+Cyclic+Dicarboxylic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fma60024a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fma60024a010%26sid%3Dliteratum%253Aachs%26aulast%3DOverberger%26aufirst%3DC.%2BG.%26aulast%3DShimokawa%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520Optical%2520Properties%2520of%2520Asymmetric%2520Polyamides%2520Derived%2520from%2520Optically%2520Active%2520Cyclic%2520Dicarboxylic%2520Acids%26jtitle%3DMacromolecules%26date%3D1971%26volume%3D4%26spage%3D718%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgetts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasley, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craven, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodbeck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieltyka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacolod, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurkauf, A.</span><span> </span><span class="NLM_article-title"><i>trans</i>-1-[(2-Phenylcyclopropyl)methyl]-4-arylpiperazines: mixed dopamine D<sub>2</sub>/D<sub>4</sub> receptor antagonists as potential antipsychotic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3923</span><span class="NLM_x">–</span> <span class="NLM_lpage">3932</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990562x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3923-3932&author=X.+Zhangauthor=K.+Hodgettsauthor=S.+Rachwalauthor=H.+Zhaoauthor=J.+W.+Wasleyauthor=K.+Cravenauthor=R.+Brodbeckauthor=A.+Kieltykaauthor=D.+Hoffmanauthor=M.+D.+Bacolodauthor=B.+Girardauthor=J.+Tranauthor=A.+Thurkauf&title=trans-1-%5B%282-Phenylcyclopropyl%29methyl%5D-4-arylpiperazines%3A+mixed+dopamine+D2%2FD4+receptor+antagonists+as+potential+antipsychotic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm990562x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990562x%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHodgetts%26aufirst%3DK.%26aulast%3DRachwal%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DWasley%26aufirst%3DJ.%2BW.%26aulast%3DCraven%26aufirst%3DK.%26aulast%3DBrodbeck%26aufirst%3DR.%26aulast%3DKieltyka%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DD.%26aulast%3DBacolod%26aufirst%3DM.%2BD.%26aulast%3DGirard%26aufirst%3DB.%26aulast%3DTran%26aufirst%3DJ.%26aulast%3DThurkauf%26aufirst%3DA.%26atitle%3Dtrans-1-%255B%25282-Phenylcyclopropyl%2529methyl%255D-4-arylpiperazines%253A%2520mixed%2520dopamine%2520D2%252FD4%2520receptor%2520antagonists%2520as%2520potential%2520antipsychotic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3923%26epage%3D3932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Jensen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguiz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetsel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title"><i>N</i>-Desalkylquetiapine, a Potent Norepinephrine Reuptake Inhibitor and Partial 5-HT<sub>1A</sub> Agonist, as a Putative Mediator of Quetiapine’s Antidepressant Activity</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2303</span><span class="NLM_x">–</span> <span class="NLM_lpage">2312</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2007&pages=2303-2312&author=N.+H.+Jensenauthor=R.+M.+Rodriguizauthor=M.+G.+Caronauthor=W.+C.+Wetselauthor=R.+B.+Rothmanauthor=B.+L.+Roth&title=N-Desalkylquetiapine%2C+a+Potent+Norepinephrine+Reuptake+Inhibitor+and+Partial+5-HT1A+Agonist%2C+as+a+Putative+Mediator+of+Quetiapine%E2%80%99s+Antidepressant+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DN-Desalkylquetiapine%252C%2520a%2520Potent%2520Norepinephrine%2520Reuptake%2520Inhibitor%2520and%2520Partial%25205-HT1A%2520Agonist%252C%2520as%2520a%2520Putative%2520Mediator%2520of%2520Quetiapine%25E2%2580%2599s%2520Antidepressant%2520Activity%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D33%26spage%3D2303%26epage%3D2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Egan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinde, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrick-Davis, K.</span><span> </span><span class="NLM_article-title">Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT<sub>2A</sub> and 5-HT<sub>2C</sub> receptors</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2000&pages=144-150&author=C.+Eganauthor=E.+Grindeauthor=A.+Dupreauthor=B.+L.+Rothauthor=M.+Hakeauthor=M.+Teitlerauthor=K.+Herrick-Davis&title=Agonist+high+and+low+affinity+state+ratios+predict+drug+intrinsic+activity+and+a+revised+ternary+complex+mechanism+at+serotonin+5-HT2A+and+5-HT2C+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEgan%26aufirst%3DC.%26aulast%3DGrinde%26aufirst%3DE.%26aulast%3DDupre%26aufirst%3DA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHake%26aufirst%3DM.%26aulast%3DTeitler%26aufirst%3DM.%26aulast%3DHerrick-Davis%26aufirst%3DK.%26atitle%3DAgonist%2520high%2520and%2520low%2520affinity%2520state%2520ratios%2520predict%2520drug%2520intrinsic%2520activity%2520and%2520a%2520revised%2520ternary%2520complex%2520mechanism%2520at%2520serotonin%25205-HT2A%2520and%25205-HT2C%2520receptors%26jtitle%3DSynapse%26date%3D2000%26volume%3D35%26spage%3D144%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheesman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span> </span><span class="NLM_article-title">Pharmacological profile of the 5-HT<sub>2C</sub> receptor agonist WAY-163909; therapeutic potential in multiple indications</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=167-177&author=J.+Dunlopauthor=K.+L.+Marquisauthor=H.+K.+Limauthor=L.+Leungauthor=J.+Kaoauthor=C.+Cheesmanauthor=S.+Rosenzweig-Lipson&title=Pharmacological+profile+of+the+5-HT2C+receptor+agonist+WAY-163909%3B+therapeutic+potential+in+multiple+indications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DLim%26aufirst%3DH.%2BK.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DKao%26aufirst%3DJ.%26aulast%3DCheesman%26aufirst%3DC.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DPharmacological%2520profile%2520of%2520the%25205-HT2C%2520receptor%2520agonist%2520WAY-163909%253B%2520therapeutic%2520potential%2520in%2520multiple%2520indications%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2006%26volume%3D12%26spage%3D167%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i115"><a href="/doi/suppl/10.1021/jm801354e">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_42477"></div></div></div></div></div><hr /></hr><p class="last">Functional activity of compounds <b>66</b>−<b>74</b>, <b>78</b>, <b>80</b>−<b>84</b>, and <b>86</b>−<b>90</b>. Copy of original spectroscopic data and purity assessment of key compounds <b>29</b> and <b>37</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm801354e/suppl_file/jm801354e_si_001.pdf">jm801354e_si_001.pdf (810.34 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm801354e&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm801354e%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-7" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm801354e" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                540KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991f503fb33da6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
